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Abstract 
ABSTRACT 
This thesis examines the chemistry and biochemistry of hydroxyrnethylpyrroles of 
the type 1.9 eX = OR). Pyrrolic compounds play an important role in many areas of 
chemistry and biology. A large number of biomolecules which are essential for life are 
derived from simple pyrrole precursors, eg porphyrins and haemoglobin. In addition, 
pyrroles have been utilised as building blocks and key intermediates in synthesis. 
Chapter One gives a general introduction to the biological, chemical and medical 
applications of pYlToles, such as in the biosynthesis of uroporphyrinogen ITr 1.20, their 
use as intelTIlediates in organic synthesis, and in the development of latent mechanism-
based inhibitors of serine proteases. 
Chapter Two desclibes a sequence, based on a Mitsunobu displacement at the 
hydroxymethyl position of the chiral deuterium-labelled N-substituted 
hydroxymethylpyrroles 2.26a-d and 2.27a-d, as a means by which to determine the 
deactivating abilities of various N-substituents on the pyrrole ring. In this reaction, an 
SN2 mechanism was found to be favoured over reaction via an azafulvenium intermediate 
2.20 by employing N-trifluoromethanesulfonyl as the deactivating group. Suppression of 
this azafulvenium reaction pathway was found to be less effective with other deactivating 
groups, and the order for deactivation was determined to be triflyl > mesyl > BOC z 
acetyl. 
Chapter Three describes the development of a ShOli, convenient and versatile 
synthetic route to dipyrromethanes which involves coupling of an N-magnesio pyrrole 
salt (derived from either an oxygen acetal or a thioacetal of pyrrole-2-carboxaldehyde) 
with a ring-deactivated chloromethylpyrrole. This methodology was extended to the 
preparation of dipyrromethanes containing a deuterium-label at the interpyrrolic 
methylene position. An X-ray crystal structure of the N-tosyl chloromethylpyrrole 3.29 
Abstract 
showed that the aromaticity of the pyrrole ring was significantly reduced by the 
introduction of the electron withdrawing group onto the pyrrole nitrogen. 
Chapter Four describes a IH NMR investigation into the mechanism of hydrolysis 
of N-acylhydroxymethylpyrroles. In this study, the chiral deuterium-labelled N-(N-
phthalyl-L-Ieucinyl)hydroxymethylpyrroles 4.8b and 4.8c in CD3CN were treated with 
potassium hydroxide in the presence of an equivalent of S-(+)-sec-butylamine. IH NMR 
spectral analysis showed that the hydrolysis proceeds by an initial intramolecular N- to 
O-acyl transfer with retention of configuration at the labelled centre. Evidence for the 
subsequent release of an azafulvene 4.3 was gained from the observed scrambling of the 
deuterium-label at the exo-methylene position of 4.11 and 4.12 on trapping with an 
external nucleophile, either S-( + )-sec-butylamine or 4.11, respectively. 
Chapter Five describes the application of N-substituted hydroxymethylpyrroles as 
mechanism-based inhibitors of serine proteases. As a result, a number of alternate 
methodologies to incorporate the hydroxymethylpyrrole-moiety into an extended peptide-
I ike sequence were attempted. From these synthetic approaches the pyrrole-based 
peptidomimetics 5.8a, 5.8b, 5.9a, 5.9b and 5.10b were prepared and subsequently 
assayed for a-chymotrypsin inhibition activity. These compounds were found to be 
modest inhibitors of a-chymotrypsin, with none proving to be better inhibitors than 
previously discussed examples. 
Chapter Six details the isolation and properties of some unexpected pyrrole-based 
molecules that were obtained from the attempted N-acylation of the 5-formylpyrrole-2-
carboxamides 5.47a-c. Attempts to N-acylate 5.47a-c with hydrocinnamoyl chloride 
using the DMAP methodology gave the pyrrolizin-3-ones 6.1a-c. These compounds 
were identified on the basis of one and two dimensional NMR spectral techniques. 
Conformation of the strncture of the pyrrolizin-3-one 6.1a was obtained by a single 
crystal X-ray analysis. Attempts to N-acylate 5.47a-c with an acid chloride using the 
sodium hydride methodology gave the azafulvene dimers 6.6a-c. Single crystal X-ray 
analysis of 6.6b and 6.6c revealed that each of these dimers were only a single 
Abstract 
diastereomer, and were further dimerised by non-covalent interactions. Spectroscopic 
evidence is discussed which indicates that the non-covalent dimeric structure was also 
present in solution. We suggest that the diastereoselective synthesis of 6.6b and 6.6c was 
controlled by this ability to form the non-covalent dimers, and so represents an example 
of molecular self-assembly. 
Chapter Seven describes a general synthesis of 5-acylpyrrole-2-carboxaldehydes 
which utilises a Stille coupling reaction between a stannylpyrrole and a (fatty) acid 
chloride. This methodology was used to prepare a series of 5-acyl-2-
hydroxymethylpyrroles, including the previously reported natural product mycalazol 11 
7.11. These compounds, together with a 5-carboxamido-2-hydroxymethylpyrrole, were 
assayed for in vitro cytotoxicity against the P388 cell line. From this assay we have 
found that an increased chain length leads to greater biological activity, and that an acyl 
side chain has greater activity relative to a carboxamido side chain. 
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CHAPTER ONE 
INTRODUCTION 
Chapter One Introduction 2 
--- --------------------------------
1.1. Modulation of chemical reactivity 
The ability to manipulate or modulate the reactivity of a molecule in a controlled 
manner is of fundamental importance in many areas of chemistry and biology. However, 
a fine balance exists in a molecule between chemical stability and useful chemical 
reactivity. If the molecule is too stable, it will not undergo the desired chemical 
transformation. On the other hand, if the molecule is too reactive its chemical reactivity 
will be unable to be controlled, resulting in the formation of undesired side products. In 
nature, this careful control of chemical reactivity is necessary in order to drive the vast 
multitude of chemical reactions which make up life. For example, the energy 
requirements for most biochemical processes are supplied by a substance called 
adenosine triphosphate (ATP) 1.1. The 'energy' in ATP is stored in such a way that it 
can be released on demand to drive essential biochemical reactions that are energetically 
and thermodynamically disfavoured. This is achieved by coupling the disfavoured 
biochemical reaction with the energy releasing hydrolysis reaction of ATP to adenosine 
NH2 
N:):N I ;> 
l.-N N 0 0 0 ~ IIIIII o-p-o-p-o-p-o-o I I I I 0- 0- 0-
H20 Useful energy 
HO OH 
• 
1.1 
NH2 
N:):N I ;> 
l.-N N 0 0 
Chemical energy from 
oxidation reactions 
~ IIII O-P-O-P-OH + o I I 0- 0-
HO OH 
1.2 
Scheme 1.1. Hydrolysis and regeneration of ATP. 
o 
II 
HO-P-O-
I 
0-
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diphosphate (ADP) 1.2 and inorganic phosphate (Pi) (Scheme 1.1). The ADP formed can 
be subsequent1y converted back into ATP by coupling the energetically disfavoured 
phosphorylation reaction with an energetically favourable process, such as the oxidation 
of glucose. 
Another example of controlled manipUlation of chemical reactivity in nature is 
found the biosynthesis of steroids. The ability of the key steroid precursor squalene 
1.3 to undergo cyclisation is only activated after its 
to squalene monoepoxide 1.4 (Scheme 1.2).1 
1.3 
j 
j 
Steroids etc 
and stereospecific epoxidation 
Scheme 1.2. Key cyclisation step in the biosynthesis of steroids. 
The modulation of chemieal reactivity has also been widely used in orgamc 
chemistry to control the outcome of a number of reactions. For example, in the 
biomimetic stererocontrolled synthesis of the etheromycin intermediate 1.6, the latent 
ability of the precursor 1.5 to cyclise is only released upon its treatment with acid 
(Scheme 1.3).2 
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~ ..... --....... ------------------------------
tBuO 
,,\\9 
-
\\\9 OH 
-
1.5 
0 I H+ 
HO OH 
1.6 
Etheromycin 
""OMe 
Scheme 1.3. Key cyclisation step in the biomimetic synthesis of etheromycin. 
Another elegant illustration of controlled manipulation of chemical reactivity in 
organic chemistry can be found in the biomimetic synthesis of the microbial elicitor 
syringolide 2 1.8. In this example, exposure the key D-xylulose derived intermediate 
1.7 to basic alumina resulted in a facile triple cyc1isation to give syringolide 2 1.8 as a 
single stereoisomer (Scheme lA)? 
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o 0 
~V\ 
o 0 
HOIII,r 
~OH 
HO 
1.7 j AI20, 
Syringolide 2 1.8 
Scheme 1.4. Biomimetic synthesis of syringolide 2 1.8. 
5 
An important application of this controlled modulation of chemical reactivity of a 
molecule can be found in the area of medicinal chemistry. Here, the controlled release of 
latent (or masked) chemical reactivity of a molecule can be utilised, in a highly specific 
manner, so as to deliver a therapeutic effect to a specific site within a biological target.4 
For example, the inhibition of enzymes, a class of proteins which catalyse many of the 
important chemical reactions of life, forms the basis of many therapies for the treatment 
of a range of human metabolic diseases. However, the inherent chemical reactivity of 
many of the inhibitor compounds, combined with a lack of enzyme specificity, can lead 
to unwanted side reactions within the biological target, along with their associated side 
effects. One potential solution to this problem is to modify the inhibitor compound in 
such a way that its inherent chemical reactivity is masked, and is only released upon 
activation by the specific action of the target enzyme. This approach forms the basis of 
mechanism-based inhibitors, as discussed in further detail in Section 1.4. 
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1.2. Reactivity of 2-hydroxymethylpyrroles 
Pyrrolic compounds play an important role in many areas of chemistry and 
biology. A large number of biomolecules which are essential for life are derived from 
simple pyrrole precursors, eg porphyrins and haemoglobin. Likewise, pyrroles are key 
components of many biologically active natural products and biopharmaceuticals. In 
addition, pyrroles have also been utilised as building blocks and key intermediates in 
organic synthesis. 
The introduction of an electron withdrawing group (EWG) onto the pyrrole 
nitrogen in compounds of the type 1.9 to give 1.11, results in a decrease in the 
aromaticity of the pyrrole ring. 5 This substitution is thought to suppress the fonnation of 
the highly reactive azafulvenium species 1.12 (Scheme 1.5) due to the delocalisation of 
the nitrogen lone pair. Under these circumstances, ring-deactivated 2-substituted pyrroles 
of the type 1.11 react with nucIeophiles via SN2 chemistry to products of the type 
1.13b (see Chapter 3 for specific examples), This is a further example of the modulation 
of chemical reactivity as discussed in Section 1.1. In this instance, the reactivity of 1.9 is 
x~ I\J 
H 
1.9 
x = OH or NH2 
1.10 
Nu n ~"N'/ 1.13a R=H 
I 1.13b R = EWG 
~ INU· 
x~ diSfa:our:d [J:i) 11.12 
1.11 EWG ~WG 
Scheme 1.5. Azafulvene formation of 2-substituted pyrroles. 
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modulated through the introduction of an EWG. In the absence of such deactivation, 
pyrroles of the type 1.9, which have a suitable leaving group eX) at the 2-position, 
undergo loss of this leaving group to form the postulated azafulvene species 1.10.6 This 
electrophilic azafulvene species readily reacts with nucleophiles to give products of the 
type 1.13a (Scheme 1.5).5a,7 
Such a sequence involving azafulvenes is thought to be involved in the 
biosynthesis of hydroxymethylbilane (Hl\1B) 1.17 and uroporphyrinogen III (uro' gen III) 
1.20, important intermediates in the biosynthesis of vitamin B 12 and related pigments 
~ [P 1 P  EnzXH ~H2:~H ~ A~ -:n:=A'~6 
1.14 1.15 
A = CH2C02H P = CH2CH2C02H 
! 3x1.15 ! -EnzXH 
p p A 
P A P 
~HO 
A P A 
p A 
1.18 1.17 
II j 1 
p 
P A 
A P A P 
f 
A P A 
P 
1.20 A 1.19 
Scheme 1.6. Biosynthesis of uroporphyrinogen III 1.20. 
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(Scheme 1.6).8 In the biosynthesis of uro'gen III, four molecules of porphobilinogen 
(PBG) 1.14 are assembled together under the combined action of the enzymes 
hydroxymethylbilane synthase (PBG deamina<;e) and uroporphyrinogen III synthase 
(uro'gen III cosynthetase). In the first step of the biosynthesis, PBG gives rise to the 
azafulvene 1.15 which becomes covalently bound to the PBG deaminase enzyme via a 
clipyrromethane cofactor. This sets up the enzyme-substrate complex 1.16, and three 
more molecules of PBG condense sequentially to 1.16, again via the azafulvene 1.15. 
This generates an enzyme bound tetrapyrrole, which is subsequently released as HMB 
1.17. The current view is that the azafulvene 1.19 is the intermediate which reacts with 
water to afford 1.17.9 Uro'gen III co synthetase then acts on the HMB 1.17 to bring about 
cyclisation with ring-D inversion to yield uro' gen III 1.20. Again, the mechanism of this 
cyc1isation is thought to involve the azafulvene 1.19. The exact mechanism of fonnation 
of the ring-D inverted uro' gen III 1.20 has been the topic of extensive speculation, and at 
least 25 biosynthetic schemes have been postulated.8b However, a number of isotopic 
labelling experiments have been carried out using both 13C_ and 14C-labelled PBG,1O and 
also with doubly l3C-Iabelled PBG,8a,1l and these labelling experiments suggest that the 
spiro-compound 1.18 is an intermediate in the mechanism of this ring cyclisation. 
For pyrroles of the type 1.11 to be useful in organic and biological chemistry, the 
inherent reactivity of these compounds (ie azafulvene fonnation) must be able to be 
released in a controlled manner when, and only when, it is desired. This is able to be 
achieved through either the chemical or enzymatic removal of the electron withdrawing 
group from 1.11 to give pyrroles of the type 1.9 - which can then undergo azafulvene 
formation (see Scheme 1.5). This ability to selectively release the latent reactivity of 
pyrroles of the type 1.11 when desired, forms the basis by which these class of 
compounds are able to be utilised as useful synthetic intermediates and as mechanism-
based inhibitors of enzymes. These applications are discussed in further detail in 
Sections 1.3 and 1.4. 
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1.3. Deactivated pyrroles as intermediates in organic synthesis 
A wide variety of electron withdrawing groups have been employed on the 
pyrrole nitrogen in order to deactivate the ring system, and so allow its use as an 
intermediate in organic synthesis. Examples of the groups which have been employed to 
effect this ring-deactivation include methanesulfonyl,12 phenyl sulfonyl, 13 tert-
butylcarbamoyl14 and alkoxycarbonyls such as tert-butoxycarbonyl (BOC)15 and 
ethoxycarbony1. 16 Consequently, a large number of synthetic applications for ring-
deactivated pyrroles have been described in the literature. What follows are some 
examples of the chemistry of pyrro1e which is possible due to this ring-deactivation. 
Diels-Alder chemistry 
Non-deactivated pyrroles and their derivatives tend to be unreactive towards 
Diels-Alder reactions. 17 In contrast, pyrroles which are substituted with a suitable 
electron withdrawing group on nitrogen are able to act as the diene component in Diels-
Alder reactions,I8 For example, in the reported synthesis of (±)-epibatidine 1.23, a potent 
analgesic alkaloid possessing a 7-azanorbornane structure, the key step involved a Diels-
Alder reaction between the N-methoxycarbonylpyrrole 1.21 and a functionalised 
phenyl sulfonyl acetylene 1.22 (Scheme 1.7).19 
+ 
~HI\J _ I CI ~ I\J 
1.23 (±)-epibatidine 
Ph02S ('-CI 
-N 
1.22 
! 80-85°C 50-70% 
Scheme 1.7. Diels-Alder route to the synthesis of (±)-epibatidine 1.23. 
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A further extension of this work has recently been reported by Singh and 
B 1" 20 asmaCJlan. In this recent example, a Diels-Alder reaction between the N-tert-
butoxycarbonylpyrrole 1.24 and the bromoacetylene 1.25 was used to generate the 
cyc10adduct 1.26. Hydrodehalogenation of 1.26 then afforded the desired 7-
azabicyclo[2.2.1 ]heptene 1.27 a possible intermediate in the synthesis of epibatidine 
1.23 and related analogues (Scheme 1.8). 
0 C02Me 
BOC'N 
90-95 DC ~C02Me + II .. N 60% I 
BOC Br Br 
1.24 
1.25 1.26 
1 
HN BOC'N 
L/J-Q-CI 
........ _ ............... 
~C02Me ~ N ,."... _ .............. 
1.23 (±)-epibatidine 1.27 
Scheme 1.8. Alternate Diels-Alder route to the 7-azabicyclo[2.2.1Jheptane skeleton. 
Regiocontrolled acylation 
The regioselective acylation of deactivated pyrrole derivatives has been reported 
in a number of instances. 21 Pyrroles normally undergo Friedel-Crafts acylation at the 
position. However, when the pyrrole is N-substituted with a phenyl sulfonyl group, as in 
1.28, the site of substitution on the pYlTole ring can be controlled by the Lewis acid 
catalyst employed. In the presence of boron trifluoride etherate acylation gives 
predominantly the 2-acyl derivative 1.29. In contrast, in the presence of aluminium 
trichloride acylation occurs exclusively at the C-3 position to give 1.30 (Scheme 1.9). 
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COR 
~ (RCOhO or RCOCI 0 (RCOhO or RCOCI d .. N COR 
BF3.oEt2 
N AICI3 
N 
I I I 
S02Ph CICH2CH2CI S02Ph CICH2CH2 CI S02Ph 
1.29 1.28 1.30 
Scheme 1.9. Regiocontrolled acylation of N-phenylsulfonylpyrrole 1.28. 
Synthesis of the tropane skeleton 
Deactivated pyrroles have been utilised in the synthesis of tropane alkaloids - an 
important class of natural products with extensive biological properties. 22 Consequently, 
a number of alternate methodologies have been employed to enable the preparation of 
compounds of this class. For example, Davies et aI. utilised a rhodium-catalysed 
cyclopropanation/sigmatropic (Cope) rearrangement of the N-methoxycarbonylpyrrole 
1.21 with a vinyldiazoester 1.31 to give access to the tropane skeleton (Scheme 1.10).23 
1.32 (±)-Anhydroecgonine 
methyl ester 
o ~ 
1.33 (±)-Ferruginine 
Scheme 1.10. Synthesis of tropane alkaloids using ring-deactivated pyrroles. 
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A similar reaction with non-deactivated N-alkylpyrroles resulted in the formation of 
alkylation products?3 This above methodology has been further extended by Davies et 
al. to enable the syntheses of the tropane natural products, (±)-anhydroecgonine methyl 
ester 1.32 and (±)-ferruginine 1.33 (see Scheme 1.10)?4 
A ring-deactivated pyrrole has also been used to prepare the tropane alkaloid 
scopoline 1.35.25 In this instance, the key step in the synthesis was a [4+3]-
cycloaddition reaction between the N-methoxycarbonylpyrrole 1.21 and the oxyallyl 
carbocation 1.34 (Scheme 1.11). 
+ 
OZnEt 
Br~Br 
,,+ ... 
1.34 
Me 16 
Ho~l 
o 
1.35 Scopoline 
.. 
o 
t-OMe 
~o 
Scheme 1.11. ?ynthesis of scopoline 1.35 using a ring-deactivated pyrrole. 
The use of electron withdrawing groups on the pyrrole nitrogen have also been 
employed for numerous other applications in organic synthesis. For example, ring-
deactivated pyrroles have been observed to stabilise intermediates in photocyclisation 
reactions,26 are readily reduced under Birch conditions,27 allow the synthesis of 
b · d 1 . l' h" 28 d h b '1' d' W' , ,2629 su stItutc pyrro es VIa U- It latlOn, an ave een utllse 111 Ittlg reactIOns, ' 
A number of non-deactivating groups have also been employed to protect the 
nitrogen and/or direct reaction of the pyrrole nucleus. These groups include methyl,30 
benzyl? 2-(trimethylsilyl)ethoxymethyl (SEM),32 trialkylsily133 and dimethylamino. 34 
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1.4. Hydroxymethylpyrroles as mechanism-based inhibitors of serine 
proteases 
Proteolytic enzymes, or simply proteases, are an important class of enzyme within 
biological systems. These enzymes are characterised by their particular function, which 
is to catalyse the hydrolytic cleavage of peptide (or amide) bonds in proteins and 
polypeptides (Scheme 1.12). 
Protease 
Scheme 1.12. Protease catalysed hydrolytic cleavage of a peptide bond. 
Proteases are divided into the four subclasses, serine, aspartic, cysteine and 
metallo-proteases, on the basis of the most important residue or functional group 
associated with enzyme activity. Each subclass of protease has a number of key 
functions, for instance digestion, blood coagulation, and honTIone metabolism, and as 
such play an important role in the overall regulation and maintenance of normal 
t · h . I Vi )IOC emlCa processes:' An imbalance in the normal functioning of any of these 
enzymes can therefore lead to metabolic disorders and disease. Table 1.1 summarises 
representative examples of these proteases in their respective subclasses, along with a 
brief mention of their normal metabolic function. 
The following section of this introduction will deal specifically with the serine 
protease subclass of proteolytic enzymes, as this class of enzyme is the topic of some of 
the work detailed in this thesis (see Chapter 5 for work in this area). 
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Protease subclass Representative examples Normal metabolic function 
Serine a-chymotrypsin, trypsin digestion 
thrombin, plasma kallikrein blood coagulation 
post-protein cleaving enzyme hormone metabolism 
elastase, cathepsin G, tryptases phagocytosis 
Aspartic remn blood pressure regulation 
HIV protease HN replication 
pepsin, thermolysin digestion 
Cysteine cathepsins B, H, L, calcium protein turnover, bone 
activated neutral proteases resorption 
papain digestion 
Metallo angiotensin converting enzyme blood pressure regulation 
enkephalinases analgesic function 
caTboxypeptidase digestion 
collagenase tissue remodelling 
Table 1.1. Examples of proteases and their nonnal metabolic function. 
The active site of a serine protease comprises a highly conserved catalytic triad of 
amino acids, for instance ASpl02, His57 and Ser195 as in a-chymotrypsin (the numbers 
102, 57 and 195 denote the position of the key residues aspartic acid, histidine and serine, 
respectively, in the polypeptide chain).36 The aspartic acid and histidine residues act as 
an electron source and sink, respectively, in a charge-transfer system that serves to 
increase the nucleophilic nature of the serine residue. 37 The proposed mechanism for the 
h ydrol ysis of a peptide bond by a-chymotrypsin is detailed in Scheme 1.13. The 
activated serine nucleophile attacks the peptide substrate 1.36 to form the tetrahedral 
intennediate 1.37. The oxyanion of 1.37 is stabilised by hydrogen bonding to NH groups 
i 11 an area of the enzyme backbone referred to as the 'oxyanion hole'. This tetrahedral 
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intermediate 1.37 is then converted into an acyl-enzyme intermediate 1.38, with the 
release of a new N-terminal peptide. The acyl-enzyme intermediate 1.38 is finally 
hydrolysed by a molecule of water in the enzyme active site, which releases the C-
terminal peptide 1.39 and regenerates the catalytic triad.36 
Enzyme 
~ , , 
~ e :: t NHvvvv ,0 ° ! Ph? ~ /H/ Y ~ ?/H---NCt Asp102 
Hydrophobic Ser195 ~. 57 HIS 
Pocket tetrahedral intermediate 
acyl-enzyme intermediate 
Scheme 1.13. Serine protease catalysed hydrolysis of a peptide bond. 
An imbalance in the activity of serine proteases has been found to be involved in 
many pathological conditions. For example, enzymes such as a-chymotrypsin, human 
neutrophil elastase, cathepsin G and pancreatic elastase are thought to play key roles in 
the initiation and progression of number of human diseases such as digestive disorders, 
pulmonary emphysema, rheumatoid arthritis and pancreatitis, respectively.38 Therefore, 
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-_ .... _ ...... _------------------------------
the selective inhibition of these enzymes is a therapeutic goal for the treatment of these, 
and other related, conditions. 
In view of this fact, we have developed N-acylhydroxymethylpyrroles as a new 
class of mechanism-based inhibitor of serine proteases. A mcchanism-based inhibitor is 
a chemically non-reactive compound which is sufficiently similar in structure to the 
natural substrate to be bound in the active site of the target enzyme. Once in the active 
site, normal enzyme action produces a reactive species, which can result in the specific, 
efficient and irreversible inhibition of the target enzyme. In this case, the N-
acylhydroxymethylpyrrole 1.40 (Scheme 1.14) is designed to mimic the enzyme's natural 
substrate (see Figure 1.1). Accommodation of this inhibitor 1.40 in the enzyme active 
Enzyme 
o 
amino aCidJ( 
o 
\ 
release of 
H 
\~ I 
1,41 ~\N~ 
amino acid ~ ~ ~ 
o C 
latent reactivity 
o 
amino aCid--.J~ 
o 
covalent 
inhibition 
\ 
Scheme 1.14. Proposed mechanism of inhibition of N-acylhydroxymethylpyrroles 1.40. 
Chapter One - Introduction 17 
site would lead to the catalytic hydrolysis of the pyrrole N-acyl bond. The subsequent 
loss of the leaving group (L) from the 2-position of this non-deactivated pyrrole would 
produce the electrophilic azafulvene 1.41, thereby releasing the latent reactivity of this 
class of mechanism-based inhibitor. The azafu1vene thus formed could then be trapped 
by one of several suitable nucleophilic residues (eg HisS? as shown in Scheme 1.14) in the 
enzyme active site to give a bound pyrro1e derivative 1.42 and an inhibited enzyme. 
The enzyme's primary specificity pocket (S1) is of main importance m 
determining which amino acids of the substrate (or inhibitor) can be accepted into the 
enzyme active site.36 Schechter and Berger39 devised terminology to describe the 
interaction between an enzyme and substrate on binding (see Figure 1.1). Numbering 
from the carbonyl end of the scissile amide bond (ie the peptide bond to be cleaved) to 
the amino terminal, the substrate (or inhibitor) amino acid residues are termed PI, P2, etc, 
while the corresponding subsites of the enzyme are termed S b S2, etc. The substrate (or 
Figure 1.1. A section of a natural substrate of a serine protease such as a-chymotrypsin 
showing the interactions between the amino acid side-chains of the substrate (Pn, Pn') and 
the corresponding subsites of the enzyme's active site (Sn, Sn'). The scissile amide bond 
is shown by an arrow. 
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inhibitor) residues going in the direction of the carboxy terminal from the scissile bond 
me termed PI', P2', etc, while the corresponding enzyme sub sites are termed SI', S2" etc 
(see Figure 1.1). 
In the case of a-chymotrypsin, the SI sub site is a large well defined hydrophobic 
pocket and is known to accept aromatic and aliphatic residues positioned at the primary 
amino acid binding site (Pd. However, enzyme-substrate recognition is not based 
entirely on the interaction between the enzyme's primary specificity pocket (S)) and the 
substrate's primary binding amino acid (PI), but it is in fact influenced by neighbouring 
and longer secondary interactions. For example, through serine protease inhibition 
studies it has been found that the residues P4, P2, P2' and P3', which are close to the 
scissile bond, are important for the recognition and binding of the substrate, as well as 
residues as far away from the active site as PI4,.40 Therefore, by incorporating the 
hydroxymethylpyrrole-moiety into an extended peptide-like sequence we aim to generate 
better inhibitors through the potential for improved enzyme recognition and binding (see 
Chapter 5 for work in this area). The structure and relative position of the substrate 
binding sites of serine proteases has only become available through X-ray 
crystallographic studies,41 NMR spectroscopy,41a,42 and enzyme inhibition studies.43 
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1.5. Hydroxymethylpyrroles and azafulvenes in natural products 
An appreciable number of hydroxymethylpyrrole- and azafulvene-based natural 
products, exhibiting a wide spectrum of biological activity, have been isolated from a 
variety of natural sources. A brief selection of some of these compounds, aJong with 
their biological activity is presented in the following section. 
Roseophilin 
In 1992, the azafulvene-based compound roseophilin 1.43 was isolated by 
Hayakawa et al. from the culture broth of an actinomycete identified as Streptomyces 
Kriseoviriciis (Figure 1.2).44 This compound showed significant cytotoxicity against the 
K562 human erythroid leukemia and KB human epidermoid carcinoma cell lines (ICso of 
0.34 ~lM and 0.88 flM, respectively). The first total, synthesis of roseophilin 1.43, by a 
convergent and highly modular approach, has recently been reported by FUrstner and 
Weintritt,45 
1.43 
l?igure 1.2. Roseophilin 1.43. 
Mycalazols 1 - 12 and mycalazals 1 - 2 
Recently, a series of fourteen pyrrole-based metabolites were isolated from a 
north-eastern Atlantic sponge Mycale micracanthoxea.46 The authors of this work 
characterised twelve 5-acyl-2-hydroxymethylpyrroles (mycalazols 1 - 12) and two 5-
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alkylpyrrole~2-carboxaldehydes (mycalazals 1 2) that differed in the length and degree 
of unsaturation of their side chain (see Figure 1.3 for representative examples). These 
compounds were assayed for cytotoxicity against the P388 murine leukemia, SCHABEL 
mice lymphoma, A549 human lung carcinoma, HT29 human colon carcinoma and 
MEL28 human me1anoma cell lines. In each case, these pyrrole-based metabolites were 
shown to possess moderate in vitro cytotoxicity (EDso of 1 10 J-Lg mL-1). 
HO~(CH2)n 
H 0 
n:::7 Mycalazol 2 
n=9 Mycalazo! 8 
HO n ~ 
'-/ ,,!\(r y "(CH2)~ HO n ~ '-/ "N/ Y "(CH2)~ 
H 0 I~ I H 0 
II/Iycalazol 7 Mycalazol 11 
Mycalazal 2 
Figure 1.3. Representative examples of mycalazols and mycalazals. 
Tambjamine and related alkaloid ... 
A large number of azafulvene-based bipyrrolic compounds, collectively known as 
the tambjamine class of alkaloids 1.44a-j (Figure 1.4), have been isolated from a wide 
range of marine organisms, including bryozoans, nudibranchs and ascidians.47 
tambjamine alkaloids are reported to playa role in the chemical defence mechanism of 
the respective organisms, having been ascribed feeding and ichthyodeterrent 
propeliies.47b In addition, these compounds have also been found to show antimicrobial 
activity (5 - 50 Ilg disk l ) against a range of bacteria, and inhibit cell division in the 
fertilised sea urchin egg assay at a concentration of 1 J-Lg mL-1 in seawater.47a A series of 
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closely related linear tri- and tetrapyrroles have also been isolated from a variety of 
natural sources. For example, prodigiosin 1.45 has been isolated from both telTestrial and 
marine bacteria,48 while 1.46 has been isolated from bryozoans, an ascidian and a mutant 
strain of the bacterium Serratia marcescens.47b ,49 
R3 OMe 
1· rl·· r=<~·H 
R~N~'N~ 
H NHR2 
R1 R2 R3 Tambjamine 
1.44a H H H A 
b Sr H H S 
c H CH2CHMe2 H C 
d H CH2CHMe2 Sr D 
e H CH2Me Sr E 
f H CH2CH2Ph H F 
9 Sr CH2Me H G 
h Sr CH2CH2Ph H H 
Sr CH2CHMe2 H I 
Sr CH(Me)CH2Me2 H J 
~H2)4Me Ol\t1e OMe 
1 \ 0,.-::::- 1 \ 
N N N Me N N 
H H H H 
1.45 1.46 
Figure 1.4. Tambjamines A J (1.44a-j) and related metabolites. 
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1.6. Work described in this thesis 
Chapter Two describes an investigation to quantify the deactivating abilities of 
various N-substituents on the pyrrole ring. It has previously been assumed that the 
introduction of an electron withdrawing group onto a pyrrole nitrogen, as in 1.11, 
suppresses the formation of highly reactive azafulvenium intermediates 1.12 (see Scheme 
1.5), but little direct evidence for this has been presented. 
Chapter Three describes an application of this pyrrole ring-deactivation. In this 
work, a short, convenient and versatile route to dipyrromethanes was developed. This 
methodology was extended to the preparation of dipyrromethanes containing a 
deuterium-label at the interpyrrolic methylene position. These compounds could 
potentially act as probes for studying some of the key stereochemical issues associated 
with the biosynthesis of porphyrins such as vitamin B12 and related pigments. 
Chapter Four describes an investigation into the removal of the nitrogen electron 
withdrawing group from hydroxymethylpyrroles, thereby allowing the release of the 
latent reactivity of this class of compound. This investigation was primarily concerned 
with the mechanism by which this removal of the EWG proceeds. 
Chapter Five describes the various synthetic attempts that were made at 
incorporating the hydroxymethylpyrrole functionality into an extended peptide-like 
sequence. This was attempted in order to develop mechanism-based inhibitors of serine 
proteases which were more closely based on the natural substrate, thereby increasing the 
enzyme specificity and selectivity for the inhibitor molecule. The isolation of unusual 
and interesting pyrrole-based molecules from some of these synthetic approaches is 
described in Chapter Six. The ability of a class of these pyrrole-based molecules to 
undergo possible molecular self-assembly is also discussed. 
Finally, Chapter Seven describes the synthesis and P388 cytoxicity assaying of a 
series of analogues of the mycalazol natural products. 
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2.1 Introduction 
The substitution of pyrrole on nitrogen with an electron withdrawing group 
(EWG), such as an acyl group as in 2.1, results in a decrease in the aromaticity of the 
pyrrole ring. This is due to delocalisation of the nitrogen lone pair onto the amide 
oxygen (see Figure 2.1).1 
Figure 2.1. Electron delocalisation in N-acylpyrroles. 
Similarly, it would be expected that the introduction of an electron withdrawing group 
onto the nitrogen of 2-substituted pyrroles of the type 2.4 would also serve to deactivate 
the ring system. In the absence of such deactivation pyrroles of type 2.2, which have a 
potential leaving group eX) at the 2-position, readily undergo substitution at this position 
via the postulated azafulvene intermediate 2.3, to give products of the type 2.6a (Scheme 
2.1)? However, with a deactivating EWG on the pyrroJe nitrogen as in 2.4, the 
analogous reaction is disfavoured due to suppression of azafulvenium 2.5 formation. In 
this instance, we postulate that pyrroles of type 2.4 will react with nuc1eophiles via SN2 
chemistry to give products of the type 2.6b. 
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x~ N 
H 
2.2 
X OH or NH2 
2.3 
Nu n ~N;> 2.6a R == H 
I 2.6b R == EWG 
~ INU' 
x~ ~ disfavoured [~J 2.5 
2.4 EWG 
Scheme 2.1. Azafulvene formation of 2-substituted pyrroles. 
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A number of electron withdrawing substituents have been utilised in order to 
protect and deactivate pyrrole. Examples of these groups include alkyl- and arylsulfonyls 
such as methane sulfonyl (mesyl), trifluoromethanesulfonyl (triflyl), phenylsulfonyl, and 
(4-methylphenyl)sulfonyl (tosyl), as well as alkoxycarbonyls such as tert-butoxycarbonyl 
(BOC), ethoxycarbonyl and methoxycarbonyl (see Chapter 1.3 for some examples that 
use ring-deactivated pyrroles as synthetic intermediates). 
Accordingly, a number of methodologies have been developed to efficiently 
substitute the pyrrole nitrogen with an appropriate deactivating group. The following 
section summarises some of the approaches that have been utilised in order to effect 
substitution on a pYlToie nitrogen. 
Pyrrolyl anion mediated N-acylation of pyrrole 
The pKa value for the NH proton of pyrrole has been determined 
spectrophotometric ally by Yagil to be 17.5.3 However, more recent measurements by 
Bordwell et al., conducted in dimethyl sulfoxide, have set the value at 23.05.4 
Consequently, pyrrole undergoes analogous reactions to alcohols (pKa ~ 18) and alkynes 
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(pKa - 22) with strong bases, to generate N-pyrrolyl metal salts of the type 2.7, which can 
then be acylated to give products of the type 2.1 (Scheme 2.2). The more commonly 
used bases to effect this N-acylation include alkali metals such as potassium, sodium or 
lithium, although the use of N-pyrrolyl salts of silver and thallium, as well as of 
quaternary ammonium ions, have also been described. 5 
0 M,MH .. 0 RGOGI 0 ,. or RM or N N (RGO)20 N H M+ 
RAo 
2.7 
2.1 
Scheme 2.2. Pyrrolyl anion mediated N-acylation of pyrrole. 
The bond character of the N-M bond depends both upon the cation and upon the 
solvent system. With small cations such as lithium, the high charge per volume ratio, 
together with the close proximity of the ions, gives a strong ion pair which has a 
reasonably high degree of covalent character. The pyrrolyl lithium salt has therefore 
been described as existing as a 'solvent-separated ion-pair' in analogy to the indolyl 
alkali salts whose structures have been deduced from NMR spectroscopy. 6 In contrast, 
with the larger cations such as sodium and potassium the bonding is predominantly ionic, 
and in a solvent which can solvate either or both of the ions, only limited association 
exists between the ions. Therefore, the pyrrolyl salts of sodium and potassium are 
described as existing as 'contact ion-pairs,.6 
Acylation of the pyrrolyl anion, generated from sodium or potassium, with either 
an acid chloride, anhydride or ester gives predominantly the N-substituted derivative (eg 
2.1 in Scheme 2.2).5,7 With the lithium derived salt, however, a mixture of N- and C-
substituted derivatives is often observed. For example, reaction of the N-pyrrolyllithium 
salt 2.8 with ethyl chloroform ate leads to the fonnation of both the N- and C-substituted 
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isomers 2.9 and 2.10, respectively. The C-isomer 2.10 is postulated to arise from the 
initially formed N-isomer 2.9 by the sequence shown in Scheme 2.3.8 
o N 
u+ 
2.8 
+ 
Scheme 2.3. Formation of the C-substituted pyrrole 2.10. 
In contrast to the sodium or potassium salts of pyrrole, acylation of the 
magnesium salt of pyrrole gives predominantly the C-substituted derivative over the N-
substituted derivative. However, the extent to which the C-acyl product prevails over the 
N-acyl product depends greatly upon both the carbonyl compound used to effect the 
acylation, and also on the coordinating ability of the solvent (see Chapter 3.3 for further 
discussion).7,9 
N-Acylation of pyrrole, and of 2-formylpyrrole, has also been reported to occur in 
high yield through the use of the corresponding pyrrolyl thallium salts. lO Similarly, high 
yields of N-acylpyrroles have been achieved through the use of tetrabutylammonium 
hydrogen sulfate under phase-transfer conditions.1l 
The presence of an electron withdrawing group on the pyrrole ring serves to 
stabilise the generated pyrrolyl anion by increasing the electron delocalisation. This aids 
in the dissociation of the nitrogen-metal bond, and as a consequence, these ring-
deactivated pyrroles can be more readily substituted at nitrogen, and under much milder 
conditions, than the corresponding non-deactivated pyrroles. 5,8,9 
The N -substitution methodology which was used to prepare a large number of the 
N-substituted pyrrole derivatives described in this thesis was based on the work of Moon 
et aZ. 12 This work rep0l1ed that treatment of substituted pyrrole derivatives with sodium 
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hydride, followed by reaction of the generated N-pyrrolyl anion with various acid 
chlolides, gave N-acylated pyrroles in good yields (ca. 75 80%). 
DMAP mediated N-acylation of pyrrole 
Steglich and Hofie13 have identified 4-dimethylaminopyridine 2.11 (DMAP, 
Scheme 2.4) as a high yielding acylating catalyst (0.1 equivalents with respect to the 
species being acylated) which is approximately 104 times more active in promoting 
acylation than pyridine. DMAP can either be used alone, or more commonly, with an 
excess of either triethylamine (TEA) or N,N-diisopropylethylamine (Hiinig's base). 
The high catalytic ability of DMAP to effect acylation is due, in part, to the 
formation of N-acylpyridinium salts 2.12 in solution, which are present as loosely-bound, 
and highly reactive, ion pairs. 13b 
x = halide 
or aeaR 
+ o- Me N~ /; ~ Me 
2.11 
o 
N 
H 
2.12 
TEA or HOnig's base 
Scheme 2.4. DMAP mediated N-acylation of pyrrole. 
a 
)l 0- Me 
R +N~ /; r{ e( 
Me 
2.12 
2.1 
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2.2. Quantifying the deactivation of pyrrole with different EWG's 
An initial goal of our studies was to develop a methodology that would allow the 
deactivating ability of an electron withdrawing group on the pyrrole ring to be quantified. 
We reasoned that such an analysis would be possible by determining the extent to which 
azafulvene formation was suppressed by a particular deactivating group during an SN2 
reaction on pyrrole (see Scheme 2.5). However, in order to allow this analysis several 
issues pertaining to this determination first needed to be established. Of foremost 
importance was to develop a procedure that would readily enable the extent of azafulvene 
suppression during a particular reaction to be ascertained. Consequently, we decided on 
the use of a series of N-deactivated hydroxymethylpyrroles of the type 2.13, which were 
stereoselectively labelled with a deuterium atom at the exo-methylene position (labelled 
* in Scheme 2.5), as the means by which to measure the extent of azafulvene 
suppression in the subsequent reaction with a nucleophile. This could be easily achieved 
by determining the configuration at the deuterated exo-methylene position, both before 
(ie 2.13) and after substitution at * (ie 2.15), and then comparing these results with each 
other, and with the corresponding unlabelled analogue, prepared as a reference sample. 
In this way, the configurational purity at the deuterium-labelled methylene position of 
2.15 would then give an indication of the degree of azafulvene 
HO~ SN2 WOW 
:: N 
IS I EWG D EWG 
2.13 2.15 
R t 
D EWG 
2.14 
Scheme 2.5. Proposed method to detennine the deactivating ability of an N-substituent. 
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formation 2.14 which had occurred during this reaction. The smaller the degree of 
scrambling of the deuterium-label at * in 2.1S, the more effective the N-substituent 
would be at suppressing azafulvene formation, ie the greater the deactivating ability of 
the electron withdrawing group on the pyrrole ring. 
Having established a method by which the deactivating ability of an N-substituent 
could be determined, several other key issues needed to be addressed before this analysis 
could be carried out. The issues which required addressing included which electron 
withdrawing groups were to be investigated, how the starting deuterated 
hydroxymethylpyrroles could be prepared in a stereoselective manner, and how these 
labelled hydroxymethylpyrroles, along with their corresponding reaction products, could 
be analysed. Finally, for this analysis to be successful we needed to select a reaction 
which was known to favour an SN2 mechanism. This was important because such a 
mechanism would be likely to allow azafulvene formation 2.14 during the reaction 
sequence. However, the more deactivating the N-substituent, the greater the extent of 
azafulvene suppression, which would result in a smaller degree of scrambling of the 
deuterium-label at *. Subsequent analysis of the configuration of these products would 
then allow the deactivating abilities of a range of N-substituents to be determined and 
compared. The following section summarises the ways the key issues identified above 
were resolved, so as to allow this analysis of the pyrrole ring-deactivation. 
Deactivating groups to be investigated 
The electron withdrawing substituents that were chosen to be investigated in this 
analysis were the trifluoromethanesulfonyl (triflyl), methanesulfonyl (mesyl), tert-
butoxycarbonyl CEOC) and acetyl groups. These groups were selected for analysis as 
they were deemed as representative examples of the different classes of substituents, 
namely sulfonyl, alkoxycarbonyl and acyl, that had previously been employed on the 
pyrrole nitrogen in order to deactivate the ring system. In addition, these groups were 
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also of relevance to our work on developing mechanism-based inhibitors of serine 
proteases (see Chapter 5). 
Preparation of stereoselectively deuterium-labelled hydroxymethylpyrroles 
In order to prepare the key deuterium-labelled N-substituted hydroxymethylpyrroles 
which were to be used in the subsequent analysis, a method wa.') required by which the R-
and S-enantiomers could be synthesised stereoselectively. This could be achieved 
through the reduction of the corresponding deuterated N-substituted formylpyrrole with a 
chiral reducing agent such as B-isopinocampheyl-9-borabicyclo[3.3.1]nonane (Ipc.BBN 
orAlpine borane®, see Scheme 2.6).14 Use of the reagent derived from either (-) or (+)-
pinene allows access to either the R or the S product stereoselectively. 
major 
--------
minor 
Scheme 2.6. Stereoselective reduction of a-deuterobenzaldehyde with Alpine borane®. 
J\tIethod for the resolution of stereochemistry at the deuterated methylene centre 
The ability to resolve the configuration at the deuterated methylene position of the 
labelled hydroxymethylpyrroles (eg 2.13), along with their corresponding reaction 
products (eg 2.15), was a key requirement for the subsequent analysis of pyrrole 
deactivation. As such, we required the introduction of a chiral functional group, or 
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derivatising agent, onto the pyrroJe hydroxymethyl group (labelled R* in Scheme 2.5) 
which would allow the discrimination of the pro-chiral hydrogens at the exo-methylene 
position by IH NMR spectral analysis. The agent which was chosen to provide this chiral 
functionality, and so allow discrimination at the exo-methylene position, was the (lS,4R)-
(-)-camphanate group. This group was selected as it had been previously described by 
Gerlach,15 and later by other research groups,16 as a useful chiral derivatising agent for 
determining the enantiomeric purity of a-deuterated primary alcohols. Thus, substitution 
of the hydroxymethylpyrrole 2.13 with the (lS,4R)-(-)-camphanate group would give a 
derivative (ie 2.15) in which the exo-methylene protons were distinguishable by IH NMR 
spectroscopy. 
Selection of a reaction known to proceed via an SN2 mechanism 
The reaction chosen to afford the SN2 conditions necessary in this analysis was the 
Mitsunobu reaction, which was first reported by Mitsunobu and Yamada in 1967. 17 In 
this paper, the authors reported that carboxylic acids could be esterified with primary and 
secondary alcohols using the redox system methyl azodicarboxylate (DEAD) and 
triphenylphosphine (Ph3P). It was subsequently demonstrated by Mitsunobu and 
Egnchi 18 that this reaction generally proceeds with inversion of configuration when 
stalting with optically pure secondary alcohols. Since this time the synthetic applications 
of the Mitsunobu reaction have been greatly extended to include reactions with a variety 
of acids (NuH in Scheme 2.7), such as imides, iminodicarbonates, sulfonamides, 
heterocycles, carbon acids and phenols, as well as with a range of inorganic nucleophiles 
such as azide, cyanide and halides. 19 The Mitsunobu reaction is believed to proceed via a 
three step mechanism, as detailed in Scheme 2.7 for the reaction between a nucleophile 
(NuH) and a chiral secondary alcohol. Initially, triphenylphosphine adds to diethyl 
azodicarboxylate to fmID a zwitterionic P-N adduct, which in the presence of the 
nucleophile is protonated to give the quaternary phosphonium salt 2.16. The phosphorus 
group is then transferred to the alcohol to form an alkoxyphosphonium salt 2.17, and in 
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+ Ph3P + NuH 
2.16 
+ 
OPPh3 
R1AR2 + 
2.17 
Nu 
H 
Et02C-~-N-C02Et + Nu 
+PPh3 
2.16 
+ 
+ 
Scheme 2.7. Proposed mechanism of the Mitsunobu reaction. 
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the final step the oxyphosphonium salt is displaced by the deprotonated nucleophile (Nu-) 
in an SN2 reaction to give the inverted product 2.18Y-19 The Mitsunobu reaction is 
therefore a redox process as in this mechanism the triphenylphosphine is oxidised to 
triphenylphosphine oxide, while diethyl azodicarboxylate is reduced to diethyl 
hydrazinedicarboxylate. 
Having established all the necessary requirements that would allow the analysis of 
the deactivating ability of an electron withdrawing group on the pyrrole ring, we 
therefore required a model system on which to investigate this ring-deactivation. As 
such, we chose to study the conversion of stereoselectively deuterium-labelled 
hydroxymethylpyrroles of the type 2.19 into the corresponding camphanates 2.21, under 
both Mitsunobu (ie SN2) conditions [Scheme 2.8, conditions (b)] and via reaction with 
(lS,4R)-(-)-camphanoyl chloride [Scheme 2.8, conditions (a)], as the means by which to 
analyse the deactivating abilities of various N-substituents (ie R group in 2.19). 
Accordingly, using the synthetic sequence shown in Scheme 2.8, reaction of 2.19 
with (lS,4R)-(-)-camphanoyl chloride would provide reference camphanate samples for 
IH NMR spectral analysis, where the configurational purity at the deuterium-labelled 
centre of 2.21a would be maintained and indeed measurable [Scheme 2.8, pathway (a)]. 
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2.19 
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2.21a 
2.20 
b ~on 01'><;( Y"~/ 
o 0 R 
2.21b 
2.21 
(a) DMAP, Hilnig's base, (lS,4R)-(-)-camphanoyl chloride 
(b) Ph3P, DEAD, (lS,4R)-(-)-camphanic acid (Mitsunobu conditions) 
Scheme 2.8. Reaction sequence to assess the deactivating ability of an N-substituent. 
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However, reaction of 2.19 with (lS,4R)-(-)-camphanic acid under Mitsunobu conditions 
could either occur via the azafulvene 2.20, resulting in scrambling of the deuterium-label 
in 2.21, or via an SN2 mechanism to give inversion of configuration at the labelled centre 
of the camphanate 2.21b [Scheme 2.8, pathway (b)]. 
As has already been discussed, it was reasoned that the greater the deactivating 
ability of the Rgroup on the pyrrolic nitrogen the less would be the contribution from the 
azafulvene mechanism. Therefore, by comparing the stereochemical integrity at the 
deuterium-labelled centre in 2.21, derived from 2.19 by the Mitsunobu sequence [Scheme 
2.8, reaction conditions (b)], with reference samples obtained from 2.19 and the 
cOITesponding unlabelled analogues by esterification with (lS,4R)-(-)-camphanoyl 
chloride [Scheme 2.8, reaction conditions (a)], the deactivating abilities of various R 
groups could then be assessed and quantified. 
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2.3. Preparation of starting materials and reference compounds 
The key deuterium-labelled formylpyrrole 2.22b was prepared in 53% yield by the 
Vilsmeier-Haack formylation of pyrrole,2o using phosphorus oxychloride and N,N-
dimethylformamide-d7 (Scheme 2.9). Mass spectrometry of 2.22b showed the compound 
to have an isotopic incorporation of 97.6% deuterium. The N-trifluoromethanesulfonyl 
(triflyl) protected formylpyrroles 2.23a and 2.24a were prepared from the corresponding 
formylpyrroles 2.22a or 2.22b in yields of 42% and 46%, respectively, by reaction with 
trifluoromethanesulfonic anhydride in the presence of Hlinig's base, at -78°C. The 
remaining N-protected formylpyrroles 2.23b-d and 2.24b-d were prepared by treating the 
corresponding formylpyrroles 2.22a or 2.22b with sodium hydride, and then reacting the 
generated N-pyrrolyl anion with either methanesulfonyl chloride, 2-(tert-
butoxycarbonyloxyimino)-2-phenylacetonitrile (BOC-ON®) or acetyl chloride (Scheme 
2.9). In this way, the unlabelled formylpyrroles 2.23b-d were prepared in yields of 93%, 
91 % and 74%, respectively, while the labelled analogues 2.24b-d were prepared in yields 
of 92%, 87% and 94%, respectively. The unlabelled hydroxymethylpyrroles 2.25a-d 
were then readily prepared, in yields of 90%, 91%, 91% and 98%, respectively, by 
reducing the N-protected formylpyrroles 2.23a-d with zinc borohydride. The 
corresponding labelled analogues, 2.26a-d and 2.27a-d, were prepared by reducing the 
deuterated formylpyrroles 2.24a-d with either S-Alpine borane®, or R-Alpine borane®, 
respectively (Scheme 2.9). However, only the hydroxymethylpyrroles 2.26b, 2.27b and 
2.27d were able to be isolated as clean products, in yields of 73%, quantitative and 85%, 
respectively. The other hydroxymethylpyrroles were unable to be fully purified from the 
by-products of the reduction reaction, and so were utilised in the subsequent steps 
without further purification. In each of these cases, however, the desired 
hydroxymethylpyrrole was the predominant compound (ca. >80% by lH NMR 
spectroscopy) . 
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Scheme 2.9. Reagents and conditions: (i) POCh, DMF-d7 , 1,2-DCE (53%); (ii) 
(CF3SOzhO, Hilnig's base, CHzC}z, -78°C (2.23a, 42%), (2.24a, 46%); (iii) NaH, THF 
then either MeSOzCl (2.23b, 93%), (2.24b, 92%) or BOC-ON® (2.23c, 91%), (2.24c, 
87%) or MeCOCl (2.23d, 74%), (2.24d, 94%); (iv) Zn(BH4h, EtzO, 0 °C (2.25a, 90%), 
(2.25b, 91%), (2.25c, 91%), (2.25d, 98%); (v) S-Alpine borane®, THF, 1't (2.26a,c~d, see 
text), (2.26b, 73%); (vi) R-Alpine borane®, THF, rt (2.27a,c, see text), (2.27b, quant.), 
(2.27d, 85%). 
Next we turned our attention to the synthesis of the key unlabelled and labelled 
camphanates 2.28a-d, 2.29a~d and 2.30a-d, respectively, which would serve as reference 
compounds in the subsequent IH NMR spectral analysis. Consequently, the unlabelled 
hydroxymethylpyrroles 2.25a~d were esterified with (lS,4R)-(-)-carnphanoyl chloride 
using standard procedures to give the carnphanates 2.28a-d in yields of 95%, 86%, 76% 
and 99%, respectively (Scheme 2.10). The IH NMR spectra of these reference 
compounds 2.28a·d revealed that, in each case, the pyrrole exo-rnethylene group was 
observed as an AB qUaltet, resonating at 8 5.32 and 5.37, 5.35 and 5.42, 5.41 and 5.45, 
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and 5.44 and 5.49, respectively. The camphanates 2.29a-d and 2.30a-d were similarly 
prepared by esterification of the corresponding labelled hydroxymethylpyrroles 2.26a-d 
and 2.27a-d with (lS,4R)-(-)-camphanoyl chloride (Scheme 2.10). In this way, the 
camphanates 2.29a-d, deIived from the S-Alpine borane® sequence, were prepared in 
yields of 40%, 53%, 69% and 35%, respectively, while the camphanates 2.30a-d, derived 
from the R-Alpine borane® sequence, were prepared in yields of 53%, 31%, 82% and 
11 %, respectively. The IH NMR spectra of the pyrrole exo-methylene group of these 
deuteIium-Iabelled analogues 2.29a-d and 2.30a-d were observed as singlets with 
distinguishable chemical shifts at 0 5.31 and 5.33,5.35 and 5.41,5.41 and 5.42, and 5.43 
and 5.44, respectively. Furthermore, in the case of the S-Alpine borane® derived 
camphanates 2.29a-d, the configurational purities at the deuterated methylene centre 
were observed to be ~9: 1, while the camphanates 2.30a-d derived from the R-Alpine 
R2 
a S02CF3 
b S02Me 
c C02ClVle3 
d COMe 
HO~ 
N 
12 
R 
2.2Sa-d 
(i) ~O~ O~>S( N 
o ~2 
2.28a-d 
H0r?, L ~tr?, 
2.26a-d (i) 2.29a-d 
HO~RI: J #sroyQ 
o IS ~2 
2.27a-d 
2.30a-d 
Scheme 2.10. Reagents and conditions: (i) DMAP, Htinig's base, (lS,4R)-(-)-
camphanoyl chloride, CHzClz (2.28a, 95%), (2.28b, 86%), (2.28c, 76%), (2.28d, 99%), 
(2.29a, 40%), (2.29b, 53%), (2.29c, 69%), (2.29d, 35%), (2.30a, 53%), (2.30b, 31%), 
(2.30c, 82%), (2.30d, 11 %). 
Chapter Two - Synthesis and properties of ring-deactivated hydroxymethylpyrroles 42 
borane® sequence were observed to have slightly higher configurational purities of -15: 1 
to > 19: 1. Therefore, as the esterification reaction has no effect on the configuration at the 
deuterated methylene position of the precursor hydroxymethylpyrroles, the 
configurational purities of 2.26a-d and 2.27a-d can also be inferred as being -9: 1 and 
-15:1 to >19:1, respectively. See the following section for the detailed analysis of the 
configurational purities of these camphanate derivatives. 
2.4. Deactivation study and configurational analysis 
In the crucial deactivation study experiments, separate samples of the deuterated 
hydroxymethylpyrroles 2.26a-d, of known configurational purity, were treated with 
(lS,4R)-(-)-camphanic acid under Mitsunobu conditions to give mixtures of the 
corresponding camphanates 2.29a-d and 2.30a-d in yields of 31 %, 54%, 46% and 43%, 
respectively (Scheme 2.11). The results of the IH NMR spectral analysis of the 
camphanates from these reactions, 2.29a-d and 2.30a-d, are given in Table 2.1, second 
Scheme 2.11. Reagents and conditions: (i) Ph3P, DEAD, (IS,4R)-(-)-camphanic acid 
(2.29a/2.30a, 31 %), (2.29b/2.30b, 54%), (2.29c/2.30c, 46%), (2.29d12.30d, 43%); (ii) 
Ph3P, DEAD, (lS,4R)-(-)-camphanic acid (2.29a/2.30a, 32%), (2.29b/2.30b, 72%), 
(2.29c/2.30c, 36%), (2.29d12.30d, 77%). 
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(a) DMAP, Htinig's base, (lS,4R)-(-)-camphanoyl chloride 
(b) Ph3P, DEAD, (lS,4R)-(-)-camphanic acid (Mitsunobu conditions) 
(c) reaction sequence was performed using unlabelled 2.2Sa-d to give 2.28a-d 
Table 2.1. IH NMR resonances (CDCb) for the exo-methylene ( *) of 2.28, 2.29, 2.30. 
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row of spectra. The ratio of 2.30 to 2.29, observed on reaction of the N-
trifluoromethanesulfonyl (triflyl), N-methanesulfonyl (mesyl), N-tert-butoxycarbonyl 
(BOC) andN-acetyl series, were ~5:1, ~3:2, ~5:4 and ~1:1, respectively. In comparison, 
the initial ratios of 2.27a-d and 2.26a-d had been determined to be ~ 1:9 by analysis of the 
reference carnphanate samples (see Scheme 2.10 and Table 2.1, first row of spectra). The 
major isomers fOlmed in these reactions, the camphanates 2.30a-c, are the products of an 
inversion of configuration due to an SN2 displacement on 2.26a-c under the Mitsunobu 
conditions (Scheme 2.11). The higher the proportion of configuration 2.30 relative to 
configuration 2.29 in these products, the greater has been the effectiveness of the electron 
withdrawing group in disfavouring reaction via the azafulvenium intermediate 2.20 (see 
Scheme 2.8). The trifluoromethanesulfonyl group was found to be most effective in 
suppressing this azafulvenium formation, with the N-triflyl deactivated 
hydroxymethylpyrrole 2.26a undergoing substitution via an SN2 mechanism almost 
exclusively to give 2.30a. At the other extreme, the tert-butoxycarbonyl and acetyl 
groups were found to be much less effective at deactivating the pyrrole ring, with the N-
BOC and N-acetyl hydroxymethylpynoles, 2.26c and 2.26d, undergoing a substantial 
amount of substitution via an azafulvenium mechanism. 
In the complementary deactivation study experiments, samples of the deuterated 
hydroxymethylpyrroles 2.27a-d, of known configurational purity, were treated with 
(lS,4R)-C-)-camphanic acid under Mitsunobu conditions as before, to give mixtures of 
the corresponding camphanates 2.29a-d and 2.30a-d in yields of 32%, 72%, 36% and 
77%, respectively (Scheme 2.11). The ratio of 2.30 to 2.29 observed on reaction of the 
N-triflyl, N-mesyl, N-BOC and N-acetyl series, as given in Table 2.1, fourth row of 
spectra, were ~ 1 :6, ~2:3, ~4:5 and ~ 1: 1, respectively. In comparison, the initial ratios of 
2.27a-d and 2.26a-d had been determined to be ~15:1 to >19:1 by analysis of the 
reference camphanate samples (see Scheme 2.10 and Table 2.1, third row of spectra). 
Finally, the absolute configurations of 2.29a-d and 2.30a-d, although being 
consistent with literahlre reports for Alpine borane® reductions/4 were confirmed by 
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ozonising a sample containing a ~3:2 mixture of 2.29b and 2.30b by the methodology of 
Klein and Steinmetz.21 The resulting acid was trapped with an excess of diazomethane to 
give a ~3:2 mixture of 2.31a and 2.31b in an overall yield of 39% for both steps (Scheme 
2.12). A lH NMR spectrum of this mixture of 2.31a and 2.31b was consistent with data 
from authentic samples of 2.31 and with the unlabelled analogue?2 
(i), (ii) 
.. 
~3 (2.29b) : 2 (2.30b) 1 2 2.31a R :=: DJ R "" H 
2.31b Ri =: H, R2;::::: D -3: 2 
Scheme 2.12. Reagents and conditions: (i) 0 3, -78°C; (ii) CH2N2, MeOH (39% for 2 
steps). 
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2.5. Conclusion 
A new methodology was developed which enabled the deactivating ability of an 
electron withdrawing group on the pyrrole ring to be quantified. This was achieved by 
reacting a series of chiral deuterium-labelled N-substituted hydroxymethylpyrroles of the 
type 2.13, with the chiral resolving agent (lS,4R)-(-)-camphanic acid under Mitsunobu 
(ie SN2) conditions (Scheme 2.8). By the subsequent analysis of the configurational 
purities at the deuterated exo-methylene centres of these product camphanates by IH 
NMR spectroscopy, and comparison of these results with previously prepared reference 
camphanate samples of known configurational purity, the degree of azafulvenium 
suppression during the SN2 reaction was able to be determined. This methodology 
therefore enables the effectiveness of a particular electron withdrawing group to 
deactivate a pyrrole ring to be quantified, and also gives a method by which the 
deactivating abilities of a range of substituents can be compared. 
The conclusion from these labelling experiments is that the order for the 
deactivating ability of the pyrrole N-protecting groups considered in this study is triflyl > 
mesyl > BOC "" acetyl. Therefore, SN2 displacements at the hydroxymethyl group of 
compounds of the type 2.4 (Scheme 2.1) are favoured by use of N-triflyl as the 
deactivating group and Mitsunobu reaction conditions. The suppression of contributions 
to the reaction from azafulvenium intermediates 2.5 is less effective with other 
deactivating groups, with the tert-butoxycarbonyl (BOC) and acetyl groups having little 
or no effect on azafulvenium suppression. An N-triflyl group should, therefore, be 
employed when maximum deactivation of a pyrrole ring is desired. It has been assumed 
that the introduction of an electron withdrawing group onto a pyrrole nitrogen, as in 2.4, 
suppresses the formation of highly reactive azafulvenium intermediates 2.5, but until now 
little direct evidence for this has been available. 
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3.1. Introduction 
\ 
Pyrroles are the key building blocks to a large number of biomolecules which are 
essential for life, such as porphyrins, haemoglobin and vitamin B 12. These compounds 
are synthesised in nature via an initial azafulvene-based tetramerisation of the pyrrole 
precursor porphobilinogen (PBG) 3.1 to give hydroxymethylbilane (HMB) 3.2, which is 
subsequently cyclised, also by azafulvene chemistry, to give uroporphyrinogen III 
(uro' gen III) 3.3 (see Chapter 1.2 for more details of the biosynthesis of uro' gen III). At 
this point the biosynthetic pathway diverges, and uro' gen III is transformed into the range 
of tetrapyrrole-based compounds found in nature (Scheme 3.1).1 
Scheme 3.1. Biosynthetic pathway of tetrapyrrole-based compounds. 
Consequently, due to their importance in a vast array of biological processes, 
much research has been focussed on unravelling the mechanisms by which these 
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important tetrapyrrole-based biomolecules are synthesised in nature.2 In chemistry, 
bilanes, such as HMB 3.2, can be prepared by coupling together two dipyrromethanes, 
such as 3.4 and 3.5, under acidic conditions (Scheme 3.2).3 
AMe pMe AMe pMe p 
J6Jj A P 
OHC N N 
H 3.4 H HO j P A 
AMe pMe AMe pMe 
A 3.2 HO~ A = CH2C02H N N P = CH2CH2C02H H 3.5 H 
Scheme 3.2. Acid-catalysed synthesis of hydroxymethylbilane 3.2. 
Accordingly, dipyrromethanes are key synthetic intermediates in the preparation 
of bilanes. As a result, the preparation of dipyrromethanes has been the focus of much 
research, and various synthetic methodologies to these compounds have been reported in 
the literature. 3,4 What follows is a brief summary of some of the methods that have been 
employed. The most common approach to preparing dipyrromethanes involves the use of 
acid catalysed electrophilic substitution. In this method, an a-unsubstituted pyrrole, such 
as 3.8, is reacted with an azafulvene of the type 3.7 to give a dipyrromethane of the type 
3.9 (Scheme 3.3)? This azafulvene can be generated in situ from either an 
acetoxymethylpyrrole (eg 3.6), a hydroxymethylpyrrole, or a chloromethylpyrrole under 
acidic conditions.4 
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AMe pMe AMe pMe AMe pMe )j ~C02Bn H+ ~ .. BUt02C N + N C02Bn H 
t 
H AcO H 
3.8 3.7 3.6 
AMe pMe AMe pMe AMe pMe AMe pMe 
~ • Jr5Jr) • Bdo2c N N C02Bn OHC I\J I\J 
H 3.9 H H H 3.4 
Scheme 3.3. Synthesis of a dipyrromethane via azafulvene chemistry. 
Similarly, in an analogous acid-catalysed procedure, electrophilic attack at the 
substituted a-position of a hydroxymethylpyrrole of the type 3.10 by its resultant 
azafulvene 3.11, followed by elimination of formaldehyde, leads to the formation of 
symmetrical dipyrromethanes of the type 3.12 (Scheme 3.4).4,5 
R2 R3 
n OH R1~N~ 
H 
3.10 
I 
R3 R2 
J::iR1 
+H 
3.11 
I 
Scheme 3.4. Synthesis of a symmetrical dipyrromethane via azafulvene chemistry. 
The preparation of dipyrromethanes under non-acidic conditions has been much 
less studied, with only a single report appearing in 1929.6 Here, a tetra-substituted 
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bromomethylpyrrole 3.13 was coupled with the N-magnesio pyrrole 3.14 to gIVe the 
dipyrromethane 3.15 in 78% yield (Scheme 3.5). 
i.LBr + rl • Et02C N N Et02C N 
H MgBr H 
3.13 3.14 3.15 
Scheme 3.5. Pyrrolylmagnesium-mediated preparation of dipyrromethane 3.15. 
Finally, the synthesis of the simple dipyrromethane 3.19 has also been achieved 
by the reduction of the corresponding dipyrroketone 3.18 (R = H) with sodium 
borohydride (Scheme 3.6).7 Dipyrroketones of the type 3.18 are in turn prepared by 
reacting an a-unsubstituted pyrrole of the type 3.17 with either a 2-(N,N-
dimethylcarboxarnido)pyrrole 3.16a via a modified Vilsmeier-Haack reaction, or with a 
pyrrole-2-carbonyl chloride 3.16b using standard acylation methods. s 
R R 
nx RAN~( 
H 0 
3.1Ga X = I\lMe2 
3.1Gb X= CI 
+ 
R R 
li N R 
H 
3.17 
R R R R 
nn RAN~('~AR 
H 0 H 
3.18 
1 NaBH4 
~ N N 
H H 
3.19 
Scheme 3.6. Synthesis of dipyrroketones and subsequent reduction to dipyrromethanes. 
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In order to enable some of the key stereochemical issues associated with the 
biosynthesis of porphyrins and related compounds to be investigated, a chemical marker 
or label, with known configuration, is required in the precursor molecules. A preliminary 
report on this topic was published by Battersby et al. in 1987.9 Consequently, by 
determining the position and configuration of this label in the final product, mechanistic 
information about the biochemical transformation can be attained. The dipyrromethanes 
3.20 and 3.21, which are stereoselectively labelled with a deuterium atom at the 
interpyrrolic methylene position, would therefore be invaluable derivatives in this 
context. Coupling these dipyrromethanes would enable the synthesis of Cs and/or CIS 
deuterium-labelled hydroxymethylbilanes (see Scheme 3.7). The C20 deuterium-labelled 
hydroxymethylbilane has already been reported by Battersby et al. 9 
AMe pMe A Me pM€! 
H H OHC~~L~/ 
H I-1(D) H 
3.20 
AMe pMe A Me pM€! Han n ~tJY~;> 
H H(D) H 
3.21 
A p 
HO 
p A 
A 
Scheme 3.7. Proposed method for the synthesis of Cs and/or C 15 deuterium-labelled 
hydroxymethylbilanes. 
However, the existing acid-catalysed azafulvene-based preparations of 
dipyrromethanes described above would almost certainly prove unsatisfactory in the 
preparation of chiral deuterium-labelled dipyrromethanes of the type 3.20 and 3.21, since 
azafulvene formation would lead to the scrambling of the deuterium-label at the 
interpyrrolic methylene position. Likewise, the dipyrroketone reduction method would 
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also be unsatisfactory, since the stereoselective incorporation of a deuterium atom into 
the interpyrrolic methylene position would not be trivial. The method of most promise in 
our opinion, therefore, was the nucleophilic displacement reaction using a 
pyrrolylmagnesium salt. This methodology has the advantage of both avoiding acidic 
conditions which could lead to azafulvene formation, and also could allow for the 
preparation of unsymmetrical dipyrromethanes. 
Accordingly, the initial aim of the research described in this chapter was to further 
investigate this pyrrolylmagnesium-based preparation of dipyrromethanes, and to extend 
this methodology to the synthesis of dipyrromethanes bearing an aldehyde functionality 
at the a-position. For the sake of synthetic ease, initial work in this area was to be 
carried out on a simplified system, using pyrroles unsubstituted at the 3- and 4-positions. 
a-Formyldipyrromethanes were selected for synthesis because the 2-formyl group 
provides a suitable site for the subsequent elaboration of these compounds into bilanes of 
the type 3.2, as shown in Scheme 3.2. A potential application of this methodology would 
be the synthesis of deuterium-labelled dipyrromethanes of the type 3.20 and 3.21. These 
compounds could then be transformed into labelled hydroxymethylbilane and uro' gen III, 
and so be used to determine important mechanistic information about key enzymes in the 
biosynthesis of porphyrins and related compounds. 
3.2. Synthesis of starting materials 
The key formyl-protected starting materials, 3.22 and 3.23, were prepared from 
pyrrole-2-carboxaldehyde 2.22a (Scheme 3.8) using standard literature procedures. The 
dioxolanylpyrrole 3.22 was prepared in three steps in 58% overall yield by the indirect 
method described by Loader and Anderson,lo while the dithiolanylpyrrole 3.23 was 
prepared in 92% yield by the method described by Wallace et aI. 11 These compounds 
were used to prepare the N-magnesio pyrroles required for the couplings. The N-
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methanesulfonyl-2-hydroxymethylpyrrole 2.25b was prepared from 2.22a by N-
mesylation followed by reduction, as described in Chapter 2. Compound 3.25 was 
similarly prepared from pyrrole-2-carboxaldehyde 2.22a in 90% yield (2 steps) by N-
substitution with tosyl chloride to give 3.24, followed by zinc borohydride reduction of 
the formyl group (Scheme 3.8). 
(iv) 
(vi) 
2.23b R = S02Me 
3.24 R = S02C6H4Me 
HO~ 
N 
I 
R 
2.25b R S02Me 
3.25 R S02C6H4Me 
Scheme 3.8. Reagents and conditions: (i) NaH, then CIC02Et; Oi) 
Me2C(CH20Hh p-TsOH, 1,2-DCE, reflux; (iii) NaOH, MeOH-H20, reflux (58% for 3 
steps); (iv) HSCH2CH2SH, PhNH2, MeOH (92%); (v) NaH, THF then either MeS02CI 
(2.23b, 93%) or p-MeC6H4S02Cl (3.24, 99%); (vi) Zn(BH4h (2.25b, 91 %), (3.25, 91 %). 
The N-substituted-2-chloromethylpyrroles 3.28 and 3.29 were prepared in yields 
of 87% and 83% from their respective hydroxymethylpyrroles 2.25b and 3.25 by 
treatment with methanesulfonyl chloride and HUnig's base. These chloromethylpynoles 
HO~ 
N 
I 
R 
(i) • [Me02S0J( ] __ .. CI~ 
N 
I 
R 
2.25b R S02Me 3.26 R = S02Me 3.28 R = S02Me 
3.25 R S02C6H4Me 3.27 R S02C6H4Me 3.29 R = S02C6H4Me 
Scheme 3.9. Reagents and conditions: (i) HUnig's base, MeS02CI then 10(/0 aq. HCl 
(3.28,87%), (3.29, 83%). 
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provided the alkylating agents for the reaction with the N-magnesio pyrroles described 
above. The O-mesylates 3.26 and 3.27 were postulated as the intermediates in this 
chlorination reaction, but were unable to be isolated due to their rapid in situ reaction 
with chloride ion. 
In order to establish whether compounds 3.26 and 3.27 were intermediates to the 
chloromethylpyrroles 3.28 and 3.29, respectively, the reaction of 2.2Sb with 
methanesulfonyl chloride was followed by low temperature IH NMR spectroscopy. 
Spectral analysis showed that the O-mesylate 3.26 was indeed formed upon the addition 
of methanesulfonyl chloride to a mixture of the hydroxymethylpyrrole 2.2Sb and Htinig's 
base in CDCb at -20°C, However, the chloromethylpyrrole 3.28 was observed to form 
concurrently. The course of the reaction was able to be followed by observing the exo-
methylene resonances at 8 4.74, 4.91 and 5.38 for the hydroxymethyl, chloromethyl and 
O-mesylpyrroles, respectively. The relative amounts of the pyrroles 2.2Sb, 3.26 and 3.28 
observed during the course of the reaction, as determined by integration of the repective 
exo-methylene resonances, are detailed in Table 3.1. 
Relative % of each compound 
Time (min) 2.2Sb 3.26 3.28 
Initial 100 0 0 
0 40 50 10 
2.5 10 60 30 
5 0 50 50 
10 0 30 70 
15 0 20 80 
20 0 10 90 
30 0 5 95 
45 0 2.5 97.5 
60 0 0 100 
Table 3.1. Relative amounts of the pyrroles 2.2Sb, 3.26 and 3.28 observed by IH NMR 
spectroscopy during the course of the reaction. 
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From the results detailed III Table 3.1 it can be seen that the 
hydroxymethylpyrrole 2.2Sb was rapidly converted into the O-mesylate 3.26 within 5 
min at -20 DC. However, the subsequent conversion of the O-mesylate 3.26 into the 
chloromethylpyrrole 3.28 occurred at a slower rate, and was not complete until around 60 
min. 
A similar reaction of N-mesyl-2-hydroxymethylpyrrole 2.2Sb was then performed 
using methane sulfonic anhydride and Htinig's base in CDCh at -20 DC. A IH NMR 
spectrum of the reaction mixture immediately after addition showed that the majority of 
the hydroxymethylpyrrole 2.2Sb had been converted into the O-mesylate 3.26, with only 
a trace (-5%) of 2.2Sb still remaining. Subsequent spectral analysis found that the 0-
mesylate 3.26 was stable up to 0 DC, after which substantial conversion back to the 
hydroxymethylpyrrole 2.2Sb was observed to occur. 
3.3. Synthesis of dipyrromethanes using pyrro/y/magnesium derivatives 
Simple N-magnesio derivatives of pyrrole are reported to react preferentially with 
alky1ating agents at carbon to produce a mixture of 2(a)- and 3(~)-alkylpyrroles, in 
which the 2-isomer usually predominates. 12 This is in contrast to the N-pyrrolyl alkali 
metal salts which react preferentially at nitrogen to give N-alkylpyrroles (see Chapter 2.1 
for further discussion). However, if the pyrrole ring already contains substituents, the 
alkylation pattern on the pyrrolylmagnesium derivative becomes more complex. Electron 
donating groups at the 2-position of the pyrrole ring preferentially enhance alkylation at 
the 3- and 5-positions, with the 5-position the more activated site for substitution due to 
the effect of the annular nitrogen. 13 Furthermore, it has been reported that bulky 
alkylating agents further enhance the formation of the 2,5-product over the 2,3-product, 
and also tend to inhibit polyalkylation products, presumably due to steric reasons. 14 In 
contrast, electron withdrawing groups at the 2-position of the pyrrole ring promote 
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substitution at the 4- and 5-positions. The ratio of these two isomers depends on the -M 
effect of the 2-substituent, with a larger -M effect giving a greater proportion of the 4-
isomer. 15 In addition, it has also been suggested that the C-alkylation of 
pyrrolylmagnesium salts occurs via an SN2 mechanism, since it was reported that reaction 
with (-)-2-bromobutane gave the corresponding 
inversion of configuration at the alkyl group.14u 
and 3-substituted pyrroles with 
The feasibility of preparing a-formyldipyrromethanes by way of alkylation of a 
suitable pyrrolylmagnesium derivative at the a-free position was initially investigated 
using a model system. In an initial trial experiment, pyrrole-2-carboxaldehyde 2.22a was 
deprotonated with methylmagnesium iodide to give the corresponding N-magnesio salt 
which precipitated from the reaction mixture. Excess methyl iodide was added and after 
stirring for 3 hours a homogeneous solution was obtained. However, subsequent work up 
of this solution gave recovered starting material 2.22a only. It was possible that 
methylation had taken place on the formyl oxygen, rather than on carbon of the pyrrole, 
to give 3.30, which had then been hydrolysed to 2.22a on work up (Scheme 3.10). 
However, this seems unlikely as magnesium alkoxides are poor nuc1eophiles and methyl 
iodide is a soft electrophile. Therefore, at this stage it remains uncertain why only 
starting material was isolated. It was then postulated that protection of the formyl group, 
such as by its conversion to the acetal 3.22, might eliminate this above complication and 
allow alkylation to proceed on carbon. 
Hfi i( "~/ 
o H 
2.22a 
(i) 
- [ HyQ] MeO 
3.30 
2.22a 
Me 
(i) O)/~ ":J:~~/ o H 
.$' 
.:; 
3.31a 
on 
+ ~r"~/'Me 
.:; 
3.31b 
+ polyalkylation 
products 
+ 3.22 
Scheme 3.10. Reagents and conditions: (i) MeMgI, THF, rt then Mel then H20. 
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Indeed, reaction of 3.22 with methylmagnesium iodide, followed by the addition of an 
excess of methyl iodide gave an inseparable mixture of C-alkylated pyrroles and starting 
materia12.22a in an approximate ratio of 2 : 5 by IH NMR spectroscopy (Scheme 3.10). 
No attempt was made to fully characterise these alkylation products. However, on the 
basis of previous work on the alkylation of pyrrolylmagnesium salts,14b it was reasoned 
that the product mixture would consist predominantly of the 2,3- and 2,5-disubstituted 
products 3.31a and 3.31b, respectively, along with various other polyalkylation products. 
Having established that we were able to effect C-alkylation of the formyl-
protected pyrrole under these conditions, we turned our attention to the coupling of 3.22 
with the chloromethylpyrrole 3.28 (Scheme 3.11) bearing an N-methanesulfonyl group to 
deactivate the pyrrole ring, and hence further favour an SN2 substitution mechanism. As 
discussed in Chapter 2.1, hydroxymethyl- and chloromethylpyrroles lacking an N-mesyl 
or related group are reactive and labile. In contrast, the chloromethylpyrrole 3.28 and its 
synthetic precursor 2.25b were stable compounds. The effect of an electron withdrawing 
group on the nitrogen of a chloromethylpyrrole was shown by determining the structure 
of the N-p-toluenesulfonyl derivative 3.29 by X-ray analysis (see Figure 3.1 and Section 
3.6 for a discussion). 
The N-mesylchloromethylpyrrole 3.28 was reacted with a 3.3 molar excess of the 
N-magnesio salt16 derived from 3.22 and methylmagnesium iodide (Scheme 3.11). It has 
been reported that polyalkylation of the pyrrolylmagnesium species is an important 
reaction when equivalent quantities of alkylating agents are used/6,17 therefore an excess 
of the N-magnesio salt derived from 3.22 was employed in an attempt to minimise such 
polyalkylation. Work up with aqueous acetic acid gave the doubly protected 
dipyrromethane 3.32 in admixture with pyrrole-2-carboxaldehyde 2.22a. The coupling 
proceeded exclusively at the a-position to give the desired 2,5-disubstituted product, with 
none of the alternative 2,3- or polysubstituted products evident by IH NMR spectroscopy, 
Deprotection of the formyl group was then achieved by treating the above sample of 3.32 
with pyridinium tosylate in 50% aqueous acetone, to give the a-formyldipyrromethane 
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3.34 in 60% overall yield for the 2 steps, which was fully characterised. An identical 
reaction of the N-magnesio salt of 3.22 with the chloromethylpyrrole 3.28, followed by 
the addition of aqueous hydrochloric acid gave 3.34 directly in a yield of 63% (Scheme 
3.11 ). 
The thioacetal 3.23 was similarly treated with methylmagnesium iodide, and the 
resulting N-magnesio salt was coupled with the chloromethylpyrrole 3.28 to give the 
protected dipyrromethane 3.33 (Scheme 3.11). Again, no other alkylation isomers were 
evident by IH NMR spectroscopy. Removal of the dithiolane protecting group from 3.33 
was then achieved using mercUlic chloride and calcium carbonate in 80% aqueous 
acetonitrile to give 3.34 in an overall yield of 40% for the two steps. 
(i) 0 n n + 2.22a 
~ (~y "~/ "-/ "~/ + 3.22 
~O S02Me ~ 3.32 
(iii) ! (ii) 
H~\ r~
N N 
, I 
o H S02Me 
3.34 
H n n [( "~/ "-/ '~/ 
o H H '1 3 35 (vi) . _ .. --- (v) 
(iv) S n n Cy "~/ "-/ "~/ + 3.23 
S 3.33 S02Me 
Scheme 3.11. Reagents and conditions: (i) MeMgI, -10 DC to rt then 3.28, -10 DC to rt 
then 10% aq. AcOH; (ii) PPTS, acetone-H20 (1:1), reflux (60% for two steps); (iii) 
MeMgI, -10 DC to rt then 3.28, -10 DC to rt then 10% aq. HCI (63%); (iv) MeMgI, -10 
DC to 11 then 3.28, -10 DC to It then aq. N"[-4CI (50%); (v) HgCh, CaC03, MeCN-FhO 
(1:4) (83%); (vi) NaOH, MeOH-H20, reflux (85%). 
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Finally, removal of the N-methanesulfonyl deactivating group from 3.34 was 
accomplished by heating 3.34 with aqueous sodium hydroxide at reflux, to give 3.35 in 
85% yield. The a-formyldipyrromethane 3.35 has previously been prepared by Clezy et 
ai. in 59% yield by formylation of the 2,2'-dipyrromethane 3.19 (see Scheme 3.6).18 
This pyrrolylmagnesium-based synthetic approach to dipyrromethanes was 
further extended, in work carried out in collaboration with Professor Sir Alan Battersby, 
by the preparation of 3.40a and its deuterated analogue 3.40b (Scheme 3.12). These 
dipyrromethanes are useful precursors to biologically important bilanes, as discussed in 
Section 3.1, with the deuterium-label in 3.40b providing a potential marker that would 
enable the study of some of the key stereochemical issues associated with the 
biosynthesis of these compounds. The key starting materials 3.37 and 3.38, that were 
AMe pMe 
ti N C02Bn 
H 
3.36 
~ ~ ref 19 
ref 19 
AMe pMe 
R~ 
CI S02Me 
3.38a R = H 
3.38b R = 0 
A Me pMe A Me pMe A Me pMe 
n (i) HH Oy<~~ -~. Oy<~y~> 
-{:-o ~ -+=0 ~ 0 ~02Me 
3.37 3.39 
(iii) 
AMe = CH2C02Me 
pMe = CH2CH2C02Me 
J (ii) 
AMe pMe A Me pMe HM' 1\ 
'1 N N 
I H I 
o R S02Me 
3.40a R = H 
3.40b R = 0 
Scheme 3.12. Reagents and conditions: (i) MeMgI, THF, -10 DC then 3.38b, -10 DC to 
rt then aq. AcOH (70%); (ii) dilute aq. HCI; (iii) MeMgI, THF, -10 DC then 3.38a,-1O 
DC to rt then dilute aq. HCl (3.40a, 75%). 
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used in the synthesis of compounds 3.40, were all prepared from a common pyrrole 
precursor 3.36, in a number of steps, as recently detailed. 19 Next, reaction of the 
pyrrolylmagnesium salt derived fi'om 3.37 with the N-mesylchloromethylpyrrole 3.38a, 
followed by work up with aqueous hydrochloric acid, gave the a-formyldipyrromethane 
3.40a in 75% yield (Scheme 3.12). An analogous sequence using the racemic deuterated 
chloromethylpyrrole 3.38b, but worked up with aqueous acetic acid, gave the doubly 
protected dipyrromethane 3.39 in 70% yield. Subsequent hydrolysis of 3.39 with 
aqueous hydrochloric acid gave the corresponding deuterium-labelled a-
formyldipyrromethane 3.40b. 
Having successfully completed the synthesis of racemic deuterium-labelled 
dipyrromethane 3.40b, work was then focussed on preparing a sample of 3.40b that was 
stereoselectively labelled at the interpyrrolic methylene position. In order to accomplish 
this, a sample of optically active N-mesylhydroxymethylpyrrole 3.42 was prepared via 
the stereos elective reduction of the corresponding deuterated N-mesylformylpyrrole 3.41 
using R-Alpine borane® (Scheme 3.13). We had shown in previous work that the 
reduction of a deuterated N-mesylformylpyrrole with R-Alpine borane® gave the 
corresponding hydroxymethylpyrrole with an excess of the S-isomer over the R-isomer of 
-15: 1 (see Chapter 2.3). Therefore, it was reasoned that the R-Alpine borane® reduction 
of the N-mesylformylpyrrole 3.41 would also have given the S-isomer of 3.42 in an 
excess of -15: 1. The chiral N-mesylhydroxymethylpyrrole 3.42 was then converted into 
the corresponding chloromethylpyrrole 3.38b by treatment with methanesulfonyl chloride 
and Htinig's base. This chloromethyl formation was anticipated to proceed with inversion 
of configuration at the deuterated methylene centre of 3.42, to give an excess of the R-
isomer of 3.38b. Subsequent coupling of this chloromethylpyrrole with the 
pyrrolylmagnesium salt derived from 3.37, followed by hydrolysis under acidic 
conditions, gave the deuterium-labelled dipyrromethane 3.40b in 66% yield (Scheme 
3.13). On the basis of the work described in Chapter 2 it was hoped that this coupling 
would proceed under SN2 conditions. Coupling under such conditions would result in an 
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Scheme 3.13. Reagents and conditions: (i) R-Alpine borane®, THF, rt (84%); (ii) 
Honig's base, MeS02CI then 10% aq. HCI; (iii) MeMgI, THF, -10 °C then 3.38b, 0 
DC to rt then dilute aq. HCI (66%); (iv) N-amino-l-ephedrine, PhH, 4 A sieves, reflux. 
inversion of configuration at the deuterated methylene centre of 3.38b to give an excess 
of the S-isomer of the dipyrromethane 3.40b. To analyse the configuration at the 
deuterated methylene centre of this dipyrromethane sample, the ex-formyl group of 3.40b 
was coupled with the chiral amine, N-amino-l-ephedrine, to give the labelled hydrazone 
3.43 (Scheme 3.13). As a consequence of this hydrazone formation, the interpyrrolic 
methylene protons of 3.43 are made diastereotopic, and are thus potentially resolvable by 
IH NMR spectroscopy. 
The ratio of diastereomers at the deuterated methylene centre of 3.43 was 
determined to be -1: 1 by integration of the methylene proton resonances at 8 3.89 and 
3.97. Consequently, this indicated that the precursor dipyrromethane 3.40b was racemic. 
This result suggested that either the coupling had not occurred under SN2 conditions, or 
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that the starting deuterium-labelled chloromethylpyrrole 3.38b was racemic. Of these 
two possibilities, we felt that the latter explanation was the most likely cause for the 
observed loss of stereochemical integrity at the deuterated methylene centre during the 
synthetic sequence. This was in light of our earlier work, discussed in Chapter 2.4, which 
found that a considerable loss of configurational purity was obtained when a chiral N-
mesylhydroxymethylpyrrole was reacted with a nucleophile under SN2 conditions. This 
loss of stereochemical integrity was attributed to azafulvenium formation during the 
reaction sequence. Therefore, in the above attempted synthesis of a chiral sample of the 
deuterium-labelled dipyrromethane 3.40b, where two separate SN2 reactions were 
employed (ie for both chloromethylpyrrole formation and in the coupling procedure), 
there was considerable scope for a similar loss of stereochemical integrity due to this 
azafulvenium formation. Consequently, the N-mesyl group may therefore not be the best 
substituent to use when attempting the synthesis of a chiral deuterium-labelled 
dipyrromethane. Instead, a better substituent to employ on the pyrrole nitrogen in such a 
synthesis, so as to minimise this loss of stereochemical integrity, would be a triflyl group. 
An N-triflyl group has previously been found to be the optimal group on pyrrole for 
suppressing azafulvenium formation, due to its greater deactivating ability (see Chapter 
2.4 for a discussion). 
3.4. Investigation into the stereochemical course of chloromethyl- and 0-
mesylpyrrole formation 
The stereochemical course of chloromethylpYHole formation was investigated in 
order to determine whether a chiral deuterium-labelled chloromethylpyrrole could be 
prepared under the conditions described for the formation of 3.38b. We had established 
in previous work, discussed in Chapter 2.3, that deuterated hydroxymethylpyrroles could 
be prepared with a high degree of stereochemical purity through the use of a suitable 
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deactivating substituent on nitrogen. The analysis of the stereochemistry at the 
deuterated methylene centre of these hydroxymethylpyrroles was achieved by the 
attachment of a chiral derivatising agent or 'handle', namely the (lS,4R)-(-)-camphanate 
group, onto the hydroxymethyl position. However, such an approach to analyse the 
stereochemistry of deuterated chloromethylpyrroles is not possible due to the lack of a 
suitable functional group onto which to attach the required chirality. To circumvent this 
problem, wc decided to incorporate the chiral handle into the nitrogen deactivating 
substituent. In this way it was envisaged that the stereochemical course of the 
hydroxymethyl- to chloromethylpyrrole transformation could be conveniently monitored 
by JH NMR spectroscopy. The group that was selected to achieve this aim was (lS,4R)-
(+ )-lO-camphorsulfonyl chloride, a chiral derivatising agent which had previously been 
employed for the resolution of chiral amines. 20 This N-substituent, as an alkylsulfonyl 
group, would be expected to have a deactivating ability on the pYlTole ring comparable to 
that observed for the previously investigated methanesulfonyl group. 
The key deuterium-labelled N-camphorsulfonyl hydroxymethylpyrroles 3.45b and 
3.45c were prepared by treating the labelled formylpyrrole 2.22b with sodium hydride, 
and reacting the resultant pyrrolyl anion with (lS,4R)-( + )-lO-camphorsulfonyl chloride to 
o n (i) 0 n (ii) or (iii) 1 "['j/ - 1 "~/ * 
R H R 80
2 
or (iv) 
2.22a R=H o~ 
2.22b R=D  
3.44a R= H 
3.44b R = D 
3.45a R1 = R2 H 
3.45b R1 = D, R2 H 
3.45c R1 = H, R2 D 
Scheme 3.14. Reagents and conditions: (i) NaH, THF then (lS,4R)-(+)-lO-
camphorsulfonyl chloride (3.44a, 95%), (3.44b, 99%); (ii) Zn(BH4h Et20, 0 DC (3.45a, 
88%); (iii) S-Alpine borane®, THF, rt (3.45b:3.45c, 19: 1, 70%); (iv) R-Alpine borane®, 
THF, rt (3.45b:3.45c, 1:19,76%). 
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give 3.44b in 99% yield. This was then followed by the stereoselective reduction of the 
deuterated formyl group with either S- or R-Alpine borane®, to give mixtures of 3.45b 
and 3.45c in yields of 70% and 76%, respectively (Scheme 3.14). The ratios of 3.45b 
and 3.45c obtained from these S- and R-Alpine borane® reductions were determined to be 
19: 1 and 1: 19, respectively, by integration of the corresponding pyrrole-CHD singlet 
resonances at 04.72 and 4.87 (see first column of spectra, Table 3.2). The unlabelled 
analogue 3.45a, which was used as a reference compound in the subsequent analysis, was 
similarly prepared by N-substitution of pyrrole-2-carboxaldehyde 2.22a with (lS,4R)-( +)-
lO-camphorsulfonyl chloride, to give 3.44a in 95% yield, followed by zinc borohydride 
reduction of the formyl group in 88% yield. 
Next, we turned our attention to studying the stereochemical course of 
chloromethylpyrrole formation by IH NMR spectroscopy. In the ensuing reactions, the 
unlabelled 3.47a and deuterium-labelled chloromethylpyrroles 3.47b and 3.47c were 
observed to form from the corresponding mixtures of unlabelled 3.45a and deuterated 
hydroxymethylpyrroles 3.45b and 3.45c, of known configurational purity, and Hunig's 
base in CDCl) atD DC, upon treatment with methanesulfonyl chloride [see Scheme 3.15, 
reaction conditions (i) and second column of spectra, Table 3.2]. Subsequent work up of 
these mixtures then gave the chloromethylpyrroles 3.47a, 3.47b and 3.47c as the reaction 
products (see third column of spectra, Table 3.2). 
~ HO~N/ (i) or (ii) 
Rj-R~~ 
3045a R 1 = R2 = H 
1 2 3045b R = D, R = H 
1 2 3045c R = H, R = D 
3.46a R1 R2 = H 
1 2 3046b R =: D, R = H 
1 H 2 3046c R '" ,R = D 
3.47a R1 = R2 = H 
1 2 3047b R = D, R = H 
1 2 3.47c R = H, R = D 
Scheme 3.15. Reagents and conditions: (i) Hlinig's base, MeS02Cl then 10% aq. HCl; 
(Ii) Hunig's base, (MeS02)20, CDCl), -20°C. 
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Unlabelled 
S-Alpine 
borane® 
sequence 
R-Alpine 
borane® 
sequence 
3.45a 3.47a 3.47a 
jJ~ L L 
i ! I i II I I I' i I I II I I II I j, I' ! II Ii!! 'II ,! II II! II j I I II! I 'I i 
4.8 5.0 4.8 5.0 4.8 
3.45c : 3.45b 3.47b : 3.47c 3.47b : 3.47c 
L J 
It 'I i j i I t I j I I II Iii! I I I I II If' I I j I \11 Ii i j j I' j I I I' j I III 
4.8 5.0 4.8 5.0 4.8 
1 : 19 ~2: 3 ~1 : 1 
I 
L_J~J~ 
iii Iii I I Ii' i I I I I I 
4.8 
19 : 1 
, I' i j I I'! til! j i I Ii 
5.0 4.8 
:2 
I I' i I! I' I I i II j I 'I! 
5.0 4.8 
~1 : 1 
Table 3.2. IH NMR resonances (CDCb) for the pyrrole exo-methylene group of 3.45 
and the reaction product 3.47. In the spectra of 3.45b-c, coupling of the signals with the 
OR proton were removed by homonuclear decoupling. 
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The key point to note from the results shown in Table 3.2 is that compared to the 
configurational purity of the starting deuterated hydroxymethylpyrroles 3.4Sb and 3.4Sc 
(19:1), only a small excess of the corresponding chloromethylpyrrole isomer (-3:2), 
resulting from net inversion of the stereochemistry at the exo-methylene position, was 
observed to form during the chlorination reaction. This isomer ratio of ~3:2 for the 
respective chloromethylpyrrole products was, however, in agreement with the isomer 
ratio of ~3:2 previously obtained from the Mitsunobu reaction of chiral N-
mesylhydroxymethylpyrroles with (lS,4R)-(-)-camphanic acid under SN2 conditions (see 
Chapter 2.4). Therefore, as predicted, this demonstrates that the two alkyl sulfonyl 
groups, camphorsulfonyl and methanesulfonyl, have analogous deactivating abilities on 
the pyrrole ring, and so both suppress azafulvenium formation to similar extents. A 
second point to note is that upon work up of the reaction mixtures, -1: 1 mixtures of the 
chloromethylpyrroles 3.4Sb and 3.4Sc were obtained (rows 2 and 3 of Table 3.2). This 
indicates that further azafulvenium formation probably occurs under the conditions used 
in the work up procedure, resulting in the total scrambling of the deuterium-label at the 
exo-methylene position. This observed scrambling of a chiral deuterium-label during 
chloromethylpyrrole formation, therefore confirms our earlier proposition that this was 
the cause of the racemisation encountered in our attempted synthesis of a chiral sample of 
the dipyrromethane 3.40b (see Scheme 3.13). A final point to note from the results 
shown in Table 3.2 is that in the case of the N-camphorsulfonyl hydroxymethylpyrroles, 
the methylene resonance is upfield for the R-isomer (eg 3.4Sb) relative to the S-isomer 
(eg 3.4Sc). This configurational assignment was based on the work of Midland et al. 21 
which had shown that reduction of an aldehyde by S- or R-Alpine borane® gives the R- or 
S-alcohol, respectively, with a high degree of enantiomeric purity. In the case of the N-
camphorsulfonyl chloromethylpyrroles 3.47b and 3.47c, however, the observed 
methylene resonances were reversed with respect to 3.4Sb and 3.4Sc, with the methylene 
resonance upfield for the S-isomcr relative to the R-isomer. The assignment of the 
configurations of the chloromethylpynoles 3.47b and 3.47c were based on the 
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assumption that the chlorination reaction proceeds with inversion of configuration at the 
deuterated methylene centre. 
Having established that chloromethylpyrrole formation proceeded with 
scrambling of the deuterium-label at the exo-methylene position, we turned our attention 
to investigating the stereochemical course of O-mesylate formation in order to ascertain 
whether we could prepare chiral O-mesylates. Such chiral O-mesylates might prove 
suitable for coupling in the stereoselective synthesis of labelled dipyrromethanes. 
Consequently, the conversion of labelled N-camphorsulfonylpyrroles 3.45b and 3.45c to 
the O-mesylates 3.46b and 3.46c was followed by low temperature IH NMR 
spectroscopy [see Scheme 3.15, reaction conditions (ii)]. Spectral analysis showed that 
upon addition of methanesulfonic anhydride to a mixture of 3.45b and 3.45c (19: 1 by IH 
NMR) and Htinig's base in CDCh at -20°C, the corresponding O-mesylates 3.46b and 
3.46c were observed to form, albeit in a lower isomer ratio of 1. A 1 H NMR spectrum 
of the reaction mixture after 30 min showed a -1: 1 ratio of the two isomers, indicating 
the total scrambling of the deuterium-label at the exo-methylene position. This loss of 
stereochemical integrity at the deuterated methylene centre was again attributed to 
azafulvenium formation during the reaction sequence. The epimeric ratio of the 0-
mesylates 3.46c and 3.46b was determined by integration of the pyrrole-CHD singlet 
resonances at 0 5.39 and 5.45, respectively. As in the case of the chloromethylpyrroles 
3.47b and 3.47c described previously, the methylene resonance of the O-mesylates 3.46b 
and 3.46c was upfield for the S-isomer relative to the R-isomer. These configurational 
assignments were based on the assumption that the initial O-mesylation reaction proceeds 
with retention of configuration at the deuterated methylene centre. Finally, in the 
complementary experiment, the mesylation reaction carried out with the 
hydroxymethylpyrroles 3.45b and 3.45c (1: 19 by lH NMR) also showed scrambling of 
the deuterium-labeL The O-mesylates 3.46b and 3.46c were initially observed to form in 
a isomer ratio of ~ 1:4, however, a IH NMR spectrum of the reaction mixture after 90 min 
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showed only a -1: 1 ratio of the two isomers. This scrambling of the deuterium-label 
during the reaction sequence was again attributed to azafulvenium formation. 
These results demonstrate that the scrambling of the deuterium-label at the exo-
methylene position of 3.45b and 3.45c occurs readily during O-mesylate formation, even 
at low temperature. This fact, therefore, greatly restricts any attempt to prepare chiral 
deuterium-labelled dipyrromethanes of the type 3.40b using the synthetic methodology 
detailed in Section 3.3. This is due to the propensity of the chiral starting material to 
undergo racemisation under the reaction conditions used to activate the leaving group 
towards nucleophilic displacement. It is important to note again, however, that this 
investigation was carried out using a camphorsulfonyl group to deactivate the pyrrole, 
due to the need for a chiral handle to allow discrimination of the stereochemistry at the 
deuterated methylene centre. As discussed previously, this would not be the best 
substituent for deactivating the pyrrole ring, and hence suppressing azafulvenium 
fOlmation. Instead, the optimal substituent to employ on the pyrrole nitrogen during 0-
mesylate formation in order to minimise this observed racemisation would be a triflyl 
group due to its greater deactivating ability on the pyrrole ring. 
3.S. Attempted preparation of chiral deuterium-labelled dipyrromethane 
From the above low temperature mesylation studies, it was therefore concluded 
that for the best chance of preparing a chiral deuterium-labelled dipyrromethane, an 0-
mesylate would need to be generated from the corresponding chiral 
hydroxymethylpyrrole at low temperature, and then be immediately coupled with the 
pyrrolylmagnesium salt, also at low temperature. In this way, it was hoped that the 
degree of scrambling of the deuterium-label in the resulting dipyrromethane could be 
minimised, by reacting the O-mesylate before it underwent an appreciable amount of 
epimerisation at the methylene centre. In this study, the N-mesyl group was again used to 
Chapter Three - Synthesis of dipyrromethanes: an application of deactivated hydroxymethylpyrroles 72 
deactivate the pyrrole ring in preference to the more deactivating N-triflyl group, as this 
group would allow a direct comparison with our previously described synthesis of the N-
mesyldipyrromethane 3.34a, which utilised the coupling of a pyrrolylmagnesium salt 
with a chloromethylpyrrole (see Section 3.3). 
In the ensuing reaction, the bismesylate 3.26a, generated at --40 DC from 2.2Sb, 
was coupled with the pyrrolylmagnesium salt derived from 3.22. Subsequent work up 
with aqueous hydrochloric acid then gave the dipyrromethane 3.34a in 53% yield 
(Scheme 3.16). The corresponding sequence was repeated using the bismesylate 3.26b, 
generated at --40 DC from a mixture of 2.26b and 2.27b (~1: 15 by camphanate analysis as 
described in Chapter 2.3). By analogy to the low temperature O-mesylation studies 
described in Section 3.4, the bismesylate 3.26b formed was assumed to have a 
configurational purity of ~4: 1 at the deuterated methylene centre. Subsequent coupling 
of 3.26b with the pyrrolylmagnesium salt derived from 3.22, followed by hydrolysis 
under acidic conditions, gave the deuterium-labelled dipyrromethane 3.34b in 54% yield 
(Scheme 3.16), 
HO 1/1.. ~N/ 
R1"R2 S02Me 
2.25b R 1 = R2 = H 
2.26b R1 = D, R2 = H 
2.27b R 1 = H, R2 = D 
(i) 
(ii) or (iii) 
3.22 
3.26a R = H 
3.26b R = D 
H fl n I( '~/ Y'~/ 
o H R S02Me 
3.34a R= H 
3.34b R= D 
Scheme 3.16. Reagents and conditions: (i) Hiinig's base, (MeS02hO, CH2Cb, --40 DC; 
(ii) MeMgI, 0 DC to rt then 3.26a, --40 DC to rt then 10% aq. HCI (3.34a, 53%); (iii) 
MeMgI, -10 DC to rt then 3.26b, --40 DC to rt then 10% aq. HCI (3.34b, 54%). 
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Attempts to investigate the stereochemical integrity at the interpyrrolic methylene 
centre of 3.34 proved problematic. Preparation of the chiral hydrazone 3.48 of the 
unlabelled dipyrromethane 3.34a (Scheme 3.17) and subsequent IH NMR spectral 
analysis failed to differentiate the interpyrrolic methylene protons. This was in contrast 
to the previously prepared hydrazone 3.43, in which the interpyrrolic methylene protons 
were readily resolved by IH NMR spectroscopy (see earlier for a discussion). Various 
NMR solvents, including CDCh, C6D6, CD3CN, pyridine-ds, acetone-d6, and CD30D, 
were unsuccessfully utilised in an attempt to circumvent this problem. However, the IH 
NMR spectra of 3.48 in all these solvents failed to show any discrimination of the 
interpyrrolic methylene protons. 
H n n Y "tj/ '-.../ '~,/ 
o H S02Me 
(i) 
3.34a 
Scheme 3.17. Reagents and conditions: (i) N-amino-l-ephedrine, PhH, 4 A sieves, 
reflux (62%). 
Consequently, other methods were tried in an attempt to differentiate the 
interpyrrolic methylene protons of our dipyn·omethanes. These included the attempted 
N-substitution of 3.34a, and also of 3.35, with the previously described chiral derivatising 
agent, (lS,4R)-( + )-camphorsulfonyl chloride. However, all attempts at N-substitution of 
3.34a and 3.35 using this chiral handle were unsuccessful. An attempt was also made to 
resolve the different enantiomers of 3.34b by deuterium NMR spectroscopy in the chiral 
liquid crystalline solvent poly-(y-benzyl-L-glutamate) (PBLG)/dichloromethane. This 
method has previously been reported to be an efficient method for the resolution of 
chirality at the deuterated centre of various compounds. 22 Examples of deuterated 
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compounds which have been resolved using this method include alcohols, acids, esters, 
ethers, epoxides, halides and tosylates. The resolution of two unsaturated hydrocarbons 
by this method has also been reported,22b although the authors of this work questioned the 
applicability of this technique to resolve other hydrocarbons. Consequently, a sample of 
3.34b was dissolved in the chiral liquid crystalline solvent and analysed by deuterium 
NMR spectroscopy. However, the subsequent spectral analysis failed to show any 
resolution of the enantiomers of 3.34b. 
Consequently, due to an inability to discriminate the interpyrrolic methylene 
protons of the product dipyrromethanes by the above mentioned spectroscopic 
techniques, we have been unable to ascertain whether we have prepared a chiral sample 
of the deuterium-labelled dipyrromethane 3.34b using our modified coupling procedure. 
We have, however, developed a new synthetic procedure for the preparation of unlabelled 
and labelled dipyrromethanes, which are themselves important intermediates to 
biologically important bilanes. 
3.6. X-Ray structure determination of N-tosyl-2-chloromethylpyrrole 3.29 
The X-ray crystal structure of 3.29 was determined to show its preferred 
conformation in the solid state, and also to measure the effect of an electron withdrawing 
N-substituent (eg tosyl) on the aromaticity of the pyrrole ring. A search of the Cambridge 
Crystallographic Data Base revealed only a few structures of N-tosyl and N-mesyl 
pyrroles had been previously reported.23 
A perspective drawing of 3.29, with atomic labelling, is presented in Figure 3.1. 
The first point to note regarding this structure is that the N(1)-C(2) and N(1)-C(5) bond 
lengths are relatively long [1.412(3) and 1.392(3) A, respectively] as compared to 
pyrroles without an electron withdrawing substituent on nitrogen.24 In addition, the C(2)-
C(3) and C(4)-C(5) bond lengths are relatively ShOlt at 1.353(4) and 1.342(4) A, 
Chapter Three Synthesis of dipY1TOmethanes: an application of deactivated hydroxymethylpyrroles 75 
Figure 3.1. ORTEP diagram of 3.29 showing the crystallographic numbering scheme. 
respectively. These observations show that the aromaticity of the pyrrole ring is 
significantly reduced by introduction of an electron withdrawing group (eg tosyl) on 
nitrogen. The result is that derivatives of the type 3.28 and 3.29 are stable entities which 
are suitable for controlled reactions with nucleophiles. This was demonstrated in the 
present study, where the stability of the N-mesylated chloromethylpyrroles 3.28 and 3.38, 
was exploited through a controlled nucleophilic displacement reaction at the methylene 
position by an N-pyrrolylmagnesium salt, to give the dipyrromethanes 3.34 and 3.40, 
respectively. A similar reaction without an electron withdrawing substituent on the 
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pyrrole nitrogen, would lead to the formation of a highly reactive azafulvene, which 
could then react in an uncontrolled manner (see Chapter 2.1 for a discussion). 
The second point to note regarding the crystal structure of 3.29 is that the tosyl 
group adopts the expected tetrahedral geometry about S(1) [0(2)-S(1)-0(1) 120.7°, N(1)-
S(l)-C(7) 105.4°, N(1)-S(l)-O(l) 104.2°, N(1)-S(1)-0(2) 106.9°, C(7)-S(1)-(01) 109.3°, 
C(7)-S(1)-(02) 109.2°]. The X-ray structures of related N-mesyl and N-tosyl pyrroles 
reveal that the sulfonyl group adopts a pseudo-staggered orientation with respect to the 
pyrrole ring23C,24 where the S-methyl or aryl vector is almost perpendicular to the pyrrole 
ling plane. The structure of 3.29 reported here displays a significant deviation from this 
staggered geometry as depicted in Figure 3.2, left hand structure [C(7)-S(l)-N(l)-C(2) 
78.9°, C(7)-S(l)-N(l)-C(5) -102.5°]. The equivalent conformation adopted by the S-
pyrrole vector shows an even greater deviation from a staggered geometry as depicted in 
Figure 3.2, right hand structure [C(8)-C(7)-S(1)-N(1) 71.8°, C(12)-C(7)-S(l)-N(l) 
-108.2°]. Finally, the sum of the angles at nitrogen [C(2)-N(l)-S(I) 129.1 0, C(2)-N(1)-
C(5) 107.7°, C(5)-N(1)-S(l) 123.3°] is 360.1°, which is consistent with a planar nitrogen. 
° 
..-'1------,) 0, ° ( ~ ~yrrole ;;'81:.. tosyl r( N\...-. 
ring //l ~ group If ~ 
\...~ \J ~.J CI 
Me 105.40 
Figure 3.2. X-ray crystallographic conformation of 3.29. 
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3.7. Conclusion and future work 
In conclusion, we have developed a short, convenient and versatile synthetic route 
to dipyrromethanes which involves the coupling of an N-magnesio pyrrole salt (derived 
from either an oxygen acetal or a thioacetal of pyrrole-2-carboxaldehyde) with a ring-
deactivated chloromethylpyrrole. The coupling occurs at the free a-position of the 
pyrrole nucleus to give the desired 2,5-disubstituted product, with none of the alternative 
2,3- or polysubstituted coupling products being isolated. This reaction sequence has been 
extended to the preparation of dipyrromethanes containing a deuterium-label at the 
interpyrrolic methylene position. These compounds could serve as useful biological 
probes for studying the biosynthesis of natural porphyrins and related pigments. 
However, subsequent analysis of this labelled dipyrromethane, by its conversion into a 
chiral hydrazone, showed that the deuterium-label had been scrambled during the 
synthetic sequence. It was reasoned that this loss of stereochemical integrity was due to 
either the coupling reaction not occurring under SN2 conditions, or the more likely cause, 
due to the starting deuterium-labelled chloromethylpyrrole being racemic. In order to 
establish whether or not this latter reason was indeed responsible for the scrambling of 
the deuterium-label, the stereochemical course of chloromethyl- and O-mesylpyrrole 
formation was investigated by IH NMR spectroscopy. This work found that scrambling 
of a chiral deuterium-label OCCUlTed rapidly, even at low temperature, under the 
conditions used to activate the hydroxymethylpyrrole towards nucleophilic attack. A 
modified coupling procedure was then developed which was envisaged might minimise 
the scrambling of the deuterium-label during the dipyrromethane preparation. 
Unfortunately, however, all attempts to analyse the stereochemistry of the interpyrrolic 
methylene position of this dipyrromethane proved unsuccessful, and so the question of 
the effectiveness of our modified procedure in preparing chiral deuterium-labelled 
dipyrromethanes remains unanswered. 
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Future work could therefore entail repeating this modified coupling procedure 
using other, more highly substituted, pyrrole substrates, which. have been shown 
previously to allow resolution of the interpyrrolic methylene position by IH NMR 
spectroscopy upon hydrazone formation. This would allow the effectiveness of our 
modified coupling procedure in preparing chiral deuterated dipyrromethanes to be 
ascertained. Further work could also entail repeating this modified coupling procedure 
using the more highly deactivating triflyl group on the pyrrole nitrogen in order to 
minimise scrambling of the deuterium-label. In this way, the preparation of deuterated 
dipyrromethanes with a higher degree of enantiopurity at the interpyrrolic methylene 
position might be achieved. 
Finally, the influence of an N-tosyl group on the aromaticity of the pyrrole ring 
was examined by the determination of the X-ray crystal structure of the N-tosyl-2-
chloromethylpyrrole 3.29. 
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4.1. Introduction 
Much research has been directed· towards the design and synthesis of amino acid 
analogues that release latent reactivity on the specific action of a target enzyme to give 
covalent inactivation.1 As such, hydroxymethylpyrroles of general type 4.1 (X = OH), 
substituted with an electron withdrawing group (EWG) on nitrogen, have been 
developed, from work in our laboratories, as a new class of mechanism-based inhibitor of 
serine proteases (see Chapter 5 for further work in this area), However, for 
hydroxymethylpyrroles of type 4.1 to be useful as mechanism-based inhibitors, a key 
requirement is that the inherent reactivity of these compounds should only be released on 
demand (ie upon activation), and in a controlled manner. In the case of compounds of 
type 4.1, this requirement is able to be achieved through either the chemical or enzymatic 
removal of the EWG (Scheme 4.1), The resulting non-deactivated pyrrole 4.2 can then 
readily undergo loss of the leaving group (X) to form a reactive azafulvene intermediate 
4.3 -the chemical species responsible for the inherent (or latent) reactivity of this class of 
compound. This azafulvene species 4.3 can then be trapped by an external nucleophile 
(Nu") to give products of the type 4.4. If this hydrolysis procedure occurs while 4.1 is 
. bound to the target enzyme, the resulting azafulvene 4.3 could then be trapped by one of 
several suitable nucleophilic residues in the active site, resulting in covalent attachment 
and irreversible enzyme inhibition. Consequently, a key issue in the application of 
hydroxymethylpyrroles of type 4.1 as mechanism-based inhibitors of serine proteases is 
!? 
X EWG 
-EWG 
po ~ X H -X [N] Nu' ~ Nu H 
4.1 4.2 4.3 4.4 
Scheme 4.1. Azafulvene formation of2-substituted pyrroles. 
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the mechanism by which this removal (or hydrolysis) of the EWG proceeds, thereby 
enabling the release of the latent reactivity. 
Previous work in this area, using the N-hydrocinnamoyl hydroxymethylpyrrole 
4.5, had shown that during the chemical hydrolysis of this compound, using potassium 
hydroxide in the presence of n-butylamine (an external nucleophile), an O-acyl 
intermediate 4.6 was observed to form. 2 This was postulated to have occurred through 
either an initial N- to O-acyl transfer [Scheme 4.2, pathway (a)], or by simple hydrolysis 
of 4.5 followed by trapping of the azafulvene intermediate 4.3 with released 
hydrocinnamate [Scheme 4.2, pathway (b)]. Subsequently, the O-acylpyrrole 4.6 was 
converted into the aminomethylpyrrole 4.7 over a period of 90 min. This conversion was 
postulated to proceed via the nucleophilic attack of n-butylamine on the azafulvene 
intermediate 4.3. This azafulvene 4.3 could have been generated from either the 
hydrolysis of 4.5 [Scheme 4.2, pathway (b)], via the loss of the O-acyl group from 4.6 
[Scheme 4.2, pathway (c)], or by a combination of both pathways. This sequence also 
serves to model the proposed mechanism of action of compounds of type 4.5 as 
mechanism-based inhibitors of serine proteases - the potassium hydroxide mimics the 
protease catalysed deacylation and the external nucleophile mimics the final inactivation 
step. 
~OH 
N 
Ph~O 
4.5 
a 
• 
1. n-BuNH2 
2. KOH/D20 
~~~ N 
H 
.. 
4.7 4.3 
Scheme 4.2. Hydrolysis of 4.5 with KOH in the presence of n-BuNH2. 
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Another important point to note from this study was the observation that the 
hydroxymethylpyrrole 4.5 did not react with n-butylamine over 48 hours in the absence 
of potassium hydroxide. This is in agreement with our previous work (see Chapters 2 
and 3 for a discussion) which has shown that an electron withdrawing substituent on the 
pyrrole nitrogen, as in 4.1, suppresses azafulvene formation and hence substitution at the 
exo-methylene position. This also provides evidence for the suitability of compounds of 
type 4.1 as mechanism-based inhibitors of serine proteases, as they fulfil the fundamental 
requirement that the inherent reactivity is only released on demand (ie upon removal of 
the EWG). 
Despite the above preliminary work having been carried out on the hydrolysis of 
N-substituted hydroxymethylpyrroles, many of the issues concerning the exact 
mechanism of this process still remained unresolved, such as the mode of formation of 
the O-acyl intermediate and whether an azafulvene was the intermediate in the formation 
of the aminomethylpyrrole final product. We therefore set out to investigate these 
unresolved questions, and also to further develop a model system which would allow the 
mechanism of action of this class of compound as latent inhibitors of serine proteases to 
be determined. 
To address these issues, work was centred on determining the stereochemical fate 
of a deuterium-label in the R- and S-[methylene-dt]-N-(N-phthalyl-L-Ieucinyl) 
hydroxymethylpyrroles 4.8b and 4.8c upon potassium hydroxide catalysed hydrolysis in 
the presence of an external chiral nuc1eophile [S-(+)-sec-butylamine] (see Scheme 4.3). 
The N-acylhydroxymethylpyrrole 4.8 is an example of the general compound 4.1, in 
which the electron withdrawing group is an N-protected amino acid. As has been 
previously proposed (see above for a discussion), the hydrolysis of compounds of type 
4.8 (and therefore of compounds of type 4.1) proceeds by an initial N- to O-acyl transfer, 
followed by the subsequent release of an azafulvene (the latent reactive species). In 
theory, the formation of the O-acylpyrrole 4.10 could occur via one of three distinct 
mechanisms, as detailed in Scheme 4.3. O-Acylpyrrole formation could occur by either 
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an intramolecular acyl transfer via the tetrahedral intermediate 4.9 [Scheme 4.3, pathway 
(a)], by the trapping of the azafulvene 4.3 with released N-phthalyl-L-Ieucine [Scheme 
4.3, pathway (b)], or by an SN2 like displacement [Scheme 4.3, pathway (c)]. Each of 
these pathways would have a different effect on the configuration of a deuterium-label 
present at the exo-methylene position of 4.8. Thus, reaction via pathways (a), (b) and (c) 
would lead to the retention, epimerisation or inversion of configuration of a deuterium-
label at the exo-methylene position, respectively. The azafulvene 4.3 formed on 
deacylation of 4.8 would then be trapped by an external nucleophile, either by S-( + )-sec-
butylamine or subsequently by the pyrrole amine 4.11b, to give the aminomethylpyrroles 
4.3 
d j H2N'(' 
, 
4.11aR=H 
4.11bR=D 
+ 
4.12a R=H 
4.12bR=D 
Pht = phthalyl 
Scheme 4.3. Proposed reaction sequence to determine the mechanistic course of the 
hydrolysis reaction. 
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4.11b and 4.12b, respectively [Scheme 4.3, pathway (d)]. Consequently, by using the 
stereoselectively deuterium-labelled N-acylhydroxymethylpyrroles 4.8b and 4.8c, and 
determining the position (or positions) of the deuterium-label in the O-acylpyrrole 
intermediates 4.10b and 4.10c, and in the aminomethylpyrrole end products 4.11b and 
4.12b formed during the hydrolysis reaction by IH NMR spectroscopy, the mechanistic 
course of the hydrolysis reaction for N-acylhydroxymethylpyrroles of general type 4.1 
could be determined. 
4.2. Synthesis of starting materials 
The key unlabelled and deuterium-labelled N-(N-phthalyl-L-Ieucinyl)pyrrole-2-
carboxaldehydes 4.13a and 4.13b were prepared in yields of 87% and 91%, respectively, 
from the corresponding formylpyrroles 2.22a and 2.22b by acylation with N-phthalyl-L-
leucine acid fluoride according to the method described by Savrda et al. (Scheme 4.4).3 
The unlabelled N-(N-phthalyl-L-Ieucinyl)pyrrole-2-carboxaldehyde 4.13a has previously 
been prepared, in a yield of 94%, by treating the formylpyrrole 2.22a with N-phthalyl-L-
leucine acid chloride and the acylation catalyst DMAP.4 In our synthesis, however, the 
N-phthalyl-L-Ieucine acid fluoride was used in preference to the acid chloride to effect 
Qyo 
H R 
2.22a R = H 
2.22b R = 0 
Pht = phthalyl 
(i) n_, 
--........ Z~.; "f0 
PhtN00R 
Y 
4.13a R = H 
4.13b R= 0 
(ii) or (iii).. n OH 
or (iv) 't:J~ PhtN~R1 R2 
~ 0 y 
4.8a R 1 = R2 = H 
4.8b R1 = 0, R2 = H (R) 
4.8c R1 = H, R2 = 0 (S) 
Scheme 4.4. Reagents and conditions: (i) NaH, THF then N-Pht-L-Leu-F (4.13a, 87%), 
(4.13b, 91%); (ii) Zn(BH4)2, Et20, 0 °C (4.8a, 88%); (iii) S-Alpine borane®, THF, rt 
(4.8b,88%); (iii)R-Alpine borane®, THF, rt (4.8c, 9(010). 
Chapter Four - Hydrolysis study of deuterium-labelled N-acylhydroxymethylpyrroles 88 
N-acylation, since it is known that amino acid fluorides can be prepared, and then 
reacted, without any appreciable racemisation.3,5 This was an important consideration in 
the subsequent configurational analysis (see later for a discussion). The unlabelled 
hydroxymethylpyrrole 4.8a was then readily prepared, in a yield of 88%, by reducing the 
formyl group of 4.13a with zinc borohydride. The corresponding deuterium-labelled 
analogues, 4.8b and 4.8c, were prepared, in yields of 88% and 90%, by reducing the 
deuterated formylpyrrole 4.13b with either S-Alpine boraneil>, or R-Alpine boraneili, 
respectively (Scheme 4.4). 
The configurational purities at the deuterated methylene centres of 4.8b and 4.8c 
were determined to be >9:1 by integration of the pyrrole-CHD singlet resonances at 0 
4.21 and 4.24, respectively (see first column, Table 4.1). This degree of configurational 
purity obtained at the deuterated methylene centres of 4.8b and 4.8c from the above 
stereoselective Alpine boraneil> reductions of the formylpyrrole 4.13b, was consistent 
with the configurational purities obtained for previous examples (ie -9:1 to >19:1) that 
were also prepared by Alpine boraneil> reductions (see Chapters 2 and 3 for details). 
Furthermore, since it is known that reduction of a deuterated aldehyde by S-Alpine 
boraneil> yields the R-alcohol, and that R-Alpine boraneili reduction yields the S-alcohol,6 
the configurations at the deuterated methylene centres of 4.8b and 4.8c were able to be 
assigned as Rand S, respectively (see Chapters 2 and 3 for further discussion). As a 
result, the observed exo-methylene resonances for 4.8b and 4.8c were able to be assigned 
as downfield for the R-isomer (eg 4.8b), and upfield for the S-isomer (eg 4.8c) (see first 
column, Table 4.1). 
A potential complication in the above configurational analysis of the 
l 
hydroxymethylpyrroles 4.8b and 4.8c arises due to the possibility of epimerisation at the 
leucine a-centre during the synthetic sequence. Any such epimerisation would lead to a 
decrease in the observed configurational purity at the deuterated methylene centres of 
4.8b and 4.8c (see later for a discussion). However, the observed configurational purities 
of>9:1 for 4.8b and 4.8c would suggest that negligible epimerisation had occurred at this 
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Unlabelled 
S-Alpine 
borane® 
sequence 
R-Alpine 
borane® 
sequence 
4.8a 
t' l' i i Iii ii' I j i i 
4.4 4.Z 
4.8b: 4.8c 
"I iii iii iii Iii i i 
4.4 4.Z 
>9: 1 
iii' t' j I i it t 1 i' i 
4.4 4.Z 
1 : >9 
4.10a 
iii i, iii iii ii' i 
4.8 4.6 
4.10c : 4.10b 
"i i. i' i" i '. i 
4.8 4.6 
1 :>9 
,i Iii iii iii iii i 
4.8 4.6 
>9: 1 
4.11a 4.12a 
i i Ii iii iii iii" i' i j iii' Ii 
3.4 3.Z 3.0 
4.11b 4.12b 
'i Iii, i it' iii i i j 1 t, •• f Iii' 
3.4 3.2 3.0 
-1 : 1 -1 : 1 
iii,' iii" i I j ii r iii iii i I 
3.4 3.Z 3.0 
-1 : 1 -1 : 1 
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Table 4.1. IH NMR resonances [CD3CN, CHCh internal standard (0 7.25)] for the 
pyrrole exo-methylene group of 4.8 and the hydrolysis products 4.10, 4.11 and 4.12 
[KOH and S-(+)-sec-butylamine added]. In the spectra of 4.8a-c, coupling of the signals 
with the OH proton were removed by homonuc1ear decoupling. 
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centre, presumably due to the use of N-phthalyl-L-Ieucine acid fluoride in the crucial N-
acylation step (see Schetpe 4.4). A subsequent attempt was made to analyse the 
configurational purity at the leucine a-centre of the hydroxymethylpyrroles 4.8 by 
preparing the O-camphanate derivatives of these compounds, in an analogous procedure 
to that discussed in Chapter 2.3. However, the conditions of the esterification reaction 
resulted in epimerisation at the leucine a-centre, thus complicating the analysis (see later 
for a discussion). 
4.3. Hydrolysis study of N~(N~phthaly/~L-/eucinyl)hydroxymethylpyrro/es 4.8 
The mechanism of hydrolysis of compounds 4.8 was then studied by IH NMR 
spectroscopy. 2 In a typical experiment, an equivalent of potassium hydroxide in D20 
(approx 10 ~) was added to a solution of either 4.8a, 4.8b or 4.8c (generally 3 mg) in 
C'DJCN (150 ~) containing CHCh as an internal standard (0 7.25), and an equivalent of 
S-(+)-sec-butylamine (external nucleophile). The ratio of theN-acyl 4.8, O-acyI4.10 and 
aminomethylpyrroles 4.11 and 4.12 was then monitored by IH NMR spectroscopy over 
time (ca. 18 hours). The exo-methylene proton resonances of these compounds are 
shown in Table 4.1. The IHNMR spectrum taken immediately after the addition of the 
potassium hydroxide showed a mixture of the starting material 4.8, O-acyl intermediate 
4.10 and aminomethylpyrrole end products 4.11/4.12 in a typical ratio of 1 : 1 : 1. IH 
NMR spectra of the mixtures after 18 hours revealed that 4.8 and 4.10 had been 
completely converted to the pyrrole amines 4.11 and 4.12. The identity of the 
aminomethylpyrroles 4.11 and 4.12 as the end products of this hydrolysis reaction was 
subsequently confirmed by an independent synthesis of these compounds (see Section 
4.4). This independent synthesis also allowed the assignment of the aminomethylpyrrole 
exo-methylene proton resonances as upfield for 4.12 relative to 4.11 (see third column, 
Table 4.1). 
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The key points to note from the results shown in Table 4.1 are that the 
configurations and stereochemical integrity (>9: 1) of the starting materials 4.8b and 4.8c 
are retained in the corresponding O-acyl intermediates 4.10b and 4.10c (rows 2 and 3, 
Table 4.1). As discussed above, the formation of the O-acylpyrrole 4.10 could occur by 
either an intramolecular acyl transfer via the tetrahedral intermediate 4.9 [Scheme 4.3, 
pathway (a), retention of configuration], by the trapping of the azafulvene 4.3 with 
released N-phthalyl-L-Ieucine [Scheme 4.3, pathway (b), epimerisation at the exo-
methylene], or by an SN2 like displacement [Scheme 4.3, pathway (c), inversion of 
configuration]. The fact that the configurational purities at the deuterated methylene 
centres of 4.10b and 4.10c are intact, and also did not change with time, implies that 
these species are not in equilibrium with the azafulvene 4.3, hence reaction via pathway 
(b) is not operating. Secondly, an SN2 displacement at the exo-methylene position of a 
hydroxymethylpyrrole has only been observed in extreme examples using a combination 
of Mitsunobu reaction conditions and an N-triflyl substituent to strongly deactivate the 
pyrrole ring, and hence suppress azafulvene formation (see Chapter 2.4 for a discussion). 
In contrast, we have found that an N-acyl group was not sufficiently deactivating to 
promote such an SN2 displacement, and hence a reaction of the type shown in pathway 
(c) of Scheme 4.3 is chemically unlikely under the conditions of the hydrolysis 
experiment. Pathway (a) in Scheme 4.3, however, is consistent with both our previous 
work, and the observed results, ie the formation of 4.10 occurs with retention of 
configuration at the deuterated methylene centre. A second point to note is that equal 
mixtures of the R- and S-deuterium-Iabelled pyrrole amines 4.llb and 4.12b were 
produced as the end products in the hydrolysis reactions of 4.8b and 4.8c, a result clearly 
consistent with the intermediacy of the azafulvene 4.3 [Scheme 4.3, pathway (d)]. 
Finally, as expected, the two oppositely labelled series 4.8b and 4.8c gave 
complementary results (rows 2 and 3, Table 4.1). 
Another key point to note from the results shown in Table 4.1 is that in the case of 
the O-acylpyrroles 4.10b and 4.10c, the methylene resonance is upfield for the R-isomer 
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(eg 4.10b) relative to the S-isomer (eg 4.10e). This is the reverse of what was observed 
for the N-acylpyrroles 4.8b and 4.8e. A similar reversal in the observed relative positions 
of the R- and S-methylene resonances was noted during the O-mesylation and 
chlorination reactions . of the R- and S-[methylene-clt]-N-camphorsulfonyl 
hydroxymethylpyrroles 3.4Sb and 3.4Se (see Chapter 3.4). 
In summary, the above observations strongly suggest that the O-acylpyrrole 4.10 
is most likely formed via an intramolecular acyl transfer on hydrolysis of the N-(N-
phthalyl-L-Ieucinyl)hydroxymethylpyrroles 4.8. Evidence for the subsequent release of 
an azafulvene 4.3 is gained from the observed scrambling of the deuterium-label at the 
exo-methylene positions of 4.11 and 4.12 on trapping with an external nucleophile -
either S-(+)-sec-butylamine or 4.11, respectively. 
4.4. Independent synthesis of aminomethylpyrro/es 4.11 and 4.12 
To confirm the identity of the aminomethylpyrroles 4.11 and 4.12 as the end 
products in the above hydrolysis study, and to allow the correct assignment for the 
respective exo-methylene resonances in the IH NMR spectra of the hydrolysis 
experiments, the pyrrole amines 4.11 and 4.12 were independently synthesised. The 
aminomethylpyrrole 4.11 was prepared by the method described by Herz et az.7 In this 
method, pyrrole was treated with a slight excess (1.05 equivalents) of a solution of (±)-
sec-butylamine hydrochloride in 37% aqueous formalin to give the aminomethylpyrrole 
4.11 in a yield of 62% (Scheme 4.5). Next, the aminomethylpyrrole 4.12 was prepared 
by an analogous procedure to that described above, in which a two molar excess of both 
pyrrole and formalin were used in order to enable the further substitution of the initially 
prepared amine 4.11. In this way, the disubstituted aminomethylpyrrole 4.12 was 
prepared in a yield of 20%, along with the monosubstituted product 4.11 in 76% yield 
(Scheme 4.5). 
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Scheme 4.5. Reagents and conditions: (i) (±)-sec-BuNH2.HCl, 37% aq. fonnalin (4.11, 
62%) or (4.11, 76%; 4.12, 20%). 
The 1H NMR spectra of these reference aminomethylpyrroles 4.11 and 4.12 
revealed that, in both cases, the pyrrole exo-methylene group was observed as an AB 
quartet, resonating at 0 3.73 and 3.81, and 3.49 and 3.65, respectively. As a result, this 
enabled the assignment of the aminomethylpyrrole exo-methylene resonances in the 1H 
NMR spectra of the hydrolysis experiments as upfield for 4.12 relative to 4.11 (see third 
column, Table 4.1). 
4.5. Attempted configurational analysis of the leucine a-centre of N-(N-
phthalylleucinyl)hydroxymethylpyrroles 
As discussed previously, a possible complication in the configurational analysis at 
the deuterated methylene centre of the hydroxymethylpyrroles 4.8b and 4.8c arises due to 
the possibility of epimerisation at the leucine a.-centre during the synthetic sequence. 
The consequences of any such epimerisation at the leucine a-centre requires an 
examination of all the possible isomers which could arise during the synthesis of 
compounds 4.8b and 4.8c (see Figure 4.1). 
If the preparation of the fonnylpyrrole 4.13b and its subsequent reduction to the 
deuterated hydroxymethylpyrroles 4.8 occurred without epimerisation at the leucine a-
centre, then the only isomers that would be produced would be the L-leucine isomers 
4.8b and 4.Sc (see Scheme 4.4 and Figure 4.1). However, ifepimerisation had occurred 
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4.8b 4.8c 
Figure 4.1. Isomers of [methylene-dtJ-N-(N-phthalylleticinyl)hydroxymethylpyrroles. 
at the leucine a-centre, then the D-Ieucine isomers 4.8e and 4.8f would also be produced. 
If in this latter case the reduction had been carried out using R-Alpine borane®, whicl,l is 
known to yield alcohols with the S-configuration,6 the major products formed would be 
the isomers 4.8c and 4.8f; which have the S-configuration at the deuterated methylene 
centre. In addition, a small amount of the R-isomers 4.8b and 4.8e would also be 
expected, since the reduction is not completely stereospecific. An important point to 
note, however, is that the isomers 4.8c14.8e and 4.8b/4.8f are enantiomeric pairs, and as 
such, are indistinguishable by IHNMR spectroscopy. As a result, it would be impossible 
to differentiate the contribution that each isomer of the enantiomt:ric pair makes to the 
particular methylene resonance. In the above example, the greater the degree of 
epimerisation at the leucine a-centre, the greater the contribution the 4.8f isomer would 
make to the downfield methylene resonance. In the absence of any such epimerisation at 
leucine, this resonance is attributed solely to the R-isomer 4.8b, and therefore gives a 
direct measure of the chiral reduction efficiency. However, with an increase in the 
downfield resonance due to 4.8f, the observed epimeric purity at the deuterated 
methylene centre of 4.8 would be decreased, and as a result, the apparent efficiency of the 
chiral reduction would also appear diminished. 
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An attempt was subsequently made to detennine whether any such epimerisation 
had occurred at the leucine ex-centre during the preparation of 4.8. This was attempted by 
the introduction of a further chiral handle, namely the previously described (IS,4R)-(-)-
camphanate group, onto the hydroxymethyl position of 4.8, in an analogous procedure to 
that discussed in Chapter 2.3. In this way, the exo-methylene resonances resulting from 
both the L- and D-Ieucine isomers (ie 4.14a and 4.15a, Scheme 4.6) could be 
discriminated, which would therefore allow the configurational purity at the leucine ex-
centre of 4.8 to be established. To enable this analysis, a 1: 1 mixture of the L- 4.8a and 
D- 4.8d N-(N-phthalylleucinyl)hydroxymethylpyrroles was prepared from pyrrole-2-
carboxaldehyde 2.22a in 81% yield (2 steps) by N-substitution with racemic N-phthalyl-
DL-Ieucine acid fluoride, followed by zinc borohydride reduction of the formyl group 
(Scheme 4.6). Subsequent esterification of this 1: 1 mixture of 4.8a and 4.8d with 
(IS,4R)-(-)-camphanoyl chloride using standard procedures then gave an equal mixture 
of the camphanates 4.14a and 4.15a in a combined yield of83%. IHNMR spectral 
(i), (ii) ~OH ~OH • N N Yt0 H R PhtN00 + P:t0 2.22a y 
~o~ 
PhtN~o 0 
R1 R2 
4.14a R1 = CH2CHMe2, R2 = H 
4.1Sa R1 = H, R2 = CH2CHMe2 
4.8a 4.8d 
~Oloa,borc 
Pht = phthalyl 
Scheme 4.6. Reagents and conditions: (i) NaH, THF then N-Pht-DL-Leu-F; (ii) 
Zn(BRt)2, EhO, 0 °C (81% for 2 steps)~ (iii) DMAP, Hiinig's base (IS,4R)-(-)-
camphanoyl chloride and either (a) 1:1 4.8a/4.8d, 24 h (83%), (b) 4.8a, 24 h (94%), or 
(c) 4.8a, 48 h (79%). 
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Figure 4.2. IH NMR resonances (CD3CN) for the pyrrole exo-methylene group of the 
camphanates 4.14a (shown in Spectrum A by #) and 4.15a (shown in Spectrum A by *). 
analysis of this reference camphanate sample revealed that, in both the L- and D-Ieucine 
isomers, the pyrrole exo-methylene group was observed as an AB quartet, resonating at 0 
5.10 and 5.20 for the D-isomer (ie 4.15a), and at 0 5.13 and 5.19 for the L-isomer (ie 
4.14a) (see Figure 4.2, Spectrum A). Next in the key experiment, the unlabelled 
hydroxymethylpyrrole 4.8a, prepared as detailed in Scheme 4.4, was esterified with 
(lS,4R)-(-)-camphanoyl chloride by the same method as used above, to give a mixture of 
the camphanates 4.14a and 4.15a in a combined yield of 94%. The ratio of 4.14a and 
4.15a observed by IHNMR spectral analysis of this camphanate sample was ,....,9: 1 (Figure 
4.2, Spectrum B), indicating a small amount of epimerisation had occurred at the leucine 
a.-centre. However, it was uncertain whether this epimerisation at the leucine a.-centre 
had occurred during the preparation of 4.8a, or was in fact a consequence of this 
camphanate analysis. This second possibility was consistent with the work of Savrda et 
al.,3 where it was found that during a peptide coupling reaction, a triethylamine favoured 
a.-H exchange led to a substantial amount of epimerisation in an amino acid which 
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possessed several electron withdrawing groups. Consequently, the epimerisation we 
observed from our camphanate analysis could in fact be due to an analogous Hunig's base 
favoured a-H exchange during the camphanate preparation. In order to establish whether 
or not this was the case, the esterification of 4.8a was repeated as before, but with the 
reaction time increased from 24 to 48 hours, so as to enable the possibility of further 
epimerisation to occur. Esterification under these conditions gave a mixture of the 
camphanates 4.14a and 4.15a in a combined yield of 79%. The ratio of 4.14a and 4.15a 
observed by IH NMR spectral analysis of the resulting camphanate sample was -5:1 
(Figure 4.2, Spectrum C). This decrease in the ratio of 4.14a relative to 4.15a with an 
increase in reaction time therefore suggests that the observed epimerisation is in fact a 
consequence of the attempted camphanate analysis. As a result, this method cannot be 
used to give an accurate measure of the configurational purity at the leucine a-centre of 
the starting hydroxymethylpyrrole 4.8a. 
In a final experiment, the above camphanate analysis was repeated using separate 
samples of the deuterium-labelled hydroxymethylpyrroles 4.8b and 4.8c, prepared as 
detailed in Scheme 4.4, in order to discriminate by IH NMR spectroscopy all of the 
resulting isomers formed (ie 4.14h-c and 4.15b-c). Consequently, separate samples of 
the deuterated hydroxymethylpyrroles 4.8b and 4.8c, which had known configurational 
y 
4.8b R1 = D, R2 = H 
4.8c R1 = H, R2 = D 
(i) 
.. 
a or b 
~oS)-
l 12~ PhtN~R R 0 
= 0 y 
4.14b R1 =D, R2=H 
4.14c R1 = H, R2= D 
+Qxoi<f 
P~tR20 
4.15b R1=D,R2 =H 
4.15c R1=H,R2=D 
Scheme 4.7. Reagents and conditions: (i) DMAP, Hiinig's base (lS,4R)-(-)-camphanoyl 
chloride, 24 h and either (a) 4.8b (74%) or (b) 4.8c (86%). 
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Figure 4.3. IH NMR resonances (CD3CN) for the pyrrole exo-methylene group of the 
deuterated camphanates 4.14b-c and 4.15b-c derived from 4.Sb (Spectrum A) and 4.Sc 
(Spectrum B). 
purities of >9:1 (see earlier for a discussion), were esterified with (lS,4R)-(-)-
camphanoyl chloride under standard conditions to give mixtures of the corresponding 
labelled camphanates 4.14b-c and 4.15b-c in combined yields of 74% and 86%, 
respectively (Scheme 4.7). 
The methylene resonances for the deuterium-labelled camphanates 4.14b-c and 
4.15b-c were observed in the IH NMR spectra as singlets with distinguishable chemical 
shifts at 05.17 and 5.13, and 5.10 and 5.19, respectively (Figure 4.3). These resonances 
were assigned by a comparison with the IH NMR spectral data obtained previously for 
the unlabelled L- and D-Ieucine camphanates 4.14a and 4.15a, respectively (see Figure 
4.2). Furthermore, the ratio of the deuterated camphanates 4.14b-c and 4.15b-c derived 
from 4.Sb (Figure 4.3, Spectrum A) and 4.Sc (Figure 4.3, Spectrum B) were determined 
to be ~9: 1 by IH NMR spectral analysis. This was in line with the isomer ratio of -9: 1 
we had observed previously in the unlabelled camphanates 4.14a and 4.15a (see Figure 
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4.2, Spectrum B). This again strongly suggests that the observed epimerisation at the 
leucine a.-centre of 4.8b and 4.8c was in fact a consequence of the attempted camphanate 
analysis. An interesting point to note from the spectra shown in Figure 4.3 is that in the 
case of the L-Ieucine camphanate 4.14, the exo-methylene resonance is upfield for the S-
isomer (eg 4.14c) relative to the R-isomer (eg 4.14b). However, in the case of the D-
leucine camphanate 4.15, these configurations are reversed, with the exo-methylene 
resonance upfield for theR-isomer (eg 4.15b) relative to the S-isomer (eg 4.15c). 
4.6. Conclusion 
We have determined the stereochemical fate of the deuterium-label in 4.8b and 
4.8c upon the potassium hydroxide catalysed hydrolysis of these compounds in the 
presence of an external nuc1eophile [S-(+)-sec-butylamine]. The observation that both 
the stereochemistry and configurational purity of the deuterated methylene centres of 
4.8b and 4.8c did not change upon formation of the O-acyl intermediates 4.10b and 
4.10c, respectively, strongly suggests that the O-acylpyrrole 4.10 is formed by an 
intramolecular N- to O-acyl transfer, via the tetrahedral intermediate 4.9, with retention 
of configuration. Evidence for the subsequent release of an azafulvene 4.3 was gained 
from the observed scrambling of the deuterium-label at the exo-methylene positions of 
4.11 and 4.12 on trapping with an external nucleophile - either S-( + )-sec-butylamine or 
4.11, respectively. The identity and assignments of the aminomethylpyrroles 4.11 and 
4.12 were subsequently confirmed by an independent synthesis of these compounds. 
Finally, an attempt to analyse the configurational purity at the leucine a.-centre of 4.8, by 
the preparation of the O-camphanates, resulted in epimerisation at the leucine a.-centre. 
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5.1. Introduction 
Serine proteases are a subclass of proteolytic enzymes which are characterised by 
the presence of a catalytic serine amino acid residue in the enzyme active site. The 
natural function of such enzymes is to catalyse the hydrolytic cleavage of peptide bonds 
in proteins and polypeptides (see Chapter 1.4 for further discussion and for the 
mechanism of serine protease catalysed hydrolysis of a peptide bond). An imbalance in 
the activity of serine proteases has been implicated in the initiation and progression of 
many human diseases, such as emphysema, adult respiratory distress syndrome (ARDS), 
pancreatitis, rheumatoid arthritis, inflammation and digestive disorders.1 Consequently, 
much research has been directed towards the development of selective inhibitors of serine 
proteases, as such compounds could then provide a means by which these, and related 
conditions, could be treated. In light of this, the N-acylhydroxymethylpyrroles 4.8a and 
5.1 have previously been developed from work in our laboratories as amino acid 
analogue, mechanism-based inhibitors of serine proteases (Figure 5.1).2 
o ~OH Ofyla 
oy 
4.8a 5.1 Cbz = carbobenzyloxy 
Figure 5.1. Previously reported hydroxymethylpyrrole-based inhibitors of serine 
proteases. 
A mechanism-based inhibitor is a chemically non-reactive or 'latent' compound 
which is sufficiently similar in structure to the natural substrate of a target enzyme such 
that it is able to be bound to the enzyme's active site. Once in the active site it can be 
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acted upon by the enzyme's normal catalytic pathway to produce a reactive species, 
which can then result in the specific and efficient inhibition of the target enzyme. In the 
case of N-acylhydroxymethylpyrrole-based inhibitors described above, the enzymatic 
removal of the N-acyl group leads to the formation of a highly reactive azafulvene in the 
active site. This azafulvene is therefore the chemical species responsible for the inherent 
(or latent) reactivity of these compounds (see Chapter 1.4 for the proposed mechanism of 
action of this class of mechanism-based inhibitor). 
The N-acylhydroxymethylpyrroles 4.8a and 5.1, however, lack the extended 
peptide-like sequences usually found in the natural substrates of a-chymotrypsin and 
other serine proteases. This would result in these peptidomimetics having a lowered 
binding affinity for the enzyme active site due to reduced enzyme-substrate recognition . 
. As a consequence, the N-acylhydroxymethylpyrroles 4.8a and 5.1 would most likely have 
a lowered, or non-selective, inhibitory effect on serine proteases. In the case of a-
chymotrypsin, a large well defined hydrophobic pocket at the enzyme's primary 
specificity pocket (SI) is known to accept and readily cleave substrates with aromatic 
residues, such as phenylalanine, tyrosine and tryptophan, positioned at the primary amino 
acid binding site (PI) (see Figure 5.2 and Chapter 1.4 for a definition of this SIP 
nomenclature). a-Chymotrypsin is also known to accept and cleave, albeit less readily, 
substrates with hydrophobic aliphatic residues positioned at the PI site. Thus, cleavage 
can occur on the carboxyl side of isoleucine, leucine and valine, although these represent 
much less favoured cleavage sites. However, enzyme-substrate recognition is not based 
solely on the SI-PI interaction, but is in fact influenced by neighbouring and longer range 
secondary interactions (see Chapter 1.4 for further discussion). Due to this importance of 
both primary and secondary interactions in enzyme-substrate (or inhibitor) recognition, 
subsequent work, detailed in this chapter, was centred on developing new methodologies 
to incorporate the hydroxymethylpyrrole-moiety into an extended peptide-like sequence 
that was more closely based on the natural substrate (see Figure 5.2). By doing this, it 
was hoped that the newly developed inhibitor molecules would have increased enzyme 
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specificity and selectivity, due to an improvement in the recognition and subsequent 
binding of these inhibitor molecules in the active site of the target enzyme. 
Figure 5.2. Natural substrate of a serine protease showing the enzyme-substrate 
recognition. The bond to be cleaved is shown by an arrow. 
An increase in the enzyme recognition of the inhibitor molecule could 
conceivably be achieved by extending the hydroxymethylpyrrole-moiety at either the 2-
or 5-positions (or in both directions), as well as by extending theN-acyl chain (see Figure 
5.3). Work detailing the synthetic efforts undertaken in these areas is presented in the 
following sections of this chapter. 
extend 5-position 0. 
< '~.~OH N 
extend 2-position 
RAo 
~ extend /ll-acyl group 
Figure 5.3. Potential ways to increase enzyme recognition of the inhibitor molecule. 
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5.2. Determination of optimal pyrrole N-substituent and leaving group for 
enzyme inhibition 
All previous studies on hydroxymethylpyrroles as mechanism-based inhibitors of 
serine proteases had employed an acyl group on nitrogen to deactivate the pyrrole, and 
hence suppress azafulvene formation?,3 This deactivation is critical to the proposed 
mechanism of action of these compounds, since release of the reactive azafulvene before 
delivery to the enzyme would decrease the effectiveness of the inhibitor. However, we 
had shown in our earlier studies that an N-acyl group was not the optimal substituent for 
suppressing this azafulvene formation. Instead, we had shown that N-sulfonyl groups, 
such as triflyl or mesyl, were more effective in deactivating the pyrrole ring than either 
N-alkoxycarbonyl or N-acyl groups, with the N-triflyl group having the best deactivating, 
and hence azafulvene suppressing, ability (see Chapter 2.4 for a discussion). In light of 
this, we decided to investigate whether N-sulfonyl substituted hydroxymethylpyrroles 
would show improved, or indeed if any, inhibition activity against serine proteases. The 
underlying issue in such a substitution, however, is the balance between chemical 
stability and useful chemical reactivity. Thus, while the N-sulfonyl substituted 
hydroxymethylpyrrole may indeed be more stable than the corresponding N-acyl 
substituted hydroxymethylpyrrole, it may in fact be too stable to undergo the crucial 
enzyme catalysed hydrolytic cleavage of the N-substituent, thereby preventing the release 
of the latent reactivity of the inhibitor molecule (ie azafulvene formation). To resolve 
this issue we decided to prepare a range of simple N-acyl and N-sulfonyl substituted 
hydroxymethylpyrroles and then assay these compounds for potential inhibition activity 
against the serine protease, a.-chymotrypsin. In this way, we hoped to determine the 
respective abilities of N-acyl and N-sulfonyl substituted hydroxymethylpyrroles to act as 
mechanism-based inhibitors of serine proteases. The compounds that were selected for 
this preliminary investigation were the N-acylhydroxymethylpyrroles 4.8a and 5.3a, and 
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the N-sulfonylhydroxymethylpyrroles 2.25b and 5.3b-d (see Scheme 5.1). These 
compounds, which varied in both size and degree of un saturation of the N-substituent, 
were selected for analysis since the target enzyme in the subsequent assay, a-
chymotrypsin, is known to cleave preferentially at aromatic and hydrophobic residues. In 
this way, it was hoped that the optimal N-substituent for binding in the enzyme's primary 
specificity pocket (Sl) could be determined. In addition, the N-(N-phthalyl-L-
leucinyl)hydroxymethylpyrrole 4.8a was selected for analysis as it had previously been 
prepared and assayed in an earlier study.3 As a consequence, this compound provided a 
reference sample by which to compare the inhibition results from this investigation with 
those of the earlier study. 
The starting N-substituted formylpyrroles 4.13a, 2.23b and 5.2b-d were prepared, 
in yields of 87%, 93%, 97%, 56% and 84%, respectively, by treating the formylpyrrole 
2.22a with sodium hydride, and then reacting the generated pyrrolyl anion with either N-
phthalyl-L-Ieucine acid fluoride, methanesulfonyl chloride, phenylsulfonyl chloride, ~­
trans-styrenesulfonyl chloride or 2-phenylethanesulfonyl chloride (Scheme 5.1). The 
remaining N-hydrocinnamoyl formylpyrrole 5.2a was prepared in 79% yield by treating 
the formylpyrrole 2.22a with hydrocinnamoyl chloride in the presence of the acylation 
catalyst 4-dimethylaminopyridine (DMAP). The N-substituted hydroxymethylpyrroles 
~ (Q or (ii) ~ (iii) R ~OH .. )I 4.13a/4.8a N-Pht-L-Leu N CHO N CHO N 
H I I 2.23b/2.25b S02Me R R 5.2a/5.3a CO(CH2hPh 
2.22a 4.13a 4.8a 5.2b/5.3b S02Ph 
2.23b 2.25b 5.2c/5.3c S02CH:CHPh 5.2a-d 5.3a-d 5.2d/5.3d S02(CH2h Ph 
Scheme 5.1. Reagents and conditions: (i) NaH then either N-Pht...L-Leu-F (4.13a, 87%) 
or MeS02C1 (2.23b, 93%) or PhS02Cl (5.2b, 97%) or PhCH:CHS02CI (5.2e, 56%) or 
Ph(CH2hS02CI (5.2d, 84%); (ii) DMAP, HUnig's base, CH2Ch then Ph(CH2)2COCI 
(5.2a, 79%); (iii) Zn(BRt)2, Et20, 0 °C (4.8a, 88%), (2.25b, 91%), (5.3a, 93%), (5.3b, 
92%), (5.3e, 95%), (5.3d, 94%). 
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4.8a, 2.25b and 5.3a-d were then readily prepared, in yields of 88%, 91%, 93%, 92%, 
95% and 94%, respectively, by reducing the corresponding formylpyrroles 4.13a, 2.23b 
and 5.3a-d with zinc borohydride. 
The hydroxymethylpyrroles 4.8a, 2.25b and 5.3a-d were tested as potential 
inhibitors of a-chymotrypsin by the method outlined by Cannell et al.4 This simple a.-
chymotrypsin assay was based on a colorimetric technique, where enzymatic release of 
yellow-coloured 4-nitroaniline 5.5 from the colourless N-succinyl-L-phenylalanine-4-
nitroanilide 5.4 substrate, indicates activity (Scheme 5.2). The advantages of this assay 
procedure are that it is rapid, and it also allows for a large number of samples to be tested 
simultaneously by using a 96 well reaction plate. For full details of the assay procedure 
see Chapter 8.5.3. 
a-chymotrypsin 
~N02 
H2N~ 
yellow 
5.5 
Scheme 5.2. Enzymic breakdown of the colorimetric substrate. 
Solutions of the pyrroles 4.8a, 2.25b and 5.3a-d were made to 1250 J,1g mL-1, 125 
J,1g mL-1 and 12.5 J,1g mL-1 as standard solutions in methanol. The pyrrole test solution, 
distilled water, Tris-HCI buffer (pH 7.6) and a solution of a-chymotrypsin in Tris-HCI 
. buffer (pH 7.6) were added to each well of a microtitre plate, and the resulting solutions 
were pre-incubated at 37°C for 30 min. The substrate 5.4 was then added, and the 
absorbance was read at 405 nm at t 0, and after incubation at 37°C when significant 
colour change had taken place. Control samples were included in all assay cases. Each 
sample was tested in triplicate and average absorbances were used to calculate the 
percentage inhibitions. The results obtained in this a.-chymotrypsin assay are presented 
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in Table 5.1. The previously determined inhibition results for compound 4.8a are given 
in parentheses directly after the current results for 4.8a. 
Compound 
4.8a 
503a 
2025b 
5.3b 
503e 
503d 
1250 Ilg mL-1 
40 
25 
0 
35 
30 
20 
% Inhibition 
125 Ilg mL-1 12.5 Ilg mL-1 
10 (25) o (20) 
10 10 
0 0 
20 5 
15 5 
10 5 
Table 5.1. Results of a-chymotrypsin assay (results rounded to nearest 5%) 
The results detailed in Table 5.1 indicate that the N-acyl and N-sulfonyl 
hydroxymethylpyrrole derivatives 4.8a and 5.3a-d were modest inhibitors of a-
chymotrypsin. In the present study, the degree of inhibition of the test enzyme for 
compound 4.8a was 10% and 0% at the 125 Jlg mL-1 and 12.5 Jlg mL-1 concentrations, 
respectively. In contrast, the previously determined inhibition results for compound 4.8a 
were 25% and 20%, respectively, at the same concentrations.3 This difference in the 
inhibitory activity of 4.8a in the two studies was attributed to the inherent differences 
between the two assay procedures, such as the use of different samples of enzyme and 
substrate, and to variations in the pH of the respective assay test solutions. Regardless of 
this difference, however, the important point to note from the results of this present 
analysis was that the N-arylsulfonyl substituted hydroxymethylpyrroles 5.3b-d all 
showed activity against a-chymotrypsin. Moreover, the inhibitory activities of these N-
sulfonyl derivatives were approximately on a par with those of the N-acyl derivatives 
4.8a and 5.3a, at all the concentrations tested. This indicates that N-sulfonyl 
hydroxymethylpyrroles, as with the analogous N-acyl derivatives, are indeed able to 
promote the inhibition of a-chymotrypsin, and also possibly of other serine proteases. 
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The one exception to this, though, was the N-mesyl derivative 2.2Sb, which showed no 
inhibition activity at any of the inhibitor concentrations tested. This was thought to be 
due to the mesyl group being a poor substituent for recognition by a-chymotrypsin, due 
to the lack of a suitable aromatic or hydrophobic group to fit in the enzyme's primary 
specificity pocket (SI). Of the arylsulfonyl groups tested in this analysis, the 
phenylsulfonyl group (ie compound S.3b) was found to have a slightly higher inhibitory 
activity against a-chymotrypsin. However, the differences in the enzyme inhibition 
activities between the different hydroxymethylpyrroles S.3b-d were too small to allow a 
definitive assignment for the optimal N-arylsulfonyl group for enzyme inhibition. 
Having established that N-arylsulfonyl hydroxymethylpyrroles were able to 
effectively inhibit a-chymotrypsin under these assay conditions, we next turned our 
attention to determining which leaving group at the 2-methyl position was optimal for 
this enzyme inhibition. Up to this time, the only pyrrole derivative which had been 
assayed with something other than a hydroxyl group at the 2-methyl position was the 
compound S.l (Figure 5.1), which had an N-carbobenzyloxy-L-valyl-L-valine dipeptide 
esterified onto the 2-hydroxymethyl group. The subsequent assay of this derivative by 
the method described above, showed a 45% inhibition of a-chymotrypsin at an inhibitor 
concentration of 12.5 I-lg mL-1. However, at the higher concentration of 125 Ilg mL-1, the 
compound was observed to precipitate out of solution during the assay, and so no reliable 
inhibition data was able to be obtained for compound S.l at this concentration. 3 
The compounds that were selected for this investigation into the optimal leaving 
group on pyrrole for enzyme inhibition were the N-phenylsulfonylpyrroles S.6a and S.6b, 
which were substituted at the 2-methyl position with either a chloro or an N-phthalyl-L-
leucinyl group, respectively (see Scheme 5.3). Consequently, the chloromethylpyrrole 
S.6a was prepared in quantitative yield by treating the hydroxymethylpyrrole S.3b with 
methanesulfonyl chloride and Hiinig's base, while the O-acylpyrrole S.6b was prepared in 
90% yield by the esterification of S.3b with N-phthalyl-L-Ieucine acid fluoride using 
standard procedures (Scheme 5.3). 
I 
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~OH ~ 
S02Ph 
5.3b 
(i) or(ii) n ----~. (~.~x ~ 
S02Ph 
5.6a X = CI 
5.6b X = N-Pht-L-LeuC02 
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Scheme 5.3. Reagents and conditions: (i) Hunigs base, MeS02CI then 10% aq. HCI 
(5.6a, quant.); (ii) DMAP, Hunig's base, N-Pht-L-Leu-F, CH1Ch (5.6b, 90%). 
The 2-substituted pyrroles 5.6a and 5.6b were then assayed as potential inhibitors 
of a-chymotrypsin by the colorimetric method outlined above. The results of this a-
chymotrypsin assay, along with the previously determined inhibition results for 
compound 5.3b, are presented in Table 5.2. 
Compound 
5.3b 
5.6a 
5.6b 
35 
5 
0* 
% Inhibition 
125 f.lg mL·1 
20 
5 
0* 
12.5 f.lg mL·1 
5 
o 
o 
* precipitation occurred in reaction wells during assay 
Table 5.2. Results of a-chymotrypsin assay (results rounded to nearest 5%). 
The results detailed in Table 5.2 clearly show that of the leaving groups examined 
in this investigation, the hydroxymethyl group (ie compound 5.3b) was by far the 
optimum group for enzyme inhibition activity. This result might be in line with our 
previous chemical studies on the hydrolytic cleavage of an N-substituted pyrrole, which 
found the initial step in this process to be an intramolecular N- to 0- transfer of the N-
substituent, to give a species analogous to 5.6b. This was then followed by the 
subsequent release of an azafulvene - the chemical species postulated to be responsible 
for the enzyme inhibition activity of this class of inhibitor (see Chapter 4 for further 
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discussion). In contrast, compounds 5.6a and 5.6b have no such hydroxyl group 
available to enable this initial intramolecular N- to 0- transfer of the N-substituent, and so 
would be unable to undergo hydrolytic cleavage by such a mechanism. Nevertheless, the 
chloromethylpyrrole 5.6a did show a small degree of enzyme inhibition activity (ca. 5%) 
. at the higher inhibitor concentrations of 1250 J.lg mL-1 and 125 J.lg mL-l . At this time, 
however, the exact mechanism of action for this compound remains unknown. Finally, 
the observation that the higher concentrations of the O-acylpyrrole 5.6b precipitated in 
the reaction wells during the assay indicated that either this compound was unstable, or 
insoluble, in the assay conditions. However, at the concentration of 5.6b at which no 
precipitation was observed to occur (ie 12.5 J.lg mL-1), no enzyme inhibition activity was 
observed. The conclusion from these results, therefore, is that a hydroxy methyl group is 
the optimal group on pyrrole to effect enzyme inhibition. However, further work is 
required in order to develop a better understanding of the mechanisms involved in 
enzyme inhibition for this class of mechanism-based inhibitor. 
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5.3. Preparation of pyrro/e-based peptidomimetics 
In a final attempt to prepare pyrrole-based inhibitors of serine proteases that had 
the potential for increased enzyme recognition, work was centred on incorporating the 
hydroxymethylpyrrole-moiety into an extended peptide-like sequence. Consequently, a 
number of key potential synthetic targets, 5.7 - 5.12 (Figure 5.4), were identified for 
further investigation. These compounds represent examples of extension in the 2- and 5-
position of the general structure shown in Figure 5.3. The following sections of work 
detail the methodologies that were attempted in the preparation of derivatives of these 
compounds, and their subsequent testing as potential serine protease inhibitors (where 
applicable). 
5.7 n ~ ~ 
o R1 
HOJ,V ~ ~OMe 
N W If RHo 
5.10 
"t;J/ y ~ "OMe 
R OH 
5.8 
o R1 ~NJyOMe 
R OH H 0 
5.9 
HO n ~J ~ "t;J/ [( = OMe 
R 0 R1 
5.12 
HO n ~ ~ ~ "t;J/ y ~ "OMe 
R 0 
R = COR' or S02R' 
5.11 
Figure 5.4. Key synthetic targets identified as potential peptidomimetics. 
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5.3.1. Attempted preparation of peptidomimetics of type 5.7 
~ (i) S) ~OEt N . CHO - + Etg I H H 0 ~OH H 0 (ii) -2.22a 
0 
5.13 
5.7 ------
5.17 
5.14 
(iv) or (v) 
· X 
5.15 
j (iii) 
n~ ~J 'N/~~ = OMe 
H 0:: 
5.16 Y 
Scheme 5.4. Reagents and conditions: (i) Ph3P:CHC02Et, PhH, reflux (5.13, 17%; 5.14 
49%); (ii) NaOH, MeOH-H20 (88%); (iii) L-LeuOMe.HCl, DCC, HOBt, Hiinig's base 
(92%); (iv) Nail, THF then Ph(CH2)2COCl; (v) DMAP, Hiinig's base then 
Ph(CH2)2COCl. 
Our synthetic route to peptidomimetics of type 5.7 is shown in Scheme 5.4. The 
starting pyrrole-2-carboxaldehyde 2.22a was reacted with (carboethoxy)methyl 
triphenylphosphorane under the Wittig conditions described by Jones and Lindners to 
give a mixture of the alkenes 5.13 and 5.14 in 66% overall yield. The cis- 5.13 and trans-
5.14 alkenes were then separated to give the desired trans-isomer 5.14 in a yield of 49%. 
The ester of pyrrole 5.14 was hydrolysed with sodium hydroxide to give the free acid 
5.15 in 88% yield, which was coupled with L-Ieucine methyl ester hydrochloride using 
the standard peptide coupling reagents 1,3-dicyclohexylcarbodiimide (DCC) and 1-
hydroxybenzotriazole (HOBt),6 to give the pyrrole amide 5.16 in 92% yield. Subsequent 
attempts to prepare the desired N-acyl derivative 5.17 by substituting the pyrrole nitrogen 
of 5.16 with hydrocinnamoyl chloride, using either the sodium hydride or DMAP-
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mediated acylation methodologies described in Chapter 2, gave returned starting material. 
IH NMR spectral analysis of the crude product from these reactions failed to show any 
evidence of the desired N-acyl product 5.17. Due to this inability to effect N-substitution 
of compound 5.16, further work on peptidomimetics of type 5.7 was discontinued. 
5.3.2. Preparation of peptidomimetics of type 5.8 and 5.9 
Peptidomimetics of type 5.8 and 5.9 were conveniently prepared from a common 
intermediate 5.18 by the synthetic routes detailed in Schemes 5.5 and 5.6. Compound 
5.18 was prepared in 49% yield by acylating pyrrole with methyl succinyl chloride7 using 
standard Grignard conditions. 8 The synthetic route then used to prepare compounds of 
type 5.8 from the intermediate 5.18 is detailed below in Scheme 5.5. 
0 (i) QyJ N N OMe 
H H 0 
5.18 j (ii) 
QyJ (iv) QyJ (iiO QyJ - X" N OMe N OMe N OMe R OH R 0 R OH 
5.8a R = S02Me 5.19a R = S02Me 5.8c R = CO(CH2hPh 
5.8b R = S02Ph 5.19b R = S02Ph 
5.19c R = CO(CH2hPh 
Scheme 5.5. Reagents and conditions: (i) MeMgI, Et20, reflux then 
Me02C(CH2)2COCI, reflux (49%); (ii) NaH, THF then either MeS02CI (5.19a, 86%) or 
PhS02CI (5.19b, 43%) or Ph(CH2)2COCI (5.19c, 82%); (iii) Zn(BH4)2, EhO, 0 °C; (iv) 
NaBH4, MeOH, 0 °C (5.8a, 85%), (5.8b, 90%). 
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The N-substituted pyrroles 5.19a-c were readily prepared in yields of 86%, 43% 
and 82%, respectively, by treating the pyrrole 5.18 with sodium hydride and then reacting 
the resultant N-pyrrolyl anion with either methanesulfonyl chloride, phenylsulfonyl 
chloride or hydrocinnamoyl chloride. An attempted reduction of the ketone of the N-
hydrocinnamoylpyrrole 5.19c with zinc borohydride gave an inseparable mixture of 
deacylated pyrrole 5.18 and desired product 5.8c in a ratio of 5 : 2 (by IH NMR 
spectroscopy). Next, we turned our attention to the reduction of the more stable N-
sulfonyl derivatives 5.19a and 5.19b. An attempted reduction of the ketone of the N-
mesylpyrrole 5.19a using zinc borohydride gave returned starting material only. 
However, a sodium borohydride reduction of 5.19a gave the desired product 5.8a in 85% 
yield. Similarly, a sodium borohydride reduction of the N-phenylsulfonylpyrrole 5.19b 
gave the desired alcohol 5.8b in 90% yield. 
The synthetic route used to prepare peptidomimetics of type 5.9 is detailed below 
in Scheme 5.6. 
0> ~ (ii) QyJN~Me 5.18 N OH H 0 H 0 H 
5.20 5.21 
~N~Me 
J Oii) 
(iv) ~Nt2Me 0( 
~ OH H ~ 0 H 
5.9a R = S02Me 5.22a R = S02Me 
5.9b R = S02Ph 5.22b R = S02Ph 
Scheme 5.6. Reagents and conditions: (i) NaOH, MeOH-H20 (78%); (ii) L-
LeuOMe.HCI, EDCI, HOBt, HOnig's base (93%); (iii) NaH, THF then either MeS02CI 
(5.22a, 50%) or PhS02CI (5.22b) (iv) NaBH., MeOH, 0 °C (5.9a, 89%), (5.9b, 38% for 
2 steps). 
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The ester of pyrrole 5.18 was hydrolysed under basic conditions to give the free 
acid 5.20 in 78% yield, which was coupled with L-Ieucine methyl ester hydrochloride, 
using standard EDCI-coupling methodology,9 to give the pyrrole amide 5.21 in 93% 
yield. N-Substitution of the pyrrole 5.21 using either methanesulfonyl chloride or 
phenylsulfonyl chloride, followed by sodium borohydride reduction of the ketone, then 
gave the desired pyrrole alcohols 5.9a and 5.9b in yields of 45% and 38%, respectively (2 
steps). 
5.3.3. Preparation of peptidomimetics of type 5.10 
o N 
H 
0) 
.. n COEt «N~ 2 
H 
5.23 
-DJt OHC N N C02Me Of H H 
5.26 
(ii) n 
--_.. OHCAN~C02Et 
H 
5.24 ! (iii) 
Ov) or (v) n OHCAN~C02H 
H 
5.25 I (vi) or (viO 
-DJt (viiO n 'i? --l 
.. HO~N~NLco~Me OHC N N C02Me 
I H 
R 
5.27a R = CO(CH2hPh 
5.27b R = S02Me 
I H 
R 
5.10a R = CO(CH2hPh 
5.10b R = S02Me 
Scheme 5.7. Reagents and conditions: (i) EtMgBr, THF, -10°C to rt then 
BrCH2CO:zEt, -10°C to rt then aq. NH4CI (61%); (ii) POCh, DMF, 1,2-DCE, reflux 
then NaOAc.3H20, reflux (56%); (iii) NaOH, MeOH-H20 (84%); (iv) L-LeuOMe.HCI, 
EDCl, HOBt, HOnig's base (85%); (v) L-LeuOMe.HCI, DCC, HOBt, Hiinig's base 
(81%); (vi) DMAP, HOnig's base then Ph(CH2)2COCI, -10°C to rt (5.27a, 81%); (vii) 
. NaH, THF then MeS02C1, -10°C to rt (5.27b, 70%); (viii) Zn(B~)2, Et20, 0 °C (5.10a, 
44%), (5.10b, 83%). 
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Our synthetic route to peptidomimetics of type 5.10 is shown above in Scheme 
5.7. Pyrrole was alkylated with ethyl bromo acetate under the Grignard conditions 
described by Schloemer et al.,to to give 5.23 in 61% yield. In this method, a 3.3 molar 
excess of the N-pyrrolylmagnesium salt was used in order to minimise the formation of 
polyalkylation side products. Vilsmeier-Haack formylation of 5.23 then gave the desired 
2,5-disubstituted pyrrole 5.24 in 56% yield. The ester of pyrrole 5.24 was hydrolysed 
under basic conditions to give the free acid 5.25 in 84% yield, which was coupled with L-
leucine methyl ester hydrochloride, using both standard EDCI and DCC-coupling 
methodologies, to give the pyrrole amide 5.26 in yields of 85% and 81%, respectively. 
Initial attempts to N-substitute the sodium salt of pyrrole 5.26 with either phenylsulfonyl 
chloride, ~-trans-styrenesulfonyl chloride or 2-phenylethanesulfonyl chloride were 
unsuccessful, giving returned starting material and/or polymeric material. However, N-
mesylation of 5.26 was subsequently achieved by employing a modified procedure in 
which the sodium salt of 5.26 was cooled to -10°C during the addition of 
methanesulfonyl chloride. In this way, the N-mesylpyrrole 5.27b was prepared in 70% 
yield. A similar modification proved successful in the preparation of the N-
hydrocinnamoylpyrrole 5.27a. Thus, addition ofhydrocinnamoyl chloride to a cooled (-
10°C) dichloromethane solution of 5.26, Hunig's base and DMAP gave the desired 
pyrrole 5.27a in 81% yield. Reduction of the formyl group of 5.27b with zinc 
borohydride then gave the desired hydroxymethylpyrrole 5.10b in 83% yield. A similar 
zinc borohydride reduction of 5.27a gave the desired hydroxymethylpyrrole 5.10a in 
44% yield. However, the resulting product 5.10a was unstable and was observed to 
slowly decompose at 0 °C. 
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5.3.4. Attempted preparation of peptidomimetics of type 5.11 
Our proposed synthetic route to peptidomimetics of type 5.11 is shown below in 
Scheme 5.S. 
n _ ~ n _ ~ 
"f'{/y ~'OMe 
H 0 
... _- --........ OHC/"f'{/y~'oMe 
H 0 
5.18 5.28 
, 
, 
, 
t 
n ~ ~ H~OMe ------. 
~ 0 
OHC/"~/y~'OMe 
~ 0 
5.29 5.11 
Scheme 5.8. Proposed synthetic route to peptidomimetics of type 5.11. 
An initial attempt to prepare 5.28 by Vilsmeier-Haack formylation of the 
corresponding pyrrole 5.18, prepared as detailed in Scheme 5.5, proved unsuccessful. 
Instead, the cx.-chlorovinylpyrrole 5.30 was obtained in low yield (13%), along with a 
considerable amount of polymeric material (Scheme 5.9). 
n ~ ~ "N/y~'OMe 
H 0 
.. 
n ~ ~ OHC/"t(y~'oMe + 
H CI 
(i) 
5~8 5~O 
polymeric 
material 
Scheme 5.9. Reagents and conditions: (i) POCh, DMF, 1,2-DCE, reflux then 
NaOAc.3H20, reflux (13%). 
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An analogous conversion of fully ring-substituted 3-acylpyrroles into ex-
chlorovinylpyrroles under Vilsmeier-Haack conditions has previously been reported by 
Mironov et al. ll The resulting ex-chlorovinylpyrroles were then readily hydrolysed under 
aqueous conditions to regenerate the starting 3-acylpyrroles (Scheme 5.10). However, 
when the more strongly basic conditions of sodium hydroxide in N,N-dimethylformamide 
were employed in this hydrolysis, 3-alkynylpyrroles were formed. 
R2 
M~R2 DMF/Poch 1CR2 NaOH M}{ • .. r ~ .. r ~ DMF r ~ R1 N R1 H20, h. R1 N R1 R1 N R1 
H H H 
Scheme 5.10. Analogous ex-chlorovinylpyrrole formation (Mironov et al.). 
A subsequent attempt was then made to prepare 5.28 using anion chemistry by 
employing the methodology described by Muchowski and Hess. 12 This method involves 
treating the azafulvene dimer 5.31 (Scheme 5.11) with a suitable organolithium reagent to 
give a dilithiated species, which after reaction with an electrophile and hydrolysis, then 
affords as-substituted pyrrole-2-carboxaldehyde. A diverse range of electrophiles have 
been utilised in this sequence to provide a wide variety of 5-substituted pyrrole-2-
carboxaldehydes, including an example of as-acyl pyrrole-2-carboxaldehyde. 12 
The azafulvene dimer 5.31 was readily prepared in a yield of 76% by treating 
pyrrole-2-carboxaldehyde 2.22a with a solution of 40% aqueous dimethylamine.12 A 
solution of the dimer 5.31 in tetrahydrofuran at -15°C was treated with terl-butyllithium 
(2.5 equivalents) to give a dilithiated species, which was then quenched at -78°C by the 
addition of 3-carbomethoxypropionyl-N-methoxy-N-methylamide.13 However, 
subsequent hydrolysis of the reaction mixture gave returned pyrrole-2-carboxaldehyde 
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H 
2.22a 
(ii) 
X .. n ~ R OHC.....-'tf .... y~'OMe 
H 0 
5.28 
120 
Scheme 5.11. Reagents and conditions: (i) 40% aq. Me2NH (76%); (ii) t-BuLi, -15°C 
to 0 °C then Me02C(CH2)2CON(OMe)Me, -78°C to rt then aq. NaOAc, reflux. 
2.22a only (68% recovery). At this stage it remains uncertain why none of the desired 2-
acylated product 5.28 was isolated from this reaction sequence. 
Due to the inability to prepare the desired compound 5.28 by the methods 
described above, we decided to investigate an alternative strategy. It was thought that a 
Stille coupling of a stannylpyrrole with an acid chloride might be a mild and versatile 
route by which to introduce the second acyl substituent onto the pyrrole ring. This was in 
light of the work by Jousseaume et aI.14 which had reported that the palladium-catalysed 
cross-coupling reactions between N-methyl-5-tributylstannylpyrrole-2-carboxaldehyde 
and chloroformates or carbamoyl chlorides gave the corresponding formylpyrrole esters 
and amides in good yields (65 -70%), and without the need for protection of the formyl 
group (see Scheme 5.12). 
n OHC N SnBu3 
I 
Me 
CIC02n-Oct 
• (PPh3hPdC~ 
70% 
CICONMePh 
.. 
n OHC N C02n-Oct 
I 
Me 
n OHC N CONMePh 
~e 
Scheme 5.12. Palladium-catalysed cross-coupling reaction of stannylpyrroles 
(Jousseaume et al.). 
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However, these previous Stille couplings had been carried out with a stannylpyrrole N-
substituted with a methyl group. Such a group would be undesirable in our current 
synthesis as it would be difficult to remove at the end of the reaction sequence. We 
therefore chose the 2-(trimethylsilyl)ethoxymethyl (SEM) group15 as an alternative, as it 
would be both stable to the reaction conditions, and would also be easily removed at the 
end of the reaction sequence. Furthermore, a SEM group is known to direct substitution 
at the a-position of pyrrole due to the formation of a stabilised chelated species upon 
lithiation.15 Our initial synthetic route to compound 5.28 utilising this SEM-protection of 
the pyrrole nitrogen is shown in Scheme 5.13. 
n 0) n (ii) n OHC N Br 
-
OHC N Br 
-
OHC N R 
H 
"'-0 "'-0 5.32 ~SiMe3 ~SiMe3 
5.33 5.34 R = SnBu3 
5.35 R = H 
Ov) ~ ~ 5.28 III OHC N OMe 
"'- 0 0 
~SiMe3 
5.36 
Scheme 5.13. Reagents and conditions: (i) NaH, DMF then SEM-CI (89%); (ii) 
Morpholine, n-BuLi, THF, -78°C then t-BuLi then n-Bu3SnCI, -78°C to rt (5.34, 60%; 
5.35,25%); (iii) Me02C(CH2)2COCI, (phiP)iPdCb, PhMe, reflux (74%); (iv) BF3.OEt2, 
CH2Cb, 0 °C then aq. NaOAc, reflux (75%). 
The starting 5-bromopyrrole-2-carboxaldehyde 5.32 was prepared by the indirect 
method described by Bray and Muchowski. 16 The N-protected pyrrole 5.33 was then 
prepared in 89% yield by treating 5.32 with sodium hydride in N,N-dimethylformamide, 
. and reacting the resultant N-pyrrolyl anion with 2-(trimethylsilyl)ethoxymethyl chloride 
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(SEM-CI). In the key stannylation step, in situ protection of the fonnyl group of 5.33 by 
treatment with lithium morpholide,17 followed by bromine-lithium exchange at -78°C 
using tert-butyllithium (2.2 equivalents) and quenching of the resultant lithiated species 
at -78°C with tri-n-butylstannyl chloride, gave a mixture of the desired stannylpyrrole 
5.34 and debrominated starting material 5.35 in a ratio of 5 : 2 (by IH NMR 
spectroscopy). These compounds were separated by flash chromatography on silica to 
give 5.34 and 5.35 in yields of 60% and 25%, respectively. The stannylpyrrole 5.34 was 
coupled with methyl succinyl chloride using bis(triphenylphosphine)palladium(II) 
dichloride in refluxing toluene to give the 5-acylpyrrole-2-carboxaldehyde 5.36 in 74% 
yield. In the final step, deprotection of the pyrrole nitrogen was readily achieved by 
treating 5.36 with boron trifluoride diethyl etherate at 0 °C, followed by heating the crude 
products at reflux with aqueous sodium acetate,15a to give the desired product 5.28 in 
75% yield. 
Having successfully prepared 5.28 through a Stille coupling of an N-protected 
stannylpyrrole, we then set out to investigate whether we could prepare 5.28 through a 
similar Stille coupling procedure, but without having to protect the pyrrole nitrogen. All 
previously reported Stille couplings of stannylpyrroles have employed N-substitution for 
protection andlor stability reasons.14,18 However, it has recently been reported by 
Fukuyama et al. 19 that an N-unprotected stannylindole was able to undergo a Stille 
coupling in good yield (71%). This suggested to us that a Stille coupling of an N-
unprotected stannylpyrrole therefore ought to be possible too. Our synthetic route to 
compound 5.28, without protection of the pyrrole nitrogen, is shown in Scheme 5.14. 
The key starting N-unsubstituted stannylpyrrole 5.37 was prepared from the 
azafulvene dimer 5.31 by a modified method to that described by Denat et al?O In this 
method, a solution of the dimer 5.31 in tetrahydrofuran at -15°C was treated with tert-
butyl lithium (2.2 equivalents) to give a dilithiated species, which was then quenched at 
-78 °C by the addition of tri-n-butylstannyl chloride. Subsequent hydrolysis of this 
reaction mixture by heating the crude products at reflux with aqueous sodium acetate for 
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~NMe2 (0, (iO 
Me2N~ • n OHC N SnBu3 H 
5.37 
(iiO. n~~ 
OHC/"N/y~"oMe 
H 0 
5.31 5.28 
Scheme 5.14. Reagent and conditions: (i) t-BuLi, THF, -15°C to 0 °C then n-Bu3SnCI, 
-78°C to rt; (ii) aq. NaOAc, THF, reflux, 5 days (37% for 2 steps); (iii) 
Me02C(CH2)2COCI, (phiP):zPdCh, PhMe, reflux then KF, MeCN, rt (78%). 
5 days then gave the stannylpyrrole 5.37 in 37% yield (2 steps). The stannylpyrrole 5.37 
was coupled with methyl succinyl chloride using bis(triphenylphosphine)palladium(ll) 
dichloride in refluxing toluene to give the desired compound 5.28 in 78% yield. The 
acylation occurred exclusively at the 5-position under these conditions, with no N-
acylated pyrrole side-products being detected by IH NMR spectroscopy. To the best of 
our knowledge, this is the first example of a Stille coupling of an N-unsubstituted pyrrole. 
This method therefore allows for a fast and efficient synthesis of a range of 5-
acylpyrrole-2-carboxaldehydes from a single key precursor, and without the need to 
protect either the formyl group or the pyrrole nitrogen (see Chapter 7 for an application 
ofthis method in the preparation of a marine natural product). 
Having successfully prepared the intermediate 5-acylpyrrole-2-carboxaldehyde 
5.28 by the methods described above, an attempt was then made to prepare the desired N-
acyl derivative 5.29 (see Scheme 5.15). Consequently, compound 5.28 with treated with 
. sodium hydride, and the resulting pyrrolyl anion was reacted with acetyl chloride 
(Scheme 5.15). Work up of the reaction mixture and purification of the residue by flash 
chromatography on silica gave a single pyrrole-based compound, which was tentatively 
assigned as the 6-acetyloxy-1-azafulvene dimer 5.38 (89% yield) on the basis of the 
NMR and mass spectral data discussed below. 
Chapter Five - Development of hydroxymethylpyrroles as serine protease inhibitors 
n _ ~ 
OHC ...... "t:J/y~"'oMe 
R 0 
C 5.28 R=H (Q 5.29 R=COMe 5.38 
Scheme 5.15. Reagents and conditions: (i) NaH, THF then MeCOCI (89%). 
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The IH NMR spectrum of the purified product was inconsistent with the desired 
N-acetylpyrrole 5.29 (Scheme 5.15), since a proton signal was not observed for the 
formyl group (expected at approximately 0 1O.3). However, the IH NMR spectrum did 
indicate that N-substitution had occurred on pyrrole since no nitrogen proton could be 
observed. Furthermore, the IH and 13C NMR spectra indicated the presence of an acetate 
group in the molecule, due to a three proton signal at 02.06 and carbon signals at 0 20.8 
and 169.4. The dimeric nature of 5.38 was then proposed on the basis of a high 
resolution mass spectrum which was consistent with the structural formulae C2zH23N20s 
(MH-CH3C02H). To confirm our structural assignment, and also to determine the 
relative stereochemistry at the 6-acetyloxy positions (ie syn- or anti-configuration), 
attempts were made to grow crystals of 5.38 suitable for X-ray crystallographic analysis. 
However, despite numerous crystallisation attempts from various solvent systems (eg 
ethyl acetate/petroleum ether, chloroform/petroleum ether and acetone/petroleum ether) 
we were unable to grow crystals suitable for such an analysis. Nonetheless, confirmation 
of our proposed dimeric structure for 5.38 was obtained by the subsequent conversion of 
5.38, via a reductive cleavage reaction,21 to the reduced pyrazine 5.39 (16% yield) which 
was then fully characterised (Scheme 5.16). 
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(i) 
C~Me 
5.38 5.39 
Scheme 5.16. Reagents and conditions: (i) Zn(BRt)2, M~SiCI, Et20, 0 °C (16%). 
A possible mechanism for the formation of the 6-acetyloxy-1-azafulvene dimer 
5.38 is shown below in Scheme 5.17. 
H n - COMe y"N'''"Y .............. 2 
o H 0 
5.28 
5.38 
NaH 
o 
H Cff1( - CO Me y"~~Y""""""" 2 ro ~ 0 
E)) j 
H~c02Me 
yO 0 
o 5.40 
Scheme 5.17. Possible mechanism for the formation ofazafulvene dimer 5.38. 
Deprotonation of the starting 5-acylpyrrole-2-carboxaldehyde 5.28 generates the 
corresponding pyrrolyl anion which can then react with acetyl chloride through the 
oxygen of the formyl group, as shown in Scheme 5.17. The resulting O-acylazafulvene 
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intermediate 5.40 can then undergo facile dimerisation to give the 6-acetyloxy-1-
azafulvene dimer 5.38. An analogous O-acylationldimerisation mechanism has been 
proposed to explain the formation of the related 6-benzoyloxy-1-azafulvene dimer 5.41 
upon benzoylation ofpyrrole-2-carboxaldehyde (Scheme 5.18).22 
NaOH 
• U N CHO 
H 
PhCOCI 
• 
Scheme 5.18. Formation of the 6-benzoyloxy-1-azafulvene dimer 5.41 (Treibs et al.). 
Due to the inability to effect the desired N-substitution of compound 5.28, further 
work on peptidomimetics oftype 5.11 was discontinued. 
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5.3.5. Attempted preparation of peptidomimetics of type 5.12 
OUf synthetic route to peptidomimetics of type 5.12 is shown in Scheme 5.19. 
(i) (ii) 0 ~ ~ .. .. N N COCC~ N C02Et 
H H H 
5.42 5.43 I (iii) 
r ~ 
OHh n N C02Et + OHC N C02Et 
H H 
5.45 5.44 
1 (iv) 
n ~ C~R2 (v) or (vi) n 
OHC"'Nn y .. OHC N C02H 
H 0 ~ H 
5.47a R1 = H, R2 = Et 
5.47b R 1 = CH2CHMe2, R2 = Me 
5.47c R 1 = CH2Ph, R2 = Me f (v10 or (v110 
n H 2 
OHC"'t:Jn
Ny C02R 
~ 0 R1 
5.48a R1 = H, R2 = Et 
5.48b R 1 = CH2CHMe2, R2 = Me 
5.48c R 1 = CH2Ph, R2 = Me 
5.46 
--_ H~~yCo,R2 
~ 0 R1 
5.12 
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Scheme 5.19. Reagents and conditions: (i) CCbCOCI, Et20 (81%); (ii) EtOH, Na 
(98%); (iii) POCh, DMF, 1,2-DCE, reflux then NaOAc.3H20, reflux (5.44, 67%; 5.45, 
15%); (iv) KOH, H20, 40 - 50°C (82%); (v) EDCI, HOBt, Hiinig's base and either 
GlyOEt.HCI (5.47a, 70%) or L-LeuOMe.HCI (5.47b, 90%) or L-PheOMe.HCI (5.47c, 
91%); (vi) L-LeuOMe.HCI, DCC, HOBt, Hiinig's base (5.47b, 89%); (vii) DMAP, 
Hiinig's base then RCOCI; (viii) NaH, THF, then RCOCI. 
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Pyrrole was acylated with trichloroacetyl chloride to give 5.42, which was then 
treated with sodium ethoxide in ethanol to give ethyl pyrrole-2-carboxylate 5.43 in 79% 
yield (2 steps).8 Vilsmeier-Haack formylation of 5.43 then afforded a mixture of the 
formylpyrrole isomers 5.44 and 5.45 in 82% overall yield. The 2,5- 5.44 and 2,4- 5.45 
disubstituted pyrroles were separated to give the desired pyrrole 5.44 in 67% yield. Next, 
the ester of pyrrole 5.44 was hydrolysed under basic conditions to give the free acid 5.46 
in 82% yield, which was coupled with either glycine ethyl ester hydrochloride, L-Ieucine 
methyl ester hydrochloride or L-phenylalanine methyl ester hydrochloride using standard 
EDCI-peptide coupling methodology to give the key 5-formylpyrrole-2-carboxamides 
5.47a-c in yields of 70%, 90% and 91%, respectively. Compound 5.47h was also 
prepared in high yield (89%) using standard DCC-peptide coupling methodology. 
Subsequent attempts to prepare the desired N-acyl derivatives 5.48a-c by N-
substitution of the corresponding 5-formylpyrrole-2-carboxamides 5.47a-c, using either 
the DMAP or sodium hydride acylation methodologies described in Chapter 2, were 
unsuccessful and instead led to the formation of the unexpected heterocyclic products 
6.1a-c and 6.6a-c, respectively (see Figure 5.5). For further discussion on the preparation 
and properties of these unexpected heterocyclic products see Chapter 6. Due to this 
inability to effect the desired N-substitution of compounds 5.47a-c, further work on 
peptidomimetics of type 5.12 was discontinued. 
6.1a-c 
a R1 = H, R2 = Et 
b R1 = CH2CHMe2, R2 = Me 
c R1 = CH2Ph, R2 = Me 6.6a-c 
Figure 5.5. Unexpected products obtained from N-substitution ofpyrroles 5.47a-c. 
Chapter Five - Development of hydroxymethylpyrroles as serine protease inhibitors 129 
5.3.6. a-Chymotrypsin assay of pyrrole-based peptidomimetics 
The peptide-based pyrroles 5.8a-b, 5.9a-b and 5.10b (Figure 5.6) were assayed as 
potential inhibitors of a-chymotrypsin by the colorimetric method outlined in Section 
5.2. The results ofthis a-chymotrypsin assay are presented in Table 5.3. 
n ~ ~ 
"~/y~'oMe 
~ OH 
5.8a R = S02Me 
5.8b R = S02Ph 
J,Vt ~ HO ~o,Me ~ Co,Me 
. n ~ ~ L __ ' 5.10b 
"~/y~'N C02Me ~ OH H 
5.9a R = S02Me 
5.9b R = S02Ph 
Figure 5.6. Peptide-based pyrroles assayed as potential inhibitors of a-chymotrypsin. 
Compound 
5.8a 
5.8b 
5.9a 
5.9b 
5.10b 
1250 !lg mL"t 
10 
25 
0 
20 
10 
% Inhibition 
125 !lgmL"l 12.5 !lg mL"l 
5 0 
10 0 
0 0 
15 10 
5 0 
Table 5.3. Results of a-chymotrypsin assay (results rounded to nearest 5%). 
The results detailed in Table 5.3 indicate that the extended pyrrole derivatives 
5.8a-b, 5.9b and 5.10b developed in this work were modest inhibitors of a-
chymotrypsin. Of the 2-extended compounds tested, the N-phenylsulfonyl derivatives 
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5.8b and 5.9b were found to show significantly greater enzyme inhibition activity than 
the corresponding N-mesyl derivatives 5.8a and 5.9a. As previously discussed, this was 
attributed to the mesyl group being a poor substituent for recognition by ct.-chymotrypsin. 
A further point to note from the results detailed in Table 5.3, was that the more extended 
peptide-like examples 5.9a and 5.9b failed to show any increase in the enzyme inhibition 
activity compared to the more simple examples 5.8a and 5.8b. In fact, in the case of the 
extended N-mesyl example 5.9a, the increase in chain length led to a complete loss of 
enzyme inhibition activity. This may have been due to either poor enzyme recognition of 
the inhibitor molecule (ie leucine not the optimal residue at the P3' subsite for binding in 
the enzyme), or due to steric congestion within the enzyme active site caused by this 
increase in chain length (ie steric interactions preventing the efficient binding of the 
inhibitor molecule in the enzyme). 
The 2,5-extended derivative 5.10b also failed to show any significant inhibition 
activity against ct.-chymotrypsin. This again was most likely due to poor enzyme 
recognition of the N-mesyl substituent. A final point to note from the results detailed in 
Table 5.3 was that of the peptide-based pyrroles tested in this current study, none proved 
to be better inhibitors than previously discussed examples. 
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5.4. Summary and future work 
We have investigated the application of N-substituted hydroxymethylpyrroles as 
mechanism-based inhibitors of serine proteases. In preliminary studies to detennine the 
optimal pyrrole N-substituent and leaving group for enzyme inhibition, we found that an 
N-arylsulfonyl group was able to promote the inhibition of a-chymotrypsin. Up to this 
time only N-acyl substituted hydroxymethylpyrroles had been investigated in this role. 
Furthermore, we have found that a hydroxyl group at the 2-methyl position of pyrrole 
was the optimum leaving group for enzyme inhibition. 
Subsequent work then focussed on identifying and developing potential lead 
compounds as possible pyrrole-based peptidomimetics. As a result, we have investigated 
a number of alternate methodologies to incorporate the hydroxymethylpyrrole-moiety 
into an extended peptide-like sequence. During the attempted preparation of many of 
these compounds, however, problems were encountered in the pyrrole N-substitution 
step, with either N-substitution failing to occur, or conversely, resulting in the fonnation 
of unexpected heterocyclic side-products. Of the compounds that were prepared and 
assayed for enzyme inhibition activity in this current work, none proved to be better 
inhibitors than previously discussed examples. 
Future work in this area could entail the further development of some of the lead 
compounds identified in this work as mechanism-based inhibitors of serine proteases. 
This could potentially lead to the preparation of derivatives which display more selective 
. and efficient enzyme inhibition activity. Further work is also required to develop a better 
understanding of the exact mechanisms involved in enzyme inhibition for this class of 
mechanism-based inhibitor. 
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6.1. Attempted N-acylation of 5.47 using DMAP methodology: 
Pyrrolizin-3-one formation 
An attempt was made to N-acylate the 5-formylpyrrole-2-carboxamide 5.47a 
using the DMAP acylation methodology described in Chapter 2. Accordingly, a 
dichloromethane solution of 5.47a, Htinig's base (2.1 equivalents) and DMAP (0.1 
equivalent) was treated with hydrocinnamoyl chloride (2.1 equivalents). The resultant 
yellow solution was then stirred for 24 hours, during which time the solution changed to a 
bright orange colour. Work up of the reaction mixture and purification of the residue by 
flash chromatography on silica gave a single orange coloured pyrrole-based compound, 
which was subsequently identified as the pyrrolizin-3-one 6.1a (58% yield) (Scheme 6.1). 
(i) 
C 5.47a R H (i) 5.48a R:= CO(CH2hPh 6.1a 
Scheme 6.1. Reagents and conditions: (0 DMAP, Htinigs base, CH2Ch then 
Ph(CH2hCOCI (58%). 
The IH NMR spectmm of the purified product (Figure 6.1) was inconsistent with 
the desired N-hydrocinnamoyl pyrrole 5.48a (see Scheme 6.1), since resonances were not 
observed for the formyl proton (expected at approximately 0 10.3) and for a methylene 
group of the hydrocinnamate (expected at approximately 0 3.2). Nonetheless, the IH 
NMR spectmm did indicate that N-acylation had occurred on pyrrole due to the 
disappearance of the signal for the pyrrole nitrogen proton, while a five proton aromatic 
signal at 07.23 - 7.37 indicated the presence of the hydrocinnamoyl group. 
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CH3 
Ph 
( 
NH ) H6 H1 H7 
I J 1{ -
Jl __ Jl11-'-------I 
Figure 6.1. IH NMR spectrum (CDCh) of the pyrrolizin-3-one 6.1a. 
The structure of the pyrrolizin-3-one 6.1a shown in Figure 6.1 was then proposed 
through the use of one and two dimensional NMR spectral techniques. Key HMBC 
correlations which enabled the structural assignment were identified between the proton 
resonance at (5 6.65 (ie pyrrolizin-3-one HI, see Figure 6.1 for pyrrolizin-3-one 
numbering scheme) and the carbon resonances at (5 31.9, 167.8 and 139.7 (ie CH2Ph, 
pyrrolizin-3-one C3 and pyrrolizin-3-one C8, respectively), and also between the proton 
resonance at (5 3.62 (ie CH2Ph) and the carbon resonances at (5 137.0, 136.8, 132.3 and 
167.8 (ie ipso-Ph, pyrrolizin-3-one C2, pyrrolizin-3-one Cl and pyrrolizin-3-one C3, 
respectively). These key HMBC correlations suggested a second ring was present in the 
structure. A high resolution mass measurement was also consistent with the structural 
formulae C19HlSN204 and hence the cyclic structure. Furthermore, the ultraviolet 
spectrum in methanol showed ~nax at 242, 338 and 423 nm, which indicated a conjugated 
aromatic system. 
Subsequent conformation of the structure of the pyrrolizin-3-one 6.1a was 
obtained by a single crystal X-ray analysis. Compound 6.1a was found to crystallise in 
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the monoclinic space group P2]/c with two independent molecules in the asymmetric unit 
(designated 6.1a and 6.1a'), each of which have similar confOlmations. A perspective 
drawing of 6.1a and 6.1a', with atomic labelling, is presented in Figure 6.2. 
Figure 6.2. X-ray crystal structure of 6.1a and 6.1a' with crystallographic numbering 
scheme. 
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A search of the Cambridge Crystallographic Data Base revealed only one other X-
ray crystal structure of a pyrrolizin-3-one, that of 6-bromopyrrolizin-3-one. 1 In 
agreement with the previously reported structure, our crystal structure of compound 6.1a 
shows that the pyrrolizin-3-one ring is planar at all positions. Another notable similarity 
between the present crystal structure and the previously reported structure is that the 
C(3)-N(4) and C(3')-N(4') bond lengths of 6.1a and 6.1a' are significantly longer 
[1.406(3) and 1.408(3) A, respectively] than that of a normal cyclic tertiary amide 
[1.335(9) A].2 These observations are consistent with reduced amide delocalisation in the 
pyrrolizin-3-one structure. This is further supported by the significant alternation of the 
bond lengths in the pyrrole ring, indicating a decrease in aromaticity relative to pyrrole.3 
Furthermore, the olefinic C(1)-C(2) and C(l')-C(2') bond lengths are relatively long 
[1.335(3) and 1.338(3) A, respectively] which indicates there is only limited conjugation 
to the pyrrole ring. 
Having unequivocally identified the product of the N-acylation reaction of 5.47a 
as the pyrrolizin-3-one 6.1a, further examples were prepared for comparison and to 
assess the scope of the reaction. Thus, reaction of 5.47b and 5.47c with hydrocinnamoyl 
chloride by the methodology described above gave the pyrrolizin-3-ones 6.1b and 6.1c in 
yields of 55% and 58%, respectively (Scheme 6.2). The structures of the compounds 
6.1b and 6.1c were assigned by comparison of the IH NMR spectral data with that of the 
previously determined pyrroHzin-3-one 6.1a. 
5.47b R CH2CHMe 
5.47c R CH2Ph 
(i) 
" 
6.1 b R = CH2CHMe2 
6.1c R = CH2 Ph 
Scheme 6.2. Reagents and conditions: (i) DMAP, HUnigs base, CH2Cb then 
Ph(CH2)2COCI (6.1b, 55%); (6.1c, 58%). 
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Characteristic IH NMR and UV spectral data for the pyrrolizin-3-one derivatives 6.la-c 
are summarised in Tables 6.1 and 6.2. 
I Compound H-l H-6 H-7 CH2Ph NH 
6.la 6.65, t 6.88, d 5.97, d 3.62, d 9.33, t 
(1.5) (3.4) (3.4) (1.5) (5.4) 
6.1b 6.61, t 6.87, d 5.96, d 3.62, d 9.22, d 
(1.7) (3.4) (3.4) (1.7) (6.8) 
6.lc 6.60, t 6.84, d 5.94, d 3.60, d 9.31, d 
(1.5) (3.4) (3.4) (1.5) (7.3) 
Table 6.1. Characteristic IH NMR spectral data for pyrrolizin-3-ones 6.1a-c [0 (300 
MHz), CDCb, multiplicity (J coupling in Hz)]. 
Compound 
6.la 
6.lb 
6.lc 
Solvent 
MeOH 
MeOH 
CHCh 
242 (11300) 
223 (11500) 
Table 6.2. UV spectra of pyrolizin-3-ones 6.la-c (nm). 
Amax (£) 
338 (25400) 
339 (9100) 
301 (12300) 
423 (200) 
436 (900) 
438 (4100) 
During an attempt to purify the pyrrolizin-3-one 6.lb from residual 
hydrocinnamic acid by eluting a small sample through an activated amino cartridge with 
methanol, evidence of a ring-opened product was observed. However, this compound 
was not characterised further. In light of this observation, separate samples of 6.la-c 
were treated using sodium methoxide in methanol to give colourless samples of the 
pyrrole acrylic esters 6.2a-c in yields of 85%, 80% and 82%, respectively (Scheme 6.3). 
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6.1a 
6.1b 
6.1c 
(i) 
.. 
6.2a R = H 
6.2b R CH2CHMe2 
6.2c R CH2Ph 
140 
Scheme 6.3. Reagents and conditions: (i) MeONa, MeOH (6.2a, 85%), (6.2b, 80%), 
(6.2c,82%). 
In the case of the leucine and phenylalanine examples 6.2b and 6.2c, only the cis-
isomer was observed. However, in the case of the glycine example 6.2a, a mixture of the 
cis- and trans-isomers were obtained in a ratio of 3 : 1 (by iH NMR spectroscopy). 
Subsequent recrystallisation of this mixture gave a pure sample of the trans-isomer (22% 
yield), which was fully eharacterised. The assignment of a cis-configuration for the 
alkene of 6.2b (and by analogy for 6.2a and 6.2c) was based on an observed strong 
positive NOB enhancement at 0 3.74 (ie CH2Ph) upon irradiation at 0 6.65 (ie pyrr-CH). 
An NOB was also observed in the reverse direction on irradiation of CH2Ph (0 3.74). 
A possible mechanism for the formation of compounds 6.1a-c would involve 
initial N-acylation of the 5-formylpyrrole-2-carboxamides 5.47a-c, followed by an 
intramolecular Knoevenagel type condensation catalysed by Htinig's base, to give the 
corresponding pyrrolizin-3-ones 6.1a-c (Scheme 6.4). An interesting point to note in this 
mechanism is that the proposed N-acyJ intermediates 5.48a-c are in fact the compounds 
we were attempting to prepare (see Scheme 6.1). 
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Hunig's base 
n H 2 ~OHC"~'ogN'(,C02R I~ ~ 5.48a-c 
n H 2 
OHC/ 'N/ f(Ny C02R 
H 0 R1 
5.47a-c 
o .. 
6.1a-c 
Scheme 6.4. Proposed mechanism for the formation of the pyrrolizin-3-ones 6.1a-c. 
An examination of the literature revealed only three other reports of pyrrolizin-3-
ones having been prepared through an analogous intramolecular Knoevenagel type 
condensation of an N-acylated-2-acylpyrrole intermediate.4-6 The products in these 
reactions were identified as the pyrrolizin-3-ones 6.3,46.45 and 6.56 (Scheme 6.5). 
R3 R3 R3 R3 R3 R3 
~ R2CH2COCI o~ 
'* 
;to 
- R N Base R1 H R1~O ~ (K4, NaH5 R2 0 
or Et3N6) R2 
R1 R2 R3 
6.3 Ph Ph H 
6.4 H Ph H 32% 
6,5 H H Ph 72% 
Scheme 6.5. Other pYlTolizin-3-ones formed via a Knoevenagel type condensation. 
Chapter Six Formation of unexpected heterocyclic products during N-acylation 142 
The more common approach to synthesise pyrrolizin-3-ones is to form the 3,4-
lactam bond as the final step in ring formation, through the use of an intramolecular 
acylation of the pyrrole nitrogen. To enable this intramolecular N-acylation step, 
however, a suitably activated acyl substituent is required at the pyrrole 2-position. The 
main methodologies by which this acyl group has been activated, and hence formation of 
a pyrrolizin-3-one achieved, include formation of a mixed anhydride followed by ring 
closure and decarboxylation,S through a base catalysed elimination from 
pyrrolepropenoic and propanoic derivatives,7 and by flash vacuum pyrolysis (FVP) of a 
Meldmm's acid or propenoate ester derivative of pyrrole. 8 A number of other 
methodologies for the formation of pyrrolizin-3-ones have also been reported in the 
literature.9 However, these methodologies require the concerted formation of two bonds 
to effect ring formation, either through the use of a ketene intermediatelO or as a result of 
a thermal elimination after a Vilsmeier-Haack acylation reaction of pyrroles with certain 
amides. 11 
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6.2. Attempted N-acylation of 5.47 using sodium hydride methodology: 
Azafulvene dimer formation 
An attempt was then made to N-acylate the 5-formylpyrrole-2-carboxamides 5.47 
using the sodium hydride methodology described in Chapter 2. In separate experiments, 
a sample of each of 5.47b and 5.47c were treated with an equivalent of sodium hydride, 
and the resulting pynolyJ anion was reacted with an equivalent of acetyl chloride. Work 
up of the reaction mixture and purification of the resulting residue by flash 
chromatography on silica gave the azafulvene dimers 6.6b and 6.6c in yields of 41 % and 
25%, respectively (Scheme 6.6). Polymeric material was also obtained from this reaction 
sequence. Significantly, the dimers 6.6b and 6.6c were subsequently found, by X-ray 
crystallographic analysis and observed optical rotation, to be present as only a single 
stereoisomer, which had a syn-diol relative configuration (see later for a discussion). No 
~vidence of any of the other possible isomers were observed in the lH NMR spectra of 
the crude products from these reactions. When the above reaction of 5.47b was repeated 
using hydrocinnamoyl chloride in place of acetyl chloride a reduced yield of 6.6b was 
obtained (25%). This was largely due to difficulties in purifying the desired product 6.6b 
from residual hydrocinnamic acid. 
5.47b R CH2CHMe2 
5.47e R = CH2Ph 
.. 
,R 
OH NH 
o )--C02Me R 
6.6b R:=: CH2CHMe2 
6.6e R = CH2Ph 
Scheme 6.6. Reagents and conditions: (i) NaH, THF then either CH3COCI (6.6b, 41 %), 
(6.6c, 25%) or Ph(CH2hCOCI (6.6b, 25%). 
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The dimeric nature of 6.6b and 6.6c were proposed on the basis of high resolution 
mass spectra which were consistent with the structural formulae C26H35N407 (MH-H20) 
and C32H31N407 (MH-H20), respectively. The proposed structures of 6.6b and 6.6c were 
further supported by a series of one and two dimensional NMR experiments. Key 
HMBC correlations for 6.6c were found between the proton resonance at 8 6.23 (ie 
pyrrole-CHOH-N) and the carbon resonance at 8 130.7 (ie pyrrole C5, see Scheme 6.6 
for pyrrole numbering), and between the proton resonance at 86.17 (ie pyrrole H4) and 
the carbon resonances at 8 130.7 and 71.5 (ie pyrrole C5 and pyrrole-CHOH-N, 
respectively). These key HMBC correlations supported our proposed dimeric structure. 
Furthermore, the optical rotary dispersion measurements in dichloromethane of [a]D25 
120.6° and -149.0° for 6.6b and 6.6c, respectively, indicated that they were optically 
active species. 
In order to confinn our structural assignment for 6.6b and 6.6c, and also to 
determine both the relative configuration of the diols (ie syn or anti) and the absolute 
configuration of the dimers, we set about growing crystals of 6.6b and 6.6c suitable for 
X-ray crystallographic analysis. After several initial attempts, suitable crystals of 6.6b 
and 6.6c were eventually obtained, from the solvent system ethyl acetate/petroleum ether, 
by employing the crystallisation technique of vapour diffusion. 
The single crystal X-ray analysis of 6.6b showed that the molecule crystallised in 
the chiral space group P42212. The asymmetric unit was also shown to contain a 
disordered solvent molecule of ethyl acetate in addition to the 6.6b molecule. A 
perspective drawing of 6.6b, with atomic labelling, is presented in Figure 6.3a. Two 
molecules pack (ie dimerise) such that they are related by a 2-fold rotational axis, having 
their central rings cofacial and the pyrrole rings offset by 45° (see Figures 6.3b and 6.3c). 
The distance between the planes of these molecules ranges from 3.5 - 4.0 A. This 
arrangement is similar to TC-TC stacking as reported for related porphyrin systems in which 
two porphyrin molecules adopt a cofacial arrangement with their centres offset, to give an 
interplanar separation of 3,4 3.6 A,12 Another key point to note in the crystal structure 
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of 6.6b is that hydrogen bonds are also evident between the amide hydrogens of one 
molecule and the ester carbonyl groups of the other (ie 09' to N7 distance is 2.965 A). 
(a) 
Figure 6.3. (a) X-ray crystal structure of compound 6.6b with crystallographic 
numbering scheme (for clarity the co-crystallised ethyl acetate molecule is not shown). 
(b) Side view showing non-covalent dimerisation. (c) Top view showing overlay of 
pyrrole rings in the non-covalent dimer. 
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(b) 
(c) 
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A single crystal X-ray analysis of the phenylalanine-based example 6.6c also 
revealed the same non-covalent dimerisation as seen in 6.6b (see Figures 6.4a-c for 
perspective drawings of 6.6c). The important points to note from the X-ray crystal 
structures of 6.6b and 6.6c, therefore, are that the dimers 6.6b and 6.6c are present as 
single diastereomers which have only one of the two possible syn-configurations of the 
diols, and that these syn-diol compounds are further dimerised by non-covalent 
interactions. 
(a) 
Figure 6.4. (a) X-ray crystal structure of compound 6.6c with crystallographic 
numbering scheme. (b) Side view showing non-covalent dimerisation. (c) Top view 
showing overlay of pyrrole rings in the non-covalent dimer. 
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(b) 
(c) 
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Another important point to note is that 6-amino-l-azaful venes of type 6.7 are 
known to dimerise to give the analogous anti-dipyrrolo[1,2-a: l' -d]pyrazines 6.8 
(Scheme 6.7).13 The formation of the dimer 6.8 is reversible, and the 6-amino-l-
azafulvene 6.7 can be regenerated by a thermal decomposition of the dimer. 14 The anti-
configuration of compounds of type 6.8 has been assigned on the basis of IH NMR 
spectroscopy14 and X-ray crystallography.I5 This preference for the anti-isomer of 6.8 
contrasts with our examples (ie 6.6b and 6.6c) where the syn-isomers were produced 
exclusively as a single diastereomer under mild conditions . 
.. 
6.7 
6.8 
Scheme 6.7. Dimerisation/thermal decomposition of 6-amino-l-azafulvenes. 
As only a single diastereomer of 6.6b and 6.6c were produced in the reaction 
sequence described above, we postulate that the diastereoselective synthesis of dimers 
6.6b and 6.6c from the corresponding pyrrole carboxamides 5.47b and 5.47c was 
controlled by their ability to form the non-covalent dimeric structures in solution, ie this 
represents an example of molecular self-assembly. Molecular self-assembly has been 
defined by Whitesides et at. I6 as "the spontaneous association of molecules under 
equilibrium conditions into stable, structurally well-defined aggregates joined by non-
covalent bonds." As such, the self-assembly of molecules to form well-defined 
supramolecular structures under the influence of weak, non-covalent forces such as 
hydrogen bonds, electrostatic interactions and hydrophobic interactions, is an important 
area of current chemical and biochemical research. I6-20 Numerous examples of self-
assembly can be found in nature, such as in the spontaneous formation of the double helix 
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of nucleic acids, in the stacking of the viral protein coat of the tobacco mosaic virus 
(TMV), and in the formation of multiprotein complexes. I7 Furthermore, self-assembly 
also has potential in the development of strategies for the preparation of non-biological 
nanostructures.1 6 
In related peptidic examples, cyclic peptides such as the eight-residue cyclo[(-L-
Phe-D-N-MeAla-)41 6.9, which have a selectively N-methylated backbone, have been 
shown to self-assemble into discrete, cylindrical dimers of the type 6.10 (Figure 6.5). 
Me Me 0 
o \~ Ph~ yN 0 NH~Ph 
JYL L 0 
M:~ND D ~:: 
Me-~N );0 
o L L 
Ph HN D --«-Ph Jr-r-~ 0 
o Me Me 
6.9 
j 1 
6.10 
Figure 6.5. A two dimensional representation of the chemical structure of the peptide 
subunit 6.9 (L and D refers to the chirality of the amino acid) and the self-assembled 
cylindrical dimer 6.10 (for clarity only four of the eight CH2Ph groups are represented). 
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In these examples, the backbone N-methyl groups block one face of the flat cycle to 
further hydrogen bonding. 18 In the absence of such N-methylation, however, cyclic 
peptides such as 6.9 self-assemble, by extended hydrogen bonding, into open-ended, 
hollow, tubular structures that act as simple models of ion channelling systems,l8 The 
introduction of aromatic rings into the cycles has also been shown to facilitate self-
assembly due to TC-TC stacking, rather than hydrogen bonding. 19 Our current examples 
6.6b and 6.6c are analogous to the first of these literature-based systems, where the syn-
hydroxyl groups block one face of the dimer molecule such that non-covalent interactions 
on the other face of the molecule then result in the formation of the non-covalent dimers 
shown in Figures 6.3 and 6.4. However, an important difference in our examples 6.6b 
and 6.6c compared to the previous literature-based systems, is that the non-covalent 
association is thought to control the diastereoselective synthesis of these compounds. A 
final important point to note is that the alternative syn- and anti-diol configurations for 
6.6b and 6.6c would block the f01TIlation of the non-covalent dimeric structures of these 
compounds due to sterk reasons. This may account for why only one of the two possible 
syn-diol configurations was observed to form in the above reaction. 
For the synthesis of the dimers 6.6b and 6.6c to be a molecular self-assembly 
process, however, requires the non-covalent dimeric structures of 6.6b and 6.6c to be 
formed under equilibrium conditions (ie in solution) during the reaction sequence. 
Evidence which suggests that these non-covalent dimers of 6.6b and 6.6c are indeed 
present in solution was obtained by examining both the frequency of the amide N-H 
stretches in the infrared spectra and the chemical shifts of the N-H protons in the IH 
NMR spectra. The appearance of an N-H stretching band at 3342 and 3352 cm-1 in the 
chloroform infrared spectra of 6.6b and 6.6c, respectively, was consistent with hydrogen 
bonding in solution as reported for the peptide dimer 6.10 (Figure 6.5).18a In this 
previous example, the formation of a tight hydrogen-bonded dimer, with an average 
intersubunit N-O distance of 2.95 A, was shown by the appearance of an N-H stretching 
band at 3309 cm-J in the infrared spectrum. 18a hl the case of our example 6.6b, the X-ray 
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crystal structure had shown a similar tight hydrogen-bonded dimer, with an intersubunit 
N-O distance of 2.965 A (see Figure 6.3b and earlier for a discussion). In addition, the 
significant downfield shifts (-1.2 - 1.4 ppm) of the amide proton resonances in CDCh 
upon going from the starting pyrrole carboxamides 5.47b and 5.47c to the azafulvene 
dimers 6.6b and 6.6c (ie () 7.03 to 8.46 and () 6.99 to 8.16, respectively) was also 
consistent with the occurrence of this hydrogen bonding in solution. 18a,19,20 In agreement, 
the cyclic peptide subunit 6.9 (Figure 6.5) also showed a significant downfield shift of 
1.75 ppm for the phenylalanine N-H resonance in the IH NMR spectrum upon formation 
of the self-assembled peptide dimer 6.10 (ie () 6.98 to 8.73).18a 
To fmiher determine whether the non-covalent dimers of 6.6b and 6.6c were 
present in solution, IH NMR spectra of 6.6b and 6.6c were obtained in the more polar 
solvents DMSO-d6 and acetone-d6 (and also in CD30D for 6.6b). In such polar solvents 
it might be expected that the solvent would be able to disrupt the hydrogen bonds 
between the non-covalent dimers of 6.6b and 6.6c, and so effect disaggregation of the 
individual dimers. Any such non-covalent dimer disaggregation would then be shown in 
the IH NMR spectra by the appearance of new upfield proton resonances cOlTesponding 
to the (solvated) amide groups of the individual dimers. However, the IH NMR spectra 
of 6.6b and 6.6c in these more polar solvents failed to show any evidence of new 
resonances for the amide protons. Consequently, the above IH NMR spectral results 
either indicate that no such intermolecular hydrogen bonding between the individual 
dimer molecules of 6.6b and 6.6c was occurring in solution, or conversely, that the non-
covalent interactions between the dimers, was so strong that the solvent was unable to 
disrupt these interactions and effect disaggregation. Further work is therefore required in 
order to establish whether or not such non-covalent dimerisation of 6.6b and 6.6c is in 
fact occurring in solution, and hence directing the diastereoselective synthesis of these 
dimers. 
Next, we set out to investigate whether the non-chiral glycine-based pYlTole 
carboxamide 5.47a would also give the conesponding azafulvene dimer 6.6a as a single 
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stereoisomer during the above reaction sequence. Consequently, a sample of 5.47a was 
treated with an equivalent of sodium hydride, followed by the addition of an equivalent 
of acetyl chloride. A LH NMR spectrum of the crude product from this reaction indicated 
the presence of a single isomer of 6.6a. Purification of this product by flash 
chromatography on silica gave the azafulvene dimer 6.6a in a yield of 50% (Scheme 6.8). 
(i) 
5.47a 
6.6a 
Scheme 6.8. Reagents and conditions: (i) NaH, THF then CH3COCI (50%). 
The 1 H NMR spectrum of the purified dimer 6.6a once again indicated only a 
single isomer. However, due to the presence of symmetry within the molecule, we were 
unable to ascertain by 1 H NMR spectroscopy whether the dimer 6.6a had a syn- or anti-
configuration of the diols. On the basis of our previous dimer examples 6.6b and 6.6c, 
we would expect 6.6a to have an analogous syn-configuration of the diols, and also to be 
further dimerised by non-covalent interactions such as hydrogen bonding. Evidence 
which indicated that this may indeed be the case for the dimer 6.6a was shown in the 
infnned and lH NMR spectra. The appearance of an N-H stretching band at 3350 cm-! in 
the chlorofOlm infrared spectrum of 6.6a, and a large downfield shift of 1.58 ppm for the 
amide proton resonance upon going from 5.47a to 6.6a (ie 8 6.94 to 8.52), were 
consistent with our previous examples 6.6b and 6.6c, and therefore imply hydrogen 
bonding in solution (see earlier for a discussion). This would indicate, therefore, that the 
glycine-based azafulvene dimer 6.6a also had a syn-configuration of the diols. However, 
with such an arrangement the dimer 6.6a would be expected to be racemic, since both 
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syn-diol configurations of 6.6a would allow the non-covalent interactions discussed 
above. 
In an effort to determine unequivocally the relative configuration of the diols in 
the glycine dimer 6.6a, several attempts were made to grow crystals of 6.6a suitable for 
X-ray crystallographic analysis. However, despite numerous crystallisation attempts we 
were unable to obtain crystals suitable for X-ray analysis. Consequently, the definitive 
answer as to the configuration of the diols of 6.6a remains unresolved, although as 
discussed above, a syn-configuration would seem most likely. Another important point to 
note regarding 6.6a was that on standing for 3 days in CDCb, approximately 15% of 
another compound, tentatively assigned as the anti-isomer, was observed to form. In 
contrast, compounds 6.6b and 6.6c were stable for extended periods in CDCI3, with no 
sign of any such epimerisation. 
The mechanism for the formation of the azafulvene dimers 6.6a-c is undoubtedly 
complex, especially in the case of 6.6b and 6.6c where we found only a single 
stereoisomer was produced. The exact role of the acid chloride in the formation of the 
dimers 6.6 remains unclear, except to say that the reactions do not proceed in its absence. 
It is possible that the acid chloride reacts with the pYlTolyl anion, generated on reaction of 
5.47 with sodium hydride, through the oxygen of the formyl group, in an analogous 
procedure to that described in the formation of the 6-acetyloxy-1-azafulvene dimer 5.38 
(see Scheme 5.17, Chapter 5). The resulting O-acylazafulvene intermediate could then 
react with another pyrrolyl anion to give 6.6 after hydrolysis. However, at this moment 
there is no direct evidence for this O-acylazafulvene intermediate since no O-acylated 
side products have been isolated from the above reactions. Consequently, further work is 
required in this area in order to establish the exact mechanisms involved in the formation 
of the azafulvene dimers 6.6. 
Finally, in a possibly related reaction, Brittain et ai. 21 in 1981 reported that diethyl 
2-dichloromethyl-4-methylpyrrole-3,5-dicarboxylate 6.11 reacted specifically with 
aqueous potassium hydroxide to yield the ·thermochromic tripyrrolic system 6.13 
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(Scheme 6.9). The structure of 6.13 was unequivocally established by way of X-ray 
crystallographic analysis. The mechanism of the formation of 6.13 was not totally 
understood, although it has since been suggested that the potassium ion acts as a template 
ion for the initial formation of 6.12.22 The important point to note from this earlier 
example, however, was that the syn-isomer was formed exclusively from the above 
hydrolysis reaction. Here, a covalent linkage, rather than a non-covalent association as 
postulated for the azafulvene dimers 6.6, determined the stereochemical outcome of the 
reaction. 
Me E ):{ 
E N CHCI2 
H 
6.11 
11 KOH 
Me E E~HE Me 
o~ 
ONE 
E-;:(H H 
Me E 
6.12 
hv 
Me E E Me 
h P~ E-'~N~jO ~ E 
N E 
~ /, 
E Me 
6.13 
Scheme 6.9. Formation of the thermochromic tripyrrolic system 6.13 (Brittain et al.). 
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6.3. Summary 
During attempts to N-acylate the 5-fOlIDylpyrrole-2-carboxamides 5.47a-c using 
standard acylation methodologies, we have observed the formation of unexpected 
heterocyclic side products. 
When the N-acylation reaction was attempted using hydrocinnamoyl chloride and 
the DMAP methodology, a series of orange/red compounds were isolated. These 
compounds were identified as the pyrrolizin-3-ones 6.1a-c on the basis of one and two 
dimensional NMR spectral techniques. Subsequent confonnation of the structure of the 
pyrrolizin-3-one 6.1a was achieved by a single crystal X-ray analysis. The most likely 
mechanism for pyrrolizin-3-one fonnation is the initial N-acylation of the fonnylpyrrole 
followed by an intramolecular Knoevenagel type condensation. 
When the N-acylation reaction was attempted using an acid chloride and the 
sodium hydride methodology, the azafulvene dimers 6.6a-c were obtained. These 
compounds were identified on the basis of one and two dimensional NMR spectral 
techniques. Subsequent single crystal X-ray analysis of the leucine and phenylalanine-
derived dimers 6.6b and 6.6c revealed that each of these compounds were present as only 
a single diastereomer, and were further dimerised by non-covalent interactions such as 
hydrogen bonding. Consequently, we have suggested that the diastereoselective 
synthesis of the azafulvene dimers 6.6b and 6.6c is controlled by this ability to form the 
non-covalent dimeric structures in solution, and as such, represents a possible example of 
molecular self-assembly. However, further work is required to more fully understand 
these observations. 
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CHAPTER SEVEN 
SYNTHESIS AND BIOACTIVITY OF 
HYDROXYMETHYLPYRROLE-BASED 
METABOLITES 
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7.1. Introduction 
Marine organisms, such as sponges, bryozoans and molluscs, have long been 
known as sources of novel compounds which possess potential pharmaceutical properties 
and/or synthetically interesting stlUctures. 1 The different classes of compounds that have 
been characterised from these marine sources include terpenes, lipids, polyketides, 
peptides and amino acid-derived compounds, and other nitrogenous compounds. This 
last class of compounds can be further divided up into different subclasses depending on 
the nitrogenous heterocycle that the natural product is based upon. For example, a 
nl1mber of compounds based on the heterocycles indole, carbazole, pyridine and pYlTole 
have been described, along with a number of guanidine-containing and nucleoside-based 
compounds (see Figure 7.1 for representative examples). 1 
Br 
Flustramine B Manzamine C 0 Pulo'upone H 
NH2 eN 
Br Br N:0 OH H2Ny O ~I 
Br H ~ Br ON N H2N)lN 1-NH2 Br NOH OH MeO OH 
Pentabromopseudilin Saxitoxin Mycalisine A 
Figure 7.1. Representative examples of nitrogen heterocycle-based natural products. 
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In 1997, Ortega et ai. isolated a series of fourteen novel pyrrole-based metabolites 
from a north-eastem Atlantic sponge Mycale micracanthoxea.2 This work reported the 
isolation and characterisation of twelve 5-acyl-2-hydroxymethylpyrroles, named 
HO~{CH2)2 
H 0 7.1 
Ji'\.~ HO~"N/y~(CH2)n~ 
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7.8 n 9 
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Figure 7.2. Mycalazols 1 - 12 (7.1-7.12) and mycalazals 1 - 2 (7.13 -7.14). 
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mycalazols 1 12 (7.1 - 7.12), along with two 5-alkylpyrrole-2-carboxaldehydes, named 
mycalazals 1 - 2 (7.13 -7.14), that differ in the length and degree of unsaturation of their 
side chain (Figure 7.2). These novel pyrrole-based metabolites were reported to show 
moderate cytoxicity (EDso of 1 - 10 )lg mL- 1) against the P388 murine leukemia, 
SCHABEL mice lymphoma, A549 human lung carcinoma, HT29 human colon 
carcinoma and MEL28 human melanoma cel11ines (see Table 7.1). 
Assay 7.1 7.2 7.3 7.4 7.5 7.6 7.7 7.8 7.9 7.10 7.11 7.12 7.14 
P388 2 2 2 2 2 1 2 2 2 2.5 2 
SCHABEL 2 2 2 2 2 1 1 2 2 2 2.5 2 2 
A549 2 2 2 2 2 1 2 2 2 1 1 5 
HT29 2 5 2.5 2.5 2.5 1 2 5 2 2.5 10 10 5 
MEL28 2.5 5 2.5 2.5 2.5 2 2 2.5 2 2.5 10 5 5 
Table 7.1. Cytotoxicity data (EDsQ, Ilg mL-1) of the mycalazols 1 12 (7.1 - 7.12) and 
mycalaza12 7.14. 
The mycalazols 1 12 were the first reported examples of 5-acyl-2-
hydroxymethylpyrrole-based natural products, although the related 
methoxymethylpyrrole 7.15 had previously been reported by Tada and Tozyo as an 
extremely unstable metabolite from the marine sponge Agelas Sp.3 
Br 
MeO rl ~N»-.Br 
H 
7.15 2,3-dibromo-5-methoxymethylpyrrole 
An examination of the literature revealed that a number of 5-alkylpyrrole-2-
carboxaldehydes related to the mycalazals 1 - 2 had previously been isolated from 
marine sources. In 1980, Stierle and Faulkner reported the isolation of four 5-
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alkylpyrrole-2-carboxaldehydes 7.16 differing in alkyl chain length, along with the 
pyrrole nitrile 7.17 and cyanohydrin 7.18, from the marine sponge Laxosuberites sp. 
(Figure 7.3).4 In 1984, Bowden et al. isolated 5-nonylpyrrole-2-carboxaldehyde 7.19 
from a soft coral-sponge association of the genus Telesto.5 A series of saturated, mono-
and di-unsaturated 3-alkylpynole-2-carboxaldehydes 7.20 - 7.23 have been reported by 
Cimino et al. from the marine sponge Oscarella lobularis,6 although it has since been 
suggested that they might also be 2,5-disubstituted pyrroles.4 
Hfl i( "N/ '(CH2)nCH3 
o H 
7.16 n = 14, 15, 16, 18 
7.22 
7.21 
7.23 
Figure 7.3. Alkylpyrrole-2-carboxaldehydes isolated from marine sources. 
Despite some similarities with the above compounds, the mycalazals 1 - 2 (Figure 
7.2) were the first reported 5-alkylpyrrole-2-carboxaldehydes to possess an extended 
conjugated unsaturated side chain. No cytotoxicity data has been reported on the 5-
alkylpyrrole-2-carboxaldehydes from the earlier studies. 
The aim of the research undertaken in this chapter was to synthesise a 
representative example of the mycalazol natural products, along with some simple 5-acyl-
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2-hydroxymethylpyrrole analogues differing in alkyl chain length, by utilising our newly 
developed Stille coupling methodology (see Chapter 5 for a discussion of this method). 
The in vitro P388 cytotoxicity of these compounds, together with a 5-carboxamido-2-
hydroxymethylpyrrole analogue, would then be assayed, and from these results a 
preliminary understanding of the structure-activity relationship of these compounds could 
be developed. 
7.2. Synthesis of Mycalazol 11 and related hydroxymethylpyrroles 
The mycalazol which was deemed to be the most suitable synthetic target in this 
investigation was the fully saturated acyl side chain example, mycalazol 11 7.11. This 
was due to the ready commercial availability of the parent fatty acid, nonadecanoic acid, 
and to allow a direct comparison with other synthesised analogues which also contained a 
fully saturated acyl or carboxamido side chain. 
The synthesis of the 5-acyl-2-hydroxymethylpyrroles 7.27, 7.28 and 7.11 began 
with the preparation of 5-(tri-n-butylstannyl)pyrrole-2-carboxaldehyde 5.37 from pyrrole-
2-carboxaldehyde, as detailed in Chapter 5. This stannylpyrrole 5.37 was then coupled 
with either n-hexanoyl chloride, lauroyl chloride or nonadecanoyl chloride7 using 
bis(triphenylphosphine)palladium(II) dichloride in refluxing toluene to give the 5-
acylpyrrole-2-carboxaldehydes 7.24 - 7.26 in yields of 77%, 91 % and 92%, respectively 
(Scheme 7.1), The acylation occurred exclusively at the 5-position under these 
conditions, with no N-acylated pynole side-products being detected by IH NMR 
spectroscopy. The synthesis was then completed by simply reducing the formyl group of 
7.24 - 7.26 with zinc borohydride to give the corresponding 5-acyl-2-
hydroxymethylpyrroles 7.27, 7.28 and 7.11 in high yields (93%, 84% and 93%, 
respectively). The IH NMR data obtained for 7.11 was identical to that reported for the 
natural product, mycalazol 11.2 
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n OHC N SnBu3 
H 
5.37 
7.27 n = 1 
7.28 n:=: 7 
7.11 n:=:14 
(i) n~ 
OHC/ 'f'f/ Y "(CH2)n~ 
H 0 
7.24 n:::: 1 
7.25 n 7 
7.26 n:::: 14 
~ 
165 
Scheme 7.1. Reagents and conditions: (i) CH3(CH2)4COCl or CH3(CH2)lOCOCl or 
CH:\(CH2)17COCl, (Ph3PhPdCh, PhMe, reflux, 1% h then KF, MeCN, rt, 1 h (7.24,77%), 
(7.25, 91 %), (7.26, 92%); (ii) Zn(B~)2' Et20, 0 °C (7.27, 93%), (7.28, 84%), (7.11, 
93%). 
An important feature of our synthetic methodology is that it allows for the 
efficient coupling of a stannylpyrrole with an acyl group without the need for protection 
of the pyrrole nitrogen. Previously reported examples of palladium-catalysed cross-
coupling reactions of a stannylpyrrole and an acyl, aryl, heteroaryl or alkyl halide have 
employed methyl,8 tert-butoxycarbonyl (BOC)8c,9 or tosyllO substitution of the pyrrole 
nitrogen for protection and/or stability reasons. Another point to note is that a synthesis 
of the 5-(l-oxohexyl)pyrrole-2-carboxaldehyde 7.24 has previously been reported by 
Muchowski and Hcss using anion chemistry. 11 In this method, a two step, one-pot 
lithiation sequence of the 6-dimethylamino-1-azafulvene dimer, followed by hydrolysis 
with sodium acetate in refluxing aqueous tetrahydrofuran, gave the desired pyrrole 7.24 
in 54% yield. In contrast, our Stille coupling methodology allows for a greater range of 
acyl substituents, with a broad range of functionality, to be incorporated onto the parent 
pyrrole compound due to the avoidance of these bases in the acylation sequence. 
The related 5-carboxamido-2-hydroxymethylpyrrole 7.30 was also prepared for 
testing against the P388 murine leukemia cell line. This compound enabled a comparison 
of the activity of hydroxymethylpyrrole derivatives bearing an amide side chain (ie 
compound 7.30) and an acyl side chain (ie compounds 7.27, 7.28 and 7.11). The 
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synthesis of 7.30 was achieved by initially coupling 5-formylpyrrole-2-carboxylic acid 
5.46, prepared as detailed in Chapter 5, with dodecylamine, using standard EDCI-
coupling methodology,12 to give the 5-carboxamidopyrrole-2-carboxaldehyde 7.29 in 
92% yield (Scheme 7.2). Reduction of the formyl group of 7.29 with zinc borohydride 
then gave the desired hydroxymethylpyrrole 7.30 in 91 % yield, 
n OHC 1\1 C02H (i) 
H 
5.46 
HOJA~'-./(CH2)9---/ 
H 0 
7.30 
Scheme 7.2. Reagents and conditions: (i) EDCI, HOBt, dodecylamine (92%); (ii) 
Zn(BH4h, Et20, 0 °C (91 %). 
7.3. P388 Cytotoxicity of mycalazol analogues 
Compounds 7.27, 7.28, 7.11 and 7.30 were assayed for in vitro cytotoxicity 
against the P388 murine leukemia cell line. The IDso results of this assay, as summarised 
in Table 7.2, showed that the most active compounds were the long acyl chain derivatives 
7.28 and 7.11, which had activities of 21 and 24 Ilg mL-1, respectively. These were 
followed in tum by the carboxarnido derivative 7.30 and the short acyl chain derivative 
7.27, which had activities of 52 and 78 Ilg mL-1, respectively. The lower the IDso value 
for a compound, the more potent its cytotoxicity. These preliminary results suggest that 
an increased chain length leads to greater activity, although it should be noted that 
compounds 7.28 and 7.11 have comparable activity (see Table 7.2). Mycalazol 11 7.11 
has previously been reported to have an EDso of 2.5 Ilg mel against the P388 cellline,2 
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while in our present study a lO-fold decrease in activity was recorded. However, the 
decreased activity of 7.11 in our assay may have been due to the observed formation of a 
precipitate in the reaction wells of this compound during the P388 assay. Attempts at 
changing the polarity of the assay solvent in order to prevent this precipitation of 7.11 
were unsuccessful, and instead resulted in a loss of activity (ID50 > 125 J.lg mL"l). From 
the assay results detailed in Table 7.2 it would also appear that an acyl side chain leads to 
increased biological activity relative to the carboxamido side chain, with 7.28 having 2.5-
fold greater activity compared to 7.30, despite similar chain lengths. 
Compound 
Number of atoms 
in side chain 
7.27 
6 
78 
7.28 
12 
21 
7.11 7.30 
19 14 
52 
Table 7.2. Cytotoxicity data (ID50, J.lg mL"l)t of the hydroxymethylpyrroles 7.27, 7.28, 
7.11# and 7.30. 
The lower the value of 1Dso the more cytotoxic the compound 
A precipitate was observed to form in the reaction wells of 7.11 during the P388 assay. 
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7.4. Summary and future work 
A new and general synthesis of 5-acylpyrrole-2-carboxaldehydes has been 
developed which utilises a Stille coupling reaction between 5-(tri-n-butylstannyl)pyrrole-
2-carboxaldehyde 5.37 and a (fatty) acid chloride. This coupling proceeds in good yield 
and without the need to protect either the a-formyl group or the pyrrole nitrogen. This 
methodology was used to prepare a series of 5-acyl-2-hydroxymethylpyrroles, including 
the previously rep011ed natural product mycalazol 11 7.11. These compounds, together 
with a 5-carboxamido-2-hydroxymethylpyrrole, were assayed for in vitro cytotoxicity 
against the P388 murine leukemia cell line. The ID50 results of this assay indicated that, 
in general, an increased chain length leads to greater biological activity, and that an acyl 
side chain has greater acti vity relative to a carboxamido side chain. 
Future work in this area will be centred on the synthesis and P388 assay of further 
examples of these compounds, incorporating either an acyl chain with varying degrees of 
unsaturation, or a polypeptide chain, in order to further explore the key features of this 
class of pyrrole-based compound that are responsible for the biological activity. 
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8.1 General Methods and Experimental Procedures 
Nuclear Magnetic Resonance 
Proton detected NMR spectra were obtained on a Varian Unity 300 spectrometer 
operating at 300 1v1Hz. Carbon detected NMR spectra were obtained on a Varian XL300 
spectrometer operating at 75 1v1Hz. Unless otherwise indicated, spectra were obtained at 
23°C. Other NMR experiments described in this thesis viz. NOE and the reverse~ 
detected HSMQC, HSQC and HMBC experiments were all obtained on the Unity 300 
spectrometer at 300 1v1Hz. At various stages this instrument was fitted with either a 
Nalorac Z.spec :MlD300 3 mm Indirect Detection Probe or a Pulsed Field Gradient MLD 
driver with a 5mm Indirect Detection Probe. Chemical shifts are reported in parts per 
million (ppm), on the 0 scale, and are referenced to the appropriate solvent peaks: CDCl3 
referenced to (CH3)4Si at 0H 0 ppm (1H) and CDCl3 at Oc 77.0 ppm (13C); CD30D 
referenced to CHD20D at 0H 3.30 ppm eH) and CD30D at Oc 49.3 ppm (13C); acetone-
d6 referenced to (CD3)(CHD2)CO oH 2.17 (1H) and (CD3hCO Oc 29.2 (13C); CD3CN 
referenced to CHD2CN 0H 2.00 eH) and CD3CN oe 1.3 ( l3C); DMSO-d6 referenced to 
(CD3)(CHD2)SO oH 2.50 (1H) and (CD3hSO Oc 39.6 (13C). IH NMR spectra were 
obtained using an acquisition time (At) of2 s. 13C]:-;rMR spectra were obtained with an At 
of 0.878 s and typically a delay (Dl) of 1 s. All difference NOE experiments were 
obtained in undegassed solutions, with an acquisition time (At) of 1 s and an irradiation 
time (D2) of 2 s. The decoupler was offset 10,000 Hz for the control experiment. 
HSMQC experiments were obtained with an At of 0.2 s, Dl was set for individual 
samples when setting the null value and IJCH = 145 Hz. fTh.1QC experiments with the 
pulsed field gradient system were run with an At of 0.137 s, a Dl of 1.0 sand IJCH = 140 
Hz. HMBC experiments were obtained with an At of 0.21 s (0.137 s with the pulsed field 
gradient system), a relaxation delay of 0.3 s, IJCH = 140 Hz and nJCH = 8.3 Hz, unless 
otherwise stated. 
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Mass Spectrometry 
Mass Spectrometry was performed on a Kratos MS80 Mass Spectrometer 
operating at 4 kV. Various ionisation techniques were used including Electron Impact 
(EI) at 70eV and chemical ionisation (CI; C4H lO). The softer ionisation technique of Fast 
Atom Bombardment (FAB) was used where necessary and was performed with an Ion 
Tech ZNllFN ion gun using Xe as the reagent gas, operating at 8 kV and 2 rnA with 
either NOB A (m-nitrobenzyl alcohol), m-b (magic bullet, 50% 
dithioerythritoIldithiothreitol), or glycerol as the matrix. 
m Spectroscopy 
IR spectra were obtained using a Shimadzu 8201PC series FTIR interfaced with a 
Intel 486 PC running Shimadzu's HyperIR software. Spectra were run in a solution of 
either CHCh or CS2. 
UV Spectroscopy 
UV spectra were obtained usmg a Hewlett Packard 8452A diode array 
spectrophotometer. Spectra were run in a solution of either CHCh or MeOH. 
I 
Melting Foints 
Melting points were taken on an Electrothermal® apparatus and are uncorrected. 
Reagents and Solvents 
Unless otherwise indicated, all reactions were conducted in oven- or flame-dried 
glassware under an atmosphere of dry nitrogen. Analytical thin layer chromatography 
(TLC) was conducted on aluminium- or plastic-backed Merck Kieselgel KG60F254 silica 
plates. Visualisation was by shortwave ultraviolet light and/or staining with Ehrlich's 
reagent1 or potassium permanganate solution. Flash chromatography was performed on 
Merck Silica 60 following the guidelines given by Still et al. 2 Solvents and reagents used 
in reactions were pvrified according to well established procedures.3 T etrahydrofuran 
(THF), ether (EhO) and benzene (PhH) were distilled from sodium benzophenone ketyl 
immediately prior to use. Pyrrole, dichloromethane (CH2Ch), 1,2-dichloroethane (1,2-
DCE), triethylamine (TEA), HOnig's base (N,N-diisopropylethylamine) and phosphorus 
oxychloride (POCh) were all distilled from calcium hydride. Methanol (MeOH) and 
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ethanol (EtOH) were distilled from iodine-magnesium turnings and stored under N2 or Ar 
over 4 A molecular sieves. Organolithiums and Grignard reagents were obtained from 
Aldrich Chemical Co. or Acros Organics. Organolithiums and Grignard reagents were 
titrated before use by the method of Watson and Eastham.4 
General Procedure A: Formylation ofpyrrole using Vilsmeier-Haack conditions 
Phosphorus oxychloride (1.1 equiv) was added dropwise over 15 min to a solution 
of N,N-dimethylformamide (1.1 equiv) cooled to 10 - 20°C under N2. 1,2-
Dichloroethane (8 mL) was added, followed by a solution of pyrrole (typically 32.3 
mmol) in 1,2-dichloroethane (8 mL) over 1 h. The mixture was heated at reflux for 15 
min, cooled to 20°C, treated with a solution of sodium acetate trihydrate (5 equiv) in 
water (30 mL) and heated at reflux for a further 15 min. The 1,2-dichloroethane layer 
was separated, and the aqueous phase was extracted with ether (3x15 mL). The 
combined orgamc phases were washed with saturated aqueous sodium 
hydrogencarbonate (3x15 mL), dried and evaporated under reduced pressure. The 
residue was purified by distillation under high vacuum and/or flash chromatography on 
silica. See experimental for details. 
General Procedure B: N-Acylation of pyrrole using sodium hydride 
To a stirred suspension of sodium hydride (typically 1.26 mmol, 80% suspension 
in oil washed twice with petroleum ether, 1.2 equiv) in THF (6 mL) under Nz was added 
the pyrrole (typically 1.09 mmol) dissolved in THF (2 mL). After stirring at rt for 15 
min, the electrophile (typically 1.2 - 1.4 equiv) in THF (2 mL) was slowly added and 
stirring was continued for 1 hat rt. Water (10 mL) was added, the THF was removed 
under reduced pressure and the aqueous residue was extracted with dichloromethane 
(3x15 mL). The combined organic phases were washed with saturated aqueous sodium 
hydrogencarbonate (10 mL), water (10 mL), saturated aqueous brine (10 mL), dried and 
concentrated under reduced pressure. The residue was purified by flash chromatography 
on silica. See experimental for details. 
Modification to general procedure B: The electrophile (typically 1.2 - 1.4 equiv) in 
THF (2 mL) was slowly added to a cooled mixture (-10 to 0 °C) of the pyrrolyl anion, 
prepared as described above. Stirring was continued at -10 to 0 °C for 30 min and then 
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for 1 h at rt, before the reaction mixture was worked up using the same method as 
described above. 
General Procedure C: N-Acylation of pyrrole using 4-dimethylaminopyridine 
To a solution of the pyrrole (typically 0.63 mmol), 4-dimethylaminopyridine (0.1 
equiv) and Hunig's base (typically 1.1 - 2.1 equiv) in dichloromethane (8 mL) at rt under 
N2 was added the electrophile (typically 1.1 - 2.1 equiv), dissolved in dichloromethane (2 
mL). The resultant mixture was then stirred for 24 hat rt. Ethyl acetate (10 inL) was 
added, and the solution was washed with 10% aqueous citric acid (10 mL), water (10 
mL), saturated aqueous brine (10 mL), dried and evaporated under reduced pressure. The 
residue was purified by flash chromatography on silica. See experimental for details. 
General Procedure D: Zinc borohydride reductions 
The N-substituted pyrrole-2-carboxaldehyde (typically 0.16 mmol) was dissolved 
in ether (10 mL) at 0 °C under N2. Zinc borohydride (1 equiv of 0.45 M or 0.14 M 
solution in ether) was added and the resultant solution was stirred at 0 °C for 30 min. 
Water (2 mL) and then 10% aqueous glacial acetic acid (2 mL) were carefully added to 
quench the reaction. The separated aqueous phase was extracted with dichloromethane 
(2x10 mL) and the combined organic phases were washed with water (2xlO mL), 
saturated aqueous brine (10 mL), dried and concentrated under reduced pressure. The 
residue was purified by flash chromatography on silica. See experimental for details. 
General Procedure E: Sodium borohydride reductions 
To a solution of the pyrrole ketone (typically 0.20 mmol) in methanol (10 mL) at 
o °C under N2 was added sodium borohydride (15 equiv). The resulting solution was 
stirred at 0 °C for 30 min, then diluted with dichloromethane (10 mL), washed with water 
(2xlO mL), and the organic layer dried and evaporated under reduced pressure. The 
residue was purified by flash chromatography on silica. See experimental for details. 
General Procedure F: Alpine borane® reductions 
The N-substituted pyrrole-2-carboxaldehyde (typically 0.49 mmol) was dissolved 
in THF (10 mL) at rt under N2. R- or S-Alpine borane® (1.1 equiv of 0.5 M solution in 
THF) was added and the resultant solution was stirred at rt for 4 h. The volatiles were 
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removed under reduced pressure and the resultant oil was purified by flash 
chromatography on silica. See experimental for details. 
General Procedure G: Camphanate preparation using camphanoyl chloride 
The hydroxymethylpyrrole (typically 0.12 mmol), 4-dimethylaminopyridine (1 
equiv) and HOnig's base (1.2 equiv) were dissolved in dichloromethane (8 mL) at rt under 
N2. (lS,4R)-(-)-Camphanoyl chloride (1.2 equiv) dissolved in dichloromethane (2 mL) 
was added and the resultant solution was stirred for 24 h. The solution was extracted 
with ethyl acetate (10 mL) and the organic phase was washed with 10% aqueous citric 
acid (10 mL), water (2x10 mL), dried and evaporated under reduced pressure. The 
resultant oil was purified by flash chromatography on silica. See experimental for 
details. 
General Procedure H: Camphanate preparation using Mitsunobu conditions 
The hydroxymethylpyrrole (typically 0.11 mmol), triphenylphosphine (1.3 equiv) 
and (lS,4R)-(-)-camphanic acid (1.5 equiv) were dissolved in THF (2 mL) and the 
solution was stirred for 5 min at rt under N2. Diethylazodicarboxylate (1.5 equiv) was 
added and the resultant solution was stirred for 3 h. The solvent was evaporated under 
reduced pressure, and the resultant oil was purified by flash chromatography on silica. 
See experimental for details. 
General Procedure I: Chlorination of hydroxymethylpyrroles 
Methanesulfonyl chloride (1.5 equiv) was added to an ice cooled solution of the 
hydroxymethylpyrrole (typically 0.38 mmol) in dichloromethane (2 mL) containing 
HOnig's base (1.5 equiv). Stirring was continued at 0 °C for 20 min and for a further 30 
min at rt. The solution was diluted with dichloromethane (10 mL), washed with ice-cold 
water (10 mL), cold 10% aqueous hydrochloric acid (10 mL), and saturated aqueous 
sodium hydrogencarbonate (10 mL). The organic phase was then dried and evaporated 
under reduced pressure. See experimental for details. 
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General Procedure J: Hydrolysis ofpyrrole esters using sodium hydroxide 
A solution of the pyrrole ester (typically 1.22 mmol) in 50% aqueous methanol (4 
mL) containing sodium hydroxide (2.5 equiv) was stirred in a warm water bath (bath 
temperature 30 40°C), and the progress of the reaction was followed by TLC. After 
ca. 1 h, water (10 mL) was added and the methanol was removed under reduced pressure. 
The aqueous solution was washed with ether (10 mL), cooled to 5 °c and acidified with 
50% aqueous sulfuric acid. The resulting solution was extracted with ether (3x15 mL), 
and the combined ethereal extracts were washed with saturated aqueous brine (10 mL), 
dried and evaporated under reduced pressure. See experimental for details. 
General Procedure K: Peptide couplings using 1,3-dicyclohexylcarbodiimide 
A solution of the pyrrole carboxylic acid (typically 0.92 mrnol), L-Ieucine methyl 
ester hydrochloride (1 equiv), Hilnig's base (2.1 equiv), and 1-hydroxybenzotriazole 
hydrate (1 equiv) was stirred in dichloromethane (5 mL) at 0 °C for 10 min under NI. 
1,3-Dicyc1ohexylcarbodiimide (1 equiv) dissolved in dichloromethane (0.5 - 1.5 mL) 
was added and the mixture was stirred at 0 °C for a further 10 min, and then overnight at 
rt. The solution was then diluted with dichloromethane (10 mL) and filtered to remove 
insoluble 1,3-dicyc1ohexylurea. The organic solution was then washed with 3 M aqueous 
hydrochloric acid (2x10 mL), water (2x10 mL), dried and evaporated under reduced 
pressure. The resultant oil was purified by flash chromatography on silica. See 
experimental for details. 
General Procedure L: Peptide couplings using 1-(3-dimethylaminopropyl)-3-
ethylcarbodiimide hydrochloride 
To a stirred solution (-0.1 M) of the pyrrole carboxylic acid (typically 1.14 
mmol) and the L-amino acid ester hydrochloride (1.1 equiv) in dichloromethane (-11 
mL) under N2 at rt were added 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide 
hydrochloride (1.3 equiv) and 1-hydroxybenzotriazole hydrate (1.5 equiv). Hilnig's base 
(1.1 equiv) was added and the reaction mixture was stirred for 16 h. The solution was 
then diluted with dichloromethane (10 mL), washed with 3 M aqueous hydrochloric acid 
(2x10 mL), water (2x10 mL), dried and evaporated under reduced pressure. The resultant 
oil was purified by flash chromatography on silica. See experimental for details. 
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General Procedure M: Stille coupling of stannylpyrroles 
A stirred mixture of the stannylpyrrole (typically 0.39 mmol), acid chloride (1 
equiv) and bis(triphenylphosphine)palladium(II) dichloride (1 mol%) in toluene (20 mL) 
under N2 was heated at reflux temperature until no starting material was evident by TLC 
(ca. 1 liz h). The reaction mixture was allowed to cool to It, dichloromethane (50 mL) was 
added, and the resultant solution was washed with water (50 mL), and saturated aqueous 
brine (50 mL). The organic phase was dried, treated with activated charcoal, filtered and 
evaporated under reduced pressure. The resulting residue was dissolved in acetonitrile (5 
mL), and potassium fluoride (-200 mg) was added. This mixture was then stirred under 
N2 at rt for 1 h before being filtered through Celiteill and evaporated under reduced 
pressure. The residue was purified by flash chromatography on silica. See experimental 
for details. 
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8.2 Experimental Work Described in Chapter Two 
8.2.1. Preparation of unlabelled and lformyl-dj-Iabelled 1-(substitnted) 
pyrrole-2-carboxaldehydes 2.23a-d and 2.24a-d 
o 
N 
H 
R2 
a S02CF3 
- b S02Me 
c C02CMe3 
d COMe 
oyQ 
R1 H 
2.22a R1 = H 
2.22b R1 = D 
oyQ 
H R2 
or 
2.23a-<l 
fformyl-dJ-Pyrrole-2-carboxaldehyde 2.22b 
oyQ 
D R2 
2.24a-<l 
General procedure A was carried out using pyrrole (2.07 mL, 32.3 mmol), POCh 
(3.33 mL, 35.7 mmol, 1.1 equiv) and DMF-d7 (2.00 mL, 35.7 mmol, 1.1 equiv). The 
resulting residue was distilled under high vacuum and recrystallised from petroleum ether 
to give 2.22b (1.64 g, 53%) as a crystalline solid: mp 43 - 44°C (lit.s for unlabelled 
analogue 2.22a mp 44 - 45°C); IR (CHCh) 3453, 3282, 1642 cm-\ IH NMR (CDCh, 
300 MHz) 0 6.36 (m, IH, pyrrole H4), 7.01 (m, IH, pyrrole H3), 7.17 (m, IH, pyrrole 
HS), 10.09 (bs, IH, NH); 13CNMR (CDCh, 75 MHz) 0111.3,122.1,127.3,132.7,179.2 
(t, J = 26.6 Hz); HRMS calcd for CsH4DNO 96.0434, found 96.0432; Isotopic 
incorporation 97.6% D. 
1-(Trifluoromethanesulfonyl)pyrrole-2-carboxaldehyde 2.23a and lformyl-dJ-l-
(trifluoromethanesulfonyl)pyrrole-2-carboxaldehyde 2.24a 
To a solution of pyrrole-2-carboxaldehyde 2.22a (200 mg, 2.10 mmol) in 
dichloromethane (5 mL) containing HOnig's base (733 ilL, 4.21 mmol, 2 equiv), cooled to 
-78°C, was added trifluoromethanesulfonic anhydride (637 J.1.L, 3.79 mmol, 1.8 equiv). 
After 5 min the brown solution was poured onto saturated aqueous sodium 
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hydrogencarbonate (10 mL). The orgamc phase, together with subsequent 
dichloromethane washings (2xlO mL), was dried, and evaporated under reduced pressure. 
Flash chromatography on silica (ethyl acetate/petroleum ether, 1 :6) gave 2.23a (203 mg, 
42%) as a yellow oil: IR (CHCh) 1680, 1175 cm-l ; IH NMR (CDCh, 300 Wiz) 0 6.63 
(m, HI, pyrrole H4), 7,41 - 7.42 (m, 2H, pyrrole H3 & pyrrole H5), 10.02 (s, IH, CHO); 
l3C NMR (CDCh, 75 Wiz) 0 114.9, 119.0 (q, J = 322.4 Hz), 124.6, 129.5, 135.3, 178.5; 
HRMS calcd for CJI4F3N03S 226.9864, found 226.9864. 
The reaction was repeated using iformyl-d]-pyrrole-2-carboxaldehyde 2.22b (102 
mg, 1.06 mmol) to give 2.24a (110 mg, 46%): l3C NMR (CDCh, 75 Wiz) 0 114.9, 
118.9 (q, J= 322.4 Hz), 124.6, 129.5, 135.2, 178.1 (t, J = 28.7 Hz); HRMS cal cd for 
CIlI3DF3N03S 227.9927, found 227.9924. 
I-(M:ethanesulfonyl)pyrrole-2-carboxaldehyd e 2.23b and [formyl-dj-I-
(methanesulfonyl)pyrrole-2-carboxaldehyde 2.24b 
General procedure B was carried out using pyrrole-2-carboxaldehyde 2.22a (104 
mg, 1.09 mmol) and methanesulfonyl chloride (122 ~, 1.58 mmol, 1.4 equiv). Flash 
chromatography on silica (ethyl acetate/petroleum ether, 1:2) gave 2.23b (177 mg, 93%) 
as a pale yellow oil which solidified upon standing: mp 41 - 42°C (lit.6 43 - 44°C); IR 
(CHCh) 1679, 1370, 1174 cm-I ; IH NMR (CDCh, 300 MHz) 0 3.63 (s, 3H, SO:zA{e), 
6,42 (m, IH, pyrrole H4), 7.24 (m, IH, pyrrole H3), 7.61 (m, IH, pyrrole H5), 9.68 (s, 
IH, CHO); 13C NMR (CDCI3, 75 MHz) 0 42.6, 111,4, 129.1, 130.4, 132.8, 178.1; HRMS 
calcd for CIlI7N03S 173.0147, found 173.0146. 
The reaction was repeated using iformyl-dJ-pyrrole-2-carboxaldehyde 2.22b (102 
mg, 1.06 mmol) to give 2.24b (170 mg, 92%): l3C NMR (CDCh, 75 Wiz) 0 42.3, 
111.2, 128.8, 130.1, 132.4, 177.6 (t, J = 28.2 Hz); HRMS calcd for C6&QN03S 
174.0209, found 174.0207. 
l-(tert-Butoxycarbonyl)pyrrole-2-carboxaldehyde 2.23c and [formyl-dj-I-(tert-
butoxycarbonyl)pyrrole-2-carboxaldehyde 2.24c 
General procedure B was carried out using pyrrole-2-carboxaldehyde 2.22a (50 
mg, 0.53 mmol) and BOC-O~ (129 mg, 0.53 mmol, 1 equiv). Flash chromatography on 
silica (ethyl acetate/petroleum ether, 1:8) gave 2.23c (94 mg, 91%) as a colourless oi1:7 
Chapter Eight - Experimental 180 
IR (CHCh) 1747, 1661 cm-\ IH NMR (CDCh, 300 MHz) 0 1.65 (s, 9H, CMe3), 6.29 (m, 
1H, pyrrole H4), 7.19 (m, 1H, pyrrole H3), 7.45 (m, 1H, pyrrole H5), 10.33 (s, 1H, 
CHO); l3C NMR (CDCh, 75 MHz) 0 27.9,85.7, 111.6, 121.1, 127.3, 134.7, 148.3, 182.3; 
HRMS calcd for ClOH13N03 195.0895, found 195.0898. 
The reaction was repeated using [formyl-dJ-pyrrole-2-carboxaldehyde 2.22b (60 
mg, 0.62 mmol) to give 2.24c (106 mg, 87%): 13C NMR (CDCh, 75 MHz) 0 27.8, 85.6, 
111.6,121.0,127.2,132.8,148.2,181.8 (t, J= 28.2 Hz); HRMS calcd for ClOH12DN03 
196.0958, found 196.0958. 
1-(Acetyl)pyrrole-2-carboxaldehyde 2.23d and [formyl-dJ-l-(acetyl)pyrrole-2-
carboxaldehyde 2.24d 
General procedure B was carried out using pyrrole-2-carboxaldehyde 2.22a (105 
mg, 1.10 mmol) and acetyl chloride (112 ~, 1.60 mmol, 1.5 equiv). Flash 
chromatography on silica (ethyl acetate/petroleum ether, 1:1) gave 2.23d (112 mg, 74%) 
as a yellow solid: mp 74 - 75°C (lit. 8 76 - 78°C); IR (CHCh) 1732, 1663 cm-I; IH 
NMR (CDCh, 300 MHz) 02.67 (s, 3H, COMe), 6.37 (m, 1H, pyrrole H4), 7.23 (m, 1H, 
pyrrole ID), 7.34 (m, IH, pyrrole H5), 10.31 (s, 1H, CHO); 13C NMR (CDCh, 75 MHz) 
o 23.6, 112.6, 122.3, 126.6, 135.3, 169.0, 182.3; HRMS calcd for C7H7N02 137.0477, 
found 137.0475. 
The reaction was repeated using [formyl-dJ-pyrrole-2-carboxaldehyde 2.22b (30 
mg, 0.31 mmol) to give returned 2.22b (6 mg) and 2.24d (33 mg, 94% based on returned 
starting material): 13C NMR (CDCh, 75 MHz) 0 23.7, 112.7, 122.4, 126.6, 135.3, 169.1, 
182.1 (t, J = 28.2 Hz); HRMS calcd for C7Rt.DN02 138.0540, found 138.0536. 
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8.2.2. Preparation of unlabelled and [metllylene-d1]-labelled 
camphanates 2.28a-d, 2.29a-d and 2.30a-d 
o~ 19 r '~: 
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2-Hydroxymethyl-l-( trifluoromethanesulfonyl)pyrrole 2.25a 
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The N-triflylpyrrole 2.23a (197 mg, 0.87 mmol) was reduced with zinc 
borohydride by general procedure D. Flash chromatography on silica (ethyl 
acetate/petroleum ether, 1:4) gave 2.25a (178 mg, 90%) as a colourless oil: IR (CHCh) 
3605, 1418, 1177 em-I; IH NMR (CDCh, 300 MHz) 0 2.55 (bs, III, OR), 4.70 (s, 2H, 
CH20H), 6.40 (m, IH, pyrrole H4), 6.47 (m, IH, pyrrole H3), 7.11 (m, III, pyrrole H5); 
13C NMR (CDCh, 75 MHz) 0 56.5, 114.2, 117.0, 119.2 (q, J = 322.4 Hz), 124.5, 136.5; 
HRMS calcd for C6~3N03S 229.0021, found 229.0018. 
2-Hydroxymethyl-l-( methanesulfonyl)pyrrole 2.25b. 
The N-mesylpyrrole 2.23b (31 mg, 0.18 mmol) was reduced with zinc 
borohydride by general procedure D. Flash chromatography on silica (ethyl 
acetate/petroleum ether, 1:1) gave 2.25b (29 mg, 91%) as a pale orange solid, An 
analytical sample was obtained by sublimation under reduced pressure to give a white 
crystalline solid: mp 67 - 68°C; IR (CHCh) 3587, 1367, 1178 em-I; IH NMR (CDCb, 
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300 MHz) 0 3.30 (s, 3H, SOzM'e), 4.77 (s, 2H, CH20H), 6.25 (m, 1H, pyrrole H4), 6.31 
(m, IE, pyrrole H3), 7.16 (m, 1H, pyrrole H5); l3C NMR (CDCh, 75 MHz) 0 42.8,56.3, 
111.1,115.2,123.1,133.5; HRMS calcd for CJI9N03S 175.0303, found 175.0303. AnaL 
Calcd for CJI9N03S: C, 41.13; H, 5.18; N, 7.99. Found: C, 41.11; H, 5.24; N, 8.30. 
2-Hydroxymethyl-l-(tert-butoxycarbonyl)pyrrole 2.25c 
The N-BOC-pyrrole 2.25c (26 mg, 0.13 mmol) was reduced with zinc 
borohydride by general procedure D. Flash chromatography on silica (ethyl 
acetate/petroleum ether, 1:5) gave 2.25c (24 mg, 91%) as a colourless oil: IR (CHCb) 
3541, 1728, 1342 em-I; IHNMR (CDCb, 300 MHz) 0 1.61 (s, 9H, CMe3), 3.63 (bs, 1H, 
OH), 4.64 (s, 2H, CH20H), 6.09 (m, 1H,. pyrrole H4), 6.17 (m, 1H, pyrrole H3), 7.16 (m, 
1H, pyrrole H5); l3C NMR (CDCb, 75 MHz) 0 27.9, 57.6, 84.5, 110.4, 113.5, 121.9, 
134.8, 150.0; HRMS calcd for ClOH1sN03 197.1052, found 197.1050. 
2-Hydroxymethyl-l-( acetyl)pyrrole 2.25d 
The N-acetylpyrrole 2.23d (31 mg, 0.22 mmol) was reduced with zinc 
borohydride by general procedure D. Flash chromatography on silica (ethyl 
acetate/petroleum ether, 1 :2) gave 2.25d (31 mg, 98%) as a yellow solid: mp 83 84°C; 
IR (CHCh) 3535, 1705, 1323 em-I; IH NMR (CDCh, 300 MHz) 02.57 (s, 3H, COMe), 
4.62 (s, 2H, CH20H), 6.19 - 6.22 (m, 2H, pyrrole H4 & pyrrole H3), 7.08 (m, IE, 
pyrrole H5); BC NMR (CDCh, 75 MHz) 0 23.5, 57.6, 112.0, 114.5, 121.6, 135.2, 170.4; 
HRMS calcd for C,H9N02 139.0633, found 139.0634. 
(lS,4R)-1-(Trifluoromethanesulfonyl)pyrrol-2-ylmethyl camphanate 2.28a 
General procedure G was carried out using the N-triflylhydroxymethylpyrrole 
2.25a (27 mg, 0.12 mmol). Flash chromatography on silica (ethyl acetate/petroleum 
ether, 1:6) gave 2.28a (46 mg, 95%) as a colourless oil: IR (CHCh) 1786, 1751, 1421, 
1177 cm-\ IH NMR (CDCb, 300 MHz) 0 0.95 (s, 3H, camph-Me), 1.05 (s, 3H, camph-
Me), 1.11 (s, 3H, camph-Me), 1.68 (m, 1H, camph-CH2), 1.88 - 2.08 (m, 2H, camph-
CH2), 2.43 (m, IH, camph-CH2), 5.32 (ABq, J= 14.4 Hz, 1H, CH20-camph), 5.37 (ABq, 
J = 14.4 Hz, IH, CH20-camph), 6.46 (m, 1H, pyrrole H4), 6.65 (m, IH, pyrrole H3), 7.20 
(m, 1H, pyrrole H5); 13C NMR (CDCh, 75 MHz) 0 9.5, 16.4, 16.5,28.8,30.6, 54.2, 54.7, 
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57.8, 90.8, 114.2, 119.0 (q, J = 322.4 Hz), 120.3, 125.6, 130.0, 166.9, 177.9; HRMS 
calcd for C16H1sF3N06S 409.0807, found 409.0812. 
(lS,4R)-1-(Methanesulfonyl)pyrrol-2-ylmethyl cam phanate 2.28b 
General procedure G was carried out using the N-mesylhydroxymethylpyrrole 
2.25b (15 mg, 0.09 mmol). Flash chromatography on silica (ethyl acetate/petroleum 
ether, 1:2) gave 2.28b (27 mg, 86%) as a colourless oil which solidified upon standing. 
An analytical sample was obtained by recrystallisation from petroleum ether: mp 73 -74 
°C; IR (CHCh) 1788, 1736, 1369, 1182,1169 cm-I; 1HNMR (CDCh, 300 MHz) 8 0.95 
(s, 3H, camph-Me), 1.09 (s, 3H, camph-Me), 1.10 (s, 3H, camph-Me), 1.68 (m, 1H, 
camph-CH2), 1.90 - 2.06 (m, 2H, camph-CH2), 2.46 (m, IH, camph-CH2), 3.37 (s, 3H, 
SO~e), 5.35 (ABq, J 12.7 Hz, 1H, CH20-camph), 5.42 (ABq, J = 12.7 Hz, 1H, 
CH20-camph), 6.28 (m, 1H, pyrrole H4), 6.44 (m, 1H, pyrrole H3), 7.23 (m, 1H, pyrrole 
H5); l3C NMR (CDCh, 75 MHz) 8 9.4, 16.4, 16.5, 28.6, 30.7, 42.9, 54.3, 54.6, 58.9, 
90.8, 111.1, 117.7, 124.3, 127.2, 166.8, 177.8; HRMS calcd for CuiH21N06S 355.1090, 
found 355.1094; Anal. Calcd for C16H21N06S: C, 54.07; H, 5.96; N, 3.94. Found: C, 
54.06; H, 5.84; N, 4.05. 
(lS,4R)-1-(tert-Butoxycarbonyl)pyrrol-2-ylmethyl camphanate 2.28c 
General procedure G was carried out using the N-BOC-hydroxymethylpyrrole 
2.25c (21 mg, 0.11 mmol). Flash chromatography on silica (ethyl acetate/petroleum 
ether, 1:4) gave 2.28c (30 mg, 76%) as a colourless oil which solidified upon standing to 
give a white solid. An analytical sample was obtained by recrystallisation from 
petroleum ether: mp 104 - 105 °C; IR (CHCh) 1784, 1749, 1346, 1319 cm-1; IH NMR 
(CDCh, 300 MHz) 8 0.93 (s, 3H, camph-Me), 1.02 (s, 3H, camp h-Me) , 1.10 (s, 3H, 
camph-Me), 1.59 (s, 9H, CMe3), 1.66 (m, 1H, camph-CH2), 1.90 (m, IH, camph·CH2), 
2.03 (m, IH, camph-CH2), 2.43 (m, 1H, camph-CH2), 5.41 (ABq, J 13.0 Hz, IH, 
CH20-camph), 5.45 (ABq, J = 13.0 Hz, IH, CH20-camph), 6.14 (m, IH, pyrrole H4), 
6.34 (m, 1H, pyrrole H3), 7.28 (m, IH, pyrrole H5); 13C NMR (CDCh, 75 MHz) 8 9.6, 
16.5,16.6,27.9,28.9,30.6,54.1,54.7,60.2,84.1, 91.1,110.1,116.3) 123.0,127.9,148.6, 
167.1, 178.1; HRMS calcd for C2oli27N06 377.1838, found 377.1845; Anal. Calcd for 
C2oH27N06: C, 63.64; H, 7.21; N, 3.71. Found: C, 63.37; H, 7.01; N, 3.43. 
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(lS,4R)-1-(Acetyl)pyrrol-2-ylmethyl camphanate 2.28d 
General procedure G was carried out using the N-acetylhydroxymethylpyrrole 
2.2Sd (27 mg, 0.19 mmol). Flash chromatography on silica (ethyl acetate/petroleum 
ether, 1:3) gave 2.28d (61 mg, 99%) as a colourless oil which solidified upon standing. 
An analytical sample was obtained by recrystallisation from ethyl acetate/petroleum 
ether: mp 85 - 86 °C; IR (CHCh) 1784, 1726, 1310 cm<I; IHNMR (CDCh, 300 MHz) 0 
0.96 (s, 3H, camph-Me), 1.04 (s, 3H, camph-Me), 1.10 (s, 3H, camph-Me), 1.67 (Ill, Ill, 
camph-CH2), 1.92 (Ill, Ill, camph-CH2), 2.04 (m, Ill, camph-CH2), 2.44 (Ill, HI, camph-
CH2), 2.56 (s, 3H, COMe), 5.44 (ABq, J 13.5 Hz, Ill, CH20-camph), 5.49 (ABq, J = 
13.5 Hz, Ill, CH20-camph), 6.24 (Ill, Ill, pyrrole H4), 6.37 (Ill, Ill, pyrrole ID), 7.15 
(m, Ill, pyrrole H5); 13C NMR (CDCh, 75 MHz) 09.4, 16.3, 16.4,23.3,28.7,30.5, 53.9, 
54.5, 60.6, 90.9, 111.4, 116.2, 122.3, 128.6, 166.8, 168.5, 178.0; HRMS calcd for 
C17H21NOs 319.1420, found 319.1421; AnaL Calcd for C17H21NOs: C, 63.94; II, 6.63; N, 
4.39. Found: C, 64.23; II, 6.79; N, 4.27. 
[methylene-dtJ-(lS,4R)-1-(Trifluoromethanesulfonyl)pyrrol-2-ylmethyl camphanate 
2.29a and 2.30a 
S-Alpine borane® sequence: General procedure F was carried out using the deuterated 
N-triflylpyrrole 2.24a (30 mg, 0.13 mmol) and S-Alpine borane® (0.29 rnL of 0.5 M 
solution in TEF, 0.14 mmol, 1.1 equiv). Flash chromatography on silica (ethyl 
acetate/petroleum ether, 1:1) gave a mixture of 2.26a and 2.27a (-9:1 from analysis of 
camphanates prepared by method G below) which was subsequently used without further 
purification: IH NMR (CDCh, 300 MHz) 0 2.64 (bs, Ill, OH), 4.68 (s, Ill, CHDOH), 
6.40 (m, Ill, pyrrole H4), 6.47 (m, Ill, pyrrole ID), 7.12 (Ill, Ill, pyrrole H5); l3C NMR 
(CDCh, 75 MHz) 0 56.2 (t, J = 23.0 Hz), 114.2, 117.0, 119.2 (q, J = 322.4 Hz), 124.5, 
136.5; HRMS calcd for C6HsDF3N03S 230.0083, found 230.0086. 
The preceding sample of 2.26a and 2.27a (12 mg, 0.05 mmol) was reacted with 
(IS,4R)-(-)-camphanoyl chloride (14 mg, 0.06 mmol, 1.2 equiv) according to general 
procedure G. Flash chromatography on silica (ethyl acetate/petroleum ether, 1:3) gave a 
mixture of2.29a and 2.30a (9 mg, 40%, -9:1) as a colourless oil: IHNMR. (CDCh, 300 
MHz) 0 0.95 (s, 3H, camph-Me), 1.05 (s, 3H, camph-Me), 1.11 (s, 3H, camph-Me), 1.68 
(m, 1H, camph-CH2), 1.89 - 2.08 (m, 2H, camph-CH2), 2.43 (m, Ill, camph-CH2), 5.31 
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(s, 0.9H, CHDO- 2.29a), 5.33 (s, 0.1H, CHDO- 2.30a), 6.46 (m, IH, pyrrole H4), 6.65 
(m, IH, pyrrole H3), 7.20 (m, IH, pyrrole H5); 13C NMR (CDCh, 75 :MHz) 0 9.5, 16.4, 
16.5, 28.8, 30.6, 54.2, 54.7, 57.5 (t, J = 22.9 Hz), 90.8, 114.2, 119.0 (q, J = 322.4 Hz), 
120.3, 125.6, 130.0, 166.9, 177.9; HRMS calcd for Cl~17DF3N06S 410.0870, found 
410.0863. 
A further sample of 2.26a and 2.27a (13 mg, 0.06 mmol) was reacted with 
(IS,4R)-(-)-camphanic acid (17 mg, O.OS mmol, 1.5 equiv) according to general method 
H. Flash chromatography on silica (ethyl acetate/petroleum ether, 1:3) gave unreacted 
2.26a and 2.27 a (5 mg) and a mixture of 2.29a and 2.30a (4 mg, 31 % based on returned 
starting material, -1 :5) as a colourless oil. Selected IH NMR (CDCh, 300 :MHz) 0 5.31 
(s, 0.17H, CHDO- 2.29a), 5.33 (s, 0.83H, CHDO- 2.30a). 
R-Alpine borane® sequence: General procedure F was carried out using the deuterated 
N-triflylpyrrole 2.24a (37 mg, 0.16 mmol) and R-Alpine borane@ (0.37 mL of 0.5 M 
solution in THF, 0.18 mmol, 1.1 equiv). Flash chromatography on silica (ethyl 
acetate/petroleum ether, 1:3) gave a mixture of2.26a and 2.27a (1:19 from an analysis of 
camphanates prepared by method G below) which was subsequently used without further 
purification. Spectral data as recorded above. 
The preceding sample of 2.26a and 2.27a (14 mg, 0.06 mmol) was reacted with 
(1S,4R)-(-)-camphanoyl chloride (16 mg, O.OS mmol, 1.2 equiv) according to general 
procedure G. Flash chromatography on silica (ethyl acetate/petroleum ether, 1:3) gave a 
mixture of2.29a and 2.30a (13 mg, 53%, 1:19) as a colourless oil. Selected IH NMR 
(CDCh, 300 MHz) 0 5.31(s, 0.05H, CHDO- 2.29a), 5.33 (s, 0.95H, CHDO- 2.30a). 
A further sample of 2.26a and 2.27a (10 mg, 0.04 mmol) was reacted with 
(IS,4R)-(-)-camphanic acid (13 mg, 0.07 mmol, 1.5 equiv) according to general method 
H. Flash chromatography on silica (ethyl acetate/petroleum ether, 1:3) gave unreacted 
2.26a and 2.27a (2 mg) and a mixture of2.29a and 2.30a (5 mg, 32% based on returned 
starting material-6:1) as a colourless oil. Selected IH NMR (CDCh, 300 1vfHz) 0 5.31 
(s, 0.S6H, CHDO- 2.29a), 5.33 (s, 0.14H, CHDO- 2.30a). 
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[methylene-dt ]-(lS,4R)-1-{l.\fethanesulfonyl)pyrrol-2-ylmethyl camphanate 2.29b 
and 2.30b 
S-Alpine borane® sequence: General procedure F was carried out using the deuterated 
N-mesylpyrrole 2.24b (50 mg, 0.28 mmol) and S-Alpine boraneoo (0.63 mL of 0.5 M 
solution in THF, 0.31 mmol, 1.1 equiv). Flash chromatography on silica (ethyl 
acetate/petroleum ether, 1:1) gave a mixture of2.26b and 2.27b (37 mg, 73%, -9:1 from 
analysis of camphanates prepared by method G below) as a pale yellow solid: IH NMR 
(CDCh, 300 MHz) 8 3.30 (s, 3H, SO:Me), 4.72 (s, III, CHDOH), 6.22 (m, IH, pyrrole 
H4), 6.29 (m, IH, pyrrole ID), 7.14 (m, IH, pyrrole H5); 13C NMR (CDCh, 75 MHz) 8 
42.7, 55.9 (t, J= 21.9 Hz), 111.0, 115.1, 123.0, 133.4; HRMS calcd for C£iDN03S 
176.0366, found 176.0365. 
The preceding sample of2.26b and 2.27b (10 mg, 0.06 mmol) was reacted with 
. . 
(IS,4R)-(-)-camphanoyl chloride (16 mg, 0.08 mmol, 1.4 equiv) according to general 
procedure G. Flash chromatography on silica (ethyl acetate/petroleum ether, 1:3) gave a 
mixture of2.29b and 2.30b (10 mg, 53%, -9:1) as a white solid: IHNMR (CDCh, 300 
MHz) 80.95 (s, 3H, camph-Me), 1.09 (s, 3H, camph-Me), 1.10 (s, 3H, camph-Me), 1.68 
(m, IH, camph-CHz), 1.90 - 2.06 (m, 2H, camph-CHz), 2.46 (m, IH, camph-CHz), 3.37 
(s, 3H, SO:Me), 5.35 (s, 0.9H, CHDO- 2.29b), 5.41, (s, 0.1H, CHDO- 2.30b), 6.28 (m, 
IH, pyrrole H4), 6.44 (m, IH, pyrrole H3), 7.23 (m, IH, pyrrole H5); 13C NMR (CDCh, 
75 MHz) 89.4, 16.4, 16.5,28.6,30.7,42.9,54.3, 54.6,58.7 (t, J 23.0 Hz), 90.8, 111.1, 
117.7, 124.3, 127.2, 166.8, 177.8; HRMS calcd for C1<>li:wDN06S 356.1152, found 
356.1146. 
A further sample of 2.26b and 2.27b (10 mg, 0.06 mmol) was reacted with 
(IS,4R)-(-)-camphanic acid (18 mg, 0.09 mmol, 1.5 equiv) according to general method 
H. Flash chromatography on silica (ethyl acetate/petroleum ether, 1 :2) gave a mixture of 
2.29b and 2.30b (11 mg, 54%, -2:3) as a white solid. Selected IH NMR (CDCh, 300 
MHz) 85.35 (s, O.4H, CHDO- 2.29b), 5.41 (s, 0.6H, CHDO- 2.30b). 
R-Alpine borane® sequence: General procedure F was carried out using the deuterated 
N-mesylpyrrole 2.24b (86 mg, 0.49 mmol) and R-Alpine boraneoo (1.09 mL of 0.5 M 
solution in THF, 0.54 mmol, 1.1 equiv). Flash chromatography on silica (ethyl 
acetate/petroleum ether, 1:1) gave a mixture of2.26b and 2.27b (quantitative, -1:15 from 
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analysis of camphanates prepared by method G below) as a white solid. Spectral data as 
recorded above. 
The preceding sample of 2.26b and 2.27b (35 mg, 0.20 mmol) was reacted with 
(lS,4R)-(-)-camphanoyl chloride (53 mg, 0.24 mmol, 1.2 equiv) according to general 
procedure G. Flash chromatography on silica (ethyl acetate/petroleum ether, 2:3) gave a 
mixture of 2.29b and 2.30b (22 mg, 31%, -1: 15) as a white solid. Selected IH NMR 
(CDCh, 300 MHz) 05.35 (s, 0.06H, CHDO- 2.29b), 5.41(s, 0.94H, CHDO- 2.30b). 
A further sample of 2.26b and 2.27b (35 mg, 0.20 mmol) was reacted with 
(lS,4R)-(-)-camphanic acid (59 mg, 0.30 mmol, 1.5 equiv) according to general method 
H. Flash chromatography on silica (ethyl acetate/petroleum ether, 2:3) gave a mixture of 
2.29b and 2.30b (51 mg, 72%, -3:2) as a white solid. Selected IH NMR (CDCh, 300 
MHz) 0 5.35 (s, 0.6H, CHDO- 2.29b), 5041 (s, OAH, CHDO- 2.30b). 
[methylene-d1l-(lS,4R)-1-(tert-Butoxycarbonyl)pyrrol-2-y1m ethyl camphanate 2.29c 
and 2.30c 
S-Alpine borane® sequence: General procedure F was carried out using the deuterated 
N-BOC-pyrrole 2.24c (34 mg, 0.17 mmol) and S-Alpine borane@ (0.38 mL of 0.5 M 
solution in THF, 0.19 mmol, 1.1 equiv). Flash chromatography on silica (ethyl 
acetate/petroleum ether, 1:6) gave a mixture of 2.26c and 2.27c (-9:1 from analysis of 
camphanates prepared by method G below) which was subsequently used without further 
purification: IHNMR (CDCh, 300 MHz) 0 1.61 (s, 9H, CMe3), 3.61 (bs, Ill, OlI), 4.63 
(s, Ill, CHDOH), 6.09 (m, 1H, pyrrole H4), 6.17 (m, 1H, pyrrole ID), 7.16 (m, Ill, 
pyrroleH5); 13CNMR (CDCh, 75 MHz) 0 27.9, 57.3 (t,J=21.9Hz), 8404,110.3, IDA, 
121.8, 134.7, 150.0; HRMS calcd for C lOH 1J)N03 198.1115, found 198.1114. 
The preceding sample of 2.26c and 2.27c (17 mg, 0.09 mmol) was reacted with 
(lS,4R)-(-)-camphanoyl chloride (22 mg, 0.10 mmol, 1.2 equiv) according to general 
procedure G. Flash chromatography on silica (ethyl acetate/petroleum ether, 1 :6) 
followed by recrystallisation from petroleum ether gave a mixture of 2.29c and 2.30c (22 
mg, 69%, -9:1) as a white solid: IH NMR (CDCh, 300 MHz) 0 0.93 (s, 3H, camph-
Me), 1.02 (s, 3H, camph-Me), 1.10 (s, 3H, camph-Me), 1.59 (s, 9H, CMe3), 1.66 (m, Ill, 
camph-CH2), 1.90 (m, Ill, camph-CH2), 2.03 (m, 1H, camph-CH2), 2.43 (m, Ill, camph-
CH2), 5.41 (s, 0.9H, CHDO- 2.29c), 5.42 (s, O.lH, CHDO- 2.30c), 6.14 (m, Ill, pyrrole 
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H4), 6.34 (m, IH, pyrrole H3), 7.28 (m, IH, pyrrole H5)~ 13C NMR (CDCh, 75 MHz) 0 
9.6,16.5,16.6,27.9,28.9,30.6,54.1,54.7,60.0 (t, J= 23.0 Hz), 84.2, 91.1,110.1,116.4, 
123.0, 127.9, 148.6, 167.1, 178.2; HRMS calcd for C2oH2J)N06 378.1901, found 
378.1911. 
A furth~r sample of 2.26c and 2.27c (17 mg, 0.09 mmol) was reacted with 
(IS,4R)-(-)-camphanic acid (26 mg, 0.13 mmol, 1.5 equiv) according to general method 
H. Flash chromatography on silica (ethyl acetate/petroleum ether, 1:7) followed by 
recrystallisation from petroleum ether gave a mixture of 2.29c and 2.30c (15 mg, 46%, 
-4:5) as a white solid. Selected IH NMR (CDCh, 300 MHz) 0 5.41 (s, 0.44H, CHDO-
2.29c), 5.42 (s, 0.56H, CHDO- 2.30c). 
R-Alpine borane® sequence: General procedure F was carried out using the deuterated 
N-BOC-pyrrole 2.24c (30 mg, 0.15 mmol) and R-Alpine borane® (0.33 mL of 0.5 M 
solution in THF, 0.17 mmol, 1.1 equiv). Flash chromatography on silica (ethyl 
acetate/petroleum ether, 1:5) gave a mixture of 2.26c and 2.27c (1:19 from analysis of 
camphanates prepared by method C below) which was subsequently used without further 
purification. Spectral data as recorded above. 
The preceding sample of 2.26c and 2.27c (15 mg, 0.08 mmol) was reacted with 
(IS,4R)-(-)-camphanoyl chloride (20 mg, 0.09 mmol, 1.2 equiv) according to general 
procedure G. Flash chromatography on silica (ethyl acetate/petroleum ether, 1:6) gave a 
mixture of 2.29c and 2.30c (24 mg, 82%, 1:19) as a white solid: Selected IH NMR 
(CDCh, 300 MHz) 05.41 (s, 0.05H, CHDO- 2.29c), 5.42 (s, 0.95H, CHDO- 2.30c). 
A further sample of 2.26c and 2.27c (15 mg, 0.08 mmol) was reacted with 
(IS,4R)-(-)-camphanic acid (23 mg, 0.11 mmol, 1.5 equiv) according to general method 
H. Flash chromatography on silica (ethyl acetate/petroleum ether, 1:6) followed by 
recrystallisation from petroleum ether gave a mixture of 2.29c and 2.30c (10 mg, 36%, 
-5:4) as a white solid. Selected IH NMR (CDCh, 300 MHz) 0 5.41 (s, 0.56H, CHDO-
2.29c), 5.42 (s, 0.44H, CHDO- 2.30c). 
[methylene-dd-(lS,4R)-1-(Acetyl)pyrrol-2-ylmethyl camphanate 2.29d and 2.30d 
S-A1pine borane® sequence: General procedure F was carried out using the deuterated 
N-acetylpyrrole 2.24d (31 mg, 0.23 mmol) and S-Alpine borane® (0.50 mL of 0.5 M 
solution in THF, 0.25 mmol, 1.1 equiv). Flash chromatography on silica (ethyl 
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acetate/petroleum ether, 1: 1) gave a mixture of 2.26d and 2.27 d (-9: 1 from analysis of 
camphanates prepared by method G below) which was subsequently used without further 
purification: IHNMR (CDCh, 300 MHz) 02.58 (s, 3H, COMe), 4.61 (s, IH, CHDOH), 
6.19 - 6.23 (m, 2H, pyrrole H4 & pyrrole H3), 7.08 (m, IH, pyrrole H5); l3C NMR 
(CDCh, 75 MHz) 0 23.6, 57.4 (1, J 21.9 Hz), 112.1, 114.6, 121.6, 135.2, 170.4; FIRMS 
calcd for C7HsDN02 140.0696, found 140.0696. 
The preceding sample of 2.26d and 2.27d (20 mg, 0.14 mmol) was reacted with 
(IS,4R)-(-)-camphanoyl chloride (37 mg, 0.17 mmol, 1.2 equiv) according to general 
procedure G. Flash chromatography on silica (ethyl acetate/petroleum ether, 1: 1) gave a 
mixture of2.29d and 2.30d (16 mg, 35%, -9:1) as a white solid: IH NMR (CDCh, 300 
MHz) 00.96 (s, 3H, camph-Me), 1.04 (s, 3H, camph-Me), 1.10 (s, 3H, camph-Me), 1.67 
(m, IH, camph-CH2), 1.92 (m, IH, camph-CH2), 2.04 (m, IH, camph-CH2), 2.44 (m, IH, 
camph-CH2), 2.56 (s, 3H, COMe), 5.43 (s, 0.9H, CHDO- 2.29d), 5.44 (s, 0.1H, CHDO-
2.30d), 6.24 (m, IH, pyrrole H4), 6.37 (m, IH, pyrrole H3), 7.15 (m, III, pyrrole H5); 
l3C NMR (CDCh, 75 MHz) 0 9.5, 16.4, 16.5, 23.5, 28.8, 30.6, 54.0, 54.6, 60.5 (1, J = 
23.0 Hz), 91.1, 111.6, 116.3, 122.3, 128.8, 167.0, 168.5, 178.1; HRMS calcd for 
C17H2oDNOs 320.1481, found 320.1478. 
A further sample of 2.26d and 2.27 d (15 mg, 0.11 mmol) was reacted with 
(IS,4R)-(-)-camphanic acid (32 mg, 0.16 mmol, 1.5 equiv) according to general method 
H. Flash chromatography on silica (ethyl acetate/petroleum ether, 1: 1) gave a mixture of 
2.29d and 2.30d (15 mg, 43%, -1:1) as a white solid. Selected IH NMR (CDCh, 300 
MHz) 05.43 (s, 0.5H, CHDO- 2.29d), 5.44 (s, 0.5H, CHDO- 2.30d). 
R-Alpine borane@ sequence: General procedure F was carried out using the deuterated 
N-acetylpyrrole 19d (27 mg, 0.20 mmol) and R-Alpine boranefll (0.43 mL of 0.5 M 
solution in THF, 0.21 mmol, 1.1 equiv). Flash chromatography on silica (ethyl 
acetate/petroleum ether, 1:5) gave a mixture of2.26d and 2.27d (23 mg, 85%, 1:19 from 
analysis of camphanates prepared by method G below) as a pale yellow solid. Spectral 
data as recorded above. 
The preceding sample of 2.26d and 2.27d (13 mg, 0.09 mmol) was reacted with 
(IS,4R)-(-)-camphanoyl chloride (26 mg, 0.12 mmol, 1.4 equiv) according to general 
procedure G. Flash chromatography on silica (ethyl acetate/petroleum ether, 1: 1) gave a 
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mixture of 2.29d and 2.30d (3 mg, 11%, 1:19) as a white solid: Selected IH NMR 
(CDCh, 300 MHz) 55.43 (s, 0.05H, CRDO- 2.29d), 5.44 (s, 0.95H, CRDO· 2.30d). 
A further sample of 2.26d and 2.27d (10 mg, 0.07 mmol) was reacted with 
(IS,4R)-(-)-camphanic acid (23 mg, 0.11 mmol, 1.5 equiv) according to general method 
H. Flash chromatography on silica (ethyl acetate/petroleum ether, 1: 1) gave a mixture of 
2.29d and 2.30d (18 mg, 77%, -1:1) as a white solid. Selected IHNMR (CDCb, 300 
MHz) 5 5.43 (s, O.5H, CRDO- 2.29d), 5.44 (s, 0.5H, CHDO- 2.30d). 
8.2.3 Ozonolysis of [methylene-dt ]-(lS,4R)-1-(methanesulfonyl)pyrrol-2-
ylmethyl camphanate 2.29b and 2.30b 
-3 (2.29b) : 2 (2.30b) 
Methyl [methylene-dtJ-(lS,4R)-camphanoylglycolate 2.31a and 2.31b 
A mixture of 2.29b and 2.30b (17 mg, 0.05 mmol, -3:2) was dissolved in 
dichloromethane and loaded onto silica (1 g, 50 - 100 mesh) by evaporation under 
reduced pressure. The residue was cooled to -78°C and ozone was bubbled through the 
silica until a blue colour persisted (ca. 20 min). After warming to rt, the products were 
eluted from the silica with ethyl acetate. The solvent was removed under reduced 
pressure and the residue was dissolved in methanol (10 mL) and treated with an excess of 
diazo methane. Flash chromatography on silica (ethyl acetate/petroleum ether, 1:2) gave 
a mixture of2.31a and 2.31b (5 mg, 39%, -3:2) as a colourless oil:9 IR (CHCh) 1788, 
1727, 1353 cm-I ; IH NMR (CDCh, 300 MHz) 5 1.04 (s, 3H, camph-Me), 1.11 (s, 3H, 
camph-Me), 1.14 (s, 3H, camp h-Me) , 1.73 (m, IH, camph-CH2), 1.98 (m, III, camph-
CH2), 2.10 (m, III, camph-CH2), 2.48 (m, IH, camph-CH2), 3.34 (s, 3H, CO#e) , 4.76 
(s, 0.6H, CHDO- 2.31a), 4.83 (s, O.4H, CRDO- 2.31b); 13C NMR (CDCh, 75 MHz) 5 
9.6, 16.6, 16.6, 28.8, 30.8, 41.8, 54.9, 54.9, 62.5 (t, J = 23.0 Hz), 90.8, 165.5, 166.7, 
178.0. 
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8.3 Experimental Work Described in Chapter Three 
8.3.1. Preparation of starting materials 
£ OyQ_ .. _Hn? o H 0 H sR _IV CY"tf .... s H 0:-
f 3.22 2.22a 
j 
HyQ . 
o S02CSH4Me 
3.24 
2-(5,5-Dimethyl-1,3-dioxan-2-yl)-lH-pyrrole 3.22 
3.23 
HO~ 
N 
I 
S02CSH4Me 
3.25 
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The formyl protected pyrrole 3.22 was prepared by the method described by 
Loader and Anderson. lO Spectral data were consistent with that reported by Loader and 
Anderson: mp 61°C (lit. IO mp 62 - 62.5 °C); IR (CHCh) 3476, 2961, 2855, 1101 em-I; 
IH NMR (CDCh, 300 MHz) 0 0.75 (s, 3H, CMe2), 1.23 (s, 3H, CMe2), 3.63 (m, 4H, 
CH2), 5.44 (s, 1H, CHO), 6.12 (m, 1H, pyrrole H4), 6.21 (m, 1H, pyrrole H3), 6.61 (m, 
1H, pyrrole H5), 8.69 (bs, 1H, NH); l3C NMR (CDCh, 75 MHz) 0 21.6,22.8,29.9, 77.0, 
96.7, 106.0, 108.0, 117.5, 128.5; HRMS calcd for ClOHlSN02 181.1103, found 181.1102. 
2-(1H-Pyrrol-2-yl)-1,3-dithiolane 3.23 
To a solution of pyrrole-2-carboxaldehyde 2.22a (1.00 g, 10.52 mmol) in 
methanol (10 mL) under N2 was added 1,2-ethanedithiol (0.97 mL, 11.57 mmol, 1.1 
equiv). Once all the solid had dissolved, aniline hydrochloride (27 mg, 0.21 mmol, 0.02 
equiv) was added, and the solution was stirred at rt for 1 h. The solvent was removed 
under reduced pressure and the resultant residue was dissolved in toluene (10 mL), 
washed with water (2x10 mL), 0.5 N aqueous potassium hydroxide (3xlO mL), water (10 
mL), dried over sodium sulfate, and evaporated under reduced pressure. Flash 
chromatography on silica (ethyl acetate/petroleum ether, 1:6) gave 3.23 (1.65 g, 92%) as 
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a pale orange solid. An analytical sample was obtained by recrystallisation from 
petroleum ether to give white crystals: mp 28°C (lit.ll mp 27 30°C); IR. (CHCh) 3460, 
3030,3011, 2930 cm-\ IH NMR (CDCh, 300 MHz) 0 3.35 (m, 4H, SCH2), 5.80 (s, 1H, 
CHS), 6.10 (m, IH, pyrrole H4), 6.18 (m, 1H, pyrrole ID), 6.74 (m, IH, pyrrole H5), 
8.48 (bs, IH, NH); l3C NMR (CDCh, 75 MHz) 0 39.6, 49.3, 107.9, 108.5, 118.4, 128.6; 
HRMS calcd forC7H9NS2171.0176, found 171.0176. 
1-[(4-Methylphenyl)sulfonyl]pyrrole-2-carboxaldehyde 3.24 
General procedure B was carried out using pyrrole-2-carboxaldehyde (105 mg, 
1.11 mmol) and (4-methylphenyl)sulfonyl chloride (306 mg, 1.60 mmol, 1.4 equiv). 
Flash chromatography on silica (ethyl acetate/petroleum ether, 1 :2) gave 3.24 (272 mg, 
99%) as a pink solid: mp 92 - 94°C (lit.12 94°C); IR. (CHCh) 1670, 1379, 1192, 1175, 
1159 cm"l; IH NMR (CDCh, 300 MHz) 0 2.41 (s, 3H, PhMe), 6.40 (m, IH, pyrrole H4), 
7.16 (m, IH, pyrrole H3), 7.33 (m, 2H, phenyl Hs), 7.63 (m, 1H, pyrrole H5), 7.81 (Ill, 
2H, phenyl Hs), 9.97 (s, III, CHO); 13c NMR (CDCh, 75 MHz) 0 21.6, 112.3, 124.4, 
127.4, 129.4, 130.0, 133.4, 135.1, 145.9, 178.9; HRMS calcd for Cl~llN03S 249.0460, 
found 249.0466. 
2-Hydroxymethyl-l-[( 4-methylphenyl)sulfonyl] pyrrole 3.25 
The N-tosylpyrrole 3.24 (82 mg, 0.33 mmol) was reduced with zinc borohydride 
by general procedure D. Flash chromatography on silica (ethyl acetate/petroleum ether, 
1:2) gave 3.25 (75 mg, 91 %) as a pale pink solid: mp 94 - 96°C (!it.l2 97°C); IR. 
(CHCh) 3582, 1367, 1175, 1150 cm"l; IHNMR (CDCh, 300 MHz) 02.38 (s, 3H, PhMe), 
2.95 (bs, 1H, OH), 4.59 (s, 2H, CH20H), 6.21 - 6.25 (m, 2H, pyrrole H4 & pyrrole H3), 
7.25 - 7.29 (m, 3H, pyrrole H5 & phenyl Hs), 7.70 (m, 2H, phenyl Hs); l3C NMR 
(CDCh, 75 MHz) 0 21.4, 56.6, 111.7,114.9, 123.3, 126.5, 130.0, 134.4, 135.8, 145.1; 
HRMS calcd for CI2Hl3N03S 251.0616, found 251.0615. 
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2-Chloromethyl-l-(methanesulfonyl)pyrrole 3.28 
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General procedure I was carried out using the N-mesylpyrrole 2.25b (67 ms, 0.38 
mmol) and methanesulfonyl chloride (46 ~, 0.58 mmol, 1.5 equiv). The residual oil 
was dried under high vacuum (oil pump) for 3 h to give the crude 3.28 (65 mg, 87%) as 
an orange oil which was used in the subsequent reaction without purification: IR 
(CHCh) 1369, 1180 cm'\ IHNMR (CDCh, 300 MHz) 0 3.40 (s, 3H, SOz,Me), 4.94 (s, 
2H, CH2CI), 6.27 (m, III, pyrrole H4), 6.43 (m, III, pyrroleH3), 7.21 (m, III, pyrrole 
H5)~ BC NMR (CDCh, 75 MHz) 0 37.8, 43.2, 111.5, 117.1, 124.2, 130.0; HRMS calcd 
for C~N02S (M-CI) 158.0276, found 158.0276. 
2-Chloromethyl-l-[( 4-methylphenyl)sulfonyl] pyrrole 3.29 
General procedure I was carried out using the N-tosylpyrrole 3.25 (70 mg, 0.28 
mmol) and methanesulfonyl chloride (33 ~, 0.42 mmol, 1.5 equiv). Flash 
chromatography on silica (ethyl acetate/petroleum ether, 1:2) gave 3.29 (62 mg, 83%) as 
a pale pink solid. An analytical sample was obtained by reerystallisation from ethyl 
acetate/petroleum ether to give pale yellow crystals: mp 84 °C; IR (CHCh) 1371, 1190, 
1175, 1150, 1123 em'l; IH NMR (CDCh, 300 MHz) 0 2.39 (s, 3H, PhMe), 4.83 (s, 2H, 
CH2CI), 6.24 (m, III, pyrrole H4), 6.36 (m, III, pyrrole H3), 7.27 - 7.33 (m, 3H, pyrrole 
H5 & phenyl Hs), 7.78 (m, 2H, phenyl Hs)~ 13C NMR (CDCh, 75 MHz) 0 21.5, 37.2, 
111.6, 116.9, 124.3, 127.1, 129.8, 130.3, 135.7, 145.2~ HRMS ealed for C12H12ClN02S 
269.0277, found 269.0276. AnaL Caled for C12H12CIN02S: C, 53.43; II, 4.48~ N, 5.19. 
Found: C, 53.88; H, 4.65; N, 5.00. 
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8.3.2. IH NMR investigation of the reaction of the pyrrole 2.25b at low 
temperature 
Reaction of 2-hydroxymethyl-l-(methanesulfonyl)pyrrole 2.25b with 
methanesulfonyl chloride 
A solution of the N~mesylpyrrole 2.25b (5 mg, 0.03 mmol) in CDCh (0.5 mL) 
containing Hiinig's base (7 J.,LL, 0.04 mmol, 1.5 equiv) was cooled to -78°C in a 5 mm 
NMR tube under a stream ofN2. Methanesulfonyl chloride (3 J.,LL, 0.04 mmol, 1.5 equiv) 
dissolved in CDCh (0.2 mL) was added with mixing. The NMR tube was then inserted 
into the cooled NMR spectrometer (-20°C probe temperature) and a IH NMR spectrum 
of the reaction mixture was recorded (t = 0 min). Spectral analysis showed a mixture of 
the alcohol 2.25b, the O~mesylate 3.26, and the chloromethylpyrrole 3.28 (4 : 5 : 1 by IH 
NMR). Selected IHNMR (CDCh, 300 MHz) assigned from the reaction mixture, 04.74 
(d, J = 5.4 Hz, CH20H 2.25b), 4.91 (s, CH2Cl 3.28), 5.38 (s, CH20Ms 3.26). The 
reaction mixture was then kept at -20°C for 60 min and IHNMR spectra were recorded 
at regular intervals in order to monitor the progress of the reaction. The reaction mixture 
was then left at It and monitored by IH NMR. 
Reaction of 2-hydroxymethyl-l-(methanesulfonyl)pyrrole 2.25b with 
methanesulfonic anhydride 
A solution of the N~mesylpyrrole 2.25b (5 mg, 0.03 mmol) in CDCh (0.5 mL) 
containing HOnig's base (7 J.,LL, 0.04 mmol, 1.5 equiv) was cooled to -78°C in a 5 mm 
NMR tube under a stream of N2. Methanesulfonic anhydride (7 mg, 0.04 mmol, 1.5 
equiv) dissolved in CDCh (0.2 mL) was added with mixing. The NMR tube was then 
inserted into the cooled NMR spectrometer (-20°C probe temperature) and a IH NMR 
spectrum of the reaction mixture was recorded. Spectral analysis showed that most of the 
alcohol 2.25b had been converted into the O-mesylated pyrrole 3.26, with only a trace 
(~5%) of 2.25b still remaining. Selected IH NMR (CDCh, 300 MHz) of 3.26 assigned 
from the reaction mixture, 0 5.38 (s, 2H, CH20Ms), 6.29 (m, Ill, pyrrole H4), 6.53 (m, 
Ill, pyrrole ID), 7.23 (m, Ill, pyrrole H5). The reaction mixture was then allowed to 
warm in 5 °C increments to It (23°C) over a period of 30 min. IH NMR spectra at each 
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5 °C increment were recorded in order to monitor the thermal stability of the O-mesylate 
derivative 3.26. A IHNMR spectrum of the reaction mixture after 18 hat rt revealed that 
the O-mesylate 3.26 had been completely converted back to the a1coho12.25b. 
8.3.3. Preliminary investigations into pyrrolylmagnesium reactions 
HY9 - [HAl 
o MeO 
2.22a 3.30 
3.22 
Me 
o)n 
... (--y'f'j/ 
~O H 
;:-' 
3.31a 
2.22a 
3.31b 
Attempted methylation of IH-pyrrole-2-carboxaldehyde 2.22a 
+ polyalkylation 
products 
+ 3.22 
Pyrrole-2-carboxaldehyde 2.22a (25 mg, 0.26 mmol) was dissolved in THF (5 
mL) and the solution was stirred at rt under N2. Methylmagnesium iodide (145 JiL of2.0 
M solution in ether, 0.29 mmol, 1.1 equiv) was added and a precipitate immediately 
formed. After stirring for 30 min, methyl iodide (115 JiL, 1.84 mmol, 7 equiv) was added 
and the mixture was stirred at rt for a further 3 h. The THF was removed under reduced 
pressure and the residue partitioned between water (10 mL) and dichloromethane (10 
mL). The organic phase, together with dichloromethane washings (2xl0 mL), was dried 
and evaporated under reduced pressure to give returned 2.22a (23 mg). 
Methylation of 2-(5,5-dimethyl-l,3-dioxan-2-yl)-lH-pyrrole 3.22 
Methylmagnesium iodide (264 JiL of 1.85 M solution in ether, 0.49 mmol, 1.1 
equiv) was added to a stirred solution of 3.22 (80 mg, 0.44 mmol) in THF (2.5 mL) at rt 
under N2, and a precipitate immediately formed. After 30 min, methyl iodide (0.5 mL, 
8.03 mmol, 18.1 equiv) was added and the mixture was stirred for 24 h. The THF was 
removed under reduced pressure and the residue partitioned between water (10 mL) and 
dichloromethane (10 mL). The organic phase, together with dichloromethane washings 
(2xlO mL), was dried and evaporated under reduced pressure. Flash chromatography on 
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silica (ethyl acetate/petroleum ether, 1:3) gave an inseparable mixture of predominantly 
returned 3.22 and the 2,3- and 2,5-disubstituted pyrroles 3.3la and 3.3lb (75 mg, 5 : 2 by 
IH NMR), along with polyalkylation products. Selected IH NMR (CDCh, 300 MHz) 0 
5.40 (s, 1H, CHO 3.3lb), 5.44 (s, 1H, CHO 3.22),5.45 (s, III, CHO 3.3la). 
8.3.4. Preparation of dipyrromethanes 3.32 - 3.35 
oyQ (- .... 0 H 
~ 3.22 
.. HyQJQ~ V ~ 
N N 
I I 
o H S02Me 
3.34 
H 11\ fi n~~/''''' ~tl'" 
o H H 11 3.35_ .. _ 
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3.22 
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S 3.33 S02Me 
5-[l-(Methanesulfonyl)pyrrol-2-ylmethyl]-2-(lH-pyrrol-2-yl)-l,3-ditMolane 3.33 
Methylmagnesium iodide (0.55 mL of 2.0 M solution in ether, 1.10 mmol, 3.3 
equiv) was added to a stirred solution of 3.23 (200 mg, 1.17 mmol, 3.5 equiv) in THF (3 
mL) cooled in an ice-sodium chloride bath (-10 °C bath temperature) under N2. The 
orange suspension was stirred at -10 °C for 30 min and then at rt for a further 30 min. 
The reaction temperature was lowered to -10 °C and the chloromethylpyrrole 3.28 (65 
mg, 0.33 mmol) dissolved in THF (2 mL) was added rapidly. The cooling bath was 
removed and the reaction mixture was stirred at rt for 2 h. Ether and excess saturated 
aqueous ammonium chloride were added. The organic phase was separated, washed with 
saturated aqueous ammonium chloride (10 mL), dried and evaporated under reduced 
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pressure. Flash chromatography on silica (ethyl acetate/petroleum ether, 1:8) gave 
recovered 3.23 (134 mg) and 3.33 (55 mg, 50%) as a yellow oil which crystallised on 
cooling to O°C. An analytical sample was obtained by recrystallisation from methanol to 
give pale orange crystals: mp 108°C; IR (CHCh) 3441, 3009, 2932, 1364, 1180 cm-I; IH 
N1v.1R (CDCh, 300 MHz) 02.57 (s, 3~ SOMe), 3.36 (m, 4~ SCH2), 4.11 (s, 2~ CH2), 
5.73 (s, 1H, CHS), 5.81 (m, 1H, pyrrole H4), 6.04 (m, 1~ pyrrole H3), 6.17 (m, IH, 
pyrrole H4'), 6.21 (m, 1~ pyrrole H3'), 7.08 (m, 1~ pyrrole H5'), 8.52 (bs, 1~ NH); 
l3C NMR (CDCh, 75 MHz) 026.0,39.8,42.0,49.2, 107.3, 108.5,111.1, 113.6, 122.2, 
127.7, 129.1, 132.5; HRMS calcd for Cl3HI<SN202S3 328.0374, found 328.0372. Anal. 
Calcd for Cl3HI6N202S3: C, 47.54; ~ 4.91; N, 8.53; S, 29.28. Found: C, 47.28; ~ 4.88; 
N, 8.74; S, 29.37. 
5~[1-(Methanesulfonyl)pyrrol-2-ylmethyl]-lH-pyrrole-2-carboxaldehyde 3.34 
Method A: A solution of3.33 (12 mg, 0.04 mmol) in 80% aqueous acetonitrile (1.5 mL) 
was added to a stirred solution of mercury(II) chloride (20 mg, 0.07 romol, 2 equiv) and 
powdered calcium carbonate (11 mg, 0.11 mmol, 3equiv) in 80% aqueous acetonitrile 
(1.5 mL). The reaction mixture was stirred at rt for 1 h. Dichloromethane (20 mL) was 
added and the solution was filtered to remove the mercury precipitate. The organic 
phase, and subsequent washings of the aqueous phase (2x5 mL), were combined and 
washed with saturated aqueous sodium hydrogencarbonate (10 mL), saturated aqueous 
brine (10 mL), dried and evaporated under reduced pressure. Flash chromatography on 
silica (ethyl acetate/petroleum ether, 1 :2) gave 3.34 (8 mg, 83%) as a pale orange solid. 
An analytical sample was obtained by recrystallisation from methanol to give pale orange 
needles: mp 141 142°C; IR(CHCh) 3431,1651,1367,1191 cm-\ IHNMR(acetone-
ck, 300 MHz) 0 3.26 (s, 3H, SOMe), 4.41 (s, 2~ CH2), 6.19 (m, 1~ pyrrole H4'), 6.25 
(m, 1H, pyrrole H4), 6.36 (m, IH, pyrrole H3'), 7.05 (m, IH, pyrroie H3), 7.25 (m, 1~ 
pyrrole H5'), 9.56 (s, 1~ CHO), 11.10 (bs, 1~ NH); l3C N1v.1R (acetone-d6, 75 MHz) 0 
25.9,42.1, 110.4, 111.3, 113.9, 121.1, 122.5, 131.9,133.1,138.4,178.3; HRMS caicd for 
CUHI2N203S 252.0569, found 252.0569. AnaL Calcd for C11H12N203S: C, 52.37; ~ 
4.79; N, 11.10. Found: C, 52.52; ~ 4.86; N, 11.09. 
Method B: Methylmagnesium iodide (0.52 mL of 2.0 M solution in ether, 1.04 mmol, 
. 3.3 equiv) was added to a stirred solution of 3.22 (201 mg, 1.11 mmol, 3.5 equiv) in THF 
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(3 mL) under the conditions used above for 3.23 to generate the N-magnesio derivative. 
This was then reacted with the chloromethylpyrrole 3.28 (61 mg, 0.32 mmol), again 
exactly as for the preparation of 3.33. After the stirring period of 2 h water (1 mL) was 
added, followed by 10% aqueous glacial acetic acid (5 mL), and the mixture was stirred 
for 10 min. Dichloromethane (10 mL) was added and the organic phase, together with 
subsequent dichloromethane washings (2x10 mL) of the aqueous phase, was washed with 
saturated aqueous sodium hydrogencarbonate (l0 mL), saturated aqueous brine (10 mL), 
dried and evaporated under reduced pressure. Flash chromatography on silica (ethyl 
acetate/petroleum ether, 1:6) gave recovered 3.22 (104 mg) and an inseparable mixture of 
2.22s and 3.32 (1 : 3 by IH NMR) which was used in the next step without further 
purification. IH NMR (CDCb, 300 MHz) of 3.32 assigned from the mixture, 0 0.77 (s, 
3H, CMe2), 1.23 (s, 3H, CMe2), 2.58 (s, 3H, SOMe), 3.63 (m, 4H, OCH2), 4.13 (s, 2H, 
CH2), 5.39 (s, 1H, CHO), 5.91 (m, 1H, pyrrole H), 6.10 (m, 1H, pyrrole H), 6.16 (m, 1H, 
pyrrole H), 6.20 (m, 1H, pyrrole H), 7.08 (m, 1H, pyrrole H), 8.51 (bs, 1H, NH). 
A solution of the crude 3.32 (81 mg, 0.24 mmol) and pyridinium tosylate (6 mg, 
0.02 mmol, 0.1 equiv) in 50% aqueous acetone (4 mL) was stirred at reflux for 45 min. 
Dichloromethane (10 mL) was added and the organic phase, together with subsequent 
dichloromethane washings (2x5 "mL) of the aqueous phase, was washed with saturated 
aqueous sodium hydrogencarbonate (10 mL), saturated aqueous brine (10 mL), dried and 
evaporated under reduced pressure. Flash chromatography on silica (ethyl 
acetate/petroleum ether, 2:3) gave 3.34 (48 mg, 60% overall for both steps) as a pale 
orange solid. Spectral data as recorded above. 
Method C: The N-magnesio salt prepared from 3.22 (96 mg, 0.53 mm01, 3.5 equiv) as 
detailed above, was reacted with the chloromethylpyrrole 3.28 (29 mg, 0.15 mmol) as 
described in method B above. The reaction was worked up by the addition of water (1 
mL), followed by 10% aqueous hydrochloric acid (5 mL). The mixture was then stirred 
for 10 min and extracted with dichloromethane as described in method B. Flash 
chromatography on silica (ethyl acetate/petroleum ether, 1:2) gave recovered 2.22s (37 
mg) and 3.34 (24 mg, 63%) as a pale orange soHd. Spectral data as recorded above. 
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5-(lH-PyrroI-2-yImetbyI)-lH-pyrroIe-2-carboxaIdebyde 3.35 
Aqueous 5 M sodium hydroxide (1 mL) was added to a stirred solution of 3.34 
(23 mg, 0.09 mmol) in methanol (4 mL) and the mixture was heated at reflux for 3 h. 
After cooling to rt, saturated aqueous ammonium chloride (10 roL) was added and the 
mixture was extracted with dichloromethane (3xl0 mL). The combined organic phases 
were washed with water (2xl0 mL), dried and evaporated under reduced pressure. Flash 
chromatography of the resulting oil on silica (ethyl acetate/petroleum ether, 1:2) gave 
3.35 (13 mg, 85%) as a pale orange solid. An analytical sample was obtained by 
recry5tallisation from ethyl acetate/petroleum ether to give colourless crystals: mp 118 
°C (lit. 13 120 - 121 °C); IR (CHCh) 3470, 3433, 3292, 3032, 3013, 1645 em-I; IH NMR 
(CDCh, 300 MHz) 5 4.02 (s, 2II, CH2), 6.03 (m, IH, pyrrole H4'), 6.11 (m, III, pyrrole 
H3 '), 6.16 (m, III, pyrrole H4), 6.67 (m, III, pyrrole H5'), 6.95 (m, III, pyrrole ill), 
9.18 (bs, IH, NH'), 9.30 (5, III, CHO), 11.10 (bs, IH, NH); l3C NMR (CDCh, 75 MHz) 
526.5, 106.6, 108.3, 110.6, 117.6, 124.6, 127.4, 132.0, 142.2, 178.7; HRMS calcd for 
ClOHlON20 174.0793, found 174.0796. 
8.3.5. Preparation and analysis of dipyrromethanes 3.40a and 3.40b 
A Me = CH2C02Me 
pMe = CH2CH2C02Me 
.. 
AMe pMe A Me pMe 
H H H ~~y~/ 
o H R S02Me 
3.40a R = H 
3.40b R = D 
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3,4' -Dimethoxycarbonylethyl-3' ,4-dimethoxycarbonylmethyl-S-[1-( methanesulfonyl) 
pyrrol-2-ylmethyl]-lH-pyrrole-2-carboxaldehyde 3.40a and the [methylene-dtJ-
analogue 3.40b 
Methylmagnesium iodide (250 IiL of 1.2 M solution in ether, 0.36 mmol, 1.2 equiv) 
was added to a stirred solution of the pyrrole 3.37 (100 mg, 0.30 mmol) in 1HF (4 mL) 
and the resultant heterogeneous mixture was stirred at rt under argon for 1 h. The 
chloromethylpyrrole 3.38a/4 in THF (1.5 mL), was added dropwise and the mixture was 
stirred at rt for 20 h. Water (1 mL) was added, followed by dilute aqueous hydrochloric 
acid (5 mL), and the mixture was stirred for 10 min. Dichloromethane (20 mL) was 
added and the organic phase, together with subsequent dichloromethane washings (2xl0 
mL) of the aqueous phase, were washed with saturated aqueous sodium 
hydrogencarbonate (10 mL), saturated aqueous brine (10 mL), dried and evaporated. 
Preparative TLC (ethyl acetate/ether, 1 :2) gave the a.-formyl derivative of 3.37 (13 mg, 
15%) and the N-mesyldipyrromethane 3.40a (141 mg, 75% based on 3.37) as a pale 
yellow oil: UV Amax 306 nm; IR (film) 2950, 1730, 1640 cm"l; IH NMR (CD2Ch, 400 
MHz) 0 2.41 (s, 3R), 2.52 (m, 2R), 2.57 (m, 2R), 2.69 (m, 2R), 2.87 (m, 2R), 3.57 (s, 
2R), 3.64 (s, 3R), 3.66 (s, 3R), 3.67 (s, 3R), 3.81 (s, 3R), 3.77 (s, 2R), 4.15 (s, 2R), 6.91 
(s, IH), 9.51 (s, lR), 10.10 (bs, lR); HRMS calcd for ~SH32N2011S 568.1727, found 
568.1731. 
The above sequence was repeated using racemic deuterium-labelled 
chloromethylpyrrole 3.38b.14 The N-magnesio salt of 3.37, prepared as described above, 
was reacted with the chloromethylpyrrole 3.38b and the resultant solution was stirred at rt 
for 48 h. Addition of excess water and aqueous acetic acid, followed by preparative TLC 
(ethyl acetate/ether, 1:2) gave recovered starting material 3.37 (26%) and the labelled 
dipyrromethane 3.39 (70%) as a labile pale yellow oil: IH NMR (CD2Ch, 400 MHz) 0 
1.24 (s, 3R), 1.37 (s, 3R), 2.33 (s, 3R), 2.43 (m, 2R), 2.56 (m, 2R), 2.67 (m, 2R), 2.78 
(m, 2R), 3.47 (s, 2R), 3.55 (s, 2R), 3.62 (s, 3H), 3.64 (s, 3R), 3.66 (s, 3R), 3.75 (s, 3R), 
4.04 (s, lR), 5.34 (s, IH), 6.90 (s, lR), 9.36 (bs, lR); BC NMR (CD2Ch, 63 MHz) 0 
19.5, 20.8, 21.5 (t, CHD), 22.0,23.0, 29.9, 30.1, 33.8, 35.7, 41.7, 51.8, 51.9, 52.0, 52.5, 
71.7, 77.8, 96.3, 113.1, 118.9, 119.5, 123.8, 124.7, 126.4, 130.2, 172.9, 173.0, 173.8, 
173.9. 
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The preceding dipyrromethane 3.39 in dichloromethane was shaken with dilute 
aqueous hydrochloric acid for 10 min. The organic phase was separated, dried and 
evaporated to give the labelled dipyrromethane 3.40b as an oil: IH N1\.1R (CD2Ch, 400 
MHz) 0 4.13 (s, IH) otherwise identical to the spectrum of 3.40a; 13C N1\.1R (CDCh, 63 
MHz) 0 18.7, 20.4, 21.4 (t, CHD), 29.5, 30.8, 33.4, 34.7, 41.9, 51.6, 51.8, 52.2, 53.1, 
119.1,119.9,122.7,124.8,128.0,129.1,133.6,171.3, 172.9, 173.0, 173.2, 177.3. 
Attempted formation of chiral deuterium-labelled N-mesyl dipyrromethane 3.40b 
and subsequent formation of the labelled hydrazone derivative 3.43 
AMe pMe AMe pMe AMe pMe 
O~ -_. HO~ -_. CI~ 
D S02Me D S02Me D S02Me 
3.41 3.42 3.38b 
AMe pMe A Me pMe 
H~~ ~~ N N H I Me .... ""N D S02Me 
HO;;Me 
o 3.43 
A solution of9-BBN (4.05 mL of 0.5 M solution in THF, 1.12 equiv) and (IR)-
(+ )-a.-pinene (360 J.LL, 1.25 equiv) was refluxed under N2 for 2 h. The solution was 
cooled to rt and the deuterium-labelled formylpyrrole 3.4114 (600mg, 1.81 mmol) in THF 
.(6.5 mL) was added. After 2 h at rt acetaldehyde (8 drops) was added. The THF was 
removed under reduced pressure, and the a.-pinene was then removed on a vacuum pump 
for 1 h. Dichloromethane (30 mL) was added and the solution was cooled to 0 °C. 2-
Aminoethanol (180 J.LL) was added and the resultant precipitate was removed by 
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filtration. The filtrate was washed with water, dried and evaporated under reduced 
pressure. Preparative TLC (ether/hexane, 9: 1) gave the deuterated hydroxymethylpyrrole 
3.42 (507 mg, 84%) which crystallised on standing: IH NMR (CDCh, 400 "MHz) 2.56 
(m, 2H), 2.70 (m, 2H), 3.10 (d, J= 6.6 Hz, 1H), 3.35 (s, 3H), 3.49 (s, 2H), 3.67 (s, 3H), 
3.73 (s, 3H), 4.74 (d, J 6.6 Hz, 1H), 6.94 (s, 1H); HRMS calcd for Cl3HliDN07S 
334.0945, found 334.0948. 
The deuterium-labelled chioromethylpyrrole 3.38b was prepared from this 
optically active sample of N-mesylhydroxymethylpyrrole 3.42 by the methodology 
described by Abell et al. 14 Subsequent reaction of this chloromethylpyrrole 3.38b with 
the N-magnesio salt of 3.37, prepared as described above, followed by work up as 
described for 3.40s, gave the a.-formyl derivative of 3.37 (28%) and the labelled a.-
formyldipyrromethane 3.40b (66%). Spectral data as recorded above. 
A solution of 3.40b and N-amino-l-ephedrine1s in benzene (2.5 mL) containing 
activated 4 A molecular sieves was heated at reflux for 2 5 h under N2 and then left at rt 
for 18 h. The sieves were removed by filtration and the filtrate was evaporated under 
reduced pressure. Preparative TLC (ether) gave the deuterium-labelled hydrazone 3.43: 
IH NMR (CD6l)6, 400 MHz) 8 1.18 (d, J = 6.7 Hz, 3H, CRMe), 2.09 (s, 3H, S02ft{e), 
2.32 (m, 2H, CH2CH2C02), 2.39 (s, 3H, NMe), 2.51 (t, J = 7.5 Hz, 2H, CH2CH2C02), 
2.66 (t, J= 7.5 Hz, 2H, CH2CH2C02), 3.01 (s, 2H, CH2C02), 3.19 (m, 3H, CH2CH2C02 
& CHMe), 3.26 (s, 3H, C02ft{e), 3.29 (s, 3H, C02ft{e), 3.36 (s, 3H, C02ft{e), 3.53 (s, 3H, 
COMe), 3.58 (s, 2H, CH2C02), 3.79 (bs, 1H, OI!), 3.89 (s, O.5H, CHD), 3.97 (s, 0.5H, 
CHD), 5.23 (d, J 2.2 Hz, III, CHOH), 6.92 (s, lH, pyrrole H), 7.10 - 7.40 (m, 6H, 
CHN & phenyl Hs), 10.05 (bs, lH, NI!); HRMS calcd for C3sH4sDN40US 731.2947, 
found 731.2946. 
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8.3.6. Preparation of unlabelled and [metltylene-d1]-labelled 2-
chloromethyl-l-camphorsulfonylpyrroles 3.47a-c 
on on Y"tf~ - Y"~/ -
R H R s~ 
2.22a R=H o~ 
2.22b R=D  
3.44a R= H 
3.44b R = D 
3.45a R1 = R2 = H 
3.45b R 1 = 0, R2 = H 
3.45c R1 =H,R2 =D 
3.47a R1 = R2 = H 
3.47b R1 =O.R2 =H 
3.47c R1 = H, R2 = D 
(18,4R)-1-(10-Camphorsulfonyl)pyrrole-2-carboxaldehyde 3.44a and [formyl-d]-
(lS,4R)-1-(1 O-camphorsulfonyl)pyrrole-2-carboxaldehyde 3.44b 
General procedure B was carried out using pyrrole-2-carboxaldehyde 2.22a (20 
mg, 0.21 mmol) and (lS,4R)-(+)-10-camphorsulfonyl chloridel6 (63 mg, 0.25 mmol, 1.2 
equiv). Flash chromatography on silica (ethyl acetate/petroleum ether, 1 :3) gave 3.44a 
(62 mg, 95%) as a colourless oil which solidified at 0 °c. An analytical sample was 
obtained by recrystallisation from petroleum ether to give a white solid: mp 97°C; IR 
(CHCh) 1747, 1678, 1377, 1171 em-I; IR NMR (CDCh, 300 MHz) 0 0.95 (s, 3H, 
camph-Me), 1.20 (s, 3H, camph-Me), 1.48 (m, Ill, camph-CH), 1.78 (m, Ill, camph-
CH), 1.92 - 2.17 (m, 3R, camph-CH), 2.36 2.55 (m, 2H, camph-CH), 3.94 (ABq, J = 
14.7 Hz, Ill, S02CH2), 4.08 (ABq, J= 14.7 Hz, 1R, S02CH2), 6.41 (m, Ill, pyrrole H4), 
7.22 (m, 1H, pyrrole H3), 7.61 (m, Ill, pyrrole H5), 9.72 (s, Ill, CHO); 13C NMR 
(CDCh, 75 MHz) 0 19.6, 19.7, 25.2, 27.0, 42.5, 42.7, 48.3, 52.6, 58.9, 111.3, 128.9, 
130.7,133.1,178.2,213.9; HRMS calcdfor CIsHl9N04S 309.1035, found 309.1037. 
The reaction was repeated using [formyl-dJ-pyrrole-2-carboxaldehyde 2.22b (20 
mg, 0.21 mmol) to give 3.44b (64 mg, 99%): BC NMR (CDCh, 75 MHz) 0 19.4, 19.5, 
25.0,26.7,42.2,42.4,48.1, 52.4, 58.7, 111.2, 128.7, 130.5, 132.8, 177.8 (t, J = 28.2 Hz), 
213.7; HRMS calcd for ClsHlgl)N04S 310.1098, found 310.1094. 
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(lS,4R)-2-Hydroxymethyl-l-(lO-camphorsulfonyl)pyrrole 3.45a 
The N-camphorsulfonylpyrrole 3.44a (27 mg, 0.09 mmol) was reduced with zinc 
borohydride by general procedure D. Flash chromatography on silica (ethyl 
acetate/petroleum ether, 1:2) gave 3.45a (24 mg, 88%) as a colourless oil: IR (CHCh) 
3514, 1746, 1369, 1175 em-I; IH NMR (CDCh, 300 :MHz) 0 0.87 (s, 3H, camph-Me), 
1.10 (s, 3H, camph-Me), 1.50 (m, IH, camph-CH), 1.85 (m, III; camph-CH), 1.95 -2.17 
(m, 3H, camp h-CH) , 2.37 - 2.50 (m, 2H, camph-CH), 3.29 (ABq, J = 14.7 Hz, IH, 
S02CH2), 3.63 (bs, IH, OB), 3.83 (ABq, J= 14.7 Hz, IH, S02CH2), 4.73 (ABq, J= 13.2 
Hz, IH, CH20H), 4.88 (ABq, J = 13.2 Hz, IH, CH20H), 6.23 (m, IH, pyrrole H4), 6.29 
(m, IH, pyrrole H3), 7.15 (m, IH, pyrrole H5); 13C NMR (CDCh, 75:MHz) 0 19.5, 19.6, 
25.3, 26.8, 42.5, 42.8, 48.3, 52.8, 56,4, 58.7, 111.0, 115.1, 123.1, 134.2, 214.7; HRMS 
calcd for CIsH21N04S 311.1191, found 311.1193. 
(lS,4R)-2-Chloromethyl-l-(lO-camphorsulfonyl)pyrrole 3.47a 
A solution of the N-camphorsulfonylpyrrole 3.45a (7 mg, 0.02 mmol) in CDCh 
(150 J.1L) containing HOnig's base (11 J.1L, 0.06 mmol, 3 equiv) in a 3 mm NMR tube was 
cooled in an ice bath under a stream ofN2. Methanesulfonyl chloride (5 J.1L, 0.06 mmol, 
3 equiv) was added with mixing and the progress of the reaction was then monitored by 
IH NMR. When no more alcohol3.45a could be observed by IH NMR spectroscopy, the 
reaction was poured into dichloromethane (10 mL), washed with ice-cold water (10 mL), 
cold 10% aqueous hydrochloric acid (10 mL), and saturated aqueous sodium 
hydrogencarbonate (10 mL). The organic phase was then dried and evaporated under 
reduced pressure. The residual oil was dried under high vacuum (oil pump) for 3 h to 
give the crude 3.47a (7 mg) as a yellow oil. IH NMR showed the compound to be ca. 
90% pure, with 10% non-pyrrole material: IR (CHCh) 1747, 1371, 1177 em-I; IH NMR 
(CDCh, 300 :MHz) 0 0.90 (s, 3H, camph-Me), 1.20 (s, 3H, eamph-Me), 1,48 (m, 1H, 
camph-CH), 1.79 (m, IH, camph-CH), 1.94 - 2.15 (m, 3H, eamph-CH), 2.37 - 2.62 (m, 
2H, camph-CH), 3.56 (ABq, J 14.7 Hz, IH, S02CH2), 3.82 (ABq, J = 14.7 Hz, 1H, 
S02CH2), 4.86 (ABq, J = 12.7 Hz, 1H, CH2CI), 5.07 (ABq, J = 12.7 Hz, IH, CH2CI), 
6.27 (m, 1H, pyrrole H4), 6,43 (m, IH, pyrrole H3), 7.25 (m, IH, pyrrole H5); 13C NMR 
(CDCb, 75:MHz) 019.7, 19.9,25.2,27.0,38.0,42.5,42.7,48.1,52.9,59.0, 111.3, 117.1, 
124.5, 129.8,213.8; HRMS calcd for ClsH20CIN03S 329.0852, found 329.0851. 
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[methylene-dt ]-(lS,4R)-2-Chloromethyl-l-(lO-camphorsulfonyl)pyrrole 3.47b and 
3.47c 
S-Alpine borane® sequence: General procedure F was carried out using the deuterated 
N-camphorsulfonylpyrrole 3.44b (12 mg, 0.04 mmol) and S-Alpine borane® (86 J,JL of 
0.5 M solution in THF, 0.04 mmol, 1.1 equiv). Flash chromatography on silica (ethyl 
acetate/petroleum ether, 1:2) gave a mixture of 3.45b and 3.45c (9 mg, 70%, 19:1) as a 
colourless oil: IH NMR (CDCh, 300 MHz) 0 0.87 (s, 3H, camp h-Me) , 1.11 (s, 3H, 
camp h-Me) , 1.51 (m, 1H, camph-CH), 1.86 (m, 1H, camph-CH), 1.95 - 2.17 (m, 3H, 
camp h-CH) , 2.37 - 2.50 (m, 2H, camph-CH), 3.28 (ABq, J = 14.7 Hz, 1H, S02CH2), 
3.58 (bs, 1H, OlI), 3.84 (ABq, J = 14.7 Hz, 1H, S02CH2), 4.72 (s, 0.95H, CEDOH 
3.45b), 4.87 (s, 0.05H, CEDOH 3.45c), 6.23 (m, 1H, pyrrole H4), 6.30 (m, 1H, pyrrole 
H3), 7.15 (m, 1H, pyrrole H5); 13C NMR (CDCh, 75 MHz) 0 19.6, 19.7,25.4, 26.9,42.5, 
42.9,48.3, 52.9, 56.3 (t, J= 21.9 Hz), 58.7, 111.1, 115.1, 123.2, 134.4,214.7; HRMS 
calcd for C1sH20DN04S 312.1254, found 312.1260. 
The preceding sample of3.45b and 3.45c (5 mg, 0.02 mmol) in CDCh (150 J,JL) 
in a 3 mm NMR tube was treated with methanesulfonyl chloride (4 J,JL, 0.05 mmol, 3 
equiv) under the conditions used for the preparation of 3.47a. IH NMR spectral analysis 
of the crude reaction mixture showed a mixture of 3.47b and 3.47c (-2:3). Selected IH 
NMR (CDCh, 300 MHz) 0 4.86 (s, 0.6H, CEDCI 3.47c), 5.05 (s, 0.4H, CEDCI 3.47b). 
Subsequent work up of the reaction mixture by the method described for 3.47a gave a 
crude mixture of3.47b and 3.47c (8 mg, -1:1 by IHNMR) as a pale yellow oil. Selected 
IH NMR (CDCh, 300 MHz) 0 4.86 (s, 0.5H, CEDCI 3.47c), 5.05 (s, 0.5H, CEDCI 
3.47b). HRMS calcd for ClsH19DCIN03S 330.0915, found 330.0918. 
R-Alpine borane® sequence: General procedure F was carried out using the deuterated 
N-camphorsulfonylpyrrole 3.44b (12 mg, 0.04 mmol) and R-Alpine borane® (83 J,JL of 
0.5 M solution in THF, 0.04 mmol, 1.1 equiv). Flash chromatography on silica (ethyl 
acetate/petroleum ether, 1 :2) gave a mixture of 3.45b and 3.45c (9 mg, 76%, 1: 19) as a 
colourless oil: Selected IHNMR (CDCh, 300 MHz) 04.72 (s, 0.05H, CEDOH 3.45b), 
4.87 (s, 0.95H, CEDOH 3.45c). 
The preceding sample of 3.45b and 3.45c (5 mg, 0.02 mmol) in CDCh (150 J,JL) 
in a 3 mm NMR tube was treated with methanesulfonyl chloride (4 J,JL, 0.05 mmol, 3 
equiv) under the conditions used for the preparation of 3.47a. IH NMR spectral analysis 
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of the crude reaction mixture showed a mixture of 3.47b and 3.47c (-3:2). Selected IH 
NMR (CDCh, 300 MHz) 0 4.86 (s, OAH, CHDCI 3.47c), 5.05 (s, 0.6H, CHDCI 3.47b). 
Subsequent work up of the reaction mixture by the method described for 3.47a gave a 
crude mixture of3.47b and 3.47c (6 mg, -1:1) as a pale yellow oil. Selected IHNMR 
(CDCh, 300 MHz) 0 4.86 (s, 0.5H, CHDCI3.47c), 5.05 (s, 0.5H, CHDCI3.47b). 
8.3.7. IH NMR investigation of the reaction of [metl,ylene-d1]-labelled 
pyrroles 3.45b and 3.45c at low temperature 
3.45b R1 = 0, R2 = H 
3.45c R1 = H, R2 = 0 
.. 
3.4Gb R1 = 0, R2 = H 
3.4Gc R1 = H, R2 = 0 
Reaction of [methylene-dd-(lS,4R)-2-hydroxymethyl-l-(lO-camphorsulfonyl)pyrrole 
3.45b and 3.45c with methanesulfonic anhydride 
A sample of 3.45b and 3.45c (4 mg, 0.01 mmol, 19:1), obtained from the S-
Alpine boraneiil sequence described above, in CDCh (0.5 rnL) containing Hunig's base (3 
J.tL, 0.02 mmol, 1.5 equiv) was cooled to -78°C in a 5 mm NMR tube under a stream of 
N2. Methanesulfonic anhydride (3 mg, 0.02 mmol, 1.5 equiv) dissolved in CDCh (0.2 
rnL) was added with mixing. The NMR tube was then inserted into the cooled NMR 
spectrometer (-20°C probe temperature) and a IHNMR spectrum of the reaction mixture 
was recorded (t = 0 min). Spectral analysis of the crude reaction mixture showed a 
mixture of3.46b and 3.46c (-4:1). Selected IHNMR (CDCh, 300 MHz) 05.39 (s, 0.2H, 
CHDOMs 3.46c), 5045 (s, 0.8H, CHDOMs 3.46b). The reaction mixture was then kept at 
-20°C and IH NMR spectra were recorded at regular intervals in order to monitor the 
progress of the reaction. A IH NMR spectrum of the reaction mixture after 30 min 
showed an equal mixture of the O-mesylated pyrroles 3.46b and 3.46c (-1:1). Selected 
Chapter Eight - Experimental 207 
IH NMR (CDCh, 300 MHz) 0 5.39 (s, 0.5H, CHDOMs 3.46c), 5.45 (s, 0.5H, CHDOMs 
3.46b). 
A sample of 3.4Sb and 3.4Sc (3 mg, 0.01 mmol, 1:19), obtained from the R-
Alpine borane® sequence above, was treated with methanesulfonic anhydride (3 mg,0.02 
mmol, 1.5 equiv) as described in above. IH NMR spectral analysis of the crude reaction 
mixture showed a mixture of3.46b and 3.46c (-1:4). Selected IHNMR (CDCh, 300 
MHz) 0 5.39 (s, O.SH, CHDOMs 3.46c), 5.45 (s, 0.2H, CHDOMs 3.46b). The reaction 
mixture was then kept at -20°C and IH NMR spectra were recorded at regular intervals 
in order to monitor the progress of the reaction. A IH NMR spectrum of the reaction 
mixture after 90 min showed an equal mixture of the O-mesylated pyrroles 3.46b and 
3.46c 01:1). Selected IHNMR (CDCh, 300 MHz) 0 5.39 (s, 0.5H, CHDOMs 3.46c), 
5.45 (s, 0.5H, CHDOMs 3.46b). 
8.3.8. Preparation and attempted analysis of unlabelled and 
[methylene-dll-labelled dipyrromethanes 3.34a and 3.34b 
HOyQ 
R1 "R2 S02Me 
2.2Sb R1=R2=H 
2.2Gb R1 = D, R2 = H 
2.27b R1 = H, R2 = D 
3.2Ga R = H 
3.2Gb R= D 
__ . HyQy? 
o H R S02Me 
3.34a R = H 
3.34b R= D 
S-[1-(Methanesulfonyl)pyrrol-2-ylmethyl]-lH-pyrrole-2-carboxaldehyde 3.34a and 
[methylene-dd-S-[l-( methanesulfonyl)pyrrol-2-ylmethyl]-lH-pyrrole-2-
carboxaldehyde 3.34b 
Methanesulfonic anhydride (45 mg, 0.26 mmol, 1.5 equiv) was added to a stirred 
solution of 2.2Sb (30 mg, 0.17 mmol) in dichloromethane (1 mL) containing Hunig's 
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base (45 ~, 0.26 mmol, 1.5 equiv) cooled to -40 °C under N2. The mixture was stirred 
at -40 °C for 2 min and the generated O-mesylpyrrole 3.26a was rapidly transferred by 
cannular into a solution of the N-magnesio salt of 3.22 (109 mg, 0.60 mmol, 3.5 equiv), 
prepared as described in method B of Section 8.3.3, which was cooled to -40 °C under 
N2. The resulting mixture was stirred at -40 °C for 2 h and then at rt for 18 h. The 
preparation was worked up by the addition of water (1 mL) followed by 10% aqueous 
hydrochloric acid (5 mL). The mixture was then stirred for 10 min and extracted with 
dichloromethane as described in method B. Flash chromatography on silica (ethyl 
acetate/petroleum ether, 1:2) gave recovered 2.22a (34 mg) and 3.34a (23 mg, 53%) as a 
pale orange solid. Spectral data as recorded above. 
The above sequence was repeated using the deuterium-labelled O-mesylpyrrole 
3.26b. Thus, the deuterated O-mesylpyrrole 3.26b, prepared as described above from a 
mixture of the deuterated hydroxymethylpyrroles 2.26b and 2.27b (39 mg, 0.22 mmol, 
~1:15), was reacted with the N-magnesio salt of 3.22 (140 mg, 0.77 mmol, 3.5 equiv), 
prepared as detailed above. Flash chromatography on silica (ethyl acetate/petroleum 
ether, 1:2) gave recovered 2.22a (59 mg) and 3.34b (30 mg, 54%) as a pale orange solid: 
IHNMR (acetone-dt;, 300:MHz) 83.25 (s, 3H, SO:zA{e), 4.39 (s, 1H, CHD), 6.19 (m, 1H, 
pyrrole H4'), 6.25 (m, 1H, pyrrole H4), 6.36 (m, 1H, pyrrole H3'), 7.06 (m, 1H, pyrrole 
H3), 7.25 (m, 1H, pyrrole H5'), 9.55 (s, 1H, CHO), 11.16 (bs, 1H, NH); 13C NMR 
(acetone-dt;, 75:MHz) 8 25.6 (t, J= 20.3 Hz), 42.0, 110.4, 111.3, 113.9, 121.1, 122.4, 
131.8, 133.1, 138.4, 178.3; HRMS calcd for Cl1H l1DN203S 253.0631, found 253.0629. 
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Formation of the hydrazone derivative of a-formyldipyrromethane 3.34a 
H n n Y"tJ/~ "~/ 
o H S02Me 
3.34a 
A solution of 3.34a (19 mg, 0.08 mmol) and N-amino-l-ephedrine (41 mg, 0.23 
mmol, 3 equiv) in benzene (3 mL) containing activated 4 A molecular sieves was heated 
at reflux for 4 h under N2• After cooling to rt, the sieves were removed by :filtration and 
the :filtrate evaporated under reduced pressure. Flash chromatography of the resulting oil 
on silica (ethyl acetate/petroleum ether, 1:4) gave 3.48 (19 mg, 62%) as an unstable 
colourless oil which rapidly decomposed on exposure to air and in the NMR solvent. IH 
NMR showed the compound to be ca. 95% pure: IR (CHCh) 3454, 3342, 1724, 1366, 
1180 cm'l; IH NMR (CDCh, 300 MHz) 0 1.05 (d, J 6.8 Hz, 3H, CHM"e), 2.75 (s, 3H, 
SO:zMe), 2.84 (s, 3H, NMe), 3.38 (m, IH, eRMe), 4.17 (s, 2H, CH2), 4.29 (bs, IH, Oll), 
5.21 (m, IH, CHOH), 5.97 (m, IH, pyrrole H4), 6.14 - 6.24 (m, 3H, pyrrole H3 & 
pyrrole H4' & pyrrole H3'), 7.10 7.41 (m, 7H, pyrrole H5' & CHN & phenyl Hs), 8.69 
(bs, IH, Nll); 13C NMR (CDCb, 75 MHz) 0 9.5,26.1, 37.7, 42.3, 67.3, 76.6, 108.5, 
109.6,111.4,113.8,122.3, 126.1,126.7, 127.1, 128.1,129.2,129.9,132.3,142.7; HRMS 
calcd for C21H26N403S 414,1726, found 414.1726. 
Attempted N-substitution of dipyrromethanes 3.34a and 3.35 with (lS,4R)-(+)-10-
camphorsulfonyl chloride 
Attempts toN-substitute 3.34a (typically 18 mg, 0.07 mmol) with (lS,4R)-(+)-10-
camphorsulfonyl chloride (1.4 equiv) by general procedure B proved unsuccessful, giving 
predominantly returned starting material 3.34a. Similarly, an attempt to N-substitute 3.35 
(7 mg, 0.04 mmol) with (IS,4R)-(+)-1O-camphorsulfonyl chloride (2.4 equiv) by the 
same methodology also proved unsuccessful. 
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Attempted analysis of 3.34b by 2H NMR in a chiralliquid crystalline solvent 
The deuterium-labelled dipyrromethane 3.34b (10 mg) was dissolved in CH2Ch 
(500 J.1L) and added to poly-y-benzyl-L-glutamate (80 mg, 16% wIV), which had been 
weighed directly into a 5 mm NMR tube. Once all the compounds had dissolved in the 
NMR tube, the sample was vortexed until an optically homogeneous birefringent phase 
was obtained. The NMR tube was then inserted into the NMR spectrometer and a 2H 
NMR spectrum of the mixture recorded. 2H NMR (CH2Ch, 46 MHz) referenced to 
CDCh [7.25 ppm],.s 4.20 (s, 1D, CHD). 
Crystallographic structure determination for compound 3.29 by X-ray analysis 
CI2H12CIN02S, M 269.74, mp 84°C, crystal dimensions 1.02 x 0.32 x 0.25 mm, 
monoclinic, a 7.645(2) A, b 15.689(5) A, c 10.543(3) A, P 105.20(2)°, V= 1220.3(6) A3, 
space group P21/n, Z = 4, F(OOO) 560, Deale = 1.468 mg/m3, absorption coefficient 0.472 
mm-I, Brange for data collection 2.39 - 22.50, index ranges -8 ~ h ~ 0, 0 ~ k ~ 16, -10 ~ 
1 ~ 11, maximum and minimum transmissions 0.3008 and 0.3345, data/restraints/ 
parameters 1593/0/155, goodness of fit on F was 1.097, final R indices [1> 2a(l)] Rl 
0.0330, wR2 = 0.0849, R indices (all data) Rl = 0.0378, wR2 0.0883, largest difference 
peak and hole 0.284 and -0.207 eA"3. 
The unit cell parameters were obtained by least-squares refinement of the setting 
angles of 19 reflections with 4.25° ~ 2B ~ 16.5° from a Siemens four circle 
diffractometer. A unique data set was measured at 293(2) K within 2~ax = 45° limit (aJ 
scans). Of the 1611 reflections obtained, 1593 were unique (Rint = 0.0051) and were used 
in the full-matrix least-squares refinement. I7 The intensities of 3 standard reflections, 
measured every 97 reflections throughout the data collection, showed only 3.97% decay. 
The structure was solved by direct methods. IS Hydrogen atoms were fixed in idealised 
positions. All non-hydrogen atoms were refined with anisotropic atomic displacement 
parameters. Neutral scattering factors and anomalous dispersion corrections for non-
hydrogen atoms were taken from Ibers and Hamilton. 19 Full details of the X-ray 
structural determination of 3.29 have been deposited with the Cambridge 
Crystallographic Data Centre (CCDC). 
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8.4 Experimental Work Described in Chapter Four 
8.4.1. Preparation of unlabelled and [methylene-dt]-labelled 
hydroxymethylpyrroles 4.8a-c 
Qyo 
H R 
2.22a R = H 
2.22b R = D 
Pht = phthalyl 
----. ?yo 
PhtN~o R 
y 
4.13a R = H 
4.13b R= D 
----- {)yOH N ~ l 1 ~ 2 PhtN~R R 
= 0 
y 
4.8a R 1 = R2 = H 
4.8b R1 = D, R2 = H 
4.8c R1 = H, R2 = D 
N-Phthalyl-L-Ieucine acid fluoride and N-phthalyl-DL-Ieucine acid fluoride 
211 
To a stirred solution of N-phthalyl-L-Ieucine (60 mg, 0.23 mmol) In 
dichloromethane (3 mL) was added diethylaminosulfur trifluoride (37 J.1L, 0.28 mmol, 1.2 
equiv) at rt under N2. After 10 min the orange mixture was washed with ice water. The 
organic layer was then separated, dried and evaporated under reduced pressure. The 
residual oil was dried under high vacuum (oil pump) for 2 h to give the crude acid 
fluoride as a yellow oil which was used in the next step without purification: IR (CHCb) 
1850,1778, 1726 cm-l ; IHNMR (CDCb, 300 MHz) 0 0.95 (d, J= 6.8 Hz, 3H, CHMe2), 
0.97 (d, J= 6.3 Hz, 3H, CHMe2), 1.52 (m, IH, CHMe2), 1.95 (m, 1H, CH2), 2.37 (m, 1H, 
CH2), 5.14 (m, IH, aH), 7.79 (m, 2H, Pht Hs), 7.89 (m, 2H, Pht Hs). 
The reaction was repeated using N-phthalyl-DL-Ieucine (60 mg, 0.23 mmol) to 
give the crude racemic acid fluoride as a yellow oil which was used in the next step 
without purification. Spectral data as recorded above. 
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l-(N-Phthalyl-L-leucinyl)pyrrole-2-carboxaldehyde 4.13a and [formyl-dJ-l-(N-
phthalyl-L-leucinyl)pyrrole-2-carboxaldehyde 4.13b 
To a stirred suspension of sodium hydride (7 mg, 0.23 mmol in 80% suspension 
in oil, washed twice with petroleum ether, 1.1 equiv) in THF (5 mL) under N z was added 
pyrrole-2-carboxaldehyde 2.22a (20 mg, 0.21 mmol) dissolved in THF (1 mL). To the 
ice-cooled mixture was added a solution of N-phthalyl-L-Ieucine acid fluoride (61 mg, 
0.23 mmol, 1.1 equiv) in THF (4 mL) over 15 min. The mixture was left to stir at 0 °C 
for 30 min, and at rt overnight. The mixture was then diluted with ethyl acetate (10 mL), 
washed with 2 M aqueous potassium hydrogensulfate (10 mL), water (10 mL), dried and 
evaporated under reduced pressure. Flash chromatography on silica (ethyl 
acetate/petroleum ether, 1:4) gave 4.13a (62 mg, 87%) as a pale yellow oil: IR (CHCh) 
1776, 1736, 1719, 1666 cm-\ IH NMR (CDCh, 300 MHz) 0 0.98 (d, J = 6.3 Hz, 3H, 
CHMe2), 1.04 (d, J = 6.3 Hz, 3H, CHMe2), 1.60 (m, 1H, CHMe2), 2.01 (m, 1H, CH2), 
2.42 (m, 1H, CH2), 5.68 (dd, J= iO.7 & 4.4 Hz, 1H, alI), 6.31 (m, 1H, pyrrole H4), 7.17 
(m, 1H, pyrrole H3), 7.30 (m, 1H, pyrrole H5), 7.78 (m, 2H, Pht Hs), 7.86 (m, 2H, Pht 
Hs), 10.14 (s, 1H, CHO); 13C NMR (CDCh, 75 MHz) 0 21.4, 23.0, 24.9, 37.5, 51.5, 
113.2, 122.6, 123.8, 125.5, 131.2, 134.6, 135.3, 167.3, 168.7, 181.7. 
The reaction was repeated using [formyl-dJ-pyrrole-2-carboxaldehyde 2.22b (25 
mg, 0.26 mmol) and N-phthalyl-L-Ieucine acid fluoride (75 mg, 0.29 mmol, 1.1 equiv) to 
give 4.13b (81 mg, 91%): 13C NMR (CDCh, 75 MHz) 0 21.2, 22.9, 24.7, 37.4, 51:4, 
113.1, 122.4, 123.6, 125.5, 131.0, 134.5, 135.3, 167.2, 168.6, 181.2 (t, J = 30.3 Hz). 
2-Hydroxymethyl-l-(N-phthalyl-L-leucinyl)pyrrole 4.8a 
The N-Ieucinylpyrrole 4.13a (30 mg, 0.09 mmol) was reduced with zinc 
borohydride by general procedure D. Flash chromatography on silica (ethyl 
acetate/petroleum ether, 1 :3) gave 4.8a (27 mg, 88%) as a colourless oil which rapidly 
changed to a red colour when exposed to air: IR (CHCh) 3551, 1776, 1720, 1383 cm-\ 
IHNMR (CDCh, 300 MHz) 00.98 (d, J= 6.3 Hz, 3H, CHMe2), 1.05 (d, J= 6.8 Hz, 3H, 
CHMe2), 1.60 (m, 1H, CHMe2), 2.00 (m, 1H, CH2), 2.46 (m, 1H, CH2), 3.52 (1, J= 6.8 
Hz, 1H, OR), 4.62 (d, J= 6.8 Hz, 2H, CH20H), 5.54 (m, 1H, alI), 6.17 (m, 1H, pyrrole 
H4), 6.23 (m, 1H, pyrrole ID), 7.06 (m, 1H, pyrrole H5), 7.76 (m, 2H, Pht Hs), 7.87 (m, 
2H, Pht Hs); 13C N1v1R (CDCh, 75 MHz) 0 21.4, 23.0, 25.0, 37.6, 51.3, 57.5, 113.0, 
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114.8, 120.1, 123.7, 131.3, 134.5, 135.9, 167.4, 169.3; HRMS calcd for Cl~:2oN:204 
340.1423, found 340.1425. 
[methlyene-dtJ-2-Hydroxymethyl-l-(N-phthalyl-L-leucinyl)pyrrole 4.8b and 4.8c 
S-Alpine borane® sequence: General procedure F was carried out using a sample of the 
deuterated N-Ieucinylpyrrole 4.13b (31 mg, 0.09 mmol) and S-Alpine boraneill (198 ~ of 
0.5 M solution in THF, 0.10 mmol, 1.1 equiv). Flash chromatography on silica (ethyl 
acetate/petroleum ether, 1 :3) gave a mixture of 4.8b and 4.8c (27 mg, 88%, >9: 1 by IH 
NMR) as a colourless oil which rapidly changed to a red colour when exposed to air: IH 
NMR (CDCh, 300 MHz) 0 0.98 (d, J= 6.3 Hz, 3H, CHM"e2), 1.05 (d, J= 6.8 Hz, 3H, 
CHMe2) , 1.60 (m, IH, CHMe2) , 2.00 (m, IH, CH2), 2.46 (m, IH, CH2), 3.52 (bs, IH, 
OlI), 4.61 (s, IH, CEDOH), 5.54 (m, IH, aH), 6.17 (m, IH, pyrrole H4), 6.23 (m, IH, 
pyrrole H3), 7.06 (m, IH, pyrrole H5), 7.76 (m, 2H, Pht Hs), 7.87 (m, 2H, Pht Hs); 13C 
NMR (CDCh, 75 MHz) 0 21.4,23.0,25.0,37.6,51.3,57.2 (1, J 21.4 Hz), 113.0, 114.8, 
120.1, 123.7, 131.3, 134.5, 135.9, 167.4, 169.3; HRMS calcd for C19H19DN204 341.1486, 
found 341.1488. 
R-Alpine borane® sequence: General procedure F was carried out using a sample of the 
deuterated N-leucinylpyrrole 4.13b (22 mg, 0.07 mmol) and R-Alpine boraneill (145 ~ 
of 0.5 M solution in THF, 0.07 mmol, 1.1 equiv). Flash chromatography on silica (ethyl 
acetate/petroleum ether, 1:3) gave a mixture of 4.8b and 4.8c (20 mg, 90%, 1:>9 by IH 
NMR) as a colourless oil which rapidly changed to a red colour when exposed to air. 
Spectral data as recorded above. 
Chapter Eight - Experimental 214 
8.4.2. Procedure for the hydrolysis of unlabelled and [methylene-d1]-
labelled 2-hydroxymethyl-l-(N-phthalyl-L-Ieucinyl)pyrroles 4.8a-c 
~OH· 
N .. I 1'2 ---.. PhtN~R R 
:: 0 
y 
4.8a R 1 = R2 = H 
4.8b R1 = D, R2 = H 
4.8c R1 = H, R2 = D 
~ ~ 0 a 'N~ ITNPht 
H R1 'R2 0 
4.10a R 1 = R2 = H 
4.10b R 1 = 0, R2 = H 
4.10c R 1 = H, R2 = 0 
Pht = phthalyl 
Qy~Y' 
H R § 
4.11a R = H 
4.11b R = 0 
----.. + R;o QyNy'" 
H R :: 
4.12a R = H 
4.12b R = D 
General Procedure: An equivalent of potassium hydroxide in D20 (approx 10 JiL) was 
added to a solution of either 4.8a, 4.8b or 4.8c (typically 3 mg) in CD3CN (150 JiL) 
containing CHCh as an internal standard (5 7.25), and an equivalent of S-(+)-sec-
butylamine (external nucleophile). The ratio of the N-acyl 4.8, O-acyl 4.10 and 
aminomethylpyrroles 4.11 and 4.12 was then monitored by IH NMR spectroscopy over 
time (ca. 18 h). See Table 4.1 in Chapter 4 for the NMR analysis. 
8.4.4. Independent synthesis of aminomethylpyrroles 4.11 and 4.12 
o 
N 
H 
• ~~!+ 
4.11 
N-(Pyrrol-2-ylmethyl)-(± )-sec-butylamine 4.11 
;0 ~N ~! 
4.12 
A solution of (±)-sec-butylamine hydrochloride (858 mg, 7.83 mmol, 1.05 equiv) 
in 37% aqueous formalin (586 JiL, 7.83 mmol, 1.05 equiv) was added slowly to pyrrole 
(517 JiL, 7.45 mmol). The mixture was stirred for 90 min and allowed to stand 
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overnight. It was then poured into 25% aqueous sodium hydroxide (20 mL) and 
extracted with ether (3x15 mL). The combined ethereal extracts were washed with water 
(2x15 mL), dried and evaporated under reduced pressure. The resulting residue was 
distilled under high vacuum to give 4.11 (704 mg, 62%) as a pale yellow oil: IR (CHCh) 
3468, 3323, 1603, 1574 cm-l; lH NMR (CDCh, 300 MHz) 6 0.89 (1, J = 7.3 Hz, 31I, 
CHzMe), 1.06 (d, J= 6.3 Hz, 31I, CHMe), 1.34 (m, IH, CH2Me), 1.52 (m, III, CH~e), 
2.62 (m, IH, CHMe), 3.73 (ABq, J= 13.2 Hz, III, CHiN), 3.81 (ABq, J= 13.2 Hz, III, 
CHiN), 6.01 (m, IH, pyrrole H4), 6.11 (m, III, pyrrole H3), 6.68 (m, III, pyrrole H5), 
9.28 (bs, III, NH); l3C NMR (CDCh, 75 MHz) 6 10.1, 19.6, 29.3, 44.1, 54.3, 105.9, 
107.7, 117.1, 130.7; HRMS calcd for C9H16N2 152.1314, found 152.1313. 
N,N-Di(pyrrol-2-ylmethyl)-(± )-sec-butylamine 4.12 
A solution of (±)-sec~butylamine hydrochloride (250 mg, 2.28 mmol) in 37% 
aqueous formalin (342 J..1.L, 4.56 mmol, 2 equiv) was treated with pyrrole (317 J..1.L, 4.56 
mmol, 2 equiv) by the procedure described above for the preparation of 4.11. Flash 
chromatography on silica (ethyl acetate/petroleum ether, 1:2 + 5% triethylamine) gave 
two compounds. The first to elute was 4.12 (104 mg, 20%) as a pale orange oil: IR 
(CHCh) 3472, 3389, 1570 cm-\ IH NMR (CDCh, 300 MHz) 6 0.90 (t, J 7.3 Hz, 31I, 
CHzMe), 0.99 (d, J= 6.8 Hz, 31I, CHMe), 1.32 (m, III, CH2Me), 1.57 (m, III, CH2Me), 
2.66 (m, IH, CHMe), 3.49 (ABq, J 14.2 Hz, 21I, CH2N), 3.65 (ABq, J= 14.2 Hz, 2H, 
CHiN), 6.02 (m, 2H, pyrrole H4), 6.10 (m, 2H, pyrrole H3), 6.69 (m, 2H, pyrrole H5), 
8.25 (bs, 2H, NH); l3C NMR (CDCh, 75 MHz) 6 11.8, 13.5, 26.5, 46.6, 55.8, 106.9, 
108.0,117.0, 130.4; HRMS calcd for Cl.Jf2lN3 231.1736, found 231.1735. The second 
compound to elute was 4.11 (265 mg, 76%) as a pale orange oil. Spectral data as 
recorded above. 
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8.4.3. Preparation of unlabelled and [methylene-d1]-labelled 
camphanates 4.14a-c and 4.1Sa-c 
.. ~OH 
N 9't0 H Pi PhtN00 
2.22a y 
~oizf 
PhtN 1... 0 X~'o 
R1 R2 
4.14a R1 = CH2CHMe2, R2 = H 
4.1Sa R1 = H, R2 = CH2CHMe2 
4.8a 
~OH N 
+ P:t0 
4.8d 
Pht = phthalyl 
216 
2-Hydroxymethyl-l-(N-phthalyl-L-leucinyl)pyrrole 4.8a and 2-hydroxymethyl-l-(N-
phthalyl-D-Ieucinyl)pyrrole 4.8d 
Pyrrole-2-carboxaldehyde 2.22a (20 mg, 0.21 mmol) was N-acylated with 
racemic N-phthalyl-DL-Ieucine acid fluoride (61 mg, 0.23 mmol, 1.1 equiv), by the 
method described for the preparation of 4.8a. The resulting sample was then reduced 
with zinc borohydride (1.50 mL of 0.14 M solution in ether, 0.21 romol, 1 equiv) by the 
method described in general procedure D. Flash chromatography on silica (ethyl 
acetate/petroleum ether, 1 :3) gave a mixture of 4.8a and 4.8d (58 mg, 81% for 2 steps, 
1: 1 from analysis of camphanates prepared by method G below) as a colourless oil which 
rapidly changed to a red colour when exposed to air. Spectral data as recorded above. 
(lS,4R)-1-(N-Phthalyl-L-leucinyl)pyrrol-2-ylmethyl camp han ate 4.14a and (lS,4R)-
1-(N-phthalyI-D-IeucinyI)pyrroI-2-ylmethyl camphanate 4.1Sa 
General procedure G was carried out on a racemic sample of the N-Ieucinyl 
hydroxymethylpyrroles 4.8a and 4.8d (15 mg, 0.05 mmol, 1:1). Flash chromatography 
on silica (ethyl acetate/petroleum ether, 1 :3) gave a mixture of 4.14a and 4.1Sa (20 mg, 
83%, 1:1) as a colourless oil: IR (CHCh) 1782,1719, 1383 cm"l; IHNMR (CD3CN, 300 
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MHz) a 0.63 (s, 3H, camph-Me), 0.73 (d, J = 6.3 Hz, 3H, CHMe2), 0.78 (s, 3H, camph-
Me), 0.80 (d, J 6.3 Hz, 3H, CHMe2), 0.82 (s, 3H, camph-Me), 1.35 - 1.44 (m, 2H, 
CHMe2 & camph-CH2), 1.67 - 1.80 (m, 3H, CH2 & camph-CH2), 2.08 - 2.25 (m, 2H, 
CH2 & camph-CH2), 5.10 (ABq, J= 12.7 Hz, 0.5H, CH20- 4.15a), 5.13 (ABq, J= 12.7 
Hz, 0.5H, CH20- 4.14a), 5.19 (ABq, J = 12.7 Hz, 0.5H, CH20- 4.14a), 5.20 (ABq, J = 
12.7 Hz, 0.5H, CH20- 4.15a), 5.36 (m, IH, aH), 6.01 (m, IH, pyrrole H4), 6.20 (m, IH, 
pyrrole H3), 6.97 (m, IH, pyrrole H5), 7.63 (m, 4H, Pht Hs); 13C NMR (CDCh, 75 MHz) 
a 9.7, 16.6, 16.7, 21.3, 23.0, 25.1, 29.0, 30.6, 37.4, 51.5, 54.2, 54.8, 60.5, 91.2, 112.6, 
116.7, 120.9, 123.7, 129.7, 131.4, 134.4, 167.1, 167.5, 167.6, 178.3; HRMS ca1cd for 
C29H32N207 520.2210, found 520.2206. 
The reaction was repeated as described in general procedure G using a sample of 
the N-Ieucinylhydroxymethylpyrrole 4.8a (20 mg, 0.06 mmol). Flash chromatography on 
silica (ethyl acetate/petroleum ether, 1:3) gave a mixture of 4.14a and 4.15a (29 mg, 
94%, -9:1) as a colourless oil. Selected IHNMR (CD3CN, 300 MHz) a 5.10 (ABq, J= 
12.7 Hz, 0.1H, CH20-4.15a), 5.13 (ABq,J= 12.7 Hz, 0.9H, CH20- 4.14a), 5.19 (ABq, J 
= 12.7 Hz, 0.9H, CH20- 4.14a), 5.20 (ABq, J= 12.7 Hz, 0.1H, CH20- 4.15a). 
The reaction was repeated using a sample of the N-Ieucinylhydroxymethylpyrrole 
4.8a (12 mg, 0.04 mmol) and a modified general procedure G in which the reaction 
mixture was stirred at rt for 48 h. Flash chromatography on silica (ethyl 
acetate/petroleum ether, 1:3) gave a mixture of 4.14a and 4.15a (15 mg, 79%, -5:1) as a 
colourless oil. Selected IHNMR (CD3CN, 300 MHz) a 5.10 (ABq, J 12.7 Hz, 0.17H, 
CH20- 4.15a), 5.13 (ABq, J= 12.7 Hz, 0.83H, CH20- 4.14a), 5.19 (ABq, J= 12.7 Hz, 
0.83H, CH20- 4.14a), 5.20 (ABq, J = 12.7 Hz, 0.17H, CH20- 4.15a). 
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4.8b R 1 = 0, R2 = H 
4.8c R 1 = H. R2 = 0 
4.14b R1 = 0, R2 = H 
4.14c R1 = H, R2 = 0 
4.15b R1 = 0, R2 = H 
4.15c R1 = H, R2= 0 
[meth{vene-dd-(lS,4R)-1-(N-Phthalyl-L-leucinyl)pyrrol-2-ylmethylcamphanate 
4.14b and 4.14c and [meth{vene-dd-(lS,4R)-1-(N-phthalyl-D-leucinyl)pyrrol-2-
ylmethyl camphanate 4.15b and 4.15c 
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A sample of 4.Sb and 4.Sc (9 mg, 0.03 mmol, >9:1) was reacted with (lS,4R)-(-)-
camphanoyl chloride (7 mg, 0.03 mmol, 1.2 equiv) according to general method G. Flash 
chromatography on silica (ethyl acetate/petroleum ether, 1 :3) gave a mixture of 4.14b and 
4~15bt (10 mg, 74%, 9:1) as a colourless oil: IHNMR. (CD3CN, 300 MHz) 0 0.63 (s, 3H, 
camph-Me), 0.73 (d, J= 6.3 Hz, 3H, CHMe2), 0.78 (s, 3H, camph-Me), 0.80 (d, J 6.3 
Hz, 3H, CHMe2), 0.82 (s, 3H, camph-Me), 1.35 - 1.44 (m, 2H, CRM~ & camph-CH2), 
1.67 1.80 (m, 3H, CH2 & camph-CH2), 2.08 - 2.25 (m, 2H, CH2 & camph-CH2), 5.10 
(s, 0.1H, CRDO· 4.15b), 5.17 (s, 0.9H, GRDO- 4.14b), 5.36 (m, 1H, alI), 6.01 (m, 1H, 
pyrrole H4), 6.20 (m, 1H, pyrrole H3), 6.97 (m, 1H, pyrrole H5), 7.63 (m, 4H, Pht Hs); 
13C NMR. (CDCh, 75 MHz) 0 9.7, 16.6, 16.7, 21.3, 23.0, 25.1, 29.0, 30.6, 37.4, 51.5, 
54.2,54.8,60.2 (t, J= 21.9 Hz), 91.2, 112.6, 116.7,120.9, 123.7, 129.7, 131.4, 134.4, 
167.1, 167.5, 167.6, 178.3; HRMS calcd for C29H31DN207 521.2271, found 521.2278. 
The reaction was repeated using a sample of 4.Sb and 4.Sc (12 mg, 0.03mmol, 
1:>9). Flash chromatography on silica (ethyl acetate/petroleum ether, 1:3) gave a mixture 
of 4.14c and 4.15ct (15 mg, 86%, 9:1) as a colourless oiL Selected IH NMR. (CD3CN, 
300 MHz) 0 5.13 (s, 0.9H, CRDO· 4.14c), 5.19 (s, O.lH, CRDO· 4.15c). 
t Also present in trace amounts «5% by IH NMR) were the corresponding deuterated isomers. For 
ease of analysis these isomers have been omitted. 
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8.5 Experimental Work Described in Chapter Five 
8.5.1. Determination of optimal pyrrole N-substituent and leaving group 
8.5.1.1. Preparation of 2-hydroxymethyl-1-( substituted)pyrroles S.3a-d 
~ ~ ~OH R 
- - CO(CH2hPh N CHO N CHO N a 
H I I b S02Ph R R 
c S02CH:CHPh 
2.22a 5.2a-<l 5.3a-d d S02(CH2hPh 
1-(3-Phenylpropionyl)pyrrole-2-carboxaldehyde 5.2a 
General procedure C was carried out using pyrrole-2-carboxaldehyde 2.22a (60 
mg, 0.63 mmol) and hydrocinnamoyl chloride20 (103 ~, 0.69 mmol, 1.1 equiv). Flash 
chromatography on silica (ethyl acetate/petroleum ether, 1:6) gave 5.2a (113 mg, 79%) as 
a white solid: mp 88°C (!it.21 89 - 90°C); IR (CHCh) 1730, 1665 em-I; IH NMR 
(CDCh, 300 MHz) B 3.14 (m, 2H, CH2Ph), 3.26 (m, 2H, COCH2), 6.34 (m, IH, pyrrole 
H4), 7.20 - 7.35 (m, 7H, pyrrole ID & pyrrole H5 & phenyl Hs), 10.30 (s, Ill, CHO); 
13C NMR (CDCh, 75 MHz) B 29.9, 37.2, 112.5, 122.1, 125.8, 126.2, 128.1, 128.3, 135.2, 
139.4, 171.0, 182.1; HRMS calcd for Cl,J{13N02 227.0946, found 227.0946. 
1-(Phenylsulfonyl)pyrrole-2-carboxaldehyde 5.2 b 
General procedure B was carried out using pyrrole-2-carboxaldehyde 2.22a (50 
mg, 0.53 mmol) and phenylsulfonyl chloride (81 ~, 0.63 mmol, 1.2 equiv). Flash 
chromatography on silica (ethyl acetate/petroleum ether, 1:3) gave 5.2b (121 mg, 97%) 
as a white solid: mp 81°C (lit?2 79.5 - 80.5 °C); IR (CHCh) 1688, 1672, 1379, 1178 
cm'\ IHNMR (CDCh, 300 MHz) B 6.43 (m, IH, pyrrole H4), 7.17 (m, Ill, pyrrole ID), 
7.52 - 7.68 (m, 4H, pyrrole H5 & phenyl Hs), 7.93 (m, 2H, phenyl Hs), 9.95 (s, IH, 
CHO); 13C NMR (CDCh, 75 MHz) B 112.5, 124.8, 127.4, 129.5, 133.5, 134.5, 138.1, 
178.7; FIRMS cal cd forCuH9N03S 235.0303, found 235.0303. 
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1-(~-trans-Styrenesulfonyl)pyrrole-2-carboxaldehyde 5.2c 
The modified general procedure B was carried out usmg pyrrole-2-
carboxaldehyde 2.22a (50 mg, 0.53 mmol) and ~-trans-styrenesulfonyl chloride (128 mg, 
0.63 mmol, 1.2 equiv). Flash chromatography on silica (ethyl acetate/petroleum ether, 
1:4) gave 5.2c (77 mg, 56%) as a pale yellow solid. An analytical sample was obtained 
by recrystallisation from ethyl acetate/petroleum ether to give a white crystalline solid: 
mp 88°C; IR (CHCh) 2837, 1682, 1612, 1377, 1167 cm-l; lHNMR (CDCh, 300 MHz) B 
6.41 (m, 1H, pyrrole H4), 7.21 (m, 1H, pyrrole H3), 7.40 - 7.47 (m, 4H, CHPh & phenyl 
Hs), 7.54 (m, 2H, phenyl Hs), 7.62 (m, 1H, pyrrole H5), 7.81 (d, J = 15.6 Hz, 1H, 
S02CH), 9.79 (s, 1H, CHO); 13C NMR (CDCh, 75 MHz) B 111.6, 123.5, 127.5, 128.9, 
129.1, 129.6, 131.4, 132.0, 133.1, 146.0, 178.2; HRMS calcd for C13Hl1NO (M-S02) 
197.0841, found 197.0841. Anal. Calcd for C13Hl1N03S: C, 59.76; H, 4.24; N, 5.36. 
Found: C, 59.74; H, 4.16; N, 5.30. 
1-(2-Phenylethanesulfonyl)pyrrole-2-carboxaldehyde 5.2d 
To a suspension of sodium 2-phenylethylsulfonate23 (5.00 g, 24.0 mmol) in 
phosphorus oxychloride (8 mL) was added powdered phosphorus pentachloride (5.00g, 
24.0 mmol, 1 equiv) portionwise. The mixture was then stirred vigorously at 70°C for 
2Yz h under N2 . The mixture was allowed to cool to rt and was extracted with 
dichloromethane (4x20 mL). The organic phase was dried and evaporated under reduced 
pressure to give the crude product which was obtained by recrystallisation from 
petroleum ether to give 2-phenylethanesulfonyl chloride (3.72 g, 76%) as a white solid: 
mp 33°C (lit.23 34°C); IR (CHCh) 1377, 1167 cm-l; lH NMR (CDCh, 300 MHz) B 3.33 
(m, 2H, CH:zPh), 3.90 (m, 2H, CH2S02CI), 7.22 - 7.38 (m, 5H, phenyl Hs); 13C NMR 
(CDCh, 75 MHz) B 30.4, 66.1, 127.6, 128.5, 129.1, 135.5; LRMS mlz (reI. intensity) 206 
(18),204 (48), 105 (100), 104 (97). 
The modified general procedure B was carried out usmg pyrrole-2-
carboxaldehyde 2.22a (50 mg, 0.53 mmol) and 2-phenylethanesulfonyl chloride (129 mg, 
0.63 mmol, 1.2 equiv). Flash chromatography on silica (ethyl acetate/petroleum ether, 
1:4) gave 5.2d (116 mg, 84%) as a pale pink solid: mp 61 - 63°C; IR (CHCh) 1680, 
1377, 1169 cm-\ lH NMR (CDCh, 300 MHz) B 3.08 (m, 2H, CH2Ph), 4.10 (m, 2H, 
S02CH2), 6.38 (m, 1H, pyrrole H4), 7.12 - 7.30 (m, 6H, pyrrole H3 & phenyl Hs), 7.56 
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(m, IH, pyrrole H5), 9.68 (s, IH, CHO); 13C NMR (CDCb, 75 MHz) 029.3, 55.8, 111.5, 
127.1, 128.2, 128.8, 129.0, 131.0, 133.1, 136.2, J 78.2; HRMS calcd for C13H13NO (M-
S02) 199.0997, found 199.0994. 
2-Hydroxymethyl-l-(3-phenylpropionyl)pyrrole S.3a 
The N-hydrocinnamoylpyrrole S.2a (50 mg, 0.22 mmol) was reduced with zinc 
borohydride by general procedure D. Flash chromatography on silica (ethyl 
acetate/petroleum ether, 1:4) gave S.3a (47 mg, 93%) as a pale orange oil: IR. (CHCb) 
3533, 1707, 1412, 1317 cm-l; lHNMR (CDCb, 300 MHz) 0 3.09 (m, 2H, CH2Ph), 3.19 
(m,2H, COCH2), 3.77 (bs, IH, Oll), 4.63 (s, 2H, CH20H), 6.18 (m, IH, pyrrole H4), 
6.22 (m, IH, pyrrole H3), 7.08 (m, IH, pyrrole H5), 7.21 - 7.35 (m, 5H, phenyl Hs); 13C 
NMR (CDCb, 75 MHz) 0 30.4, 37.4, 57.9, 112.2, 114.6, 120.8, 126.5, 128.3, 128.7, 
135.5, 139.9, 172.2; HRMS calcd for ClJIlSN02 229.1103, found 229.1103. 
2-Hydroxymethyl-l-(phenylsulfonyl)pyrrole S.3b 
The N-phenylsulfonylpyrrole S.2b (50 mg, 0.21 mmol) was reduced with zinc 
borohydride by general procedure D. Flash chromatography on silica (ethyl 
acetate/petroleum ether, 1:2) gave S.3b (46 mg, 92%) as a pale pink: solid: mp 41 - 42 
°C; IR (CHCb) 3578, 1369, 1177 cm-l; lHNMR (CDCb, 300 MHz) 0 2.57 (bs, IH, Oll), 
4.61 (s, 2H, CH20H), 6.24 - 6.28 (m, 2H, pyrrole H4 & pyrrole ID), 7.28 (m, IH, 
pyrrole H5), 7.49 -7.65 (m, 3H, phenyl Hs), 7.82 (m, 2H, phenyl Hs); 13C NMR (CDCb, 
75 MHz) 056.8, 112.0, 115.3, 123.6, 126.6, 129.5, 134.0, 134.6, 139.0; HRMS calcd for 
CllHllN03S 237.0460, found 237.0458. 
2-Hydroxymethyl-l-(f3-trans-styrenesulfonyl)pyrrole S.3e 
The N-styrenesulfonylpyrrole S.2e (50 mg, 0.19 mmol) was reduced with zinc 
borohydride by general procedure D. Flash chromatography on silica (ethyl 
acetate/petroleum ether, 1:3) gave S.3e (48 mg, 95%) as a pink: solid: mp 76 - 77°C; IR. 
(CHCb) 3585, 3026, 1614, 1369, 1173 cm-l; lH NMR (CDCb, 300 MHz) 0 2.64 (bs, IH, 
Oll), 4.73 (s, 2H, CH20H), 6.24 (m, IH, pyrrole H4), 6.30 (m, IH, pyrrole H3), 7.02 (d, 
J = 15.6 Hz, IH, CHPh), 7.18 (m, IH, pyrrole H5), 7.36 - 7.48 (m, 5H, phenyl Hs), 7.63 
(d, J = 15.6 Hz, IH, S02Cll); 13C NMR (CDCb, 75 MHz) 0 56.7, 111.6, 115.2, 123.0, 
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124.3, 128.7, 129.1, 131.5, 131.7, 134.1, 143.4; HRMS calcd for C13H13N03S 263.0616, 
found 263.0616. 
2-Hydroxymethyl-l-(2-phenylethanesulfonyl)pyrrole 5.3d 
The N-phenylethanesulfonylpyrrole 5.2d (50 mg, 0.19 mmol) was reduced with 
zinc borohydride by general procedure D. Flash chromatography on silica (ethyl 
acetate/petroleum ether, 1:3) gave 5.3d (47 mg, 94%) as a colourless oil: IR (CHCh) 
3578, 1369, 1175 cm-I; IH NMR (CDCh, 300 MHz) B 2.47 (bs, IH, OH), 2.99 (m, 2H, 
CH2Ph), 3.70 (m, 2H, S02CH2), 4.76 (s, 2H, CH20H), 6.23 (m, IH, pyrrole H4), 6.32 (m, 
IH, pyrrole ID), 7.11 - 7.31 (m, 6H, pyrrole H5 & phenyl Hs); 13C NMR (CDCb, 75 
MHz) B 29.3, 56.7 (2xC), 111.1, 115.6, 124.0, 127.2, 128.3, 128.9, 133.8, 136.6; HRMS 
caled for C13HISN03S 265.0773, found 265.0771. 
8.5.1.2. Preparation of 2-substituted pyrroles 5.6a and 5.6b 
~OH ~ 
S02Ph 
S.3b 
~x N 
I 
S02Ph 
5.6a X = CI 
5.6b X = N-Pht-L-LeuC02 
2-Chloromethyl-l-(phenylsulfonyl)pyrrole 5.6a 
General procedure I was carried out using the N-phenylsulfonylpyrrole 5.3b (30 
mg, 0.13 mmol) and methanesulfonyl chloride (15 ~, 0.19 mmol, 1.5 equiv). The 
residual oil was eluted through a short plug of silica (ethyl acetate/petroleum ether, 1: 1) 
to give 5.6a (quantitative) as a white solid: mp 66°C; IR (CHCh) 1371, 1178 em·l ; IH 
NMR (CDCh, 300 MHz) B 4.84 (s, 2H, CH2CI), 6.26 (m, IH, pyrrole H4), 6.38 (m, IH, 
pyrrole ID), 7.34 (m, IH, pyrrole H5), 7.48 - 7.64 (m, 3H, phenyl Hs), 7.89 (m, 2H, 
phenyl Hs); l3C NMR. (CDCh, 75 MHz) B 37.2, 111.8, 117.1, 124.5, 127.1, 129.3, 134.0, 
138.8, 142.6; HRMS calcd for CU HlON02S (M-Cl) 220.0432, found 220.0435. 
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l-(Phenylsulfonyl)pyrrol-2-ylmethyl N-phthalyl-L-Ieucine S.6b 
The hydroxymethylpyrrole S.3b (30 mg, 0.13 mmoI), DMAP (15 mg, 0.13 mmol, 
1 equiv) and HOnig's base (26 IlL, 0.15 mmol, 1.2 equiv) were dissolved in 
dichloromethane (8 mL) at It. N-PhthalyI-L-Ieucine acid fluoride (40 mg, 0.15 mmoI, 1.2 
equiv) dissolved in dichloromethane (2 mL) was added and the resultant solution was 
stirred for 24 h under N2. Ethyl acetate (10 mL) was added and the mixture was washed 
with 10% aqueous citric acid (10 mL), water (2x10 mL), dried and evaporated under 
reduced pressure. Flash chromatography on silica (ethyl acetate/petroleum ether, 1 :2) 
gave S.6b (55 mg, 90%) as a colourless oil which solidified at 0 °C. An analytical 
sample was obtained by recrystallisation from ethyl acetate/petroleum ether to give a 
white solid: mp 112°C; IR (CHCh) 1776, 1742, 1717, 1389, 1371, 1186 cm"I; IH NMR 
(CDCb, 300:MHz) 0 0.88 (d, J= 6.3 Hz, 3II, CRMe2), 0.89 (d, J= 6.3 Hz, 3II, CRMe2), 
1.43 (m, 1H, CHM~) 1.75 (m, III, CH2CITh1e2), 2.29 (m, III, CH2CITh1e2), 4.80 (m, III, 
aH), 5.30 (m, 2II, CH20-Leu), 6.25 (m, III, pyrrole H4), 6.37 (m, III, pyrrole ID), 7.32 
(m, 1H, pyrrole H5), 7.52 - 7.87 (m, 9II, Pht Hs & phenyl Hs); 13C NMR (CDCb, 75 
:MHz) 0 20.9,23.1,25.0,37.0,50.7,58.8,111.8,117.9, 123.5, 124.3, 126.7, 128.3, 129.5, 
131.8,134.0, 134.1, 139.2, 167.7, 169.4; HRMS calcd for C2sH2~206S 480.1355, found 
480.1361; Anal. Calcd for C2sH24N206S: C, 62.49; II, 5.03; N, 5.83. Found: C, 62.50; II, 
5.33; N, 5.96. 
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8.5.2. Preparation of pyrrole-based peptidomimetics 
8.5.2.1. Attempted preparation of peptidomimetics of type 5.7 
~ N CHO 
H 
- Q\+ Et~) ~OEt H 0 -~OH H 0 2.22a 
5.7 ...... -----
o 
5.13 
5.17 
5.14 
4 X 
Ethyl (E)-3-(lH-pyrrol-2-yl)-2-propenoate 5.14 
5.15 
j 
IT\ /Y ~J '''N''''~n = OMe 
H 0:: 
5.16 Y 
Pyrrole-2-carboxaldehyde 2.22a (2.02g, 21.2 mmol) and 
(ethoxycarbonyl)methylene triphenylphosphorane24 (7.40 g, 21.2 mmol, 1 equiv) in 
benzene (80 mL) were heated at reflux for 2 h and then allowed to stand at rt for 12 h. 
The benzene was removed under reduced pressure and the residual oil was purified by 
distillation under reduced pressure followed by flash chromatography on silica (ethyl 
acetate/petroleum ether, 1: 10 to 1: 1) to give two compounds. The first to elute was the 
cis-isomer 5.13 (0.60 g, 17%) as a yellow oil: IR (CHCh) 3279, 1686, 1601 cm-l~ IH 
NMR (CDCh, 300 MHz) 0 1.28 (t, J 7.1 Hz, 3H, C02CH2CH3), 4.18 (q, J= 7.1 Hz, 
2H, C02CH2), 5.50 (d, J = 12.6 Hz, IH, CHC02), 6.24 (m, IH, pyrrole H4), 6.48 (m, IH, 
pyrrole H3), 6.72 (d, 12.6 Hz, IH, CHCHC02), 6.96 (m, IH, pyrrole H5), 12.25 (bs, 
IH, NH); l3C NMR (CDCh, 75 MHz) 0 14.1, 60.2, 107.5, 110.0, 118.5, 122.7, 129.0, 
134.5, 169.0. The second compound to elute was the trans-isomer 5.14 (1.70 g, 49%) as 
a pale yellow solid: mp 51 - 52°C (lit.2s 54 - 56°C); IR (CHCh) 3475, 3321, 1692, 
1628 em-I; IHNMR(CDCh, 300 MHz) 01.31 (t,J= 7.3 Hz, 3H, C02CH2CH3), 4.24 (q, 
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J= 7.3 Hz, 2H, C02CH2), 6.08 (d, J= 15.6 Hz, HI, CHC02), 6.27 (m, 1H, pyrrole H4), 
6.56 (m, 1H, pyrrole H3), 6.92 (m, 1H, pyrrole H5), 7.58 (d, J = 15.6 Hz, 1H, 
CHCHC02), 9.29 (bs, 1H, NH); I3C NMR (CDCh, 75 MHz) 0 14.3, 60.3, 110.8, 111.0, 
114.2, 122.5, 128.4, 134.5, 168.1; HRMS calcd for C9HuN02 165.0790, found 165.0790. 
(E)-3-(lH-Fyrrol-2-yl)-2-propenoic acid 5.15 
The pyrrole ester 5.14 (201 mg, 1.22 mmol) was hydrolysed with sodium 
hydroxide by general procedure I Flash chromatography on silica (ethyl 
acetate/petroleum ether, 1:1) gave 5.15 (147 mg, 88%) as a pale yellow solid: mp >155 
°C decomp.; (lit.26 150 - 200°C decomp.); IR (CHCh) 3475, 1695, 1630 cm>l; IH NMR 
(CD30D, 300 MHz) 0 6.04 (d, J 15.6 Hz, 1H, CHC02), 6.17 (m, 1H, pyrrole H4), 6.48 
(m, 1H, pyrrole ill), 6.90 (m, 1H, pyrrole H5), 7.51 (d, J = 15.6 Hz, 1H, CHCHC02), 
10.99 (bs, 1H, NH); l3C NMR (CD30D, 75 MHz) 0 11 1.2, 111.5, 116.2, 124.6, 130.0, 
137.1, 172.1; HRMS calcd for C7H7N02 137.0477, found 137.0474. 
N-[(E)-3-(lH-Pyrrol-2-yl)-2-propenoyl]-L-leucine methyl ester 5.16 
The pyrrole acid 5.15 (127 mg, 0.92 mmol) was coupled with L-Ieucine methyl 
ester hydrochloride (168 mg, 0.92 mmol, 1 equiv) according to general procedure K. 
Flash chromatography on silica (ethyl acetate/petroleum ether, 1:2 then 1: 1) gave 5.16 
(224 mg, 92%) as a yellow oil: IR (CHCh) 3476, 3439, 3315,1736,1663,1618,1510 
cm>l; lHNMR (CDCh, 300 MHz) 0 0.92 (d, J= 5.9 Hz, 3H, CHMe2), 0.93 (d, J= 6.3 
Hz, 3H, CHMe2), 1.60 - 1.77 (m, 3H, CH2CHMe2), 3.70 (5, 3H, CO"Me), 4.65 (m, 1H, 
aH), 6.15 - 6.20 (m, 2H, pyrrole H4 & CHC02), 6.37 (m, 1H, pyrrole ill ), 6.85 (m, IH, 
pyrrole H5), 7.17 (d, J= 7.3 Hz, IH, CONH), 7.45 (d, J 15.6 Hz, IH, CHCHC02), 
10.12 (bs, IH, NH); I3C NMR (CDCh, 75 MHz) 0 21.7, 22.7, 24.8, 41.0, 51.2, 52.3, 
110.2, 112.6, 113.4, 122.1, 128.5, 1322, 167.7, 174.3; HRMS calcd for C14H:zoN203 
264.1474, found 264.1473. 
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Attempted preparation of the N-hydrocinnamoylpyrrole 5.17 
Attempts to N-substitute 5.16 (typically 81 mg, 0.31 mmol) with hydrocinnamoyl 
chloride (1.4 equiv) by general procedure B proved unsuccessful, giving returned starting 
material 5.16. Similarly, an attempt to N-substitute 5.16 (63 mg, 0.24 mrnol) with 
hydrocinnamoyl chloride (1.1 equiv) by general procedure C also proved unsuccessful, 
with the lH NMR spectrum of the crude reaction work up showing returned starting 
material 5.16, with no evidence of any of the desired product 5.17. 
8.5.2.2. Preparation of peptidomimetics of type 5.8 and 5.9 
0 • Q\yJ N N OMe 
H H 0 
5.18 
J 
~ ~ ~ - N OMe~ NOMe N OMe R OH R 0 R OH 
5.8a R = S02Me 5.19a R = S02Me 5.8c R = CO(CH2hPh 
5.8b R = S02Ph 5.19b R = S02Ph 
5.19c R = CO(CH2hPh 
Methyl 4-oxo-4-(lH-pyrrol-2-yl)butanoate 5.18 
A solution of pyrrole (1.50 g, 22.4 mmol) in ether (9 mL) was added dropwise to 
a solution of methyl magnesium iodide (11.74 mL of2.0 M solution in ether, 23.5 mrnol, 
1.05 equiv) under N2 so as to cause slight reflux. The solution was then heated at reflux 
for an additional 30 min. After cooling to rt, methyl succinyl chloride27 (2.75 mL, 22.4 
mmol, 1 equiv) in ether (6 mL) was added, and the resulting mixture was heated at reflux 
for 1 h. The reaction was left overnight, and then poured into cold water. The aqueous 
and ether layers were separated, and the aqueous phase was extracted with ether (3xlO 
mL). The combined ethereal layers were washed with water (2xlO mL), dried and 
evaporated under reduced pressure. The resulting residue was distilled at reduced 
pressure (oil pump) to give 5.18 (1.97 g, 49%) as yellow solid. An analytical sample was 
obtained by recrystallisation from petroleum ether to give white crystals: mp 49°C; IR 
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(CHCh) 3452, 3285,1736,1647 cm'\ IHNMR (CDCh, 300 MHz) a 2.74 (t, J= 6.8 Hz, 
2H, CH2C02Me), 3.16 (t, J 6.8 Hz, 2H, COCH2), 3.69 (s, 3H, CO~e), 6.27 (m, IH, 
pyrrole H4), 6.99 (m, IH, pyrrole H3 ), 7.05 (m, IH, pyrrole H5), 10.20 (bs, IH, NH); 
13CNMR (CDCb, 75 MHz) a 28.2,32.4,51.7,110.6,116.6,125.1,131.3,173.3,188.5; 
HRMS calcd for C9HUN03 181.0739, found 181.0740. Anal. Calcd for C9HllN03: C, 
59.66; H, 6.12; N, 7.73. Found: C, 59.62; H, 6.07; N, 7.58. 
Methyl 4-oxo-4-[1-(methanesulfonyl)pyrrol-2-yl]butanoate 5.19a 
General procedure B was carried out using the pyrrole 5.18 (60 mg, 0.33 mmol) 
and methanesulfonyl chloride (37 ~, 0.46 mmol, 1.4 equiv). Flash chromatography on 
silica (ethyl acetate/petroleum ether, 1 :2), followed by recrystallisation from petroleum 
ether, gave 5.19a (74 mg, 86%) as fine white needles: mp 92 °C; IR (CHCh) 1734, 1676, 
1367,1175 em-I; IHNMR (CDCh, 300 MHz) a 2.75 (t, J= 6.6 Hz, 2H, CH2CO~e), 
3.18 (t, J= 6.6 Hz, 2H, COCH2), 3.70 (s, 3H, CO~e), 3.72 (s, 3H, SO~e), 6.31 (m, IH, 
pyrrole H4), 7.21 (m, IH, pyrrole H3), 7.57 (m, IH, pyrrole H5); 13C NMR (CDCh, 75 
MHz) 027.6,33.6,42.8, 51.6, 110.0, 124.1, 129.6, 132.3, 172.9, 187.6; HRMS calcd for 
ClOH13NOsS 259.0515, found 259.0511. 
Methyl 4;.oxo-4-[1-(phenylsulfonyl)pyrrol-2-yl]butanoate 5.19b 
General procedure B was carried out using the pyrrole 5.18 (60 mg, 0.33 mmol) 
and phenylsulfonyl chloride (51 ~, 0.40 mmol, 1.2 equiv). Flash chromatography on 
silica (ethyl acetate/petroleum ether, 1 :2), followed by recrystallisation from ethyl 
acetate/petroleum ether, gave 5.19b (46 mg, 43%) as fine white crystals: mp 139 - 140 
°C; IR (CHCh) 1734, 1682, 1371, 1175 em-I; IH NMR (CDCh, 300 MHz) a 2.61 (t, J 
6.8 Hz, 2H, CH2C02Me), 3.03 (t, J = 6.8 Hz, 2H, COCH2), 3.61 (s, 3H, CO~e), 6.35 
(m, IH, pyrrole H4), 7.12 (m, IH, pyrrole H3), 7.48 - 7.62 (m, 3H, phenyl Hs), 7.80 (m, 
IH, pyrrole H5), 7.97 (m, 2H, phenyl Hs); 13C NMR (CDCh, 75 MHz) a 27.9,33.8,51.7, 
110.5, 123.6, 128.1, 128.7, 130.2, 132.8, 133.6, 138.8, 142.7; HRMS calcd for 
ClsHlSNOsS 321.0671, found 321.0679. 
Chapter Eight - Experimental 228 
Methyl 4-oxo-4-[1-(3-phenylpropionyl)pyrrol-2-yl]butanoate 5.l9c 
General procedure B was carried out using the pyrrole 5.18 (60 mg, 0.33 mmol) 
and hydrocinnamoyl chloride (59 J,LL, 0.40 mmol, 1.2 equiv). Flash chromatography on 
silica (ethyl acetate/petroleum ether, 1:3) gave 5.19c (86 mg, 82%) as a pale yellow oil: 
IR (CHCh) 1734, 1649 cm-l; lH NMR (CDCh, 300 MHz) 0 2.73 (t, J = 6.6 Hz, 2II, 
CH2C02Me), 3.06 - 3.13 (m, 6H, COCH2 & CH2CH2Ph), 3.62 (s, 3II, CO~e), 6.20 (m, 
1H, pyrrole H4), 7.03 (m, III, pyrrole H3), 7.17 -7.29 (m, 6H, pyrrole H5 & phenyl Hs); 
13C NMR (CDCh, 75 MHz) 0 28.1,31.1,33.9, 39.6, 51.7, 110.6, 122.7, 126.2, 127.6, 
128.3, 128.4, 132.9, 140.0, 173.0, 173.4, 189.2; LRMS (F AB) mlz (reI. intensity) 312 
(16), 182 (100), 181 (86), 150 (96). 
Methyl 4-hydroxy-4-[1-(methanesulfonyl)pyrrol-2-yl]butanoate 5.8a 
The N-mesylpyrrole 5.19a (51 mg, 0.20 mmol) was reduced with sodium 
borohydride by general procedure E. Flash chromatography on silica (ethyl 
acetate/petroleum ether, 1:1) gave 5.8a (44 mg, 85%) as a colourless oil which solidified 
at 0 °c. An analytical sample was obtained by recrystallisation from petroleum ether to 
give white needles: mp 70°C; IR (CHCh) 3580, 1732, 1366, 1178 em-I; IH NMR 
(CDCh, 300 MHz) 0 2.24 (m, 2II, CHOHCH2), 2.57 (m, 2H, CH2C02Me), 2.98 (bs, III, 
Oll), 3.29 (s, 3II, SO,ji1e), 3.70 (s, 3H, CO~e), 5.06 (t, J = 6.6 Hz, III, CHOR), 6.25 
(m, III, pyrrole H4), 6.34 (m, III, pyrrole H3), 7.15 (m, III, pyrrole H5); BC NMR 
(CDCh, 75 MHz) 0 30.2, 30.7, 43.0, 51.8, 64.8, 111.2, 112.2, 123.1, 136.7, 174.2; HRMS 
calcd for ClOHISNOsS 261.0671, found 261.0671. 
Methyl 4-hydroxy-4-[1-(phenylsulfonyl)pyrrol-2-yl]butanoate 5.8b 
The N-phenylsulfonylpyrrole 5.19b (25 mg, 0.08 mmol) was reduced with sodium 
borohydride by general procedure E. Flash chromatography on silica (ethyl 
acetate/petroleum ether, 2:3) gave 5.8b (23 mg, 90%) as a pale purple oil: IR (CHCh) 
3578, 1776, 1732, 1367, 1177 cm-l; IH NMR (CDCb, 300 MHz) 0 2.06 (m, 2H, 
CHOHCH:z), 2.40 (m, 2II, CH2C02Me), 3.59 (s, 3II, CO~e), 4.84 (m, III, CHOR), 6.19 
(m, 1H, pyrrole H4), 6.25 (m, III, pyrrole H3), 7.22 (m, III, pyrrole H5), 7.42 -7.57 (m, 
3II, phenyl Hs), 7.71 (m, 2H, phenyl Hs); BC NMR (CDCb, 75 MHz) 0 30.2, 30.6, 51.6, 
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64.7, 111.9, 112.6, 123.6, 126.5, 129.5, 134.0, 137.6, 139.1, 173.9; HRMS calcd for 
ClsHlSN04S (Nl-H20) 305.0722, found 305.0723. 
Attempted reduction of the N-hydrocinnamoylpyrrole S.19c 
The pyrrole S.19c (33 mg, 0.10 mmol) was reduced with zinc borohydride by 
general procedure D. Flash chromatography on silica (ethyl acetate/petroleum ether, 1:2) 
gave an inseparable mixture of predominantly deacylated starting material S.18 with a 
small amount of the desired product S.8c (S : 2 by IHNMR). Selected IHNMR (CDCh, 
300 MHz) ofS.8c assigned from the mixture, 01.89 (m, 4H), 2.18 (m, 2H), 2.55 (m, 2H), 
4.25 (m, 1B.), 4.84 (m, 1B.), 6.18 (m, 1B.), 7.07 (m, 1H). 
5.18 
n _ ~ 
~ '~/~~'OH 
H 0 
5.20 
QyJN~Me 
~ OH H 
5.9a R = S02Me 
5.9b R = S02Ph 
.. 
4-0xo-4-(lH-pyrrol-2-yl)butanoic acid S.20 
~Nt2Me 
H 0 H 
5.21 
I 
QyJNt2Me 
~ 0 H 
5.22a R = S02Me 
5.22b R = S02Ph 
The pyrrole ester 5.18 (300 mg, 1.66 mmol) was hydrolysed with sodium 
hydroxide by general procedure J to give 5.20 (217 mg, 78%) as a yellow solid: mp 141 
°C (lit. 2S 140 -141°C); IR(CHCh) 3452,1717,1649,1410 em-I; IHNMR (acetone-d6, 
300 MHz) 02.79 (t, J= 6.6 Hz, 2~ CH2C02H), 3.22 (t, J= 6.6 Hz, 2~ COCH2), 6.35 
(m, l~ pyrrole H4), 7.14 (m, lH, pyrrole H3 ), 7.23 (m, 1~ pyrrole ill), 10.99 (bs, 1~ 
NH); 13C NMR (acetone-d6, 75 MHz) 0 27.7, 32.4, 110.0, 115.9, 124.8, 132.0, 173.6, 
188.0; HRMS calcd for CSH9N03 167.0582, found 167.0582. 
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N-[4-0xo-4-(lH-pyrrol-2;.yl)]butanoyl-L-leucine methyl ester 5.21 
The pyrrole acid 5.20 (190 mg, 1.14 mmol) was coupled with L-Ieucine methyl 
ester hydrochloride (227 mg, 1.25 mmol, 1.1 equiv) according to general procedure K. 
Flash chromatography on silica (ethyl acetate/petroleum ether, 1: 1) gave 5.21 (312 mg, 
93%) as a mauve solid. An analytical sample was obtained by recrystallisation from 
ethyl acetate/petroleum ether to give colourless crystals: mp 100 - 101°C; IR (CHCh) 
3450, 3344, 1740, 1672, 1645, 1514 cm-l ; IH NMR (CDCh, 300:-MHz) (5 0.91 (d, J = 5.9 
Hz, 6H, CH.i\de2), 1.51 - 1.67 (m, 3H, CH2CHMe2), 2.68 (m, 2H, CH2CONH), 3.18 (m, 
2H, COCH2), 3.72 (s, 3H, COMe), 4.66 (m, IH, aE), 6.27 (m, III, pyrrole H4), 6.77 (d, 
J= 7.8 Hz, III, CONH), 6.98 (m, III, pyrrole H3), 7.04 (m, III, pyrrole H5), 10.02 (bs, 
III, NH); 13C NMR (CDCh, 75 :-MHz) (5 21.9, 22.7, 24.8, 30.3, 33.0, 41.7, 50.6, 52.2, 
110.6, 116.8, 124.9, 131.4, 172.0, 173.9, 189.2; HRMS calcd for ClsH22N204 294.1580, 
found 294.1582. Anal. Calcd for ClsH22N204: C, 61.21; H, 7.53; N, 9.52. Found: C, 
61.09; II, 7.60; N, 9.46. 
N-{4-0xo-4-[I-(methanesulfonyl)pyrrol-2-yl]}butanoyl-L-leucine methyl ester 5.22a 
General procedure B was carried out using the pyrrole 5.21 (60 mg, 0.20 mmol) 
and methanesulfonyl chloride (23 ~, 0.29 mmol, 1.4 equiv). Flash chromatography on 
silica (ethyl acetate/petroleum ether, 2:1) gave 5.22a (38 mg, 50%) as a white solid. An 
analytical sample was obtained by recrystallisation from ethyl acetate/petroleum ether to 
give a white solid: mp 106 - 107°C; IR (CHCh) 3435, 1740, 1672, 1514, 1367, 1175 
cm-
1; IH NMR (CDCh, 300 :-MHz) (5 0.92 (d, J 5.9 Hz, 3H, CH.i\de2), 0.93 (d, J 6.3 
Hz, 3H, CH.i\de2), 1.51 -1.71 (m, 3H, CH2CHMe2), 2.65 (m, 2H, CH2CONH), 3.22 (m, 
2H, COCH2), 3.71 (s, 3H, COMe), 3.72 (s, 3H, SOMe), 4.61 (m, IH, aE), 6.11 (d, J= 
8.3 Hz, IH, CONH), 6.30 (m, III, pyrrole H4), 7.22 (m, IH, pyrrole H3 ), 7.57 (m, III, 
pyrrole H5); l3C NMR (CDCh, 75 :-MHz) (5 21.9, 22.7, 24.8, 29.9, 34.3, 41.6, 43.1, 50.8, 
52.2, 110.3, 124.5, 129.9, 132.5, 171.5, 173.4, 188.4; HRMS calcd for Cl~24N206S 
372.1355, found 372.1347. 
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N-{4-Hydroxy-4-[I-(methanesulfonyl)pyrrol-2-yl]}butanoyl-L-Ieucine methyl ester 
5.9a 
The N-mesylpyrrole 5.22a (54 mg, 0.14 mmol) was reduced with sodium 
borohydride by general procedure E. Flash chromatography on silica (ethyl 
acetate/petroleum ether, 5:2) gave 5.9a (48 mg, 89%), which was a mixture of 
diastereomers (2 : 1 by IH NMR), as a pink oil: IR (CHCh) 3570, 3433, 3306, 1740, 
1666, 1514, 1366, 1178 cm-I; IHNMR (CDCh, 300 MHz) of major isomer, 0 0.94 (d, J = 
6.3 Hz, 6H, CHMe2), 1.51 - 1.68 (m, 3H, CH2CHMe2), 2.24 (m, 2H, CHOHCH2), 2.51 
(m, 2H, CH2CONH), 3.32 (s, 3H, SO;zMe), 3.74 (s, 3H, CO;zMe), 4.62 (m, Ill, aH), 5.07 
(m, lH, CHOR), 6.21 - 6.25 (m, 2H, CONH & pyrrole H4), 6.34 (m, IH, pyrrole ID), 
7.14 (m, Ill, pyrrole H5); selected IHNMR of minor isomer, 0 3.31 (s, 3H, SO;zMe); 13C 
NMR (CDCh, 75 MHz) of major isomer, 021.9,22.7,24.8, 30.6, 32.9, 41.4, 43.0, 50.8, 
52.3,64.8,111.1,112.1,122.9,137.0,173.1,173.6; selected 13C NMRofminor isomer, 
o 30.7, 33.0,41.5, 50.8,65.1, 173.1, 173.5; HRMS calcd for Cl6li24N20sS (M-H20) 
356.1406, found 356.1407. 
N-{ 4-Hydroxy-4-[I-(phenylsulfonyl)pyrrol-2-yl]} butanoyl-L-Ieucine methyl ester 
5.9b 
General procedure B was carried out using the pyrrole 5.21 (50 mg, 0.17 mmol) 
and phenylsulfonyl chloride (52 J,LL, 0.41 mmol, 2.4 equiv). Flash chromatography on 
silica (ethyl acetate/petroleum ether, 1: 1) gave an inseparable mixture of 5.21 and 5.22b 
(1 : 5 by IH NMR) which was used in the next step without further purification. IH NMR 
(CDCh, 300 MHz) of 5.22b assigned from the mixture, 0 0.88 (m, 6H, CHMe2), 1.42-
1.62 (m, 3H, CH2CHMe2), 2.51 (m, 2H, CH2CONH), 3.07 (m, 2H, COCH2), 3.68 (s,3H, 
CO;zMe), 4.52 (m, IH, aH), 6.03 (d, J 8.3 Hz, Ill, CONH), 6.34 (m, Ill, pyrrole H4), 
7.13 (m, IH, pyrrole H3 ), 7.47 - 7.6I(m, 3H, phenyl Hs), 7.79 (m, Ill, pyrrole H5), 
7.96 (m, 2H, phenyl Hs). 
The above sample of N-phenylsulfonylpyrrole 5.22b (48 mg, 0.11 mmol) was 
reduced with 'sodium borohydride by general procedure E. Flash chromatography on 
silica (ethyl acetate/petroleum ether, 2:1) gave 5.9b (28 mg, 38% overall for both steps), 
which was a mixture of diastereomers (2 : 1 by IH NMR), as a pale purple oil which 
solidified at 0 °C. An analytical sample was obtained by recrystallisation from ethyl 
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acetate/petroleum ether to give colourless crystals: mp 99 - 101 °C; IR (CHCh) 3568, 
3433,3317,1740,1670,1514, 1367, 1177 cm-I; IHN1v1R (CDCh, 300 MHz) of major 
isomer, 8 0.94 (d, J= 5.9 Hz, 6II, CHAle2), 1.51 - 1.67 (m, 3H, CH2CHM~), 2.15 (m, 
2H, CHOHCH2), 2.42 (m, 2H, CH2CONH), 3.75 (s, 3H, COzN[e), 4.63 (m, Ill, aH), 4.96 
(m, Ill, CHOH), 6.10 (d, J= 7.3 Hz, Ill, CONH), 6.25 (m, Ill, pyrrole H4), 6.33 (m, 
Ill, pyrrole H3), 7.26 (m, IH, pyrrole H5), 7.48 -7.63 (m, 3H, phenyl Hs), 7.78 (m, 2H, 
phenyl Hs); selected IH N1v1R of minor isomer, 8 3.73 (s, 3II, COzN[e); I3C N1v1R 
(CDCh, 75 MHz) of major isomer, 821.9, 22.7, 24.8, 31.0, 32.9, 41.6, 50.8, 52.3, 65.3, 
112.0, 112.7, 123.4, 126.5, 129.5, 134.0, 138.0, 139.1, 172.9, 173.5; selected 13C N1v1R of 
minor isomer, 8 31.0, 65.4, 126.5; HRMS calcd for C21H26N20SS (M-H20) 418.1562, 
found 418.1557. Anal. Calcd for C2IH2SN206S: C, 57.78; H, 6.47; N, 6.42. Found: C, 
57.86; II, 6.25; N, 6.51. 
8.5.2.3. Preparation of peptidomimetics of type 5.10 
o N 
H 
n 
--" OHCAN~C02Et 
H 
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AJ-Jtt OHC N N C02Me 
H H 
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AJ-Jt t -" HOJ.V t OHC N N C02Me N N C02Me 
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5.27b R = S02Me 5.10b R = S02Me 
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Ethyl 2-(lH-pyrrol-2-yl)ethanoate 5.23 
Ethylmagnesium bromide (20.0 mL of 3.9 M solution in ether, 78.4 mmol, 3.3 
equiv) was added to a stirred solution ofpyrrole (5.57 g, 83.1 mmol, 3.5 equiv) in THF 
(125 mL) cooled in an ice-sodium chloride bath (-10°C bath temperature) under N2. The 
resulting suspension was stirred at -10°C for 30 min and then at rt for a further 30 min. 
The reaction temperature was re-cooled to -10°C and ethyl bromoacetate (2.63 mL,23.7 
mmol) was added rapidly (small exotherm). The cooling bath was removed and the 
reaction mixture was stirred at rt for 2 h. Ether and excess saturated aqueous ammonium 
chloride were added. The organic phase was separated, washed with saturated aqueous 
ammonium chloride, dried and evaporated under reduced pressure. The residual oil was 
fractionally distilled in vacuo using a short path distillation head, to give first recovered 
pyrrole, followed by 5.23 (2.20 g, 61%) as a pale yellow oil: IR (CHCh) 3470, 1728 
cm-
I; IH NMR (CDCh, 300 MHz) 0 1.24 (t, J = 7.3 Hz, 3H, C02CH2CH3), 3.61 (s, 2H, 
CH2C02), 4.14 (q, 7.3 Hz, 2H, C02CH2CH3), 5.99 (m, IH, pyrrole H4), 6.10 (m, IH, 
pyrrole H3), 6.66 (m, IH, pyrrole H5), 8.79 (bs, IH, NH); 13C NMR (CDCh, 75 MHz) 0 
13.9,33.0,60.8,107.0,107.9,117.5,123.1, 171.1; HRMS calcd for CsHllN02 153.0790, 
found 153.0788. 
EthyI2-(5-formyl-lH-pyrrol-2-yl)ethanoate 5.24 
General procedure A was carried out using pyrrole 5.23 (2.19 g, 14.3 mmol) and 
the resulting oil was distilled at reduced pressure to give 5.24 (1.45 g, 56%) as a pale 
orange solid. An analytical sample was obtained by sublimation under reduced pressure 
to give a white crystalline solid: mp 73 - 75°C; IR (CHCh) 3433, 1732, 1651 cm-l ; IH 
NMR (CDCh, 300 MHz) 0 1.29 (t, J= 7.3 Hz, 3H, C02CH2CH3), 3.72 (s, 2H, CH2C02), 
4.22 (q, J= 7.3 Hz, 2H, C02CH2CH3), 6.18 (m, IH, pyrrole H3), 6.90 (m, IH, pyrrole 
H4), 9.45 (s, IH, CHO), 9.88 (bs, IH, NH); l3C NMR (CDCh, 75 MHz) 0 14.0, 33.4, 
61.4, 111.0, 122.2, 132.6, 133.8, 169.6, 178.7; HRMS calcd for C9HllN03 181.0739, 
found 181.0738. Anal. Calcd for C9HllN03: C, 59.66; H, 6.12; N, 7.73. Found: C, 59.89; 
H, 5.99, N, 7.71. 
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2-(5-Formyl-lH-pyrrol-2-yl)ethanoic acid 5.25 
The pyrrole ester 5.24 (300 mg, 1.66 mmol) was hydrolysed with sodium 
hydroxide by general procedure Jto give 5.25 (213 mg, 84%) as a yellow solid: mp 123 
- 124°C; IR (CHCh) 3433, 3263, 1726, 1651 cm"l; IH NMR (acetone-d6, 300 MHz) 0 
3.86 (s, 2H, CHzCOz), 6.33 (dd, J = 3.4 & 2.4 Hz, 1H, pyrrole H3), 7.08 (dd, J 3.4 & 
2.4 Hz" 1H, pyrrole H4), 9.43 (s, 1H,CHO), 11.49 (bs, 1H, NH); 13C NMR (acetone-dt;, 
75 MHz) 0 33.0, 111.2, 122.6, 132.4, 135.3, 171.9, 179.3; HRMS calcd for C7H7N03 
153.0426, found 153.0427. 
N-[2-(5-Formyl-lH-pyrrol-2-yl)]ethanoyl-L-leucine methyl ester 5.26 
The pyrrole acid 5.25 (210 mg, 1.37 mmol) was coupled with L-Ieucine methyl 
ester hydrochloride (274 mg, 1.51 mmol, 1.1 equiv) according to general procedure L. 
Flash chromatography on silica (ethyl acetate/petroleum ether, 2:1) gave 5.26 (326 mg, 
85%) as a pale orange solid: mp 54°C; IR (CHCh) 3422,3298, 1744, 1676, 1653, 1518, 
1491 cm"\ IHNMR (CDCh, 300 MHz) 0 0.88 (d, J= 5.9 Hz, 6H, CRMez), 1.48 1.64 
(m, 3H, CHzCHMez), 3.69 (s, 2H, CHzCOz), 3.72 (s, 3H, CO:Me), 4.63 (m, 1H, aH), 
6.24 (dd, J= 3.9 & 2.4 Hz, 1H, pyrrole H3), 6.79 (d, J= 7.8 Hz, 1H, CONH), 6.95 (dd, J 
= 3.9 & 2.4 Hz, 1H, pyrrole H4), 9.38 (s, 1H, CHO), 10.89 (bs, 1H, NH); 13C NMR 
(CDCh, 75 MHz) 0 21.6, 22.5, 24.7, 35.4, 40.9, 50.9, 52.2, 111.2, 122.9, 132.4, 135.5, 
168.8, 173.6, 178.7; HRMS calcd for Cl~zoNz04 280.1423, found 280.1430; AnaL 
Calcd for Cl~zoNz04: C, 59.99; H, 7.19; N, 9.99. Found: C, 60.16; H, 7.20; N, 9.84. 
The pyrrole acid 5.25 (120 mg, 0.78 mmol) was also coupled with L-Ieucine 
methyl ester hydrochloride (142 mg, 0.78 mmol, 1 equiv) according to general procedure 
K. Flash chromatography on silica (ethyl acetate/petroleum ether, 1:1) gave 5.26 (178 
mg, 81%) as a pale orange solid. Spectral data as recorded above. 
N-{2-[5-Formyl-l-(3-phenylpropionyl)pyrrol-2-yl]} ethanoyl-L-Ieucine methyl ester 
5.27a 
A solution of pyrrole 5.26 (60 mg, 0.21 mmol), DMAP (3 mg, 0.02 mmol, 0.1 
equiv) and HOnig's base (41 ~, 0.24 mmol, 1.1 equiv) in dichloromethane (8 mL) was 
cooled in an ice-sodium chloride bath (-10 °C bath temperature) under Nz and 
hydrocinnamoyl chloride (35 ~, 0.24 mmol, 1.1 equiv), dissolved in dichloromethane (2 
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mL), was added. The resultant mixture was stirred at -10°C for 30 min and then at rt for 
24 h, before being worked up by the method described in general procedure C. Flash 
chromatography on silica (ethyl acetate/petroleum ether, 1:2) gave 5.27a (72 mg, 81%) as 
a yellow solid. An analytical sample was obtained by recrystallisation from petroleum 
ether to give small white crystals: mp 71°C; IR (CHCb) 3427, 1740, 1666 em-I; IH 
NMR (CDCb, 300:MHz) 0 0.90 (d, J= 5.9 Hz, 3H, CHMe2), 0.91 (d, J= 5.9 Hz, 3H, 
C.H:A4e2), 1.50 - 1.66 (m, 3H, CH2CHMe2), 3.07 (m, 2H, CH2Ph), 3.24 (m, 2H, COCH2), 
3.56 (ABq, J= 16.1 Hz, 1H, CH2CO), 3.62 (ABq, J= 16.1 Hz, 1H, CH2CO), 3.70 (s, 3H, 
COMe), 4.56 (m, 1H, aH), 6.27 (d, J = 3.9 Hz, 1H, pyrrole H3), 6.42 (d, J = 7.8 Hz, 1H, 
CONH), 7.04 (d, J = 3.9 Hz, 1H, pyrrole H4), 7.16 - 7.29 (m, 5H, phenyl Hs), 9.49 (s, 
1H, CHO); l3C NMR (CDCb, 75 MHz) 0 21.9, 22.7, 24.8, 31.1, 35.2, 41.4, 41.7, 51.0, 
52.3, 113.2, 126.3, 127.4, 128.3, 128.5, 133.7, 137.6, 139.9, 167.8, 173.1, 176.7, 178.1; 
HRMS calcd for C23H28N20s 412.1998, found 412.1995. 
N-{2-[5-Formyl-l-(methanesulfonyl)pyrrol-2-yl]}ethanoyl-L-leucine methyl ester 
5.27b 
The modified general procedure B was carried out using pyrrole 5.26 (50 mg, 
0.18 mmol) and methanesulfonyl chloride (17 ~, 0.21 mmol, 1.2 equiv). Flash 
chromatography on silica (ethyl acetate/petroleum ether, 1:1) gave 5.27b (45 mg, 70%) 
as a pale yellow oil: IR (CHCb) 3429, 3327, 1740, 1684, 1518, 1491, 1369, 1180 cm-\ 
IH NMR (CDCh, 300 :MHz) 0 0.95 (d, J = 6.3 Hz, 6H, CHMe2), 1.53 - 1.80 (m, 3H, 
CH2CHMe2), 3.65 (s, 3H, SOMe), 3.74 (s, 3H, COMe), 3.93 (ABq, J = 16.6 Hz, 1H, 
CH2CO), 4.00 (ABq, J = 16.6 Hz, 1H, CH2CO), 4.64 (m, 1H, aH), 6.19 (d, J = 8.3 Hz, 
1H, CONH), 6.25 (d, J 3.9 Hz, 1H, pyrrole H3), 7.12 (d, J 3.9 Hz, 1H, pyrrole H4), 
9.70 (s, 1H, CHO); 13C NMR (CDCh, 75:MHz) 021.8,22.8, 24.6,36.2,41.6,42.4, 50.9, 
52.4, 115.1, 126.7, 135.4, 138.6, 168.6, 173.3, 178.2; HRMS calcd for ClsH22N206S 
358.1199, found 358.1190. 
An analogous reaction using the pyrrole 5.26 (typically 60 mg, 0.21 mmol) and 
, 
either phenyl sulfonyl chloride, ~-trans-styrenesulfonyl chloride or 2-
phenylethanesulfonyl chloride proved unsuccessfuL IH NMR spectra of the crude 
reaction work ups did not indicate the presence of any of the desired N-substituted 
products. 
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N-{2-[S-Hydroxymethyl-l-(3-phenylpropionyl)pyrrol-2-yl]}ethanoyl-L-leucine 
methyl ester 5.10a 
236 
The N-hydrocinnamoylpyrrole 5.27a (25 mg, 0.06 mmol) was reduced with zinc 
borohydride by general procedure D. Flash chromatography on silica (ethyl 
acetate/petroleum ether, 1:1) gave 5.10a (11 mg, 44%) as an unstable orange oil which 
slowly decomposed at 0 °C. IH NMR showed the compound to be ca. 90% pure: IR 
(CHCh) 1738, 1674, 1514 cm,l; IHNMR (CDCh, 300 MHz) 0 0.89 (d, J= 5.9 Hz, 6H, 
C.Hi\£e2), 1.44 - 1.62 (m, 3H, CH2CHMe2), 3.01 - 3.10 (m, 3ll, OH & CH2Ph), 3.30 (m, 
2ll, COCH2), 3.68 (s, 3ll, CO:zi\1e), 3.74 (s, 2ll, CH2CO), 4.54 - 4.62 (m, 3ll, CH20H & 
alI), 6.03 (d, J= 7.8 Hz, Ill, CONH), 6.12 (d, J= 3.4 Hz, Ill, pyrrole H), 6.18 (d, J= 
3.4 Hz, IH, pyrrole H), 7.18 - 7.32 (m, 5ll, phenyl Hs); 13C NMR (CDCh, 75 MHz) 0 
21.8, 22.7,24.8,30.6, 37.8,39.1,41.2,50.8, 52.3, 58.5, 113.8, 114.9, 126.4, 128.3, 128.4, 
128.5, l36.0, 140.0, 169.3, 173.2, 174.5; HRMS (FAB) calcd for C23liJIN20S (MH) 
415.2233, found 415.2230. 
N-{2-[S-Hydroxymethyl-l-( methanesulfonyl)pyrrol-2-yl]} ethanoyl-L-leucine methyl 
ester 5.10b 
The N-mesylpyrrole 5.27b (35 mg, 0.10 mmol) was reduced with zinc 
borohydride by general procedure D. Flash chromatography on silica (ethyl 
acetate/petroleum ether, 2:1) gave 5.10b (29 mg, 83%) as an orange solid. An analytical 
sample was obtained by recrystallisation from methanol to give thin colourless needles: 
mp 150 - 151°C; IR (CHCh) 1740, 1676, l364, 1169 cm'\ IH NMR (CD30D, 300 
:MHz) 0 0.94 (m, 6H, CHMe2), 1.55 - 1.81 (m, 3H, CH2CHM~), 3.40 (s, 3ll, SOzA{e), 
3.70 (s, 3ll, CO:zi\1e), 3.80 (ABq, J= 17.1 Hz, Ill, CH2CO), 3.89 (ABq, J= 17.1 Hz, Ill, 
CH2CO), 4.47 (m, 1H, alI), 4.67 (ABq, J 13.2 Hz, Ill, CH20H), 4.74 (ABq, J= l3.2 
Hz, 1H, CH20H), 6.09 (d, J = 3.4 Hz, Ill, pyrrole H3), 6.22 (d, J = 3.4 Hz, Ill, pyrrole 
H4), 8.30 (d, J= 7.8 Hz, Ill, CONH); 13C NMR (CD30D, 75 :MHz) 0 22.1, 23.6, 26.1, 
36.7,41.8,42.8,52.6,53.0,58.4,114.7,115.1, l32.3, 137.5,173.2,175.1; HRMS calcd 
for CIsH24N206S 360.l355, found 360.l366. AnaL Calcd for CIsH24N206S: C, 49.99; ll, 
6.71; N, 7.77. Found: C, 49.70; H, 6.93; N, 7.50. 
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8.5.2.4. Attempted preparation of peptidomimetics of type 5.11 
11\ ~ ~ 
'N/y~'oMe 
H 0 
11\ ~ R 
OHC' 'N' y~ 'OMe 
H CI 
5.18 5.30 
Methyl (Z)-4-chloro-4-(5-formyl-1H-pyrrol-2-yl)-3-butenoate 5.30 
General procedure A was carried out using pyrrole 5.18 (1.00 g, 5.52 mmol). 
Distillation of the residue at reduced pressure followed by flash chromatography on silica 
(ethyl acetate/petroleum ether, 1 :3) and recrystallisation from petroleum ether gave 5.30 
(168 mg, 13%) as white needles: mp 80 "C; IR (CHCh) 3433, 1738, 1651 em-I; IHNMR 
(CDCh, 300 MHz) 0 3.47 (d, J= 6.8 Hz, 2II, CHCH2), 3.75 (s, 3II, CO~e), 6.57 (m, 
III, pyrrole H3), 6.67 (t, J = 6.8 Hz, III, CHCH2), 6.94(m, III, pyrrole H4), 9.52 (s, III, 
CHO), 10.29 (bs, III, NH); 13C NMR (CDCh, 75 MHz) 0 34.3, 52.2, 110.4, 119.9, 121.8, 
125.5, 133.0, 136.1, 170.7, 179.3; HRM:S calcd for CloHlOClN03 227.0349, found 
227.0347. 
U N CHO 
H 
x " 11\ ~ ~ OHC ....... "'N/y~'oMe 
H 0 
2.22a 5.28 
5,10-Bisdimethylamino-5H,1 OH-dipyrrolo [1,2-a: l' ,2' -d]pyrazine 5.31 
A solution of pyrrole-2-carboxaldehyde 2.22a (4.00g, 42.1 mmol) in 40% 
aqueous dimethylamine (20 mL) was stirred at rt for 3Y2 h and then diluted with an equal 
volume of water. The solid was collected by filtration, washed successively with 1 M 
aqueous sodium hydroxide and ethyl acetate, then dried under high vacuum (oil pump) to 
give 5.31 (3.91 g, 76%) as a white solid: mp 110 - 111 °C (lit.29 113°C); IR (CHCh) 
1655, 1308 cm-\ IH NMR (CDCh, 300 MHz) 0 2.21 (s, 12II, NMe2), 5.87 (s, 2II, H-
5,10),6.17 (m, 2II, H-l,6), 6.26 (m, 2II, H-2,7), 6.95 (m, 2H, H-3,8); 13C NMR (CDCh, 
75 MHz) 0 39.1, 71.9, 105.5, 108.3, 119.5, 125.3; HRMS calcd for ClJi20N4 244.1688, 
found 244.1689. 
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Attempted preparation of the acylpyrrole 5.28 by anion chemistry 
Methyl succinyl chloride (343 JJL, 2.79 mmol) and N,O-dimethylhydroxylamine 
hydrochloride (299 mg, 3.07 mmol, 1.1 equiv) were dissolved in dichloromethane (10 
mL) at rt under N2. The mixture was cooled to 0 °C and pyridine (496 JJL, 6.14 mmol, 
2.2 equiv) was added. The resulting mixture was then stirred at rt for 1 h. The solution 
was diluted with saturated aqueous ammonium chloride (10 mL) and ether (15 mL) was 
added. The organic phase was separated, washed with saturated aqueous sodium 
hydrogencarbonate (10 mL), saturated aqueous ammonium chloride (10 mL), saturated 
aqueous brine (10 mL), dried and evaporated to give 3-carbomethoxypropionyl-N-
methoxy-N-methylamide (441 mg, 90%) as a yellow oil which was used in the next step 
without purification. lH NMR (CDCb, 300 MHz) 0 2.65 (m, 2H), 2.77 (m, 2H), 3.19 
(s,3H), 3.70 (s,3H), 3.73 (s, 3H). 
The azafulvene dimer 5.31 (200 mg, 0.82 mmol) was dissolved in TIiF (10 mL) 
under N2 at -15°C and tert-butyllithium (1.36 mL of 1.5 M solution in pentane, 2.05 
mmol, 2.5 equiv.) was added over 2 min. The resulting solution was stirred at -15°C for 
15 min and then at 0 °C for 30 min to give a deep violet solution. The reaction mixture 
was cooled to -78°C and 3-carbomethoxypropionyl-N-methoxy-N-methylamide (430 
mg, 2.46 mmol, 3 equiv) dissolved in THF (2 mL) was added. The resulting mixture was 
stirred at -78°C for 1 h and then at rt for 2 h. A solution of sodium acetate (302 mg, 3.68 
mmol, 4.5 equiv) in water (10 mL) was added and the mixture was heated at reflux for 4 
h. The reaction mixture was then poured into dilute aqueous sodium hydrogencarbonate, 
and extracted with dichloromethane (3xl0 mL). The combined organic extracts were 
washed with saturated aqueous brine (10 mL), dried and evaporated under reduced 
pressure. Flash chromatography of the resulting oil on silica (ethyl acetate/petroleum 
ether, 1:2) gave only the hydrolysed starting material2.22a (106 mg, 68%). 
Chapter Eight - Experimental 
n OHC N Br 
-H 
5.32 
n OHC N SnBu3 
H 
5.37 
n OHC N Br-
.. 
~O 
~SiMe3 
5.33 
5.28 
5-Bromo-lH-pyrrole-2-carboxaldehyde 5.32 
n OHC N R 
~O 
~SiMe3 
5.34 R = SnBu3 
5.35 R = H 
1 
JT\ _ ~ 
OHC ..... ·'~/y ..................... OMe 
~ 0 
o 
~SjMe3 
5.36 
239 
5-Bromo-1H-pyrrole-2-carboxaldehyde 5.32 was prepared by the indirect method 
described by Bray and Muchowski.30 Spectral data was consistent with that reported by 
Bray and Muchowski: mp 92 - 94°C (lit.30 mp 94 - 96°C); IR (CS2) 3427, 3215, 1665, 
1655 em-I; IH NMR (CDCh, 300 MHz) 6 6.33 (dd, J = 3.9 & 2.4 Hz, HI, pyrrole H4), 
6.94 (dd, J= 3.9 & 2.4 Hz, HI, pyrrole H3), 9.37 (s, 1H, CHO), 11.17 (bs, 1H, NH); 13C 
NMR(CDCh, 75 MHz) 6 112.1, 113.8,123.3,133.7,178.3; HRMS calcd for CsHiBrNO 
172.9476, found 172.9479. 
5-Bromo-l-[2-( trimethylsilyl)ethoxymethyl]pyrrole-2-carboxaldehyde 5.33 
The modified general procedure B was carried out with the bromopyrrole 5.32 
(288 mg, 1.66 mmol) and 2-(trimethylsilyl)ethoxymethyl chloride (322 ~, 1.82 mmol, 
1.1 equiv) using DMF as the solvent. The mixture was then poured into ice-cold 10% 
aqueous sodium hydrogencarbonate solution (10 mL), and the product was extracted into 
ether (3x10 mL). The combined ethereal phases were washed with saturated aqueous 
brine (10 mL), dried and evaporated under reduced pressure. Flash chromatography on 
silica (ethyl acetate/petroleum ether, 1:10) gave 5.33 as a pale yellow oil (447 mg, 89%): 
IR (CS2) 1670, 1099 em-I; IH NMR (CDCh, 300 MHz) 6 -0.07 (s, 9H, SiMe3), 0.87 (t, J 
= 8.1 Hz, 2H, CH2Si), 3.56 (t, J= 8.1 Hz, 2H, OCH2CH2), 5.77 (s, 2H, CH20), 6.35 (m, 
1H, pyrrole H4), 6.92 (m, 1H, pyrrole H3), 9.40 (s, 1H, CHO); 13C NMR (CDCh, 75 
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MHz) B -1.5, 17.8, 66.0, 74.2, 110.6, 113.8, 116.7, 125.4, 178.2; HRMS calcd for 
CllHlSBrN02Si 303.0290, found 303.0293. 
5-(tri-n-Butylstannyl)-1-[2-(trimethylsilyl)ethoxymethyl]pyrrole-2-carboxaldehyde 
5.34 
To a solution of morpho line (69 jlL, 0.80 mmol, 1. 1 equiv) in TIIF(6 mL) at -78 
°C under N2 was added n-butyllithium (497 jlL of 1.6 M solution in hexane, 0.80 mmol, 
1. 1 equiv). After stirring for 20 min, 5.33 (220 mg, 0.72 mmol) dissolved in TIIF (2 mL) 
was slowly added. After stirring for another 20 min, tert-butyl lithium (936 jlL of 1.7 M 
solution in pentane, 1.59 mmol, 2.2 equiv) was added dropwise. Stirring was continued 
at -78°C for a further 15 min before tri-n-butylstannyl chloride (216 jlL, 0.80 mmo], 1. 1 
equiv) was added. The reaction temperature was left to waim to rt during 1 h, and was 
stirred at rt for 30 min. The solution was then poured into water and was extracted with 
ether (3xlO mL). The combined ethereal phase was washed with saturated aqueous brine 
(10 mL), dried and evaporated under reduced pressure. Flash chromatography on silica 
(ethyl acetate/petroleum ether, 1:20) gave two compounds. The first to elute was 5.34 
(222 mg, 60%) as a pale yellow oil: IR (CHCb) 1655, 1088 cm- l ; IHNMR (CDCh, 300 
MHz) B -0.04 (s, 9H, SiMe3), 0.86 - 1.63 (m, 29H, SnBU3 & CH2Si), 3.47 (m, 2H, 
OCH2CH2), 5.74 (s, 2H, CH20), 6.37 (m, 1H, pyrrole H4), 6.97 (m, 1H, pyrrole ID), 
13 . 9.53 (s, 1H, CHO); C NMR (CDCb, 75 MHz) B -1.5, 10.4, 13.6, 17.8,27.3,29.0,65.3, 
76.3, 121.2, 125.9, 135.7, 148.8, 178.4; HRMS calcd for C19H36N02SiSn (M-Bu) 
458.1537, found 458.1541. The second compound to elute was the debrominated starting 
material 5.35 (41 mg, 25%) as a colourless oil: IR (CHCb) 1665, 1081 cm-l ; IH NMR 
(CDCb, 300 MHz) B -0.06 (s, 9H, SiMe3), 0.88 (t, J = 8.3 Hz, 2H, CH2Si), 3.52 (t, J = 
8.3 Hz, 2H, OCH2CH2), 5.69 (s, 2H, CH20), 6.28 (m, 1H, pyrrole H4), 6.96 (m, 1H, 
pyrrole H3), 7.13 (m, 1H, pyrrole H5), 9.57 (s, 1H, CHO); 13C NMR (CDCb, 75 MHz) B 
-1.5, 17.8, 66.1, 76.5, 110.6, 110.5, 125.2, 131.0, 131.8, 179.6; HRMS calcd for 
CUH19N02Si 225.1185, found 225.1180. 
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Methyl 4-oxo-4-{5-formyl-l-[2-( trimethylsilyl)ethoxymethyl] pyrrol-2-yl} butanoate 
5.36 
The stannylpyrrole 5.34 (215 mg, 0.42 mmol) was coupled with methyl succinyl 
chloride (51 J,.LL, 0.42 mmol, 1 equiv) according to general procedure M with the 
exception that the resulting residue was not treated with potassium fluoride. Flash 
chromatography on silica (ethyl acetate/petroleum ether, 1:4) gave 5.36 (l05 mg, 74%) as 
an orange oil: IR (CHCb) 1734, 1692, 1666 ern-I; IH NMR (CDCb, 300 MHz) 0 -0.10 
(s,9H, SiMe3), 0.83 (~J= 7.8 Hz, 2H, CH2Si), 2.70 (t, J= 6.8 Hz, 2H, CH2CO~e), 3.20 
(~J= 6.8 Hz, 2H, COCH2), 3.50 (t, J= 7.8 Hz, 2H, OCH2CH2), 3.67 (s, 3H, CO~e), 
6.12 (s, 2H, CH20), 6.95 (d, J= 4.4 Hz, 1H, pyrrole H3), 7.04 (d, J= 4.4 Hz, 1H, pyrrole 
H4), 9.83 (s, HI, CHO); 13C NMR (CDCb, 75 MHz) 0 -1.6, 17.8,27.7,35.1, 51.8,66.0, 
73.9, 118.4, 121.7, 135.2, 136.0, 173.0, 181.6, 190.8; HRMS calcd for CIJI2INOsSi (M-
C2H4) 311.1189, found 311.1188. 
5-(tri-n-Butylstannyl)-lH-pyrrole-2-carboxaldehyde 5.37 
To a stirred solution of the azafulvene dimer 5.31 (1.00 g, 4.09 mrnol) in TRF (50 
mL) cooled to -15°C was added dropwise tert-butyllithium (5.30 mL of 1.7 M solution 
in pentane, 9.00 mmol, 2.2 equiv). The resulting mixture was stirred for 15 min at -15 
°c and then for 30 min at 0 °c. The violet solution formed was cooled to -78°C and tri-
n-butylstannyl chloride (2.44 mL, 9.00 mmol, 2.2 equiv) was slowly added. The reaction 
mixture was then stirred for 3 hat rt, before being hydrolysed with excess 0.4 M aqueous 
sodium acetate solution. The resulting mixture was extracted with dichloromethane, 
dried and concentrated under reduced pressure. The residue was dissolved in TRF (30 
mL) and a solution of sodium acetate (1.01 g, 12.28 mmol, 3 equiv) in water (30 mL) was 
added, and the resultant mixture was stirred at reflux temperature for 5 days. After 
cooling to rt the reaction mixture was extracted with dichloromethane (3x30 mL), and the 
combined organic phase was washed with water (2x50 mL), saturated aqueous brine (50 
mL), dried and evaporated under reduced pressure. Flash chromatography on silica 
(petroleum ether to ethyl acetate/petroleum ether, 1:10) gave 5.37 (1.18 g, 37% for 2 
steps) as a pale yellow oil: IR (CHCh) 3445, 3285, 1645 em-I; IH NMR (CDCh, 300 
MHz) 0 0.86 - 1.63 (m, 27H, SnBU3), 6.42 (dd, J = 3.9 & 2.4 Hz, HI, pyrrole H4), 7.04 
(dd, J= 3.9 & 2.4 Hz, 1H, pyrroleH3), 9.49 (s, 1H, CHO), 10.03 (bs, 1H, NH); l3c NMR 
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(CDCh, 75 :MHz) 0 10.0, 13.6, 27.2, 28.9, 121.0, 121.7, 136.6, 142.4, 178.0; FIRMS 
calcd for C13H22NOSn (M-Bu) 328.0723, found 328.0727. 
Methyl 4-oxo-4-(5-formyl-lH-pyrrol-2-yl)butanoate 5.28 
Method A: To a stirred solution of 5.36 (23 mg, 0.07 mmol) in dichloromethane (2 mL) 
cooled to 0 °C was slowly added boron trifluoride diethyl etherate (43 llL. 0.34 mmol, 5 
equiv). The solution was left to come to rt after which time stirring was continued for 20 
min. The reaction mixture was poured into dichloromethane (10 mL), washed with water 
(10 mL), saturated aqueous brine (1OmL), dried and evaporated under reduced pressure. 
The resulting residue was dissolved in dichloromethane (2 mL) and a solution of sodium 
acetate (56 mg, 0.68 mmol, 10 equiv) in water (1 mL) was added. The stirred mixture 
was heated at reflux for 1 h and then worked up as described above. Flash 
chromatography on silica (ethyl acetate/petroleum ether, 1:2) gave 5.28 (11 mg, 75%) as 
a white solid. An analytical sample was obtained by recrystallisation from ethyl 
acetate/petroleum ether to give colourless crystals: mp 102 104°C; IR (CHCh) 3422, 
1736, 1682, 1665 cm-\ lH NMR (CDCh, 300 :MHz) 0 2.78 (1, J = 6.8 Hz, 2H, 
CH2CQiMe), 3.21 (t, J = 6.8 Hz, 2H, COCH2), 3.70 (s, 3H, CO:v\1e), 6.97 (m, 2H, 
pyrrole H3 & pyrrole H4), 9.73 (s, III, CHO), 10.12 (bs, III, NIl); 13C NMR (CDCh, 75 
:MHz) 0 27.6, 33.3, 51.9, 115.5, 119.5, 134.8, 134.9, 173.0, 180.8, 189.8; HRMS calcd 
for ClOHUN04 209.0688, found 209.0685. Anal. Calcd for CloHuN04: C, 57.41; II, 5.30; 
N, 6.70. Found: C, 57.38; II, 5.17; N, 6.68. 
Method B: The stannylpyrrole 5.37 (150 mg, 0.39 mmol) was coupled with methyl 
succinyl chloride (48 llL, 0.39 mmol, 1 equiv) according to general procedure M. Flash 
chromatography on silica (ethyl acetate/petroleum ether, 1:2) gave 5.28 (64 mg, 78%) as 
a white solid. Spectral data as recorded above. 
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Attempted N-acylation of pyrrole 5.28 using general procedure B: Azafulvene dimer 
formation 
n ~ ~ 
OHC ....... 'tj'Y ............... 'OMe 
H 0 
5.28 
5.39 
.. 
5,38 
.. 
3,8-Bis(3-carbomethoxy-l-oxopropyl)-S,1 O-bisacetyloxy-SH,l OH-
dipyrrolo[I,2-a: l' ,2'-d]pyrazine 5.38 
General procedure B was carried out using pyrrole 5.28 (20 mg, 0.10 mmol) and 
acetyl chloride (8 J,J.L, 0.11 mmol, 1.2 equiv). Flash chromatography on silica (ethyl 
acetate/petroleum ether, 1:1) gave 5.38 (21 mg, 89%) as a pale yellow solid. An 
analytical sample was recrystallised from ethyl acetate/petroleum ether to give colourless 
crystals: mp 152 - 153°C; IR (CHCh) 1738, 1666, 1121 cm-1; lH NMR (CDCh, 300 
1vfHz) 15 2.06 (s, 6H, COMe), 2.74 (t, 6.8 Hz, 4H, CH2C02Me), 3.17 (m, 4H, COCH2), 
3.69 (s, 6H, COzMe), 6.65 (d, J= 4.4 Hz, 2H, H-1,6), 7.11 (d, J 4.4 Hz, 2H, H-2,7), 
8.41 (s, 2H, H-5,10); 13C NMR (CDCh, 75 1vfHz) 15 20.8, 27.7, 33.6, 51.8, 71.6, 111.7, 
119.9, 129.6, 131.9, 169.4, 173.1, 188.9; HRMS (FAB) calcd for C22H23N20 g (MH-
AcOH) 443.1454, found 443.1453. 
3,8-Bis(3-carbomethoxy-l-oxopropyl)-5H,1 OH-dipyrrolo [1,2-a: l' ,2' -d]pyrazine 5.39 
The azafulvene dimer 5.38 (20 mg, 0.04 mmol) was dissolved in ether (10 mL) at 
o °C under N2. Zinc borohydride (284 J,J.L of 0.14 M solution in ether, 0.04 mmol, 1 
equiv.) and trimethylsilyl chloride (11 J,J.L, 0.09 mmol, 2.2 equiv.) were added and the 
resultant solution was stirred at 0 °C for 2 h. Water (2 mL) and then 10% aqueous glacial 
acetic acid (2 mL) were carefully added to quench the reaction. The separated aqueous 
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phase was extracted with dichloromethane (2x10 mL) and the combined organic phase 
was washed with water (2x10 mL), saturated aqueous brine (10 mL), dried and 
evaporated under reduced pressure. Flash chromatography on silica (ethyl 
acetate/petroleum ether, 1:2) gave 5.39 (2 mg, 16%) as a white solid: mp 165°C; IR 
(CHCh) 1734, 1649 em-I; IH NMR (CDCh, 300 MHz) 0 2.72 (t, J 6.8 Hz, 4H, 
CH2C02Me), 3.16 (t, J = 6.8 Hz, 4H, COCH2), 3.71 (s, 6H, CO:zM"e), 5.67 (s, 4H, H-
5,10),6.15 (d, J= 3.9 Hz, 2H, H-l,6), 7.09 (d, J= 3.9 Hz, 2H, H-2,7); l3C NMR (CDCh, 
75 MHz) 0 28.2,33.3,43.5,51.8, 105.8, 119.7, 129.0, 132.4, 173.5, 188.5; fIRMS (FAB) 
calcd for C2oH23N206 (MH) 387.1556, found 387.1568. 
8.5.2.5. Attempted preparation of peptidomimetics of type 5.12 
o N 
H 
~ N COCCI3 
H 
5.42 
OHC 
n N C02Et 
H 
5.45 
5.48a R1 = H, R2 = Et 
5.48b R 1 = CH2CHMe2. R2 = Me 
5.48c R 1 = CH2Ph. R2 = Me 
5.44 
~ 
n OHC N C02H 
H 
5.46 
HO fl ~ CO R2 
............. '~/n y 2 
~ 0 R1 
5.12 
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2-(Trichloroacetyl)-lH-pyrrole 5.42 
To a solution of trichloroacetyl chloride (7.32 mL, 66 mmol, 1.1 equiv) in ether 
(10 mL) was added a solution of pyrrole (4.14 mL, 60 mmol) in ether (33 mL) via a 
dropping funnel over a 3 h period. The exothermic reaction caused the mixture to reflux 
during the addition. The resulting mixture was stirred for 1 h before the reaction was 
quenched slowly with the addition of a solution of potassium carbonate (5.2 g) in water 
(20 mL). The layers were separated, and the organic phase was dried, treated with 
activated charcoal (300 mg), and filtered. The solvent was removed under reduced 
pressure, and the residue was dissolved in petroleum ether (-12 mL). The solution was 
cooled in ice, and the title product crystallised out as a tan solid. The solid was collected 
by filtration, washed with cold petroleum ether (10 mL) and air dried to give 5.42 (10.29 
g, 81%): mp 72 - 74°C (lit.31 73 - 75°C); IR (CHCh) 3444, 1665 cm"l; IH NMR 
(CDCh, 300:MHz) 0 6.39 (m, IH, pyrrole H4), 7.19 (m, IH, pyrrole H3), 7.41 (m, IH, 
pyrrole H5), 9.87 (bs, IH, NH); 13C NMR (CDCb, 75 MHz) 0 94.9, 111.8, 121.4, 122.9, 
127.4, 173.3; HRMS calcd for C6H4ChNO 210.9359, found 210.9359. 
EthyllH-pyrrole-2-carboxylate 5.43 
To a 100 mL RBF was added absolute ethanol (20 mL) and sodium metal (-150 
mg). Once all the sodium had dissolved, 5.42 (10.29 g, 48 mmol) was added portionwise 
over a 10 min period. After the addition was complete, the solution was stirred for 30 
min, and evaporated to dryness under reduced pressure. The oily residue was then 
. " 
partitioned between ether and 3 M aqueous hydrochloric acid. The ether layer was 
separated, and the aqueous layer was extracted once with ether. The ether solutions were 
combined, washed once with saturated aqueous sodium hydrogencarbonate, dried and 
evaporated under reduced pressure. The residue was distilled at reduced pressure to give 
5.43 (6.58 g, 98%) as a pale yellow oil which crystallised upon standing: mp 39 - 40°C 
(lit.31 40 - 42°C); IR (CHCh) 3459, 3313, 1700 cm"l; IH NMR (CDCh, 300 :MHz) 0 
1.35 (t, J= 7.3 Hz, 3H, COzCHzCH3), 4.33 (q, J 7.3 Hz, 2H, COzCHzCH3), 6.25 (m, 
IH, pyrrole H4), 6.92 ... 6.96 (m, 2H, pyrrole H3 & pyrrole H5), 9.82 (bs, IH, NH); 13C 
NMR (CDCb, 75:MHz) 0 14.3, 60.3, 110.2, 115.2, 122.8, 123.0, 161.5; HRMS calcd for 
C7H9NOZ 139.0633, found 139.0633. 
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Ethyl 5-formyl-lH-pyrrole-2-carboxylate 5.44 
General procedure A was carried out using the pyrrole 5.43 (6.58 g, 47 mmol). 
Distillation of the resulting residue at reduced pressure, followed by flash 
chromatography on silica (ethyl acetate/petroleum ether, 1:3 to 1: 1) gave two 
compounds. The first to elute was 5.44 (5.29 g, 67%) as a pink: solid. An analytical 
sample was obtained by sublimation under reduced pressure to give a white crystalline 
solid: mp 72 -74 DC (lit.32 75 DC); IR (CHCh) 3428, 1713, 1669 em-I; IH NMR (CDCh, 
300 MHz) (5 1.39 (t, J = 7.3 Hz, 3H, C02CH2CH3), 4.41 (q, J = 7.3 Hz, 2H, 
C02CH2CH3), 6.93 - 6.97 (m, 2H, pyrrole ID & pyrrole H4), 9.70 (s, IH, CHO), 10.69 
(bs, IH, NH); BC NMR (CDCh, 75 MHz) (5 14.1, 61.2, 115.4, 119.6, 128.6, 134.5, 160.4, 
180.5; HRMS calcd for CsH9N03 167.0582, found 167.0583. Anal. Calcd for CsH9N03: 
C, 57.48; H, 5.43; N, 8.38. Found: C, 57.35; H, 5.47; N, 8.31. The second compound to 
elute was 5.45 (1.21 g, 15%) as a white solid: mp 102 - 104°C (lit.32 104 - 106 DC); IR 
(CHCh) 3437, 1707, 1678 em-I; IH NMR (CDCh, 300 MHz) (5 1.38 (t, J = 7.3 Hz, 3H, 
C02CH2CH3), 4.37 (q, J = 7.3 Hz, 2H, C02CH2CH3), 7.34 (rn, IH, pyrrole ID), 7.65 (m, 
IH, pyrrole H5), 9.86 (s, IH, CHO), 10.94 (bs, IH, NH); BC NMR (CDCh, 75 MHz) (5 
14.1,61.0, 114.1, 125.0, 127.2, 129.2, 161.1, 185.9. 
5-Formyl-lH-pyrrole-2-carboxylic acid 5.46 
A solution of 5.44 (370 mg, 2.21 mmol) and potassium hydroxide (497 mg, 8.85 
mmol, 4 equiv) in distilled water (10 mL) was stirred in a warm water bath (40 - 50 DC 
bath temperature) for 2 h. The solution was then acidified with 10M aqueous 
hydrochloric acid and extracted with ether (3x20 mL). The combined ethereal solutions 
were washed with water (2xl0 mL), dried and evaporated under reduced pressure to give 
5.46 (251 mg, 82%) as an orange solid: mp >150 °c decomp. (lit.32 202 - 203°C); IR 
(CHCh) 3695, 3431,1709,1674 em-I; IHNMR (acetone~, 300 MHz) (56.81 (dd, J= 
3.9 & 2.4 Hz, IH, pyrrole ID), 6.90 (dd, J = 3.9 & 2.4 Hz, IH, pyrrole H4), 9.63 (s, IH, 
CHO), 11.52 (bs, IH, NH); BC NMR (acetone-d6, 75 MHz) (5 114.0, 116.4, 127.2, 134.1, 
159.3, 179.0; HRMS calcd for CJISN03 139.0269, found 139.0270. 
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N-(5-Formyl-lH-pyrrole-2-carbonyl)glycine ethyl ester 5.47a 
The pyrrole acid 5.46 (153 mg, 1.10 mmol) was coupled with glycine ethyl ester 
hydrochloride (169 mg, 1.21 mmol, 1.1 equiv) according to general procedure L. Flash 
chromatography on silica (ethyl acetate/petroleum ether, 1: 1) gave 5.47 a (173 mg, 70%) 
as a white solid: mp 149 °c, IR (CHCh) 3425, 1740, 1678, 1553, 1533 em-I; IH NMR 
(CDCh, 300 MHz) 0 1.31 (t, J = 7.3 Hz, 3H, C02CH2CH3), 4.24 - 4.31 (m, 4H, 
CH2C02CH2CH3), 6.73 (dd, J 3.9 & 2.4 Hz, 1H, pyrrole H3), 6.93 - 6.96 (m, 2H, 
pyrrole H4 & CONE), 9.64 (s, 1H, CHO), 10.56 (bs, 1H, NH); 13C NMR (CDCh, 75 
MHz) 0 14.1,41.5,61.9, 111.1, 119.9, 131.0, 134.0,160.0, 169.9,180.3; HRMS calcd 
for ClOH12N204 224.0797, found 224.0802. 
N-(5-Formyl-lH-pyrrole-2-carbonyl)-L-leucine methyl ester 5.47b 
The pyrrole acid 5.46 (180 mg, 1.29 mmol) was coupled with L-Ieucine methyl 
ester hydrochloride (259 mg, 1.42 mmol, 1.1 equiv) according to general procedure L. 
Flash chromatography on silica (ethyl acetate/petroleum ether, 1:2) gave 5.47b (310 mg, 
90%) as a pale yellow oil: IR (CHCh) 3425, 1740, 1676, 1551, 1529 em-I; IH NMR 
(CDCh, 300 MHz) 0 0.94 (m, 6H, CHMe2), 1.59 - 1.73 (m, 3H, CH2CHMe2), 3.77 (s, 
3H, COz&{e), 4.85 (m, 1H, aH), 6.70 (dd, J 3.9 & 2.4 Hz, 1H, pyrrole H3), 6.90 (dd, J 
= 3.9 & 2.4 Hz, 1H, pyrrole H4), 7.03 (d, J = 7.8 Hz, 1H, CONH), 9.59 (s, 1H, CHO), 
10.49 (bs, 1H, NH); DC NMR (CDCh, 75 MHz) 0 21.8, 22.8, 24.9, 41.5, 50.9, 52.6, 
111.3, 120.0, 131.3, 133.9, 159.7, 173.9, 180.2; HRMS calcd for C13H1SN204 266.1267, 
found 266.1265; Anal. Calcd for C13HISN204: C, 58.63; H, 6.81; N, 10.52. Found: C, 
58.47; H, 7.14; N, 10.13. 
The pyrrole acid 5.46 (311 mg, 2.24 mmol) was also coupled with L-Ieucine 
methyl ester hydrochloride (406 mg, 2.24 mmol, 1 equiv) according to general procedure 
K. Flash chromatography on silica (ethyl acetate/petroleum ether, 1:2) gave 5.47b (531 
mg, 89%) as a yellow oil. Spectral data as recorded above. 
N-(5-Formyl-lH-pyrrole-2-carbonyl)-L-phenylalanine methyl ester 5.47c 
The pyrrole acid 5.46 (210 mg, 1.51 mmol) was coupled with L-phenylalanine 
methyl ester hydrochloride (358 mg, 1.66 mmol, 1.1 equiv) according to general 
procedure L. Flash chromatography on silica (ethyl acetate/petroleum ether, 1 :2) gave 
Chapter Eight - Experimental 248 
5.47c (413 mg, 91%) as a pale yellow oil which solidified at 0 °C. An analytical sample 
was obtained by recrystallisation from petroleum ether to give a white solid: mp 49°C, 
IR (CHCh) 3423, 1742, 1678, 1551, 1529 em-I; IH NMR (CDCh, 300 MHz) 0 3.23 (m, 
2H, CH"h), 3.77 (s, 3H, C02i\d"e), 5.15 (m, 1H, aH), 6.66 (m, 1H, pyrrole ID), 6.92 (m, 
1H, pyrrole H4), 6.99 (d, J= 7.3 Hz, 1H, CONH), 7.11 -7.31 (m, 5H, phenyl Hs), 9.56 
(s, 1H, CHO), 10.82 (bs, 1H, NH); 13C NMR (CDCh, 75 MHz) 0 37.9, 52.5, 53.3, 111.4, 
120.0, 127.2, 128.6, 129.2, 131.3, 134.0, 135.6, 159A, 171.9, 180.3; HRMS calcd for 
C1Ji16N204 300.1110, found 300.1109. 
8.5.3. a.-Chymotrypsin assay and results 
8.5.3.1. General Assay Conditions 
The assay was based on a colorimetric technique and carried out in microtitre 
plates (NUNC flat bottomed plates, GillCO). The enzyme and test solution were 
preincubated to ensure maximum inhibition before addition of substrate. After the 
addition of substrate the optical density was measured over approximately 3 h. The lack 
of colour development, caused by enzymic release of 4-nitroanilide derivatives, indicated 
inhibition. Control samples were included in all cases. Each sample was assayed in 
triplicate. Methanol was used to dissolve the proposed inhibitor and for sample dilution, 
as it is water soluble and directly compatible with the assay system. 
8.5.3.2. a.-Chymotrypsin Assay 
Solutions of the pyrroles 4.8a, 2.25b, 5.3a-d, 5.6a-b, 5.8a-b, 5.9a-b and 5.10b 
were made to 1250 J.1g mr., 125 J.1g mL-1 and 12.5 J.1g mL·I in methanol. Tris-HCI (50 
J.1L ofOA M solution in water, pH 7.6), distilled water (50 J.1L), test solution (50 J.1L) and 
a.-chymotrypsin (50 J.1L, Sigma ex-Bovine pancreas, 9 units mL·1 in 50 roM Tris-HCl 
buffer, pH 7.6) were added to each well of the microtitre plate. Incubation at 37°C for 
30 min was followed by the addition of N-succinyl-L-phenylalanine-4-nitroanilide (100 
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~, 1 mg mL-1 solution in 50 mM Tris-HCI buffer, pH 7.6). The absorbance was read at 
405 nm at t = 0, and after incubation at 37°C when significant colour change had taken 
place. Each sample was assayed in triplicate and average absorbances were used to 
calculate the percentage (%) inhibition (see Table 8.1). Sample blanks in which 50 mM 
Tris-HCI buffer, pH 7.6, replaced a-chymotrypsin were run concurrently. 
Compound % Inhibition 
1250 Ilg mL-1 125 Ilg mL-1 12.5 Ilg mL-1 
4.8a 40 10 0 
5.3a 25 10 10 
2.25b 0 0 0 
5.3b 35 20 5 
5.3e 30 15 5 
5.3d 20 10 5 
5.6a 5 5 0 
5.6b 0* 0* 0 
5.8a 10 5 0 
5.8b 25 10 0 
5.9a 0 0 0 
5.9b 20 15 10 
5.10b 10 5 0 
* precipitation occurred in reaction wells during assay 
Table 8.1. Results of a.-chymotrypsin assay (results rounded to the nearest 5%). 
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8.6 Experimental Work Described in Chapter Six 
8.6.1. Attempted N-acylation of 5.47a-c using general procedure C: 
Pyrrolizin-3-one formation 
5.47a R1 = H. R2 = Et 
5.47b R1 = CH2CHMe2. R2 = Me 
5.47c R1 = CH2Ph. R2 = Me 
6.2a R1 = H 
6.2b R1 = CH2CHMe2 
6.3c R1 = CH2Ph 
.. 
• 
6.1a R1 = H. R2 = Et 
6.1b R1 = CH2CHMe2. R2 = Me 
6.1c R1 = CH2Ph. R2 = Me 
I 
N-(2-Benzyl-3-oxopyrrolizin-5-ylcarbonyl)glycine ethyl ester 6.1a 
250 
The pyrrole 5.47a (45 mg, 0.20 mmol) was treated with hydrocinnamoyl chloride 
(62 ~, 0.42 mmol, 2.1 equiv) according to general procedure C. Flash chromatography 
on silica (ethyl acetate/petroleum ether, 1:2) gave 6.1a (39 mg, 58%) as an orange solid. 
An analytical sample was recrystallised from ethyl acetate/petroleum ether to give thin 
orange crystals: mp 104 - 105 °C; UV (MeOH) Amax 242 nm (8 11300), 338 (25400), 
423 (200); IR (CHCh) 3294, 1726, 1647, 1582, 1560 cm-\ IH NMR (CDCh, 300 MHz) 
81.30 (t, J= 7.3 Hz, 3H, C02CH2CH3), 3.62 (d, J= 1.5 Hz, 2H, CH2Ph), 4.19 - 4.28 (m, 
4H, CH2C02CH2CH3), 5.97 (d, J= 3.4 Hz, 1H, pyrrolizin-3-one H7), 6.65 (t, J= 1.5 Hz, 
1H, pyrrolizin-3-one HI), 6.88 (d, J= 3.4 Hz, 1H, pyrrolizin-3-one H6), 7.23 - 7.37 (m, 
5H, phenyl Hs), 9.33 (t, J= 5.4 Hz, 1H, CONH); l3C NMR (CDCh, 75 MHz) 8 14.1, 
31.9,41.7, 61.4, 111.0, 124.3, 126.9, 128.8 (2xC), 130.3, 132.3, 136.8, 137.0, 139.7, 
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158.2, 167.8, 169.6; HRMS calcd for Cl9Hl8N20 4 338.1267, found 338.1264. Anal. 
Calcd for CI9H18N204: C, 67.45; H, 5,36; N, 8.28. Found: C, 67.48; H, 5.32; N, 8.47. 
Crystallographic structure determination for compound 6.1a by X-ray analysis 
C19H18N204, M 338.36, mp 104 - 105°C, crystal dimensions 0.9 x 0.2 x 0.1 mm, 
monoclinic, a 9.530(16) ~ b 10.48(3) ~ C 33.36(9) ~ P 97.24(6)°, V = 3304(13) A3, 
space group P2I/c, Z = 4, F(OOO) = 1424, Deale = 1.360 mg/m3, absorption coefficient 
0.097 mm-t, e range for data collection 2.30 - 26.54, index ranges -11 ~ h ~ 4, -13 ~ k ~ 
13, -41 ~ I ~ 41, data/restraints! parameters 6758/0/453, goodness offit onF was 0.791, 
finalR indices [1>20(1)] Rl = 0.0375, WR2 = 0.0716, R indices (all data) RI = 0.1065, wR2 
= 0.0799, largest difference peak and hole 0.211 and -0.220 eA-3• 
A unique data set was measured at 158(2) K within 2~ax ,= 53° limit (m scans). 
Of the 23851 reflections obtained, 6758 were unique (Rint 0.0538) and were used in the 
full-matrix least-squares refinement. 17 The structure was solved by direct methods.18 
Hydrogen atoms were fixed in idealised positions. All non-hydrogen atoms were refined 
with anisotropic atomic displacement parameters. Neutral scattering factors and 
anomalous dispersion corrections for non-hydrogen atoms were taken from Ibers and 
Hamilton. 19 
N-(2-Benzyl-3-oxopyrrolizin-S-ylcarbonyl)-L-Ieucine methyl ester 6.1b 
The pyrrole S.47b (50 mg, 0.19 mmol) was treated with hydrocinnamoyl chloride 
(59 IlL, 0.39 mmol, 2.1 equiv) according to general procedure C. Flash chromatography 
on silica (ethyl acetate/petroleum ether, 1:2) gave 6.1b (39 mg, 55%) as an orange oil: 
UV (MeOH) A.max 223 nm (8 11500), 339 (9100), 436 (900); IR (CHCh) 3277, 1726, 
1645, 1582, 1560 cm-l; IH NMR (CDCh, 300 MHz) 0 0.94 (d, J 5.4 Hz, 3H, CRUe2), 
0.97 (d, J= 5,4 Hz, 3H, CRUe2), 1.72 1.79 (m, 3H, CH2CHMe2), 3.62 (d, J= 1.7 Hz, 
2H, CH2Ph), 3.75 (s, 3H, COMe), 4.71 (m, 1H, alI), 5.96 (d, J= 3.4 Hz, 1H, pyrrolizin-
3-one H7), 6.61 (t, J = 1.7 Hz, 1H, pyrrolizin-3-one HI), 6.87 (d, J = 3.4 Hz, 1H, 
pyrrolizin-3-one H6), 7,24 - 7.37 (m, 5H, phenyl Hs), 9.22 (d, J = 6.8 Hz, 1H, CONH); 
DC NMR (CDCh, 75 MHz) 0 21.8,22.8,24.9, 31.8,41.0,51.3,52.2, 111.0, 124.3, 126.9, 
128.8, 128.9, 130.5, 132.3, 136.9, 137.0, 139.7, 157.9, 167.9, 173.2; FIRMS calcd for 
C2~24N204 380.1736, found 380.1734. 
Chapter Eight - Experimental 252 
N-(2-Benzyl-3-oxopyrrolizin-5-ylcarbonyl)-L-phenylalanine methyl ester 6.1c 
The pyrrole 5.47c (59 mg, 0.20 mmol) was treated with hydrocinnamoyl chloride 
(62 ~, 0.41 mmol, 2.1 equiv) according to general procedure C. Flash chromatography 
on silica (ethyl acetate/petroleum ether, 1 :2) followed by recrystallisation from ethyl 
acetate/petroleum ether gave 6.1c (47 mg, 58%) as orange/red crystals: mp 158 °C; UV 
(CHCh) Amax 301 nm (E 12300), 438 (4100); IR (CHCh) 3516, 3269, 1728, 1647, 1605, 
1580, 1558 em-I; iH NMR (CDCh, 300 MHz) 0 3.19 (m, 2H, CH2Ph), 3.60 (d, J = 1.5 
Hz, 2H, CH2Ph), 3.72 (s, 3H, CO~e), 4.96 (m, Ill, aH), 5.94 (d, J = 3.4 Hz, Ill, 
pyrrolizin-3-one H7), 6.60 (t, J= 1.5 Hz, IH, pyrrolizin-3-one HI), 6.84 (d, J= 3.4 Hz, 
Ill, pyrrolizin-3-one H6), 7.21 - 7.38 (m, lOll, phenyl Hs), 9.31 (t, J = 7.3 Hz, Ill, 
CONH); i3C NMR (CDCh, 75 MHz) 0 31.9,38.0, 52.3,54.3, 110.9, 124.3, 126.9 (2xC), 
128.4, 128.8, 128.9, 129.2, 130.3, 132.2, 136.3, 136.9, 137.1, 139.7, 157.8, 167.6, 172.0; 
HRMS calcd for C2sH22N204 414.1580, found 414.1592. AnaL Calcd for G sH22N204: C, 
72.45; H, 5.35; N, 6.76. Found: C, 72.68; H, 5.47; N, 6.95. 
N- [5-(2-Carbomethoxy-3-phenyl-1-propenyl)-1H-pyrrole-2-carbonyl] glycine methyl 
ester 6.2a 
To a stirred solution of the pyrrolizin-3-one 6.1a (12 mg, 0.04 mmol) in methanol 
(3 mL) at rt under N2 was added sodium methoxide (29 mg, 0.53 mmol, 15 equiv) 
dissolved in methanol (2 mL). After stirring for 1 min the solution was acidified with 1 
M aqueous sulfuric acid and extracted with dichloromethane (2xl0 mL). The combined 
organic fractions were washed with water (2xlO mL), saturated aqueous brine (10 mL), 
dried and evaporated under reduced pressure. Flash chromatography on silica (ethyl 
acetate/petroleum ether, 1:1) gave 6.2a (11 mg, 85%) as a mixture of the cis- and trans-
isomers (3 : 1 by iH NMR) as a white solid: iH NMR (CDCh, 300 MHz) of cis-isomer 
assigned from mixture, 0 3.67 (s, 5H, CO~e & CH2Ph), 3.71 (s, 3H, CO~e), 4.15 (d, J 
= 5.4 Hz, 2H, CH1C02), 6.29 (dd, 3.9 & 2.4 Hz, Ill, pyrrole H4), 6.43 (t, J = 5.4 Hz, 
Ill, CONH), 6.54 (dd, J = 3.9 & 2.4 Hz, Ill, pyrrole H3), 6.59 (s, Ill, acrylic H), 7.11 -
7.24 (m, 5H, phenyl Hs), 12.38 (bs, Ill, NH); BC NMR (CDCh, 75 MHz) of cis-isomer 
assigned from mixture, 0 33.6, 41.2, 52.2, 52.4, 110.2,1 118.1, 124.2, 126.3, 128.4, 128.6, 
129.9, 130.7, 131.9, 139.6, 160.5, 168.6, 170.6. This sample was recrystallised from 
ethyl acetate/petroleum ether to give the trans-isomer as a white crystalline solid (3 mg, 
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22%): mp 91- 92°C; IR (CHCh) 3435,3306, 1746, 1697, 1655, 1605, 1541, 1516 em-I; 
IH NMR (CDCh, 300 MHz) of trans-isomer, 0 3.77 (s, 3H, COzMe), 3.78 (s, 3H, 
COzMe), 4.03 (s, 2H, CHiPh), 4.26 (d, J 4.9 Hz, 2H, CH2C02), 6.43 - 6.47 (m, 2H, 
pyrrole H4 & CONH), 6.61 (dd, J= 3.9 & 2.4 Hz, IH, pyrrole ill), 7.19 -7.31 (m, 5H, 
phenyl Hs), 7.83 (s, IH, acrylic H), 10.21 (bs, IH, NH); l3C NMR (CDCh, 75 MHz) of 
trans-isomer, 0 33.6, 41.2, 52.2, 52.5, 111.4, 114.1, 126.4, 127.2, 127.5, 127.9, 128.7, 
129.8, 131.3, 138.3, 160.4, 168.6, 170.4; HRMS calcd for C19H20N20S 356.1372, found 
356.1379. 
N-{(Z)-5-[2-Carbomethoxy-3-p henyl-l-propenyl]-lH-pyrrole-2-carbonyl}-L-leucine 
methyl ester 6.2b 
The pyrrolizin-3-one 6.1b (25 mg, 0.07 mmol) was treated with sodium 
methoxide (54 mg, 0.99 mmol, 15 equiv) by the method described above for the 
preparation of 6.2a. Flash chromatography on silica (ethyl acetate/petroleum ether, 1:4) 
gave 6.2b (22 mg, 80%) as a white solid. An analytical sample was recrystallised from 
ethyl acetate/petroleum ether to give white crystals: mp 113 - 114°C; IR (CHCh) 3439, 
3310,1738,1699,1655,1514 cm-\ IHNMR (CDCh, 300 MHz) 0 0.96 (m, 6H, CHMe2), 
1.61 1.75 (m, 3H, CH2CHMe2), 3.74 (s, 5H, COzMe & CHiPh), 3.75 (s, 3H, COzMe), 
4.85 (m, IH, aH), 6.36 (dd, J 3.7 & 2.4 Hz, IH, pyrrole H4), 6.40 (d, J = 8.5 Hz, IH, 
CONE), 6.60 (dd, J= 3.7 & 2.4 Hz, IH, pyrrole H3), 6.65 (s, IH, acrylic H), 7.18 -7.31 
(m, 5H, phenyl Hs), 12.43 (bs, IH, NH); I3C NMR (CDCh, 75 MHz) 0 22.0, 22.8, 24.9, 
41.3,42.0, 50.6,52.2, 52.3, 109.9, 118.1, 124.0, 126.3, 127.7, 128.4, 128.6, 130.7, 132.0, 
136.9, 139.6, 142.7, 160.1, 168.5, 173.7; HRMS calcd for C23H28N20s 412.1998, found 
412.2001. AnaL Calcd for C23H28N20s: C, 66.97; H, 6.84; N, 6.79. Found: C, 67.07; H, 
6.55; N, 6.61. 
N-{(Z)-5-[2-Carbomethoxy-3-phenyl-l-propenyl]-lH-pyrrole-2-carbonyl}-L-
phenylalanine methyl ester 6.2c 
The pyrrolizin-3-one 6.1c (16 mg, 0.04 mmol) was treated with sodium 
methoxide (31 mg, 0.58 mmol, 15 equiv) by the method described above for the 
preparation of 6.2a. Flash chromatography on silica (ethyl acetate/petroleum ether, 1:2) 
gave 6.2c (14 mg, 82%) as a white solid: mp 43 - 44°C; IR (CHCh) 3429, 3296,1742, 
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1697, 1655, 1607, 1541, 1514 cm>l; IHNMR (CDCh, 300 MHz) 0 3.23 (m, 2H, CHiPh), 
3.74 - 3.76 (m, 8H;' 2xCO:zMe & CH2Ph), 5.06 (m, 1H, aH), 6.34 - 6.36 (m, 2H, pyrrole 
H4 & CONH), 6.50 (m, 1H, pyrrole ID), 6.67 (s, 1H, acrylic H), 7.11 - 7.31 (m, 10H, 
phenyl Hs), 12.48 (bs, 1H, NH); l3C NMR (CDCb, 75 MHz) 0 38.1, 41.2, 52.2, 52.3, 
53.1, 110.1, 118.1, 124.1, 126.3, 127.1, 127.6, 128.4, 128.6 (2xC), 129.3, 130.7, 132.0, 
135.8, 139.6, 159.8, 168.6, 172.0; HRMS calcd for C2<JI2~20S 446.1842, found 
446.1849. 
8.6.2. Attempted N-acylation of 5.47a-c using general procedure B: 
Azafulvene dimer formation 
n H 2 
OHC" "f'j/ yNy C02R 
H 0 R1 
5.47a R1 = H, R2 = Et 
S.47b R1 = CH2CHMe2, R2 = Me 
5.47c R1 = CH2Ph, R2 = Me 
Glycine-based azafulvene dimer 6.6a 
R1 
6H 0 NH ~CO R2 R1 2 
6.6a R 1 = H, R2 = Et 
6.6b R1 = CH2CHMe2, R2 = Me 
6.6c R1 = CH2Ph, R2 = Me 
The modified general procedure B was carried out using pyrrole 5.47a (48 mg, 
0.22 mmol) and acetyl chloride (15 J.LL, 0.22 mmol, 1 equiv). Flash chromatography on 
silica (ethyl acetate/petroleum ether, 2: 1) followed by recrystallisation from ethyl 
acetate/petroleum ether gave 6.6a (24 mg, 50%) as colourless crystals: mp 137 - 139°C; 
IR (CHCh) 3350, 1732, 1638, 1560, 1535 cm>l; IHNMR (CDCb, 300 MHz) 0 1.36 (t,J 
= 7.3 Hz, 6H, C02CH2CH3), 3.69 (dd, J= 18.1 & 4.4 Hz, 2H, CH2C02), 4.34 (q, J= 7.3 
Hz, 4H, C02CH2CH3), 4.69 (dd, J= 18.1 & 8.3 Hz, 2H, CH2C02), 6.27 (d, J= 3.9 Hz, 
2H, H-1,6), 6.29 (d, J= 3.9 Hz, 2H, H-5, 10), 6.50 (d, J= 3.9 Hz, 2H, OH), 6.90 (d, J= 
3.9 Hz, 2H, H-2,7), 8.52 (m, 2H, CONE); I3C NMR (CDCb, 75 MHz) 0 14.1,41.0,62.3, 
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71.6, 108.0, 115.1, 124.3, 130.8, 162.1, 173.0; HRMS (FAB) calcd for C2oH23N407 (MH-
H20) 431.1567, found 431.1564. 
Upon standing for 3 days in CDCh in a 3 mm NMR tube, approximately 15% of a 
second compound was obseIVed to form. Selected IH NMR (CDCb, 300 MHz) of 
second compound assigned from the mixture, () 6.35 (d, J = 3.9 Hz, 2H), 6.61 (d, J = 3.9 
Hz, 2H), 6.93 (d, J= 3.9 Hz, 2H), 7.06 (d, 3.9 Hz, 2H), 7.69 (m, 2H). 
L-Leucine-based azafulvene dimer 6.6b 
The modified general procedure B was carried out using pyrrole 5.47b (47 mg, 
0.18 mmol) and acetyl chloride (13 !JL, 0.18 mmot, 1 equiv). Flash chromatography on 
silica (ethyl acetate/petroleum ether, 1 :2) followed by recrystallisation from ethyl 
acetate/petroleum ether gave 6.6b (19 mg, 41%) as colourless crystals: mp 166°C; 
[0.]025 =-120.6° (c = 0.165, CH2Ch); lR (CHCh) 3342,1732, 1632, 1553 cm-\ IHNMR 
(CDCh, 300 MHz) () 0.90 (d, J = 6.3 Hz, 6H, CHMe2), 0.96 (d, J = 6.8 Hz, 6H, CHMe2), 
1.61 - 1.87 (m, 6H, CH2CHMe2), 3.89 (s, 6H, CO:Ne), 4.75 (m, 2H, a.H), 6.21 - 6.23 
(m, 4II, H-l,6 & H-5,1O), 6.49 (d, J= 3.9 Hz, 2H, OlI), 6.88 (d, J= 4.4 Hz, 2H, H-2,7), 
8.46 (d, J= 7.8 Hz, 2II, CONlI); BC NMR (CDCh, 75 MHz) () 21.0,23.2,25.0,40.2, 
50.9, 52.9, 71.5, 107.9, 115.0, 124.3, 130.7, 161.9, 176.9; HRMS (EI) calcd for 
C13HlSN20 4 (YiM) 266.1267, found 266.1273; HRMS (FAB) calcd for C26H35N407 (MH-
H20) 515.2506, found 515.2519. Anal. Calcd for C26H36N40 g: C, 58.63; II, 6.81; N, 
10.52. Found: C, 58.25; II, 6.95; N, 10.21. 
The reaction was repeated using pyrrole 5.47b (48 mg, 0.18 mmol) and 
hydrocinnamoyI chloride (27 !JL, 0.18 mmo!, 1 equiv) to give 6.6b (12 mg, 25%). 
Spectral data as recorded above. 
Crystallographic structure determination for compound 6.6b by X-ray analysis 
C2~20N408.C4H802, M 604.62, mp 166°C, crystal dimensions 0.73 x 0.4 x 0.4 mm, 
tetragonal, a 13.1462(4) ~ b 13.1462(4) ~ c 19.5541(8) ~ V 3379.4(2) A3, space 
group P42212, Z == 8, F(OOO) = 1280, Deale = 1.188 mg/m3, absorption coefficient 0.089 
mm-I, Orange for data collection 1.87 - 21.96°, index ranges -13 :::;; h :::;; 13, -13 :::;; k:::;; 13, 
-20 :::;; 1 :::;; 18, data/restraints/ parameters 2073/8/218, goodness of fit on F2 was 1.077, 
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finalR indices [1>20(0] Rl = 0.0562, wR2 = 0.1335, R indices (all data)R1 = 0.0620, wR2 
= 0.1382, largest difference peak and hole 0.478 and -0.292 eA-3. 
A unique data set was measured at 144(2) K within 2~ax = 44° limit (a> scans). 
Of the 11262 reflections obtained, 2073 were unique (Rint = 0.1024) and were used in the 
full-matrix least-squares refinement. 17 The structure was solved by direct methods. 18 
Hydrogen atoms were fixed in idealised positions. All non-hydrogen atoms were refined 
with anisotropic atomic displacement parameters. Neutral scattering factors and 
anomalous dispersion corrections for non-hydrogen atoms were taken from Thers and 
Hamilton. 19 
Analytical data was consistent with the presence of one ethyl acetate solvent 
molecule in the asymmetric unit. However, electron density maps showed this molecule 
to be disordered and positioned across a two fold rotational axis of symmetry. In this 
situation the best fitting model was necessarily distorted by self superposition, therefore 
its geometry is poorly defined. Electron density maps also showed a small degree of 
disorder present in the terminal methyl groups of the leucine side chains. However, all 
attempts to model this disorder were unsatisfactory. 
L-Pbenylalanine-based azafulvene dimer 6.6c 
The modified general procedure B was carried out using pyrrole 5.47c (52 mg, 
0.17 romol) and acetyl chloride (12 ~, 0.17 mmol, 1 equiv). Flash chromatography on 
silica (ethyl acetate/petroleum ether, 1: 1) followed by recrystallisation from ethyl 
acetate/petroleum ether gave 6.6c (13 mg, 25%) as colourless crystals: mp 133 - 135°C; 
[a]n2S = -149.0° (c = 0.05, CH2Ch); IR (CHCh) 3427, 3352, 1732, 1636, 1551, 1528 cm-
1; IH NMR (CDCh, 300 MHz) .s 3.15 (m, 4H, CH2Ph), 3.90 (s, 6H, COzMe), 4.98 (m, 
2H, aH), 6.17 (d, J= 4.4 Hz, 2H, H-1,6), 6.23 (d, J= 3.9 Hz, 2H, H-5,10), 6.27 (d, J= 
3.9 Hz, 2H, OlI), 6.72 (d, J= 4.4 Hz, 2H, H-2,7), 7.21 7.30 (m, 10H, phenyl Hs), 8.16 
(d, 7.3 Hz, 2H, CONlI); 13C NMR (CDCh, 75 MHz) .s 37.7, 53.0, 54.0, 71.5, 107.9, 
114.8, 124.0, 127.3, 128.7, 128.9, 130.7, 136.1, 161.6, 175.2; HRMS (FAB) calcd for 
C32H31N407 (MIl-H20) 583.2193, found 583.2183. 
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Crystallographic structure determination for compound 6.6c by X-ray analysis 
C2tJi36N40s, M 532.59, mp 133 - 135°C, crystal dimensions 0.45 x 0.30 x 0.26 mm, 
monoclinic, a 25.748(4) A, b 10.440(5) A, c 24.801(4) A, P 96.548(12)°, V= 6624(3) A3, 
space group P2., Z = 4, F(OOO) = 2528, Deale = 1.205 mg/m3, absorption coefficient 0.727 
mm,1, Orange for data collection 3.46 - 47.23, index ranges 0 ::;; h ::;; 24,0::;; k::;; 9, -23 ::;; 1 
::;; 23, data/restraintsl parameters 3224/1371788, goodness of fit on P. was 1.223, final R 
indices [1>20(1)] R1 = 0.0958, wRz = 0.2344, R indices (all data) R1 0.1132, WR2 = 
0.2529, largest difference peak and hole 1.059 and -0.367 eA·3. 
A unique data set was measured at 293(2) K within 2~ax = 94° limit (aJ scans). 
Of the 3320 reflections obtained, 3224 were unique (Rint = 0.0447) and were used in the 
full-matrix least-squares refinement. 17 The structure was solved by direct methods. 1s 
Hydrogen atoms were fixed in idealised positions. All non-hydrogen atoms were refined 
with anisotropic atomic displacement parameters. Neutral scattering factors and 
anomalous dispersion corrections for non-hydrogen atoms were taken from !bers and 
Hamilton. 
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8.7 Experimental Work Described in Chapter Seven 
8.7.1. Preparation of acid chlorides33 
n~Hexanoyl chloride 
Into a 50 mL RBF fitted with a reflux condenser was placed n-hexanoic acid 
(7.00g, 60.3 mmol) and oxalyl chloride (6.31 mL, 72.3 mmol, 1.2 equiv), and the 
resultant mixture was heated and stirred at 60 70°C for 2 h. The crude acid chloride 
was then distilled at reduced pressure (oil pump) to give n-hexanoyl chloride (7.60 g, 
94%) as a colourless oil: IR (CHCh) 1794 cm-\ IHNMR (CDCh, 300 MHz) 0 0.91 (m, 
3H, H-6), 1.31 - 1.37 (m, 4H, H-4 & H-5), 1.72 (m, 2H, H-3), 2.89 (t, J = 7.3 Hz, 2H, H-
2). 
Dodecanoyl (lauroyl) chloride 
Lauroyl chloride (8.32 g, 95%) was prepared from lauric acid (8.00 g, 39.9 mmol) 
and oxalyl chloride (4.18 mL, 47.9 mmol, 1.2 equiv) by the method described above for 
n-hexanoyl chloride. IR (CHCh) 1794 cm-I; IHNMR (CDCh, 300 MHz) 00.89 (t, J= 
6.8 Hz, 3H, H-12), 1.27 - 1.31 (broad signal, 16H, H-4 H-l1), 1.71 (m, 2H, H-3), 2.88 
(1, J = 7.3 Hz, 2H, H-2). 
Nonadecanoyl chloride 
Nonadecanoic acid (200 mg, 0.67 mmol) was dissolved in benzene (5 mL) and 
oxalyl chloride (70 ilL, 0.80 mmol, 1.2 equiv) was added. The stirred mixture was 
heated at 60 -70°C for 2 h. The solvent was then removed at reduced pressure to give 
the crude acid chloride as a white solid (208 mg, 98%) which was kept under high 
vacuum (oil pump) until required: IR (CHCh) 1794 cm-1; IH NMR (CDCh, 300 MHz) 0 
0.88 (t, J= 6.8 Hz, 3H, H-17), 1.26 -1.31 (broad signal, 30H, H-4 -H-18), 1.71 (m, 2H, 
H-3), 2.88 (t, J = 7.3 Hz, 2H, H-2). 
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8.7.2. Preparation ofhydroxymethylpyrroles 7.27, 7.28 and 7.11 
lfl._ 
-_10 oHc......-"!f'y'(CHi)n~ 
H 0 
n OHC N SnBu3 
H 
5.37 7.24 n = 1 
7.25 n = 7 
7.26 n=14 
HO lfl. - ~ 
"'-./'N/Y '(CHi)n~ 
H 0 
7.27 n = 1 
7.28 n = 7 
7.11 n = 14 
5-(1-Oxohexyl)-lH-pyrrole-2-carboxaldehyde 7.24 
259 
The stannylpyrrole 5.37 (150 mg, 0.39 mmol) was coupled with n-hexanoyl 
chloride (55 ilL, 0.39 mmol, 1 equiv) according to general procedure M. Flash 
chromatography on silica (ethyl acetate/petroleum ether, 1:5) gave 7.24 (58 mg, 77%) as 
a white solid: mp 48°C (lit.34 48 - 49°C); IR (CHCb) 3422, 1678, 1659 cm-1; 1H NMR. 
(CDCh, 300 MHz) 0 0.91 (m, 3II, H-ll), 1.32 -1.38 (m, 4II, H-9 & H-lO), 1.74 (m, 2II, 
H-8), 2.85 (t, J= 7.3 Hz, 2II, H-7), 6.91 (dd, J= 3.9 & 2.4 Hz, III, pyrrole H4), 6.97 (dd, 
J = 3.9 & 2.4 Hz, IH, pyrrole H3), 9.73 (s, III, CHO), 10.25 (bs, III, NH); 13C NMR. 
(CDCb, 75 MHz) 0 13.8,22.4,24.1,31.4,38.7, 115.3, 119.5, 134.7, 135.5, 180.9, 192.3; 
HRMS calcd for Cu H1sN02 193.1103, found 193.1104. 
5-(1-Oxododecyl)-lH-pyrrole-2-carboxaldehyde 7.25 
The stannylpyrrole 5.37 (150 mg, 0.39 mmol) was coupled with lauroyl chloride 
(90 ilL, 0.39 mmol, 1 equiv) according to general procedure M. Flash chromatography 
on silica (ethyl acetate/petroleum ether, 1:6) gave 7.25 (99 mg, 91%) as a white solid. An 
analytical sample was obtained by recrystallisation from petroleum ether to give a fine 
white solid: mp 66°C; IR (CHCb) 3422, 1678, 1661 cm-1; IH NMR. (CDCb, 300 MHz) 
00.88 (t, J= 6.8 Hz, 3H, H-17), 1.26 - 1.33 (broad signal, 16H, H-9 - H-16), 1.73 (m, 
2H, H-8), 2.84 (t, J= 7.3 Hz, 2II, H-7), 6.90 (dd, J 3.9 & 2.4 Hz, III, pyrrole H4), 6.96 
(dd, J= 3.9 & 2.4 Hz, III, pyrrole H3), 9.72 (s, III, CHO), 10.06 (bs, III, NH); 13C NMR. 
Chapter Eight - Experimental 260 
(CDCb, 75 MHz) 0 14.1,22.6,24.5,29.3 - 29.6 (6xC), 31.9, 38.8, 115.2, 119.5, 134.7, 
135.5, 180.8, 192.3; HRMS calcd for C17H27N02 277.2042, found 277.2034. 
5-(1-Oxononadecyl)-lH-pyrrole-2-carboxaldehyde 7.26 
The stannylpyrrole 5.37 (150 mg, 0.39 mmol) was coupled with nonadecanoyl 
chloride (124 mg, 0.39 mmol, 1 equiv) according to general procedure M. Flash 
chromatography on silica (ethyl acetate/petroleum ether, 1:8) gave 7.26 (135 mg, 92%) as 
a white solid. An analytical sample was obtained by recrystallisation from petroleum 
ether to give a fine white solid: mp 85°C; IR (CHCb) 3422, 1678, 1659 cm-1; IH NMR 
(CDCh, 300 MHz) 0 0.88 (t, J = 6.8 Hz, 3ll, H-24), 1.25 1.32 (broad signal, 30ll, H-9 
H-23), 1.73 (m, 2ll, H-8), 2.83 (t, J= 7.6 Hz, 2H, H-7), 6.90 (dd, 3.9 & 2.4 Hz, Ill, 
pyrrole H4), 6.96 (dd, J = 3.9 & 2.4 Hz, 1H, pyrrole H3), 9.72 (s, Ill, CHO), 10.01 (bs, 
Ill, NIl); 13C NMR (CDCb, 75 MHz) 0 14.1,22.7,24.5,29.3 - 29.7 (13xC), 31.9, 38.8, 
115.2, 119.5, 134.6, 135.5, 180.8, 192.3; HRMS calcd for C2J1ilN02 375.3137, found 
375.3131. 
2-Hydroxymethyl-5-(1-oxohexyl)-lH-pyrro Ie 7.27 
The pyrrole 7.24 (40 mg, 0.21 mmol) was reduced with zinc borohydride by 
general procedure D. Flash chromatography on silica (ethyl acetate/petroleum ether, 1:2) 
gave 7.27 (47 mg, 93%) as a pale pink solid: mp 55 - 56°C, IR (CHCh) 3439, 3308, 
1620 cm-\ IHNMR(CDCh, 300 MHz) 0 0.90 (m, 3ll, H-11), 1.32- 1.38 (m, 4ll, H-9 & 
H-10), 1.72 (m, 2H, H-8), 2.78 (t, J = 7.3 Hz, 2ll, H-7), 4.27 (bs, Ill, OR), 4.74 (s, 2ll, 
CH20H), 6.15 (dd, J = 3.4 & 2.4 Hz, 1H, pyrrole ill), 6.94 (dd, J = 3.4 & 2.4 Hz, 1H, 
pyrrole H4), 11.12 (bs, Ill, NIl); 13C NMR (CDCh, 75 MHz) 0 13.9, 22.4, 25.3, 31.5, 
37.7, 57.7, 108.8, 118.5, 131.5, 140.9, 192.4; HRMS calcd for CUH17N02 195.1259, 
found 195.1261. 
2-Hydroxymethyl-5-(1-oxododecyl)-lH-pyrrole 7.28 
The pyrrole 7.25 (30 mg, 0.11 mmol) was reduced with zinc borohydride by 
general procedure D. Flash chromatography on silica (ethyl acetate/petroleum ether, 1:2) 
gave 7.28 (25 mg, 84%) as a white solid: mp 70 - 71 °C; IR (CHCh) 3439, 3308, 1618 
em-I; IH NMR (CDCh, 300 MHz) 0 0.88 (t, J = 6.8 Hz, 3H, H-17), 1.25 - 1.32 (broad 
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signal, 16H, H-9 -H-16), 1.71 (m, 2H, H-8), 2.78 (t, J= 7.6 Hz, 2H, H-7), 4.26 (bs, IH, 
OR), 4.73 (s, 2H, CH20R), 6.15 (dd, J= 3.9 & 2.4 Hz, IH, pyrrole H3), 6.93 (dd, J= 3.9 
& 2.4 Hz, IH, pyrrole H4), 11.11 (bs, IH, NH); 13C NMR (CDCh, 75 MHz) 0 14.1, 22.6, 
25.7,29.3 - 29.6 (6xC), 31.9, 37.8, 57.7, 108.8, 118.5, 131.5, 140.9, 192.4; HRMS calcd 
for C17H29N02 279.2198, found 279.2197. 
2-Hydroxymethyl-5-(1-oxononadecyl)-lH-pyrrole7 .11 (Mycalazol 11) 
The pyrrole 7.26 (35 mg, 0.09 mmol) was reduced with zinc borohydride by 
general procedure D. Flash chromatography on silica (ethyl acetate/petroleum ether, 1:2) 
gave 7.11 (33 mg, 93%) as a fine white solid. An analytical sample was obtained by 
recrystallisation from methanol to give fine white crystals: mp 78 °C (lit.35 amorphous 
powder); IR (CHCh) 3439, 3306, 1624 cm,l; IH NMR (CDCh, 300 MHz) 0 0.88 (t, J 
6.8 Hz, 3H, H-24), 1.25 - 1.32 (broad signal, 30H, H-9 - H-23), 1.72 (m, 2H, H-8), 2.78 
(t, J= 7.6 Hz, 2H, H-7), 4.13 (bs, IH, OR), 4.74 (s, 2H, CH20R), 6.15 (dd, J= 3.9 & 2.4 
Hz, IH, pyrrole H4), 6.93 (dd, J = 3.9 & 2.4 Hz, IH, pyrrole H3), 11.04 (bs, IH, NH); 
l3C NMR (CDCh, 75 MHz) 0 14.1, 22.7,25.7,29.3 - 29.7 (13xC), 31.9,37.8, 57.8, 
108.8, 118.4, 131.5, 140.8, 192.4; HRMS calcd for C24linN02 377.3294, found 
377.3296. 
8.7.3. Preparation of hydroxymethylpyrrole 7.30 
n OHC N C02H 
H 
5.46 
HO~~"-./(CH,).-../ 
H 0 
7.30 
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5-Dodecylcarboxamido-lH-pyrrole-2-carboxaldehyde 7.29 
To a stirred solution (-0.1 M) of the pyrrole acid 5.46 (100 mg, 0.72 mmol) and 
dodecylamine (147 mg, 0.79 rnrnoI, 1. 1 equiv) in dichloromethane (8 rnL) under N2 at rt 
were added 1-(3-dimethyiaminopropyI)-3-ethylcarbodiimide hydrochloride (207 mg, 1.08 
mmol, 1.5 equiv) and 1-hydroxybenzotriazole hydrate (194 mg, 1.44 rnrnol, 2.0 equiv). 
The reaction mixture was stirred at rt for 16 h, then diluted with dichloromethane (10 
rnL), washed with 3 M aqueous hydrochloric acid (2x10 rnL), water (2xlO rnL), saturated 
aqueous brine (10 rnL) dried and evaporated under reduced pressure. Flash 
chromatography on silica (ethyl acetate/petroleum ether, 1 :2) gave 7.29 (202 mg, 92%) as 
a white solid: mp 79°C, IR (CHCh) 3422, 1676, 1553, 1535 ern-I; IHNMR (CDCh, 300 
MHz) 0 0.88 (t, J = 6.8 Hz, 3H, H-19), 1.25 - 1.32 (broad signal, 18H, H-lO - H-18), 
1.60 (m, 2H, H-9), 3.45 (q, J= 6.8 Hz, 2H, H-8), 6.55 (t, J= 5.4 Hz, 1H, CONE), 6.68 
(dd, J= 3.9 & 2.4 Hz, 1H, pyrrole H4), 6.96 (dd, J= 3.9 & 2.4 Hz, 1H, pyrrole H3), 9.63 
(s, 1H, CHO), 10.78 (bs, 1H, NE); 13C NMR (CDCh, 75 MHz) 0 14.0,22.6,26.9,29.3 -
29.6 (7xC), 31.8, 39.9, 111.3, 120.1, 132.4, 133.8, 160.1, 180.4; HRMS calcd for 
ClsH30N202 306.2307, found 306.2311. 
2-Hydroxymethyl-5-dodecylcarboxamido-lH-pyrrole 7.30 
The pyrrole 7.29 (50 mg, 0.16 mmol) was reduced with zinc borohydride by 
general procedure D. Flash chromatography on silica (ethyl acetate/petroleum ether, 2:1) 
gave 7.30 (46 mg, 91%) as a white solid. An analytical sample was obtained by 
recrystallisation from methanol to give a white solid: mp 127°C, IR (CHCh) 3445, 
3304, 1628, 1537 ern-I; IHNMR (DMSO-d6, 300 MHz) 00.85 (t, J= 6.6 Hz, 3H, H-19), 
1.23 (broad signal, 18H, H-lO H-18), 1.46 (m, 2H, H-9), 3.17 (q, J= 6.8 Hz, 2H, H-8), 
4.38 (d, J= 5.6 Hz, 2H, CH20H), 4.90 (t, J= 5.6 Hz, 1H, OE), 5.94 (d, J= 3.9 Hz, 1H, 
pyrrole H3), 6.63 (d, J = 3.9 Hz, 1H, pyrrole H4), 7.87 (t, J = 5.6 Hz, 1H, CONE), 11.10 
13 ' (bs, 1H, NH); C NMR (DMSO-c4, 75 MHz) 0 14.0,22.2, 26.6, 28.8 - 29.2 (6xC), 29.6, 
31.4, 38.5, 56.1 106.8, 110.0, 125.8, 136.2, 160.6; HRMS calcd for ClsH32N202 
308.2464, found 308.2459. 
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8.7.4. P388 Cytotoxicity assay and results 
P388 Cytotoxicity assay 
The P388 murine leukemia cell line (ATCC CCL 46, P388Dl) was used to assay 
for cytoxicity, with activities expressed as an IDso in J,.1g mL- l . MTT tetrazolium (yellow 
colour) is reduced to MTT formazan (purple colour) by healthy cells, so this can be used 
to determine the concentration of a sample required to reduce the P388 cell growth by 
50% relative to the controL 36 Media, solvent, cell and positive controls were included 
with each assay run. The results of the cytotoxicity assay are presented in Table 8.2. 
Compound 7.27 7.28 7.11 7.30 
Solvent* A A B 
78 21 52 
* Solvent: A 3: 1 MeOHlCH2Ch; B = MeOH 
Table 8.2. Cytotoxicity data (IDso, Ilg mL-1) of the hydroxymethylpyrroles 7.27, 7.28, 
7.11 and 7.30. 
t Compound also assayed with solvent = 1:1 MeOH/CHzCh, IDso > 125 IlgmL-l . 
A precipitate was observed to form in the reaction wells of 7.11 during the P388 assay. 
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